{
  "category": "Clinical Pathology",
  "subject": {
    "name": "Toxicology, Body Fluids, and Special Techniques",
    "url": "https://app.pathprimer.com/curriculum/3a44520e-af7e-4820-84df-76fbe045fcf3",
    "lessons": {
      "Toxicology": {
        "name": "Toxicology",
        "url": "https://app.pathprimer.com/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
        "topics": {
          "Heavy Metal Poisoning (Acute Mercury Poisoning, Lead)": {
            "name": "Heavy Metal Poisoning (Acute Mercury Poisoning, Lead)",
            "url": "https://app.pathprimer.com/document/8d428db7-2a12-4b4f-9b35-290ec62c90d9/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Organic and inorganic forms have different levels of toxicity"
                  },
                  {
                    "text": "Inorganic forms are more toxic than organic forms"
                  },
                  {
                    "text": "Lead is the most frequently encountered toxic metal in the United States"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Organic and inorganic forms have different levels of toxicityInorganic forms are more toxic than organic forms",
                    "sub_points": [
                      "Inorganic forms are more toxic than organic forms"
                    ]
                  },
                  {
                    "text": "Heavy metals alter activities of enzymes by binding to 3 key functional groups in proteinsOxygen groupNitrogen groupSulfhydryl group",
                    "sub_points": [
                      "Oxygen group",
                      "Nitrogen group",
                      "Sulfhydryl group"
                    ]
                  },
                  {
                    "text": "Heavy metals are transported and excreted by many proteins through their affinity for sulfhydryl groupsThese proteins includeMetalloproteinsTransferrinFerritinAlbuminHemoglobin",
                    "sub_points": [
                      "These proteins includeMetalloproteinsTransferrinFerritinAlbuminHemoglobin",
                      "Metalloproteins",
                      "Transferrin",
                      "Ferritin",
                      "Albumin",
                      "Hemoglobin"
                    ]
                  },
                  {
                    "text": "Some metals are transported throughout the body by competing with ionized species (e.g., calcium, zinc)e.g., lead follows calcium pathways in body and can deposit in bone and gingivaee.g., thallium is taken up into cells like potassium because of their similar ionic radii",
                    "sub_points": [
                      "e.g., lead follows calcium pathways in body and can deposit in bone and gingivae",
                      "e.g., thallium is taken up into cells like potassium because of their similar ionic radii"
                    ]
                  },
                  {
                    "text": "Heavy metal toxicity impacts nearly all organ systems"
                  },
                  {
                    "text": "Most commonly involved organ systemsCentral nervous system (CNS)Peripheral nervous system (PNS)Digestive system and gastrointestinal (GI) tractHematopoietic systemRenal systemCardiovascular (CV) system",
                    "sub_points": [
                      "Central nervous system (CNS)",
                      "Peripheral nervous system (PNS)",
                      "Digestive system and gastrointestinal (GI) tract",
                      "Hematopoietic system",
                      "Renal system",
                      "Cardiovascular (CV) system"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "LeadMost frequently encountered toxic metal in United StatesPrimarily due to long-term exposureIn children, exposure shown to result from living in houses that contain lead paintApproximately 4 million US households with lead exposure are inhabited by childrenAccording to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)2374 exposures1100 were children aged 5 years or younger652 were adults aged 20 years or older",
                    "sub_points": [
                      "Most frequently encountered toxic metal in United StatesPrimarily due to long-term exposureIn children, exposure shown to result from living in houses that contain lead paintApproximately 4 million US households with lead exposure are inhabited by children",
                      "Primarily due to long-term exposure",
                      "In children, exposure shown to result from living in houses that contain lead paint",
                      "Approximately 4 million US households with lead exposure are inhabited by children",
                      "According to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)2374 exposures1100 were children aged 5 years or younger652 were adults aged 20 years or older",
                      "2374 exposures",
                      "1100 were children aged 5 years or younger",
                      "652 were adults aged 20 years or older"
                    ]
                  },
                  {
                    "text": "ArsenicAccording to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)738 human exposures related to arsenic (excluding pesticides)50% (405/738 cases) were adults aged 21 or older2nd highest impacted population (124/738 cases) was children aged 4 years or younger34 exposures related to arsenic-containing pesticidesMajority of exposures were children aged 4 years or younger (16/34 cases)2nd highest impacted population was adults aged 21 years or older (11/34 cases)Worldwide, up to 100 million people are at risk of exposure due to excessive arsenic in drinking water",
                    "sub_points": [
                      "According to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)738 human exposures related to arsenic (excluding pesticides)50% (405/738 cases) were adults aged 21 or older2nd highest impacted population (124/738 cases) was children aged 4 years or younger34 exposures related to arsenic-containing pesticidesMajority of exposures were children aged 4 years or younger (16/34 cases)2nd highest impacted population was adults aged 21 years or older (11/34 cases)",
                      "738 human exposures related to arsenic (excluding pesticides)50% (405/738 cases) were adults aged 21 or older2nd highest impacted population (124/738 cases) was children aged 4 years or younger",
                      "50% (405/738 cases) were adults aged 21 or older",
                      "2nd highest impacted population (124/738 cases) was children aged 4 years or younger",
                      "34 exposures related to arsenic-containing pesticidesMajority of exposures were children aged 4 years or younger (16/34 cases)2nd highest impacted population was adults aged 21 years or older (11/34 cases)",
                      "Majority of exposures were children aged 4 years or younger (16/34 cases)",
                      "2nd highest impacted population was adults aged 21 years or older (11/34 cases)",
                      "Worldwide, up to 100 million people are at risk of exposure due to excessive arsenic in drinking water"
                    ]
                  },
                  {
                    "text": "MercuryMercury toxicity can occur in 3 formsPure elemental formMainly through exposure to mercury vapor (e.g., melting mercury-containing dental amalgam)Inorganic saltVacuuming spilled mercury from a broken thermometerOrganic compoundLess toxic form and converted to inorganic form for its toxicityAccording to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)1384 exposures to mercury (excluding thermometers)79 were children aged 5 years or younger630 were adults aged 21 years or older1607 exposures to mercury-containing thermometers321 were children aged 5 years or younger504 were adults aged 20 years or older",
                    "sub_points": [
                      "Mercury toxicity can occur in 3 formsPure elemental formMainly through exposure to mercury vapor (e.g., melting mercury-containing dental amalgam)Inorganic saltVacuuming spilled mercury from a broken thermometerOrganic compoundLess toxic form and converted to inorganic form for its toxicity",
                      "Pure elemental formMainly through exposure to mercury vapor (e.g., melting mercury-containing dental amalgam)",
                      "Mainly through exposure to mercury vapor (e.g., melting mercury-containing dental amalgam)",
                      "Inorganic saltVacuuming spilled mercury from a broken thermometer",
                      "Vacuuming spilled mercury from a broken thermometer",
                      "Organic compoundLess toxic form and converted to inorganic form for its toxicity",
                      "Less toxic form and converted to inorganic form for its toxicity",
                      "According to 2014 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS)1384 exposures to mercury (excluding thermometers)79 were children aged 5 years or younger630 were adults aged 21 years or older1607 exposures to mercury-containing thermometers321 were children aged 5 years or younger504 were adults aged 20 years or older",
                      "1384 exposures to mercury (excluding thermometers)79 were children aged 5 years or younger630 were adults aged 21 years or older",
                      "79 were children aged 5 years or younger",
                      "630 were adults aged 21 years or older",
                      "1607 exposures to mercury-containing thermometers321 were children aged 5 years or younger504 were adults aged 20 years or older",
                      "321 were children aged 5 years or younger",
                      "504 were adults aged 20 years or older"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Hallmarks of acute metal ingestionNauseaPersistent vomitingDiarrheaAbdominal painDehydration also common",
                    "sub_points": [
                      "Nausea",
                      "Persistent vomiting",
                      "Diarrhea",
                      "Abdominal pain",
                      "Dehydration also common"
                    ]
                  },
                  {
                    "text": "Hallmarks for acute poisoning of specific heavy metalsArsenic\"Rice water\" diarrheaEncephalopathyCadmiumPneumonitis (oxide fumes)ChromiumAcute renal failure (Cr6+ ingestion)CobaltDilated cardiomyopathy (beer-drinkers' cardiomyopathy)CopperBlue vomitusIronCardiac depressionMetabolic acidosisLeadEncephalopathyHeadacheSeizuresAtaxiaMercuryElementalFeverVomitingDiarrheaInorganicCaustic gastroenteritis",
                    "sub_points": [
                      "Arsenic\"Rice water\" diarrheaEncephalopathy",
                      "\"Rice water\" diarrhea",
                      "Encephalopathy",
                      "CadmiumPneumonitis (oxide fumes)",
                      "Pneumonitis (oxide fumes)",
                      "ChromiumAcute renal failure (Cr6+ ingestion)",
                      "Acute renal failure (Cr6+ ingestion)",
                      "CobaltDilated cardiomyopathy (beer-drinkers' cardiomyopathy)",
                      "Dilated cardiomyopathy (beer-drinkers' cardiomyopathy)",
                      "CopperBlue vomitus",
                      "Blue vomitus",
                      "IronCardiac depressionMetabolic acidosis",
                      "Cardiac depression",
                      "Metabolic acidosis",
                      "LeadEncephalopathyHeadacheSeizuresAtaxia",
                      "EncephalopathyHeadacheSeizuresAtaxia",
                      "Headache",
                      "Seizures",
                      "Ataxia",
                      "MercuryElementalFeverVomitingDiarrheaInorganicCaustic gastroenteritis",
                      "ElementalFeverVomitingDiarrhea",
                      "Fever",
                      "Vomiting",
                      "Diarrhea",
                      "InorganicCaustic gastroenteritis",
                      "Caustic gastroenteritis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Remove from source of exposure"
                  },
                  {
                    "text": "Good supportive care"
                  },
                  {
                    "text": "Chelation rarely indicated in emergent settingException: Lead encephalopathyDimercaprol or British antilewisite (BAL)Treatment of lead, arsenic, and mercury toxicityEdetate calcium disodium (Calcium Disodium Versenate)Second line for lead toxicityMost effective if early course of acute poisoningOnly effective with extracellular lead",
                    "sub_points": [
                      "Exception: Lead encephalopathy",
                      "Dimercaprol or British antilewisite (BAL)Treatment of lead, arsenic, and mercury toxicity",
                      "Treatment of lead, arsenic, and mercury toxicity",
                      "Edetate calcium disodium (Calcium Disodium Versenate)Second line for lead toxicityMost effective if early course of acute poisoningOnly effective with extracellular lead",
                      "Second line for lead toxicity",
                      "Most effective if early course of acute poisoning",
                      "Only effective with extracellular lead"
                    ]
                  },
                  {
                    "text": "Chelation therapy for patients should be made in conjunction with medical toxicologist or local poison control center"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Common analytesLeadMercuryArsenicCadmiumChromium",
                    "sub_points": [
                      "Lead",
                      "Mercury",
                      "Arsenic",
                      "Cadmium",
                      "Chromium"
                    ]
                  },
                  {
                    "text": "Other analytesAluminumBerylliumCobaltCopperIronManganeseNickelPlatinumSeleniumSiliconSilverThalliumZinc",
                    "sub_points": [
                      "Aluminum",
                      "Beryllium",
                      "Cobalt",
                      "Copper",
                      "Iron",
                      "Manganese",
                      "Nickel",
                      "Platinum",
                      "Selenium",
                      "Silicon",
                      "Silver",
                      "Thallium",
                      "Zinc"
                    ]
                  },
                  {
                    "text": "Many analytes have organic and inorganic forms"
                  },
                  {
                    "text": "Typically performed in reference laboratories, which have combinations of different heavy metals for testing"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Quantitative inductively coupled plasma-mass spectrometry"
                  },
                  {
                    "text": "Quantitative high-performance liquid chromatography"
                  },
                  {
                    "text": "Atomic absorption"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Blood sampleRoyal blue tube (K2EDTA or Na2EDTA)Mercury is volatile and its concentration may reduce after 7 or more days of storageArsenic, cadmium, and lead values do not change with time if specimen is drawn and stored in appropriate containerRoom temperature storage recommended, but refrigeration acceptableAvoid shellfish and seafood for 48-72 hours prior to sample collection",
                    "sub_points": [
                      "Royal blue tube (K2EDTA or Na2EDTA)",
                      "Mercury is volatile and its concentration may reduce after 7 or more days of storage",
                      "Arsenic, cadmium, and lead values do not change with time if specimen is drawn and stored in appropriate containerRoom temperature storage recommended, but refrigeration acceptable",
                      "Room temperature storage recommended, but refrigeration acceptable",
                      "Avoid shellfish and seafood for 48-72 hours prior to sample collection"
                    ]
                  },
                  {
                    "text": "Urine samplePreferred for measuring inorganic forms of mercury and arsenicMethylmercury is an organic, highly toxic form of mercury that can be detected in blood but not in urineCollect 24-hour or random urineSpecimen must be collected in a plastic container and should be refrigerated during collection period and storageAvoid shellfish and seafood for 48-72 hours prior to sample collection",
                    "sub_points": [
                      "Preferred for measuring inorganic forms of mercury and arsenic",
                      "Methylmercury is an organic, highly toxic form of mercury that can be detected in blood but not in urine",
                      "Collect 24-hour or random urineSpecimen must be collected in a plastic container and should be refrigerated during collection period and storage",
                      "Specimen must be collected in a plastic container and should be refrigerated during collection period and storage",
                      "Avoid shellfish and seafood for 48-72 hours prior to sample collection"
                    ]
                  },
                  {
                    "text": "Hair and fingernail samplesAnalysis can indicate long-term or historic exposure",
                    "sub_points": [
                      "Analysis can indicate long-term or historic exposure"
                    ]
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Blood per volumeArsenic: 0.0-13.0 µg/LCadmium: 0.0-5.0 µg/LMercury: 0.0-10.0 µg/LLead (venous blood): 0.0-4.9 µg/dL",
                    "sub_points": [
                      "Arsenic: 0.0-13.0 µg/L",
                      "Cadmium: 0.0-5.0 µg/L",
                      "Mercury: 0.0-10.0 µg/L",
                      "Lead (venous blood): 0.0-4.9 µg/dL"
                    ]
                  },
                  {
                    "text": "Urine per volumeArsenic: 0.0-35.0 µg/L (based on biological exposure indices [BEI])Cadmium: 0.0-2.6 µg/LCopper: 0.2-8.0 µg/dLLead: 0.0-23.0 µg/LMercury: 0.0-10.0 µg/LZinc: 15.0-120.0 µg/dL",
                    "sub_points": [
                      "Arsenic: 0.0-35.0 µg/L (based on biological exposure indices [BEI])",
                      "Cadmium: 0.0-2.6 µg/L",
                      "Copper: 0.2-8.0 µg/dL",
                      "Lead: 0.0-23.0 µg/L",
                      "Mercury: 0.0-10.0 µg/L",
                      "Zinc: 15.0-120.0 µg/dL"
                    ]
                  },
                  {
                    "text": "Urine per 24 hoursArsenic: 0.0-50.0 µg/dCadmium: 0.0-3.3 µg/dCopper: 3.0-50.0 µg/dLead:0.0-31.0 µg/dMercury: 0.0-15.0 µg/dZinc:150.0-1200.0 µg/d",
                    "sub_points": [
                      "Arsenic: 0.0-50.0 µg/d",
                      "Cadmium: 0.0-3.3 µg/d",
                      "Copper: 3.0-50.0 µg/d",
                      "Lead:0.0-31.0 µg/d",
                      "Mercury: 0.0-15.0 µg/d",
                      "Zinc:150.0-1200.0 µg/d"
                    ]
                  },
                  {
                    "text": "Urine ratio to creatinineArsenic: < 30.0 ug/g crtCadmium: 0.0-3.0 µg/g crtCopper: No reference interval (µg/g crt)Lead: < 5.0 ug/g crtMercury: ≤ 35.0 µg/g crtZinc: No reference interval (µg/g crt)",
                    "sub_points": [
                      "Arsenic: < 30.0 ug/g crt",
                      "Cadmium: 0.0-3.0 µg/g crt",
                      "Copper: No reference interval (µg/g crt)",
                      "Lead: < 5.0 ug/g crt",
                      "Mercury: ≤ 35.0 µg/g crt",
                      "Zinc: No reference interval (µg/g crt)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Toxicity and Antidotes (Acetaminophen, Methanol)": {
            "name": "Toxicity and Antidotes (Acetaminophen, Methanol)",
            "url": "https://app.pathprimer.com/document/b010ff3b-52b1-46ad-826b-90d2290bf8ec/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Acetaminophen poisoning is among most common causes of medication-related poisoning and death"
                  },
                  {
                    "text": "Supportive management of acetaminophen-poisoned patient may include stabilization and decontamination"
                  },
                  {
                    "text": "Adverse effects of methanol thought to be from accumulation of formic acid"
                  },
                  {
                    "text": "Acetaminophen can be treated withN-acetylcysteine, a specific antidote"
                  },
                  {
                    "text": "Antidotes for methanol poisoning include ethanol and fomepizole"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "AcetaminophenAcetaminophen poisoning is among most common causes of medication-related poisoning and deathAcetaminophen is safe for most people up to 4,000 mg (4 g) in 24-hour periodSupportive management of acetaminophen-poisoned patient may include stabilization and decontaminationHepatotoxicity can occur with acetaminophen overdoseNormal dose: Acetaminophen is metabolized by conjugationOverdose: Oxidation of excess acetaminophen toN-acetyl-p-benzoquinone imine (NAPQI) occurs by cytochrome P-450 (CYP) enzymes (CYP2E1, CYP1A2, CYP2A6, and CYP3A4)NAPQI is hepatotoxic reactive metabolite with extremely short half-lifeNAPQI is rapidly conjugated with glutathione, a sulfhydryl donor, and is excreted renallyWhen NAPQI is in excess, NAPQI covalently binds to cysteinyl sulfhydryl groups of hepatocellular proteins, forming NAPQI-protein adductsCauses ensuing cascade of oxidative damage and mitochondrial dysfunctionResult is subsequent inflammatory response that propagates hepatocellular injury and death",
                    "sub_points": [
                      "Acetaminophen poisoning is among most common causes of medication-related poisoning and deathAcetaminophen is safe for most people up to 4,000 mg (4 g) in 24-hour period",
                      "Acetaminophen is safe for most people up to 4,000 mg (4 g) in 24-hour period",
                      "Supportive management of acetaminophen-poisoned patient may include stabilization and decontamination",
                      "Hepatotoxicity can occur with acetaminophen overdoseNormal dose: Acetaminophen is metabolized by conjugationOverdose: Oxidation of excess acetaminophen toN-acetyl-p-benzoquinone imine (NAPQI) occurs by cytochrome P-450 (CYP) enzymes (CYP2E1, CYP1A2, CYP2A6, and CYP3A4)NAPQI is hepatotoxic reactive metabolite with extremely short half-lifeNAPQI is rapidly conjugated with glutathione, a sulfhydryl donor, and is excreted renallyWhen NAPQI is in excess, NAPQI covalently binds to cysteinyl sulfhydryl groups of hepatocellular proteins, forming NAPQI-protein adductsCauses ensuing cascade of oxidative damage and mitochondrial dysfunctionResult is subsequent inflammatory response that propagates hepatocellular injury and death",
                      "Normal dose: Acetaminophen is metabolized by conjugation",
                      "Overdose: Oxidation of excess acetaminophen toN-acetyl-p-benzoquinone imine (NAPQI) occurs by cytochrome P-450 (CYP) enzymes (CYP2E1, CYP1A2, CYP2A6, and CYP3A4)",
                      "NAPQI is hepatotoxic reactive metabolite with extremely short half-life",
                      "NAPQI is rapidly conjugated with glutathione, a sulfhydryl donor, and is excreted renally",
                      "When NAPQI is in excess, NAPQI covalently binds to cysteinyl sulfhydryl groups of hepatocellular proteins, forming NAPQI-protein adductsCauses ensuing cascade of oxidative damage and mitochondrial dysfunctionResult is subsequent inflammatory response that propagates hepatocellular injury and death",
                      "Causes ensuing cascade of oxidative damage and mitochondrial dysfunction",
                      "Result is subsequent inflammatory response that propagates hepatocellular injury and death"
                    ]
                  },
                  {
                    "text": "MethanolMethanol has relatively low toxicityAdverse effects of methanol thought to be from accumulation of formic acidFormic acid has very long half-life resulting in metabolic acidosisFormic acid accumulates within optic nerve, which results in classic visual symptoms of flashes of light and blurring",
                    "sub_points": [
                      "Methanol has relatively low toxicity",
                      "Adverse effects of methanol thought to be from accumulation of formic acidFormic acid has very long half-life resulting in metabolic acidosisFormic acid accumulates within optic nerve, which results in classic visual symptoms of flashes of light and blurring",
                      "Formic acid has very long half-life resulting in metabolic acidosis",
                      "Formic acid accumulates within optic nerve, which results in classic visual symptoms of flashes of light and blurring"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Acetaminophen toxicityMost common cause of acute hepatic failure (replaced viral hepatitis)Second most common cause of liver failure requiring transplantationAnnual Report of American Association of Poison Control Centers' National Poison Data System in 201450,396 single exposures to acetaminophen alone22,951 single exposures to acetaminophen in combination with other drugsAcetaminophen exposure alone resulted in 65 deathsAcetaminophen combinations resulted in 42 deaths",
                    "sub_points": [
                      "Most common cause of acute hepatic failure (replaced viral hepatitis)",
                      "Second most common cause of liver failure requiring transplantation",
                      "Annual Report of American Association of Poison Control Centers' National Poison Data System in 201450,396 single exposures to acetaminophen alone22,951 single exposures to acetaminophen in combination with other drugsAcetaminophen exposure alone resulted in 65 deathsAcetaminophen combinations resulted in 42 deaths",
                      "50,396 single exposures to acetaminophen alone",
                      "22,951 single exposures to acetaminophen in combination with other drugs",
                      "Acetaminophen exposure alone resulted in 65 deaths",
                      "Acetaminophen combinations resulted in 42 deaths"
                    ]
                  },
                  {
                    "text": "Methanol toxicityCommon in life from methylated spirits and methanol-containing antifreezeAnnual Report of American Association of Poison Control Centers' National Poison Data System in 2014457 single exposures to methanol (not including automotive products and cleaning agents)190 single exposures due to automotive products with glycol and methanol mixture1153 single exposures due to other methanol-containing automotive products (e.g., dry gas, windshield washing solution)",
                    "sub_points": [
                      "Common in life from methylated spirits and methanol-containing antifreeze",
                      "Annual Report of American Association of Poison Control Centers' National Poison Data System in 2014457 single exposures to methanol (not including automotive products and cleaning agents)190 single exposures due to automotive products with glycol and methanol mixture1153 single exposures due to other methanol-containing automotive products (e.g., dry gas, windshield washing solution)",
                      "457 single exposures to methanol (not including automotive products and cleaning agents)",
                      "190 single exposures due to automotive products with glycol and methanol mixture",
                      "1153 single exposures due to other methanol-containing automotive products (e.g., dry gas, windshield washing solution)"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "AcetaminophenFirst 24 hoursNausea, vomiting, stomach painPalenessTirednessSweating24-72 hoursPain in upper right sideDark urineLess frequent urinationSkin and whites of eyes turn yellow (jaundice)72-96 hoursBlood in urineFeverFast or troubled breathingExtreme tirednessBlurred visionConfusionComa",
                    "sub_points": [
                      "First 24 hoursNausea, vomiting, stomach painPalenessTirednessSweating",
                      "Nausea, vomiting, stomach pain",
                      "Paleness",
                      "Tiredness",
                      "Sweating",
                      "24-72 hoursPain in upper right sideDark urineLess frequent urinationSkin and whites of eyes turn yellow (jaundice)",
                      "Pain in upper right side",
                      "Dark urine",
                      "Less frequent urination",
                      "Skin and whites of eyes turn yellow (jaundice)",
                      "72-96 hoursBlood in urineFeverFast or troubled breathingExtreme tirednessBlurred visionConfusionComa",
                      "Blood in urine",
                      "Fever",
                      "Fast or troubled breathing",
                      "Extreme tiredness",
                      "Blurred vision",
                      "Confusion",
                      "Coma"
                    ]
                  },
                  {
                    "text": "MethanolInitiallyDisinhibitionAtaxiaLaterHeadacheNausea, vomiting, or epigastric painLater stagesDrowsinessObtundationComaSeizures may occurVision loss possible",
                    "sub_points": [
                      "InitiallyDisinhibitionAtaxia",
                      "Disinhibition",
                      "Ataxia",
                      "LaterHeadacheNausea, vomiting, or epigastric pain",
                      "Headache",
                      "Nausea, vomiting, or epigastric pain",
                      "Later stagesDrowsinessObtundationComa",
                      "Drowsiness",
                      "Obtundation",
                      "Coma",
                      "Seizures may occur",
                      "Vision loss possible"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "AcetaminophenTreatment depends on time that has passed and doseActivated charcoal to soak up acetaminophen that remains in stomachGastric lavage to clean out stomachCan be treated withN-acetylcysteine, a specific antidote",
                    "sub_points": [
                      "Treatment depends on time that has passed and doseActivated charcoal to soak up acetaminophen that remains in stomachGastric lavage to clean out stomachCan be treated withN-acetylcysteine, a specific antidote",
                      "Activated charcoal to soak up acetaminophen that remains in stomach",
                      "Gastric lavage to clean out stomach",
                      "Can be treated withN-acetylcysteine, a specific antidote"
                    ]
                  },
                  {
                    "text": "MethanolMetabolic acidosisAdministration of bicarbonate and assisted ventilationBicarbonate potentially may reverse visual deficitsAntidote therapyEthanolCompetes with enzyme for methanol with 10-20x higher affinityCommonly usedFomepizoleCompetes with enzyme for methanol metabolismHigh cost and lack of availabilityHemodialysis can easily remove methanol and formic acid",
                    "sub_points": [
                      "Metabolic acidosisAdministration of bicarbonate and assisted ventilationBicarbonate potentially may reverse visual deficits",
                      "Administration of bicarbonate and assisted ventilationBicarbonate potentially may reverse visual deficits",
                      "Bicarbonate potentially may reverse visual deficits",
                      "Antidote therapyEthanolCompetes with enzyme for methanol with 10-20x higher affinityCommonly usedFomepizoleCompetes with enzyme for methanol metabolismHigh cost and lack of availability",
                      "EthanolCompetes with enzyme for methanol with 10-20x higher affinityCommonly used",
                      "Competes with enzyme for methanol with 10-20x higher affinity",
                      "Commonly used",
                      "FomepizoleCompetes with enzyme for methanol metabolismHigh cost and lack of availability",
                      "Competes with enzyme for methanol metabolism",
                      "High cost and lack of availability",
                      "Hemodialysis can easily remove methanol and formic acid"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Acetaminophen"
                  },
                  {
                    "text": "Methanol"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Acetaminophen measured by immunoassay"
                  },
                  {
                    "text": "Methanol measured by headspace gas chromatography (GC)"
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Hemolysis can cause significant interference with some acetaminophen assays"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "AcetaminophenTherapeutic levels: 5-20 µg/mL (33-132 µmol/L)",
                    "sub_points": [
                      "Therapeutic levels: 5-20 µg/mL (33-132 µmol/L)"
                    ]
                  },
                  {
                    "text": "MethanolNo reference rangeToxic level: > 20 mg/dL",
                    "sub_points": [
                      "No reference range",
                      "Toxic level: > 20 mg/dL"
                    ]
                  }
                ],
                "Alternate Methods": [
                  {
                    "text": "Acetaminophen overdoseMay be accompanied by liver function testing",
                    "sub_points": [
                      "May be accompanied by liver function testing"
                    ]
                  },
                  {
                    "text": "Methanol overdoseBasic electrolytes with anion gap determinationSerum osmolalitySerum ethanol concentrationSerum methanol, ethylene glycol, and isopropyl alcohol concentrationsOthers",
                    "sub_points": [
                      "Basic electrolytes with anion gap determination",
                      "Serum osmolality",
                      "Serum ethanol concentration",
                      "Serum methanol, ethylene glycol, and isopropyl alcohol concentrations",
                      "Others"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug Overdose and Intoxication Presentations": {
            "name": "Drug Overdose and Intoxication Presentations",
            "url": "https://app.pathprimer.com/document/74b119f9-8397-4168-a30a-a3a767247153/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Cocaine: Concentrations of > 1 mg/L are toxic; however, deaths have been reported with concentrations as low as 0.1 mg/L"
                  },
                  {
                    "text": "Opiates: Intoxication and overdose present as coma, arrhythmias, and respiratory depression and arrest"
                  },
                  {
                    "text": "Amphetamines: EMIT or Toxi-lab strips are used for detection; antihistamines and diphenhydramine may cause false-positive result on Toxi-lab strips"
                  },
                  {
                    "text": "Benzodiazepines: Toxicity can manifest as drowsiness, slurred speech, ataxia and coma, respiratory depression, or cardiotoxic effects"
                  },
                  {
                    "text": "Marijuana: Intoxication presents as euphoria, conjunctival erythema, tachycardia, and decreased motor coordination"
                  },
                  {
                    "text": "Lysergic acid diethylamide: Toxicity can occur at low levels because compound is highly potent"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Cocaine": [
                  {
                    "text": "Derivative of alkaloid ecgonine"
                  },
                  {
                    "text": "Nasal inhalation is most common route of administration"
                  },
                  {
                    "text": "Half-life = 1-2 hours; polar metabolites eliminated in ~ 2 daysShort half-life makes it difficult to assess for compound or metabolites in patient sample",
                    "sub_points": [
                      "Short half-life makes it difficult to assess for compound or metabolites in patient sample"
                    ]
                  },
                  {
                    "text": "Concentration of > 1 mg/L is toxic; however, deaths have been reported with concentration as low as 0.1 mg/L"
                  },
                  {
                    "text": "Cocaine obeys 1st-order elimination kinetics, and metabolites may be detected by immunoassay up to 36 hours after ingestion"
                  },
                  {
                    "text": "Intoxication presentationSeizuresHypertensionChest painShortness of breathCranial hemorrhageEpistaxisTachycardia",
                    "sub_points": [
                      "Seizures",
                      "Hypertension",
                      "Chest pain",
                      "Shortness of breath",
                      "Cranial hemorrhage",
                      "Epistaxis",
                      "Tachycardia"
                    ]
                  },
                  {
                    "text": "Long-term use may lead toPsychiatric illnessCardiomyopathyArrhythmiasBlindnessInfarction (kidney, brain, heart, limbs)",
                    "sub_points": [
                      "Psychiatric illness",
                      "Cardiomyopathy",
                      "Arrhythmias",
                      "Blindness",
                      "Infarction (kidney, brain, heart, limbs)"
                    ]
                  }
                ],
                "Opiates": [
                  {
                    "text": "Class of compounds that act on opioid receptorsIncludes morphine, codeine, and heroin",
                    "sub_points": [
                      "Includes morphine, codeine, and heroin"
                    ]
                  },
                  {
                    "text": "Can be administered orally or intravenously (heroin)"
                  },
                  {
                    "text": "Half-life of opiates differHeroin half-life = 3 minutes; effects can last for up to 3 hoursMorphine half-life = 3 hours",
                    "sub_points": [
                      "Heroin half-life = 3 minutes; effects can last for up to 3 hours",
                      "Morphine half-life = 3 hours"
                    ]
                  },
                  {
                    "text": "Major metabolites of heroin include N-acetylmorphine and morphine"
                  },
                  {
                    "text": "Intoxication and overdose presentationComaArrhythmiasRespiratory depressionRespiratory arrest",
                    "sub_points": [
                      "Coma",
                      "Arrhythmias",
                      "Respiratory depression",
                      "Respiratory arrest"
                    ]
                  }
                ],
                "Methadone": [
                  {
                    "text": "Partial agonist of Mu receptor that is often used in patients with heroin dependency or addiction"
                  },
                  {
                    "text": "Competes with morphine to bind to mu receptors and renders decreased addictive potential"
                  },
                  {
                    "text": "Doses are lowered over time to reduce dependency, but addiction can occur"
                  },
                  {
                    "text": "Thin-layer chromatography (TLC) is used to distinguish methadone from opiatesEnzyme-multiplied immunoassay technique (EMIT) and fluorescence polarization immunoassay (FPIA) may also be of use",
                    "sub_points": [
                      "Enzyme-multiplied immunoassay technique (EMIT) and fluorescence polarization immunoassay (FPIA) may also be of use"
                    ]
                  }
                ],
                "Amphetamines": [
                  {
                    "text": "Structurally similar to epinephrine and norepinephrine"
                  },
                  {
                    "text": "Generally cause euphoria and alertness"
                  },
                  {
                    "text": "Intoxication presentationTachycardiaHypertensionAnxietyArrhythmiasHeart blockAcute psychosisParanoiaDeliriumHyperpyrexiaRhabdomyolysis",
                    "sub_points": [
                      "Tachycardia",
                      "Hypertension",
                      "Anxiety",
                      "Arrhythmias",
                      "Heart block",
                      "Acute psychosis",
                      "Paranoia",
                      "Delirium",
                      "Hyperpyrexia",
                      "Rhabdomyolysis"
                    ]
                  },
                  {
                    "text": "Most common cause of death in acute toxicity is cardiovascular collapse"
                  },
                  {
                    "text": "Long-term use may result inMental impairmentSocial withdrawalParanoid schizophreniaPancytopenia",
                    "sub_points": [
                      "Mental impairment",
                      "Social withdrawal",
                      "Paranoid schizophrenia",
                      "Pancytopenia"
                    ]
                  },
                  {
                    "text": "EMIT or Toxi-lab strips are used for detectionAntihistamines and diphenhydramine may cause false-positive result on Toxi-lab strips",
                    "sub_points": [
                      "Antihistamines and diphenhydramine may cause false-positive result on Toxi-lab strips"
                    ]
                  },
                  {
                    "text": "3,4-methylenedioxymethamphetamine (MDMA) is derivative of methamphetamine that can have additional hallucinogenic effects"
                  }
                ],
                "Benzodiazepines": [
                  {
                    "text": "Class of compounds of minor tranquilizers with shared common molecular structure and similar pharmacological activity"
                  },
                  {
                    "text": "Benzodiazepines (BZDs) are safer than barbiturates, hence now drug of choice and widely prescribedLower addiction potentialGreater efficacyFewer side effects",
                    "sub_points": [
                      "Lower addiction potential",
                      "Greater efficacy",
                      "Fewer side effects"
                    ]
                  },
                  {
                    "text": "Development of tolerance is much lower than barbituratesCan still occur with prolonged use",
                    "sub_points": [
                      "Can still occur with prolonged use"
                    ]
                  },
                  {
                    "text": "Intoxication presentationDrowsinessSlurred speechAtaxia and comaRespiratory depression or cardiotoxic effectsDeath is rare (usually in setting of multiple drug ingestion)",
                    "sub_points": [
                      "Drowsiness",
                      "Slurred speech",
                      "Ataxia and coma",
                      "Respiratory depression or cardiotoxic effects",
                      "Death is rare (usually in setting of multiple drug ingestion)"
                    ]
                  },
                  {
                    "text": "Clinically important to detect presence of BZD alone and in presence of other compounds in cases of coingestion (e.g., with opioids, tricyclic antidepressants, barbiturates)Combined ingestion of these compounds can lead to decreased metabolism, and therefore increased toxicity",
                    "sub_points": [
                      "Combined ingestion of these compounds can lead to decreased metabolism, and therefore increased toxicity"
                    ]
                  },
                  {
                    "text": "Because BZDs are largely protein bound (> 85%), they confer large volume of distribution"
                  },
                  {
                    "text": "Metabolized through liver via hepatic oxidation and conjugationMany downstream products are active metabolites",
                    "sub_points": [
                      "Many downstream products are active metabolites"
                    ]
                  },
                  {
                    "text": "Urine or serum immunoassay is method of choice as screening test for suspected overdoseIf screening test is positive, confirmatory test is performed via GC-MS",
                    "sub_points": [
                      "If screening test is positive, confirmatory test is performed via GC-MS"
                    ]
                  }
                ],
                "Phencyclidine": [
                  {
                    "text": "Drug of abuse with tricyclic structure (a.k.a. PCP or angel dust)"
                  },
                  {
                    "text": "Interacts with cholinergic, adrenergic, serotoninergic, opiate, and GABA receptors"
                  },
                  {
                    "text": "Intoxication presentationDepressionCatatonic affectViolenceAuditory and visual hallucinogensTachycardiaSeizuresComaDeath",
                    "sub_points": [
                      "Depression",
                      "Catatonic affect",
                      "Violence",
                      "Auditory and visual hallucinogens",
                      "Tachycardia",
                      "Seizures",
                      "Coma",
                      "Death"
                    ]
                  },
                  {
                    "text": "Acidification of urine increases excretion of PCP"
                  },
                  {
                    "text": "PCP is lipophilic compound (can be stored in fat cells)Makes quantification of ingestion difficult, as much of compound is not found circulating in blood or serumHowever, due to slow release from fat stores, it can be detected at low levels for weeks to months",
                    "sub_points": [
                      "Makes quantification of ingestion difficult, as much of compound is not found circulating in blood or serum",
                      "However, due to slow release from fat stores, it can be detected at low levels for weeks to months"
                    ]
                  },
                  {
                    "text": "False-positive result can be caused by diphenhydramine and dextromethorphan"
                  }
                ],
                "Barbiturates": [
                  {
                    "text": "Class of sedative-hypnotic drugs that are derivatives of barbituric acid"
                  },
                  {
                    "text": "Compounds can be long-acting (phenobarbital), short-acting (pentobarbital), ultra-short-acting (thiopental)"
                  },
                  {
                    "text": "All drugs in this class are lipid soluble and can cross blood-brain barrier to act on central nervous system"
                  },
                  {
                    "text": "Intoxication presentationDepressionCyanosisHypotensionTachycardiaAbnormal respiration (Cheyne-Stokes)",
                    "sub_points": [
                      "Depression",
                      "Cyanosis",
                      "Hypotension",
                      "Tachycardia",
                      "Abnormal respiration (Cheyne-Stokes)"
                    ]
                  },
                  {
                    "text": "Immunoassays are primary method of detectionTLC used as confirmatory test",
                    "sub_points": [
                      "TLC used as confirmatory test"
                    ]
                  }
                ],
                "Methaqualone": [
                  {
                    "text": "2,3-disubstituted quinazoline with sedative-hypnotic effects"
                  },
                  {
                    "text": "Exhibits rapid and complete absorption after oral administration; highly plasma-protein bound in circulation (80%)"
                  },
                  {
                    "text": "Half-life = 20-60 hours; peak concentrations in plasma achieved in 2-3 hours"
                  },
                  {
                    "text": "Metabolism is predominantly in liver (CYP450), minimally excreted in urine"
                  },
                  {
                    "text": "Toxic serum concentrations are > 10 ug/mLLethal doses of ingestions vary from 2-8 gConcurrent consumption of alcohol can increase toxicity",
                    "sub_points": [
                      "Lethal doses of ingestions vary from 2-8 g",
                      "Concurrent consumption of alcohol can increase toxicity"
                    ]
                  },
                  {
                    "text": "Intoxication presentationRespiratory depressionComaHypertonicityHyperreflexiaMyoclonus",
                    "sub_points": [
                      "Respiratory depression",
                      "Coma",
                      "Hypertonicity",
                      "Hyperreflexia",
                      "Myoclonus"
                    ]
                  },
                  {
                    "text": "Testing performed on urine by gas-liquid chromatography (GLC) for up to 90 hoursFalse-positive result on immunoassay may occur with diphenhydraminePositive immunoassay result should be confirmed with GC-MS",
                    "sub_points": [
                      "False-positive result on immunoassay may occur with diphenhydramine",
                      "Positive immunoassay result should be confirmed with GC-MS"
                    ]
                  }
                ],
                "Marijuana": [
                  {
                    "text": "Most commonly used illicit drug"
                  },
                  {
                    "text": "Active compound is delta-9-tetrahydrocannabinol (THC)Lipid-soluble compound that can cross blood-brain barrier",
                    "sub_points": [
                      "Lipid-soluble compound that can cross blood-brain barrier"
                    ]
                  },
                  {
                    "text": "Binds and acts upon CB1 receptors to release GABA"
                  },
                  {
                    "text": "Half-life = 1 week; THC is stored in fat cells"
                  },
                  {
                    "text": "Testing performed on urine for detection of major metabolites delta-9-carboxy-THC and 11-hydroxy-delta-9-THCCan be detected in urine for up to 4 weeks",
                    "sub_points": [
                      "Can be detected in urine for up to 4 weeks"
                    ]
                  },
                  {
                    "text": "Intoxication presentationEuphoriaConjunctival erythemaTachycardiaDecreased motor coordination",
                    "sub_points": [
                      "Euphoria",
                      "Conjunctival erythema",
                      "Tachycardia",
                      "Decreased motor coordination"
                    ]
                  },
                  {
                    "text": "EMIT is used for urine testingCan detect as little as 20 ng/mL",
                    "sub_points": [
                      "Can detect as little as 20 ng/mL"
                    ]
                  },
                  {
                    "text": "Quantitative assays available but not widely used"
                  },
                  {
                    "text": "False-positive result may occur with ibuprofen, naproxen, or dronabinol"
                  }
                ],
                "Lysergic Acid Diethylamide": [
                  {
                    "text": "Highly potent hallucinogenic drug classified as an indolealkylamine"
                  },
                  {
                    "text": "Affects central nervous system and both parasympathetic and sympathetic pathways"
                  },
                  {
                    "text": "Usual dose = 1-2 ug/kg; begins to take effect within 1 hour"
                  },
                  {
                    "text": "Peak concentrations occur at 2-3 hours; can last up to 12 hours"
                  },
                  {
                    "text": "Metabolism is predominantly in liver, with excretion in bile"
                  },
                  {
                    "text": "Toxicity can occur at low levels because compound is highly potent"
                  },
                  {
                    "text": "Intoxication presentationVivid auditory and visual hallucinationsBlurred visionUnstable moodsAcute panic attacksDeath from ingestion is rare",
                    "sub_points": [
                      "Vivid auditory and visual hallucinations",
                      "Blurred vision",
                      "Unstable moods",
                      "Acute panic attacks",
                      "Death from ingestion is rare"
                    ]
                  },
                  {
                    "text": "Testing involves detection of inactive metabolite, 2-oxy-lysergic acid diethylamide, present in urineCan be seen up to 24 hours after ingestion, and may be positive for up to 120 hours",
                    "sub_points": [
                      "Can be seen up to 24 hours after ingestion, and may be positive for up to 120 hours"
                    ]
                  },
                  {
                    "text": "Radioimmunoassay can be used for detectionHigh-performance liquid chromatography (HPLC) required for confirmation",
                    "sub_points": [
                      "High-performance liquid chromatography (HPLC) required for confirmation"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Peak and Trough Concentration Calculation": {
            "name": "Peak and Trough Concentration Calculation",
            "url": "https://app.pathprimer.com/document/7a9764aa-1b6f-439c-b4ae-73ca18dabc3f/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "CLINICAL CORRELATES": {
                "Overview": [
                  {
                    "text": "Optimal dosing relies on peak and trough concentrations of drug in bloodPeak doses: Highest concentration that drug reaches in blood over dosing periodIdeally this should be less than minimum toxic concentration (MTC)Peak levels are commonly measured and used for assessing efficacy of various drugs (e.g., aminoglycoside monitoring)Trough doses: Lowest concentration that drug reaches in blood before next dose is givenIdeally this should be higher than or equal to minimum effective concentration (MEC)Certain drugs are commonly measured in troughs (e.g., vancomycin)Trough levels may also help assess toxicity in patients on other drugs",
                    "sub_points": [
                      "Peak doses: Highest concentration that drug reaches in blood over dosing periodIdeally this should be less than minimum toxic concentration (MTC)Peak levels are commonly measured and used for assessing efficacy of various drugs (e.g., aminoglycoside monitoring)",
                      "Ideally this should be less than minimum toxic concentration (MTC)",
                      "Peak levels are commonly measured and used for assessing efficacy of various drugs (e.g., aminoglycoside monitoring)",
                      "Trough doses: Lowest concentration that drug reaches in blood before next dose is givenIdeally this should be higher than or equal to minimum effective concentration (MEC)Certain drugs are commonly measured in troughs (e.g., vancomycin)Trough levels may also help assess toxicity in patients on other drugs",
                      "Ideally this should be higher than or equal to minimum effective concentration (MEC)",
                      "Certain drugs are commonly measured in troughs (e.g., vancomycin)Trough levels may also help assess toxicity in patients on other drugs",
                      "Trough levels may also help assess toxicity in patients on other drugs"
                    ]
                  },
                  {
                    "text": "Ideally, dosing interval is equal to half-life of drug"
                  },
                  {
                    "text": "Using multiple doses, steady-state is eventually reached (usually after administration of 4-5 doses)"
                  },
                  {
                    "text": "Therapeutic range = range of concentrations between MTC and MEC"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Calculations": [
                  {
                    "text": "General conceptsD = doseτ = dosing intervalCl = clearanceke = elimination rate constantT = duration of infusionC = plasma concentration",
                    "sub_points": [
                      "D = dose",
                      "τ = dosing interval",
                      "Cl = clearance",
                      "ke = elimination rate constant",
                      "T = duration of infusion",
                      "C = plasma concentration"
                    ]
                  },
                  {
                    "text": "Oral administrationPeak calculation: Cmax = C0/(1 - e - (ke)(t))Trough calculation: Cmin = (C0 x e - (ke)(t))/(1 - e - (ke)(t))Average calculation: Cpss = D/(Cl x t)",
                    "sub_points": [
                      "Peak calculation: Cmax = C0/(1 - e - (ke)(t))",
                      "Trough calculation: Cmin = (C0 x e - (ke)(t))/(1 - e - (ke)(t))",
                      "Average calculation: Cpss = D/(Cl x t)"
                    ]
                  },
                  {
                    "text": "Short-term infusionSingle dosePeak calculation: Cmax = (D/(Cl x T)) x (1 - e - (ke)(T))Trough calculation: Cmin = Cmax (e - (ke)(t - T))Multiple dosePeak calculation: Cmax = (D/(Cl x T)) x ((1 - e - (ke)(T))/(1 - e - (ke)(t))Trough calculation: Cmin = Cmax (e - (ke)(t - T))",
                    "sub_points": [
                      "Single dosePeak calculation: Cmax = (D/(Cl x T)) x (1 - e - (ke)(T))Trough calculation: Cmin = Cmax (e - (ke)(t - T))",
                      "Peak calculation: Cmax = (D/(Cl x T)) x (1 - e - (ke)(T))",
                      "Trough calculation: Cmin = Cmax (e - (ke)(t - T))",
                      "Multiple dosePeak calculation: Cmax = (D/(Cl x T)) x ((1 - e - (ke)(T))/(1 - e - (ke)(t))Trough calculation: Cmin = Cmax (e - (ke)(t - T))",
                      "Peak calculation: Cmax = (D/(Cl x T)) x ((1 - e - (ke)(T))/(1 - e - (ke)(t))",
                      "Trough calculation: Cmin = Cmax (e - (ke)(t - T))"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Drug Interaction": {
            "name": "Drug-Drug Interaction",
            "url": "https://app.pathprimer.com/document/dd9c471a-7514-47e3-91e1-51001b7f6f98/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Drug-drug interaction can produce synergistic effect, antagonistic effect, or potentially novel effect (i.e., one not produced by either drug alone)"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Drug interactions can occur through actions on receptors, signal cascades, or interruption of normal physiology"
                  },
                  {
                    "text": "Pharmacokinetic effects: Drug interactions that interfere with absorption, plasma transport, metabolism, or excretion"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Overview": [
                  {
                    "text": "Drug-drug interaction: Effect of 1 drug on absorption, metabolism, or action of another drug when administered concurrently (effects on pharmacokinetic and pharmacodynamic properties)"
                  },
                  {
                    "text": "Effects can be synergistic, antagonistic, or potentially novel (i.e., effect not produced by either drug alone)Synergistic effects: Result in increase in effect of drug; may cause unintentional overdoseAntagonistic effects: Result in decrease in effect of drug; may cause subtherapeutic effect of drug",
                    "sub_points": [
                      "Synergistic effects: Result in increase in effect of drug; may cause unintentional overdose",
                      "Antagonistic effects: Result in decrease in effect of drug; may cause subtherapeutic effect of drug"
                    ]
                  },
                  {
                    "text": "Interactions can also occur between a drug and foods or herbal medicines"
                  },
                  {
                    "text": "Factors affecting drug interactionsAge (reduced liver or renal function with increasing age)Ingestion of multiple drugsGenetic polymorphisms in CYP450Liver or renal disease",
                    "sub_points": [
                      "Age (reduced liver or renal function with increasing age)",
                      "Ingestion of multiple drugs",
                      "Genetic polymorphisms in CYP450",
                      "Liver or renal disease"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Pharmacodynamic Effects": [
                  {
                    "text": "Interactions can occur through actions on receptors, signal cascades, or interruption of normal physiology"
                  },
                  {
                    "text": "Receptor effectsDrugs can act on same receptor or different receptors, both competitively and noncompetitively, with various effectsAgonists: Both drugs act on same receptor, resulting in synergistic effectAntagonists: Both drugs act on same receptor and have opposing effects, resulting in reduced effect",
                    "sub_points": [
                      "Drugs can act on same receptor or different receptors, both competitively and noncompetitively, with various effectsAgonists: Both drugs act on same receptor, resulting in synergistic effectAntagonists: Both drugs act on same receptor and have opposing effects, resulting in reduced effect",
                      "Agonists: Both drugs act on same receptor, resulting in synergistic effect",
                      "Antagonists: Both drugs act on same receptor and have opposing effects, resulting in reduced effect"
                    ]
                  },
                  {
                    "text": "Signal cascade effectsOccur when 1 drug’s effect through particular signalling cascade is then affected downstream due to interaction of second drug with molecule or mechanism in that cascadeExample: Hypoglycemia due to insulin administration may be masked if patient is also on β-blocker, which prevents manifestation of symptoms of hypoglycemia",
                    "sub_points": [
                      "Occur when 1 drug’s effect through particular signalling cascade is then affected downstream due to interaction of second drug with molecule or mechanism in that cascadeExample: Hypoglycemia due to insulin administration may be masked if patient is also on β-blocker, which prevents manifestation of symptoms of hypoglycemia",
                      "Example: Hypoglycemia due to insulin administration may be masked if patient is also on β-blocker, which prevents manifestation of symptoms of hypoglycemia"
                    ]
                  },
                  {
                    "text": "Physiologic effectsOccur when 1 drug causes increase in particular compound; second drug is more effective in presence of this particular compound, and therefore in presence of first drug it will be more effective; this can also be antagonisticExample: Digoxin is more effective in low-potassium environment, so when taken together with furosemide (which lowers potassium by increasing its excretion in urine) digoxin will be more efficacious",
                    "sub_points": [
                      "Occur when 1 drug causes increase in particular compound; second drug is more effective in presence of this particular compound, and therefore in presence of first drug it will be more effective; this can also be antagonistic",
                      "Example: Digoxin is more effective in low-potassium environment, so when taken together with furosemide (which lowers potassium by increasing its excretion in urine) digoxin will be more efficacious"
                    ]
                  }
                ],
                "Pharmacokinetic Effects": [
                  {
                    "text": "Drug interactions that interfere with absorption, plasma transport, metabolism, or excretionAbsorptionWhen 1 drug affects absorption of another drugOccurs when taking prokinetic drugs (which cause decrease in absorption of other drug) or with antikinetic drugs (which change pH of stomach and can also have this interaction)Plasma transportationWhen 2 drugs that need to be protein-bound compete in plasma for bindingDrug with higher affinity for binding will leave other drug more dissolved in plasmaMetabolismMost interactions are due to modification of drug’s metabolismBecause most drugs are metabolized in liver by CYP450 enzymes, this is most common avenue for such interactionsCan result in enzyme inhibition or induction, and either of these can cause agonistic or antagonistic effects, because some drugs require first-pass metabolism to be efficaciousExcretionDrugs that are not protein-bound are able to pass through glomerular filtration system and into urinepH can modify drug’s excretion into urine (especially for drugs that are weak acids or weak bases)",
                    "sub_points": [
                      "AbsorptionWhen 1 drug affects absorption of another drugOccurs when taking prokinetic drugs (which cause decrease in absorption of other drug) or with antikinetic drugs (which change pH of stomach and can also have this interaction)",
                      "When 1 drug affects absorption of another drug",
                      "Occurs when taking prokinetic drugs (which cause decrease in absorption of other drug) or with antikinetic drugs (which change pH of stomach and can also have this interaction)",
                      "Plasma transportationWhen 2 drugs that need to be protein-bound compete in plasma for bindingDrug with higher affinity for binding will leave other drug more dissolved in plasma",
                      "When 2 drugs that need to be protein-bound compete in plasma for binding",
                      "Drug with higher affinity for binding will leave other drug more dissolved in plasma",
                      "MetabolismMost interactions are due to modification of drug’s metabolismBecause most drugs are metabolized in liver by CYP450 enzymes, this is most common avenue for such interactionsCan result in enzyme inhibition or induction, and either of these can cause agonistic or antagonistic effects, because some drugs require first-pass metabolism to be efficacious",
                      "Most interactions are due to modification of drug’s metabolism",
                      "Because most drugs are metabolized in liver by CYP450 enzymes, this is most common avenue for such interactions",
                      "Can result in enzyme inhibition or induction, and either of these can cause agonistic or antagonistic effects, because some drugs require first-pass metabolism to be efficacious",
                      "ExcretionDrugs that are not protein-bound are able to pass through glomerular filtration system and into urinepH can modify drug’s excretion into urine (especially for drugs that are weak acids or weak bases)",
                      "Drugs that are not protein-bound are able to pass through glomerular filtration system and into urine",
                      "pH can modify drug’s excretion into urine (especially for drugs that are weak acids or weak bases)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Retention Time and Reference Range": {
            "name": "Retention Time and Reference Range",
            "url": "https://app.pathprimer.com/document/eabc02d3-660f-4d7d-bec7-987ce19f6b9d/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Retention time: Time it takes to elute 1 compound off HPLC or GC columnCompound-specific in given analysis",
                    "sub_points": [
                      "Compound-specific in given analysis"
                    ]
                  },
                  {
                    "text": "Reference interval: Range of values for physiologic measurement in healthy individualsTypically based on middle 95% population measurements",
                    "sub_points": [
                      "Typically based on middle 95% population measurements"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Significance": [
                  {
                    "text": "Retention time: Time it takes to elute 1 compound off high-performance liquid chromatography (HPLC) or gas chromatography (GC) columnCompound-specific in a given analysisProvides important parameter for positive identification of compoundIncreases specificity for compound of interest and its identification",
                    "sub_points": [
                      "Compound-specific in a given analysis",
                      "Provides important parameter for positive identification of compound",
                      "Increases specificity for compound of interest and its identification"
                    ]
                  },
                  {
                    "text": "Reference range/reference intervalRange of values for physiologic measurement in healthy individualsTypically based on middle 95% population measurements",
                    "sub_points": [
                      "Range of values for physiologic measurement in healthy individualsTypically based on middle 95% population measurements",
                      "Typically based on middle 95% population measurements"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Retention timeUsed for HPLC assaysUsed for HPLC assay coupled with mass spectrometry analysisApplied for GC",
                    "sub_points": [
                      "Used for HPLC assays",
                      "Used for HPLC assay coupled with mass spectrometry analysis",
                      "Applied for GC"
                    ]
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Also called reference ranges"
                  },
                  {
                    "text": "Values are higher or lower than intervals considered \"abnormal\" and requiring medical attention"
                  },
                  {
                    "text": "5% of healthy population incorrectly classified as \"abnormal\""
                  },
                  {
                    "text": "Reference intervals are dependent on the followingInstrument/analytical platformMethodologySample type",
                    "sub_points": [
                      "Instrument/analytical platform",
                      "Methodology",
                      "Sample type"
                    ]
                  },
                  {
                    "text": "Reference intervals can be stratified based on various factorsAgeGenderRaceOther",
                    "sub_points": [
                      "Age",
                      "Gender",
                      "Race",
                      "Other"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Testing Interference and Limitations": {
            "name": "Testing Interference and Limitations",
            "url": "https://app.pathprimer.com/document/3c574a13-06cb-47c6-b36f-1e9133343ad2/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Urine samples can sometimes be adulterated to avoid positive test results"
                  },
                  {
                    "text": "Certain types of samples may be limited by existence of, or stability of, compounds of interest in that sample type"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Interference by other compounds in sample is well-known limitation of immunoassays and can cause both false-positive and false-negative results"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Limitations": [
                  {
                    "text": "AdulterationUrine samples can sometimes be adulterated to avoid positive test resultsSupervised collection reduces ability to alter sampleMethods of adulterationDecrease concentration in sampleConsumption of water (though dilution can occur even with < 2 L of water, or in patients receiving IV fluids)Consumption of detoxifying liquids or compounds (e.g., household chemicals or oxidizing agents)Adding water to sample after collectionFirst 2 methods can be circumvented by preventing consumption of water for certain period of time before collection and by measuring creatinine or specific gravity in urine sample; additionally, test strips are available to assess for exogenous adulterating compoundsSubstitute synthetic urineSynthetic urine retains specific gravity and creatinine levelsHowever, temperature is lower than body temperatureSome tests will alert examiner to low temperature in sample",
                    "sub_points": [
                      "Urine samples can sometimes be adulterated to avoid positive test results",
                      "Supervised collection reduces ability to alter sample",
                      "Methods of adulterationDecrease concentration in sampleConsumption of water (though dilution can occur even with < 2 L of water, or in patients receiving IV fluids)Consumption of detoxifying liquids or compounds (e.g., household chemicals or oxidizing agents)Adding water to sample after collectionFirst 2 methods can be circumvented by preventing consumption of water for certain period of time before collection and by measuring creatinine or specific gravity in urine sample; additionally, test strips are available to assess for exogenous adulterating compoundsSubstitute synthetic urineSynthetic urine retains specific gravity and creatinine levelsHowever, temperature is lower than body temperatureSome tests will alert examiner to low temperature in sample",
                      "Decrease concentration in sampleConsumption of water (though dilution can occur even with < 2 L of water, or in patients receiving IV fluids)Consumption of detoxifying liquids or compounds (e.g., household chemicals or oxidizing agents)Adding water to sample after collectionFirst 2 methods can be circumvented by preventing consumption of water for certain period of time before collection and by measuring creatinine or specific gravity in urine sample; additionally, test strips are available to assess for exogenous adulterating compounds",
                      "Consumption of water (though dilution can occur even with < 2 L of water, or in patients receiving IV fluids)",
                      "Consumption of detoxifying liquids or compounds (e.g., household chemicals or oxidizing agents)",
                      "Adding water to sample after collection",
                      "First 2 methods can be circumvented by preventing consumption of water for certain period of time before collection and by measuring creatinine or specific gravity in urine sample; additionally, test strips are available to assess for exogenous adulterating compounds",
                      "Substitute synthetic urineSynthetic urine retains specific gravity and creatinine levelsHowever, temperature is lower than body temperatureSome tests will alert examiner to low temperature in sample",
                      "Synthetic urine retains specific gravity and creatinine levels",
                      "However, temperature is lower than body temperature",
                      "Some tests will alert examiner to low temperature in sample"
                    ]
                  },
                  {
                    "text": "Limitations based on sample typeCertain types of samples can be limited by existence of, or stability of, compounds of interest in that sample typeUrine: Better as qualitative test because serum concentrations often are not correlated to urine concentrationsSaliva: Low levels of drug may be presentHair: Cannot assess for acute drug use; expensiveBlood or serum: Best for accurate estimation of dose; however, requires invasive collection and complex storage, and has less stability",
                    "sub_points": [
                      "Certain types of samples can be limited by existence of, or stability of, compounds of interest in that sample type",
                      "Urine: Better as qualitative test because serum concentrations often are not correlated to urine concentrations",
                      "Saliva: Low levels of drug may be present",
                      "Hair: Cannot assess for acute drug use; expensive",
                      "Blood or serum: Best for accurate estimation of dose; however, requires invasive collection and complex storage, and has less stability"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Interference": [
                  {
                    "text": "ImmunoassayMost initial &/or screening tests for drugs call for this techniqueInterference by other compounds in sample is well-known limitation for this platform and can cause both false-positive and false-negative resultsAdditionally, false-negative test results can be caused by variety of assays and antibodies availableHook effect can result in falsely decreased value",
                    "sub_points": [
                      "Most initial &/or screening tests for drugs call for this technique",
                      "Interference by other compounds in sample is well-known limitation for this platform and can cause both false-positive and false-negative results",
                      "Additionally, false-negative test results can be caused by variety of assays and antibodies available",
                      "Hook effect can result in falsely decreased value"
                    ]
                  },
                  {
                    "text": "Gas chromatography-mass spectrometry (GC-MS)Generally used as confirmation test after positive result from immunoassayLimited due to complexity, need for trained professionals, and lengthy time required to complete testDifficulty in detection of difference between isomers (important when detecting methamphetamines)",
                    "sub_points": [
                      "Generally used as confirmation test after positive result from immunoassay",
                      "Limited due to complexity, need for trained professionals, and lengthy time required to complete test",
                      "Difficulty in detection of difference between isomers (important when detecting methamphetamines)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Testing Methods": {
            "name": "Testing Methods",
            "url": "https://app.pathprimer.com/document/2fb1bd94-a730-4e2e-8c50-3617c4166512/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Immunoassay (IA): Biochemical laboratory testing platform that aids in detection &/or measurement of compound of interest through use of antibody or antigenMay incorporate label to aid detection or quantification",
                    "sub_points": [
                      "May incorporate label to aid detection or quantification"
                    ]
                  },
                  {
                    "text": "Gas chromatography-mass spectrometry (GC-MS): Combination of techniques that allows for identification, quantification, and analysis of compounds in sample"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Immunoassay": [
                  {
                    "text": "Biochemical laboratory testing platform that aids in detection &/or measurement of compound of interest through use of antibody or antigenMay incorporate use of label",
                    "sub_points": [
                      "May incorporate use of label"
                    ]
                  },
                  {
                    "text": "ClassificationCompetitive, homogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound labeled analyte is quantifiedAmount of unbound labeled analyte present is proportional to amount in sampleCompetitive, heterogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound analyte is washed away, and remaining labeled bound analyte is quantifiedOne-site, noncompetitive immunoassayLabeled antibodies are added to unknown analyteUnbound labeled antibodies are washed away, and bound labeled antibodies are quantifiedIntensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sampleTwo-site, noncompetitive immunoassay (“sandwich” assay)Generally, 2 separate antibodies are generated to different parts of analyteFirst (capture) antibody is affixed to solid state (e.g., 96 well plate)Analyte is then addedSecond (detection) antibody, normally conjugated to detecting agent (e.g., fluorophore or enzyme), is then added to detect captured analyteDetecting solution (e.g., substrate that is converted to product) is then addedProduct intensity (color change, excited ion, etc.) is proportional to analyte concentrationAll steps require washing procedures to decrease nonspecific binding",
                    "sub_points": [
                      "Competitive, homogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound labeled analyte is quantifiedAmount of unbound labeled analyte present is proportional to amount in sample",
                      "Labeled and unlabeled analytes compete to bind to antibody",
                      "Unbound labeled analyte is quantified",
                      "Amount of unbound labeled analyte present is proportional to amount in sample",
                      "Competitive, heterogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound analyte is washed away, and remaining labeled bound analyte is quantified",
                      "Labeled and unlabeled analytes compete to bind to antibody",
                      "Unbound analyte is washed away, and remaining labeled bound analyte is quantified",
                      "One-site, noncompetitive immunoassayLabeled antibodies are added to unknown analyteUnbound labeled antibodies are washed away, and bound labeled antibodies are quantifiedIntensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample",
                      "Labeled antibodies are added to unknown analyte",
                      "Unbound labeled antibodies are washed away, and bound labeled antibodies are quantified",
                      "Intensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample",
                      "Two-site, noncompetitive immunoassay (“sandwich” assay)Generally, 2 separate antibodies are generated to different parts of analyteFirst (capture) antibody is affixed to solid state (e.g., 96 well plate)Analyte is then addedSecond (detection) antibody, normally conjugated to detecting agent (e.g., fluorophore or enzyme), is then added to detect captured analyteDetecting solution (e.g., substrate that is converted to product) is then addedProduct intensity (color change, excited ion, etc.) is proportional to analyte concentrationAll steps require washing procedures to decrease nonspecific binding",
                      "Generally, 2 separate antibodies are generated to different parts of analyte",
                      "First (capture) antibody is affixed to solid state (e.g., 96 well plate)",
                      "Analyte is then added",
                      "Second (detection) antibody, normally conjugated to detecting agent (e.g., fluorophore or enzyme), is then added to detect captured analyte",
                      "Detecting solution (e.g., substrate that is converted to product) is then added",
                      "Product intensity (color change, excited ion, etc.) is proportional to analyte concentration",
                      "All steps require washing procedures to decrease nonspecific binding"
                    ]
                  },
                  {
                    "text": "TypesPrecipitation immunoassay: Antigen and antibody react without label; resulting precipitation can be seen or detected through detectorParticle immunoassay: Makes use of inert particles (e.g., erythrocytes, latex) that attach to either antigens or antibodies, which causes agglutinationRadioimmunoassay: Uses radioisotopes as labelsEnzyme immunoassay: Uses enzymes as labelsFluorescent immunoassay: Uses fluorophores as labelsChemiluminescent immunoassay: Uses chemiluminescent compounds as labels",
                    "sub_points": [
                      "Precipitation immunoassay: Antigen and antibody react without label; resulting precipitation can be seen or detected through detector",
                      "Particle immunoassay: Makes use of inert particles (e.g., erythrocytes, latex) that attach to either antigens or antibodies, which causes agglutination",
                      "Radioimmunoassay: Uses radioisotopes as labels",
                      "Enzyme immunoassay: Uses enzymes as labels",
                      "Fluorescent immunoassay: Uses fluorophores as labels",
                      "Chemiluminescent immunoassay: Uses chemiluminescent compounds as labels"
                    ]
                  },
                  {
                    "text": "Immunoassay sensitivityAssay sensitivity is affected by association constant, signal intensity, and signal to noise ratioImmunoassays can be tremendously affected by interference by other molecules",
                    "sub_points": [
                      "Assay sensitivity is affected by association constant, signal intensity, and signal to noise ratio",
                      "Immunoassays can be tremendously affected by interference by other molecules"
                    ]
                  },
                  {
                    "text": "Analytical techniquesPrecipitation immunoassayAntigen-antibody complexes are formed that are insoluble and can be seen with naked eye or detectedLimitsDecreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)Factors that alter assay performanceConcentration of reactantsTemperaturepH of samplePoint of equivalence: Point of optimal precipitation during reaction; addition of more antigen will cause dissolution of precipitateParticle immunoassayInert particles attached cause agglutinationVarious particles have been implemented in different immunoassaysDirect agglutination: Antibodies bind directly to antigens and agglutinateIndirect (passive) agglutination: Inert particles or cells are coated with antigen, which are exposed to antibodies and then agglutinateReverse agglutination: Inert particles or cells are coated with antibody, which are exposed to antigens and then agglutinateRadioimmunoassayCan be either competitive or noncompetitive heterogeneous assayDependent on binding affinity of antibody (﻿﻿K﻿﻿)B/F = K([Ab]t - B) delineates Scatchard plot, which can be used to evaluate performance of antibody(B/F = ratio of bound to free antigen, ﻿K﻿ =binding affinity constant, and Ab = antibody concentration)AdvantagesHigher sensitivityReduced interferenceDisadvantagesRadioactivityShorter shelf life for assayEnzyme immunoassay (EIA)Can be either heterogeneous competitive or noncompetitive, similar to RIA without radioactivityCan also be homogeneous assay without washing stepDifferent enzymes are used as labelsHeterogeneous EIA contains washing step for separationHomogeneous EIA uses 1 solution for entire reactionDetection for all EIA is by optical density, fluorescence, or luminescenceAdvantagesHigh sensitivityInexpensive and long-lasting reagentsInexpensive assay and equipmentNo hazardsDisadvantagesComplex quantificationInterference by plasma proteinsPossible need for complex reagentsFluorescent immunoassaySimilar to EIA except uses fluorophores as labelsEnzyme reaction causes production of fluorophore with specific excitation wavelengthDetected by fluorometer or photomultiplier tubeChemiluminescent immunoassayCompound of interest reacts, causing chemical reaction that results in oxidation of compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygenUsually in presence of nonbiological catalystLuminometer = instrumentation for measuring this type of light emissionMeasures light given off with chemical reactionComposed of sample cell (which is protected from external light), injection system for adding various reagents to sample cell, and detector (photomultiplier tube)Bioluminescence is similar, except it uses biological catalyst, such as luciferase or aequorinElectroluminescence is similar, except that oxidation reaction occurs on surface of electrodeBenefits include very low level of detection, in zeptomole range (10-21)LimitationsAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                    "sub_points": [
                      "Precipitation immunoassayAntigen-antibody complexes are formed that are insoluble and can be seen with naked eye or detectedLimitsDecreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)Factors that alter assay performanceConcentration of reactantsTemperaturepH of samplePoint of equivalence: Point of optimal precipitation during reaction; addition of more antigen will cause dissolution of precipitate",
                      "Antigen-antibody complexes are formed that are insoluble and can be seen with naked eye or detected",
                      "LimitsDecreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)",
                      "Decreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)",
                      "Factors that alter assay performanceConcentration of reactantsTemperaturepH of sample",
                      "Concentration of reactants",
                      "Temperature",
                      "pH of sample",
                      "Point of equivalence: Point of optimal precipitation during reaction; addition of more antigen will cause dissolution of precipitate",
                      "Particle immunoassayInert particles attached cause agglutinationVarious particles have been implemented in different immunoassaysDirect agglutination: Antibodies bind directly to antigens and agglutinateIndirect (passive) agglutination: Inert particles or cells are coated with antigen, which are exposed to antibodies and then agglutinateReverse agglutination: Inert particles or cells are coated with antibody, which are exposed to antigens and then agglutinate",
                      "Inert particles attached cause agglutination",
                      "Various particles have been implemented in different immunoassays",
                      "Direct agglutination: Antibodies bind directly to antigens and agglutinate",
                      "Indirect (passive) agglutination: Inert particles or cells are coated with antigen, which are exposed to antibodies and then agglutinate",
                      "Reverse agglutination: Inert particles or cells are coated with antibody, which are exposed to antigens and then agglutinate",
                      "RadioimmunoassayCan be either competitive or noncompetitive heterogeneous assayDependent on binding affinity of antibody (﻿﻿K﻿﻿)B/F = K([Ab]t - B) delineates Scatchard plot, which can be used to evaluate performance of antibody(B/F = ratio of bound to free antigen, ﻿K﻿ =binding affinity constant, and Ab = antibody concentration)AdvantagesHigher sensitivityReduced interferenceDisadvantagesRadioactivityShorter shelf life for assay",
                      "Can be either competitive or noncompetitive heterogeneous assay",
                      "Dependent on binding affinity of antibody (﻿﻿K﻿﻿)B/F = K([Ab]t - B) delineates Scatchard plot, which can be used to evaluate performance of antibody(B/F = ratio of bound to free antigen, ﻿K﻿ =binding affinity constant, and Ab = antibody concentration)",
                      "B/F = K([Ab]t - B) delineates Scatchard plot, which can be used to evaluate performance of antibody",
                      "(B/F = ratio of bound to free antigen, ﻿K﻿ =binding affinity constant, and Ab = antibody concentration)",
                      "AdvantagesHigher sensitivityReduced interference",
                      "Higher sensitivity",
                      "Reduced interference",
                      "DisadvantagesRadioactivityShorter shelf life for assay",
                      "Radioactivity",
                      "Shorter shelf life for assay",
                      "Enzyme immunoassay (EIA)Can be either heterogeneous competitive or noncompetitive, similar to RIA without radioactivityCan also be homogeneous assay without washing stepDifferent enzymes are used as labelsHeterogeneous EIA contains washing step for separationHomogeneous EIA uses 1 solution for entire reactionDetection for all EIA is by optical density, fluorescence, or luminescenceAdvantagesHigh sensitivityInexpensive and long-lasting reagentsInexpensive assay and equipmentNo hazardsDisadvantagesComplex quantificationInterference by plasma proteinsPossible need for complex reagents",
                      "Can be either heterogeneous competitive or noncompetitive, similar to RIA without radioactivity",
                      "Can also be homogeneous assay without washing step",
                      "Different enzymes are used as labels",
                      "Heterogeneous EIA contains washing step for separation",
                      "Homogeneous EIA uses 1 solution for entire reaction",
                      "Detection for all EIA is by optical density, fluorescence, or luminescence",
                      "AdvantagesHigh sensitivityInexpensive and long-lasting reagentsInexpensive assay and equipmentNo hazards",
                      "High sensitivity",
                      "Inexpensive and long-lasting reagents",
                      "Inexpensive assay and equipment",
                      "No hazards",
                      "DisadvantagesComplex quantificationInterference by plasma proteinsPossible need for complex reagents",
                      "Complex quantification",
                      "Interference by plasma proteins",
                      "Possible need for complex reagents",
                      "Fluorescent immunoassaySimilar to EIA except uses fluorophores as labelsEnzyme reaction causes production of fluorophore with specific excitation wavelengthDetected by fluorometer or photomultiplier tube",
                      "Similar to EIA except uses fluorophores as labels",
                      "Enzyme reaction causes production of fluorophore with specific excitation wavelengthDetected by fluorometer or photomultiplier tube",
                      "Detected by fluorometer or photomultiplier tube",
                      "Chemiluminescent immunoassayCompound of interest reacts, causing chemical reaction that results in oxidation of compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygenUsually in presence of nonbiological catalystLuminometer = instrumentation for measuring this type of light emissionMeasures light given off with chemical reactionComposed of sample cell (which is protected from external light), injection system for adding various reagents to sample cell, and detector (photomultiplier tube)Bioluminescence is similar, except it uses biological catalyst, such as luciferase or aequorinElectroluminescence is similar, except that oxidation reaction occurs on surface of electrodeBenefits include very low level of detection, in zeptomole range (10-21)LimitationsAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                      "Compound of interest reacts, causing chemical reaction that results in oxidation of compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygenUsually in presence of nonbiological catalyst",
                      "Usually in presence of nonbiological catalyst",
                      "Luminometer = instrumentation for measuring this type of light emissionMeasures light given off with chemical reactionComposed of sample cell (which is protected from external light), injection system for adding various reagents to sample cell, and detector (photomultiplier tube)",
                      "Measures light given off with chemical reaction",
                      "Composed of sample cell (which is protected from external light), injection system for adding various reagents to sample cell, and detector (photomultiplier tube)",
                      "Bioluminescence is similar, except it uses biological catalyst, such as luciferase or aequorin",
                      "Electroluminescence is similar, except that oxidation reaction occurs on surface of electrode",
                      "Benefits include very low level of detection, in zeptomole range (10-21)",
                      "LimitationsAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                      "Any light entering sample cell can cause inaccurate results",
                      "Assay reagents and instrumentation tubing can add background light into system"
                    ]
                  }
                ],
                "Gas Chromatography-Mass Spectrometry": [
                  {
                    "text": "Gas chromatography-mass spectrometry (GC-MS): Combination of techniques that allows for identification, quantification, and analysis of compounds in sample"
                  },
                  {
                    "text": "Generally implemented as confirmatory test in toxicology to assess for presence of drugs"
                  },
                  {
                    "text": "Gas chromatographyUtilizes gas chromatograph, which encompasses capillary columnCompounds are first heated until they enter gas phaseGas sample is run through column, and different compounds separate out based on chemical properties of column and compoundsCompounds that are retained on column will be run off in elution step (retention time)",
                    "sub_points": [
                      "Utilizes gas chromatograph, which encompasses capillary column",
                      "Compounds are first heated until they enter gas phase",
                      "Gas sample is run through column, and different compounds separate out based on chemical properties of column and compounds",
                      "Compounds that are retained on column will be run off in elution step (retention time)"
                    ]
                  },
                  {
                    "text": "Mass spectrometryUtilizes mass spectrometer that receives compounds previously separated by columnCompounds are broken down based on their mass-to-charge ratios into ionized fragmentsThey are then accelerated and deflected, which produces different detection signalMass spectrometer detects these signals and allows for characterization of compounds",
                    "sub_points": [
                      "Utilizes mass spectrometer that receives compounds previously separated by column",
                      "Compounds are broken down based on their mass-to-charge ratios into ionized fragments",
                      "They are then accelerated and deflected, which produces different detection signal",
                      "Mass spectrometer detects these signals and allows for characterization of compounds"
                    ]
                  },
                  {
                    "text": "AdvantagesHighly specific, with high reproducibilityHighly sensitive; able to detect small amounts of compoundsCombination of these 2 techniques allows for minimal overlap between compounds, resulting in certain characterization of compoundsLarge reference libraries available to characterize compoundsConsidered gold standard of drug testing",
                    "sub_points": [
                      "Highly specific, with high reproducibility",
                      "Highly sensitive; able to detect small amounts of compounds",
                      "Combination of these 2 techniques allows for minimal overlap between compounds, resulting in certain characterization of compounds",
                      "Large reference libraries available to characterize compounds",
                      "Considered gold standard of drug testing"
                    ]
                  },
                  {
                    "text": "LimitationsInability to detect compounds that are polar, thermally labile, and nonvolatileComplex instrumentation requiring highly trained staff and time needed for testingCannot distinguish between isomers",
                    "sub_points": [
                      "Inability to detect compounds that are polar, thermally labile, and nonvolatile",
                      "Complex instrumentation requiring highly trained staff and time needed for testing",
                      "Cannot distinguish between isomers"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug Dosing": {
            "name": "Drug Dosing",
            "url": "https://app.pathprimer.com/document/6e045d5c-1341-4a28-8256-9d770c18f8a0/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Drug dosing is essential to therapeutic drug monitoring in patientsDetermined by plasma or blood concentrations of drug within therapeutic range",
                    "sub_points": [
                      "Determined by plasma or blood concentrations of drug within therapeutic range"
                    ]
                  },
                  {
                    "text": "Goal of drug dosing is to achieve steady-state concentration of drug"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Steady-state concentrations are reached when amount of drug excreted is equal to amount of drug administered over certain time period"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definitions": [
                  {
                    "text": "Pharmacokinetics: Study of what happens to compounds in body; governed by dose, dosing intervals, and route of administration; in clinical settings, these are usually measured by drug concentration in blood or plasma"
                  },
                  {
                    "text": "Pharmacodynamics: Study of fate of compounds in body over time; governed by absorption, distribution, biotransformation, and excretion"
                  }
                ],
                "Overview": [
                  {
                    "text": "Drug dosing is essential to therapeutic drug monitoring in patientsDetermined by plasma or blood concentrations of drug within therapeutic rangeGoal of drug dosing is to achieve steady-state concentration of drug",
                    "sub_points": [
                      "Determined by plasma or blood concentrations of drug within therapeutic range",
                      "Goal of drug dosing is to achieve steady-state concentration of drug"
                    ]
                  },
                  {
                    "text": "Principles affecting drug dose includePharmacokineticsPharmacodynamics",
                    "sub_points": [
                      "Pharmacokinetics",
                      "Pharmacodynamics"
                    ]
                  },
                  {
                    "text": "Dosing for drug may differ from patient to patient due to various factors"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Pharmacokinetics and Pharmacodynamics": [
                  {
                    "text": "Drug administrationDrugs may be administered continuously or discontinuously (more common)Most medications are given at fixed intervals and are taken orallyIn continuous administrations, small dose of medication is given constantly, usually through intravenous route, which ensures constant rate of excretion and metabolism at steady-state concentrationsSteady-state concentrations are reached when amount of drug excreted is equal to amount of drug administered over certain time periodUsually achieved after administration of 4-5 dosesIn discontinuous administrations, medication is given in fixed intervals allowing for excretion of some of previous dose before ingesting next doseInterval of time between each dose is usually half-life of drug being givenSteady-state concentrations can be achieved with discontinuous administration, but instead of constant concentration of drug in blood or plasma, concentration oscillates through peaks and troughsHalf-life of drug is value unaffected by concentration in blood or plasma",
                    "sub_points": [
                      "Drugs may be administered continuously or discontinuously (more common)Most medications are given at fixed intervals and are taken orally",
                      "Most medications are given at fixed intervals and are taken orally",
                      "In continuous administrations, small dose of medication is given constantly, usually through intravenous route, which ensures constant rate of excretion and metabolism at steady-state concentrationsSteady-state concentrations are reached when amount of drug excreted is equal to amount of drug administered over certain time periodUsually achieved after administration of 4-5 doses",
                      "Steady-state concentrations are reached when amount of drug excreted is equal to amount of drug administered over certain time periodUsually achieved after administration of 4-5 doses",
                      "Usually achieved after administration of 4-5 doses",
                      "In discontinuous administrations, medication is given in fixed intervals allowing for excretion of some of previous dose before ingesting next doseInterval of time between each dose is usually half-life of drug being givenSteady-state concentrations can be achieved with discontinuous administration, but instead of constant concentration of drug in blood or plasma, concentration oscillates through peaks and troughs",
                      "Interval of time between each dose is usually half-life of drug being given",
                      "Steady-state concentrations can be achieved with discontinuous administration, but instead of constant concentration of drug in blood or plasma, concentration oscillates through peaks and troughs",
                      "Half-life of drug is value unaffected by concentration in blood or plasma"
                    ]
                  },
                  {
                    "text": "Dosing calculationsGeneral valuesD = doseτ = dosing interval (time between doses, ideally equal to half-life of drug)Cl = clearance (rate at which drug is cleared from plasma, generally through renal excretion)Vd = volume of distribution (volume needed to contain drug at same concentration in plasma; if drug is not absorbed into tissue, this equals plasma concentration; if it is absorbed into tissue, this can exceed plasma volume by large amount)ke = elimination rate constant (describes how fast drug is eliminated from system)ka = absorption rate constant (describes how fast drug is absorbed via first-order kinetics from site of administration)F = bioavailability (proportion of drug that is available in circulation for use)K0 = infusion rate (rate of infusion to attain steady-state concentration)T = duration of infusionC = plasma concentrationElimination rate constantke = Cl/Vd = (ln(C1/C2))/(t1 – t2)Half-lifet1/2 = ln(2)/ke = (0.693 x Vd)/ClVolume of distributionVd = Vplasma + Vtissue + KplasmaClearanceCl = dose/AUC = ke/VdIV administrationIV bolusC0 = D/Vd for initial concentrationC = C0(e –ke(t)) for single doseC = (C0(e –ke(t)))/(1- e –keτ) for multiple dosesIV constant rateC = (k0/Cl)(1 - e –ke(t))(Steady state concentration) Css = k0/ClOral administrationSingle doseC = (FDka)/(Vd(ka-ke)) x (e –ke(t) - e –ka(t))(Time of max concentration) tmax = (ln(ka/ke))/ (ka - ke)Multiple dosesC = (FDka)/(Vd(ka-ke)) x (e –ke(t)/(1 - e –ke(τ))) - (e –ka(t)/(1 - e –ka(τ)))(Time of max concentration) tmax = ln[ka(1 - e –ke(τ))/(ke(1 - e –ka(τ))]/(ka - ke)(Steady state concentration) Css = FD/Clτ",
                    "sub_points": [
                      "General valuesD = doseτ = dosing interval (time between doses, ideally equal to half-life of drug)Cl = clearance (rate at which drug is cleared from plasma, generally through renal excretion)Vd = volume of distribution (volume needed to contain drug at same concentration in plasma; if drug is not absorbed into tissue, this equals plasma concentration; if it is absorbed into tissue, this can exceed plasma volume by large amount)ke = elimination rate constant (describes how fast drug is eliminated from system)ka = absorption rate constant (describes how fast drug is absorbed via first-order kinetics from site of administration)F = bioavailability (proportion of drug that is available in circulation for use)K0 = infusion rate (rate of infusion to attain steady-state concentration)T = duration of infusionC = plasma concentration",
                      "D = dose",
                      "τ = dosing interval (time between doses, ideally equal to half-life of drug)",
                      "Cl = clearance (rate at which drug is cleared from plasma, generally through renal excretion)",
                      "Vd = volume of distribution (volume needed to contain drug at same concentration in plasma; if drug is not absorbed into tissue, this equals plasma concentration; if it is absorbed into tissue, this can exceed plasma volume by large amount)",
                      "ke = elimination rate constant (describes how fast drug is eliminated from system)",
                      "ka = absorption rate constant (describes how fast drug is absorbed via first-order kinetics from site of administration)",
                      "F = bioavailability (proportion of drug that is available in circulation for use)",
                      "K0 = infusion rate (rate of infusion to attain steady-state concentration)",
                      "T = duration of infusion",
                      "C = plasma concentration",
                      "Elimination rate constantke = Cl/Vd = (ln(C1/C2))/(t1 – t2)",
                      "ke = Cl/Vd = (ln(C1/C2))/(t1 – t2)",
                      "Half-lifet1/2 = ln(2)/ke = (0.693 x Vd)/Cl",
                      "t1/2 = ln(2)/ke = (0.693 x Vd)/Cl",
                      "Volume of distributionVd = Vplasma + Vtissue + Kplasma",
                      "Vd = Vplasma + Vtissue + Kplasma",
                      "ClearanceCl = dose/AUC = ke/Vd",
                      "Cl = dose/AUC = ke/Vd",
                      "IV administrationIV bolusC0 = D/Vd for initial concentrationC = C0(e –ke(t)) for single doseC = (C0(e –ke(t)))/(1- e –keτ) for multiple dosesIV constant rateC = (k0/Cl)(1 - e –ke(t))(Steady state concentration) Css = k0/Cl",
                      "IV bolusC0 = D/Vd for initial concentrationC = C0(e –ke(t)) for single doseC = (C0(e –ke(t)))/(1- e –keτ) for multiple doses",
                      "C0 = D/Vd for initial concentration",
                      "C = C0(e –ke(t)) for single dose",
                      "C = (C0(e –ke(t)))/(1- e –keτ) for multiple doses",
                      "IV constant rateC = (k0/Cl)(1 - e –ke(t))(Steady state concentration) Css = k0/Cl",
                      "C = (k0/Cl)(1 - e –ke(t))",
                      "(Steady state concentration) Css = k0/Cl",
                      "Oral administrationSingle doseC = (FDka)/(Vd(ka-ke)) x (e –ke(t) - e –ka(t))(Time of max concentration) tmax = (ln(ka/ke))/ (ka - ke)Multiple dosesC = (FDka)/(Vd(ka-ke)) x (e –ke(t)/(1 - e –ke(τ))) - (e –ka(t)/(1 - e –ka(τ)))(Time of max concentration) tmax = ln[ka(1 - e –ke(τ))/(ke(1 - e –ka(τ))]/(ka - ke)(Steady state concentration) Css = FD/Clτ",
                      "Single doseC = (FDka)/(Vd(ka-ke)) x (e –ke(t) - e –ka(t))(Time of max concentration) tmax = (ln(ka/ke))/ (ka - ke)",
                      "C = (FDka)/(Vd(ka-ke)) x (e –ke(t) - e –ka(t))",
                      "(Time of max concentration) tmax = (ln(ka/ke))/ (ka - ke)",
                      "Multiple dosesC = (FDka)/(Vd(ka-ke)) x (e –ke(t)/(1 - e –ke(τ))) - (e –ka(t)/(1 - e –ka(τ)))(Time of max concentration) tmax = ln[ka(1 - e –ke(τ))/(ke(1 - e –ka(τ))]/(ka - ke)(Steady state concentration) Css = FD/Clτ",
                      "C = (FDka)/(Vd(ka-ke)) x (e –ke(t)/(1 - e –ke(τ))) - (e –ka(t)/(1 - e –ka(τ)))",
                      "(Time of max concentration) tmax = ln[ka(1 - e –ke(τ))/(ke(1 - e –ka(τ))]/(ka - ke)",
                      "(Steady state concentration) Css = FD/Clτ"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug Metabolism": {
            "name": "Drug Metabolism",
            "url": "https://app.pathprimer.com/document/8a863543-0a86-41a6-b83f-61c488dd762c/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Phase I reactions alter chemical structure via oxidation, reduction, or hydrolysis"
                  },
                  {
                    "text": "Phase II reactions conjugate compound by glucuronidation or sulfation to become water-soluble"
                  },
                  {
                    "text": "Currently, clinically relevant enzymes for pharmacogenetics include TPMT, CYP450 (CYP2D6, CYP2C19, CYP2C9), NATs"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Liver is primary organ responsible for majority of drug metabolismConverts nonpolar (lipophilic) drugs to polar (water-soluble) forms via phase I or phase II reactions",
                    "sub_points": [
                      "Converts nonpolar (lipophilic) drugs to polar (water-soluble) forms via phase I or phase II reactions"
                    ]
                  },
                  {
                    "text": "Phase I reactions alter chemical structure via oxidation, reduction, or hydrolysis"
                  },
                  {
                    "text": "Phase II reactions conjugate compound by glucuronidation or sulfation to become water-soluble"
                  },
                  {
                    "text": "MetabolitesMay be metabolized even further with multiple phase I or II reactionsCan be active, inactive, and even more active than parent compound",
                    "sub_points": [
                      "May be metabolized even further with multiple phase I or II reactions",
                      "Can be active, inactive, and even more active than parent compound"
                    ]
                  },
                  {
                    "text": "Cytochrome P450 (CYP450) = major enzyme in metabolism of drugs"
                  }
                ],
                "Clinical Considerations": [
                  {
                    "text": "Rate of metabolism differs among various patients; can also differ at various time points for same patient"
                  },
                  {
                    "text": "Factors affecting rate of metabolismGenetic differencesLiver diseaseCoingestion of drugs or foodsRenal functionMany more",
                    "sub_points": [
                      "Genetic differences",
                      "Liver disease",
                      "Coingestion of drugs or foods",
                      "Renal function",
                      "Many more"
                    ]
                  },
                  {
                    "text": "CYP450 is encoded by multiple genes and contains numerous polymorphisms that alter metabolism of drugs from patient to patient"
                  },
                  {
                    "text": "Due to these polymorphisms, pharmacogenetics has become important factor to consider in therapeutic drug monitoring and in occurrence of adverse drug reactions"
                  },
                  {
                    "text": "Currently, clinically relevant enzymes for pharmacogenetics include TPMT, CYP450 (CYP2D6, CYP2C19, CYP2C9), and NATs"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cholinergic Syndrome": {
            "name": "Cholinergic Syndrome",
            "url": "https://app.pathprimer.com/document/ddd55733-f3c5-4063-bb21-c1324dfe848e/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Cholinergic syndrome is due to increased acetylcholine activity"
                  },
                  {
                    "text": "SLUDGEandDUMBELLSare mnemonics for symptoms of increased cholinergic stimulation"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Cholinesterase activity is measured to assess exposure and to monitor reactivation during treatment; enzymes monitored include acetylcholinesterase and pseudocholinesterase (butyrylcholinesterase)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Cholinergic syndrome is due to increased acetylcholine activity"
                  },
                  {
                    "text": "Acetylcholine is neurotransmitter at preganglionic and postganglionic parasympathetic, preganglionic sympathetic, and somatic nerves"
                  },
                  {
                    "text": "Acetylcholine is important neurotransmitter in central nervous system (CNS)"
                  },
                  {
                    "text": "Cholinergic syndrome arises from acetylcholinesterase enzyme inhibition or direct agonist action at muscarinic or nicotinic receptors"
                  },
                  {
                    "text": "It is potentially lethal"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Cholinergic syndrome is a type of toxic syndrome (toxidrome)"
                  },
                  {
                    "text": "Toxidromes are essential for successful recognition of potential poisoning patterns"
                  },
                  {
                    "text": "Actual signs and symptoms vary depending onPatient variabilityIngestion dosePoison agentsStage of poisoning",
                    "sub_points": [
                      "Patient variability",
                      "Ingestion dose",
                      "Poison agents",
                      "Stage of poisoning"
                    ]
                  },
                  {
                    "text": "SLUDGEis mnemonic for symptoms of increased cholinergic stimulation﻿Salivation﻿Lacrimation (tearing)﻿Urination﻿Diaphoresis (sweat)﻿Gastrointestinal upset﻿Emesis (vomiting)",
                    "sub_points": [
                      "﻿Salivation",
                      "﻿Lacrimation (tearing)",
                      "﻿Urination",
                      "﻿Diaphoresis (sweat)",
                      "﻿Gastrointestinal upset",
                      "﻿Emesis (vomiting)"
                    ]
                  },
                  {
                    "text": "DUMBELLSis another mnemonic for cholinergic syndrome﻿Diarrhea﻿Urination﻿Miosis/muscle weakness﻿Bradycardia﻿Emesis﻿Lacrimation﻿Lethargy﻿Salivation/sweating",
                    "sub_points": [
                      "﻿Diarrhea",
                      "﻿Urination",
                      "﻿Miosis/muscle weakness",
                      "﻿Bradycardia",
                      "﻿Emesis",
                      "﻿Lacrimation",
                      "﻿Lethargy",
                      "﻿Salivation/sweating"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Spectrophotometric analysis measures cholinesterase activity to assess exposure and to monitor reactivation during treatmentAcetylcholinesteraseButyrylcholinesterase (or pseudocholinesterase)",
                    "sub_points": [
                      "Acetylcholinesterase",
                      "Butyrylcholinesterase (or pseudocholinesterase)"
                    ]
                  },
                  {
                    "text": "Agents that cause cholinergic clinical effectsOrganophosphateCarbamate insecticidesCertain species of mushroomNicotinic receptor agonists nicotine, lobeline, coniine",
                    "sub_points": [
                      "Organophosphate",
                      "Carbamate insecticides",
                      "Certain species of mushroom",
                      "Nicotinic receptor agonists nicotine, lobeline, coniine"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Diagnosis depends mainly onExposure historyPhysical presentationClinical suspicionLaboratory support",
                    "sub_points": [
                      "Exposure history",
                      "Physical presentation",
                      "Clinical suspicion",
                      "Laboratory support"
                    ]
                  },
                  {
                    "text": "Suspicion of specific compounds (e.g., organophosphate) can be analyzed by gas chromatography (GC) or liquid chromatography tandem-mass spectrometry (LC-MS/MS)"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Acetylcholinesterase measured in red blood cells (RBCs)"
                  },
                  {
                    "text": "Whole-blood samples collected to analyze acetylcholinesterase"
                  },
                  {
                    "text": "Pseudocholinesterase measured in serum"
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Oral contraceptives can result in decreased cholinesterase activities"
                  },
                  {
                    "text": "Hepatic disease may cause decrease (up to 70%) in enzyme levels"
                  },
                  {
                    "text": "Cholinesterase may be slightly elevated in patients with obesity or diabetes"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Therapeutic Drug Monitoring Strategy": {
            "name": "Therapeutic Drug Monitoring Strategy",
            "url": "https://app.pathprimer.com/document/69c06d61-8046-495e-aa51-baf13a5cfacd/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "CLINICAL CORRELATES": {
                "Goals of Therapeutic Drug Monitoring (TDM) Strategy": [
                  {
                    "text": "To determine or avoid toxicity associated with medication use"
                  },
                  {
                    "text": "To determine dose adjustment, assessment of loading dose or predicting future doses"
                  },
                  {
                    "text": "Monitoring medication compliance, assuring therapeutic drug levels, and determining failed therapy"
                  }
                ],
                "Indications for TDM": [
                  {
                    "text": "Drugs which have established correlation between plasma concentrations and effect"
                  },
                  {
                    "text": "Management or therapeutic dose of drug may change depending on plasma concentrations"
                  },
                  {
                    "text": "Drugs with narrow therapeutic index, to avoid under or over medication"
                  },
                  {
                    "text": "For patients with compliance difficulty"
                  },
                  {
                    "text": "TDM can be implemented before initial dose of medication (a priori) or after medication has been started or discontinued (a posteriori)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Cardiotropics"
                  },
                  {
                    "text": "Anticonvulsants"
                  },
                  {
                    "text": "Antiasthmatics"
                  },
                  {
                    "text": "Antiinflammatory and analgesics"
                  },
                  {
                    "text": "Immunosuppressants"
                  },
                  {
                    "text": "Lithium and tricyclic antidepressants"
                  },
                  {
                    "text": "Neuroleptics"
                  },
                  {
                    "text": "Chemotherapeutics"
                  },
                  {
                    "text": "Toxins (cyanide, alcohols, carbon monoxide, environmental carcinogens, heavy metals, organophosphates and carbamates)"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Immunoassay is utilized for essentially all TDM"
                  },
                  {
                    "text": "Usually done by fluorescence polarization immunoassay"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Testing is almost exclusively performed on serum samples rather than urine"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Impact of Sample Collection": {
            "name": "Impact of Sample Collection",
            "url": "https://app.pathprimer.com/document/c38d459b-fe58-4674-991e-d66539b5543d/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Serum sample: Advantages include reduced ability to adulterate specimen and its accuracy when attempting to determine blood concentrations"
                  },
                  {
                    "text": "Urine sample: Advantages include high-volume samples, easily detectable concentrations of compounds (generally), ease of collection, stability of sample, ability to freeze for later use, inexpensive testing, on-site testing kits, longer window of detection (compared to blood)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Overview": [
                  {
                    "text": "Most testing is performed on urine or serum samples"
                  },
                  {
                    "text": "Type of sample and type of testing can indicate method of collection, storage, transport, and many other preanalytical factors"
                  },
                  {
                    "text": "Less commonly used samples include saliva and hair"
                  }
                ],
                "Serum Samples": [
                  {
                    "text": "Obtained from blood collection, which must be done intravenously (invasive)"
                  },
                  {
                    "text": "Generally collected in red-top collection tubes, which do not contain additional compounds"
                  },
                  {
                    "text": "Best used for electrophoresis, chemistry analytes (except potassium), and in therapeutic drug monitoring and toxicology"
                  },
                  {
                    "text": "Provides most accurate correlation to acute blood value of compounds of interest"
                  },
                  {
                    "text": "AdvantagesReduced ability to adulterate specimen and its accuracy when attempting to determine blood concentrations",
                    "sub_points": [
                      "Reduced ability to adulterate specimen and its accuracy when attempting to determine blood concentrations"
                    ]
                  },
                  {
                    "text": "DisadvantagesShorter period of detection (compared to urine)Invasive collectionNeed for special storage and transportation methods decreases specimen stability",
                    "sub_points": [
                      "Shorter period of detection (compared to urine)",
                      "Invasive collection",
                      "Need for special storage and transportation methods decreases specimen stability"
                    ]
                  }
                ],
                "Urine Samples": [
                  {
                    "text": "Most commonly used samples for drugs of abuse"
                  },
                  {
                    "text": "AdvantagesEase of collectionHigh-volume samplesGenerally contain easily detectable concentrations of compoundsStability of sampleAbility to freeze for later useInexpensive testingOn-site testing kitsLonger window of detection (compared to blood)",
                    "sub_points": [
                      "Ease of collection",
                      "High-volume samples",
                      "Generally contain easily detectable concentrations of compounds",
                      "Stability of sample",
                      "Ability to freeze for later use",
                      "Inexpensive testing",
                      "On-site testing kits",
                      "Longer window of detection (compared to blood)"
                    ]
                  },
                  {
                    "text": "DisadvantagesAbility to tamper with sampleNo established correlation with plasma concentrations",
                    "sub_points": [
                      "Ability to tamper with sample",
                      "No established correlation with plasma concentrations"
                    ]
                  }
                ],
                "Hair Samples": [
                  {
                    "text": "Not widely used in clinical settings (despite ease of collection) due to its cumbersome testing"
                  },
                  {
                    "text": "AdvantagesEase of collectionVery stable sampleEasy to store and transportLong period of detectionGood indicator of chronic use or abuse",
                    "sub_points": [
                      "Ease of collection",
                      "Very stable sample",
                      "Easy to store and transport",
                      "Long period of detection",
                      "Good indicator of chronic use or abuse"
                    ]
                  },
                  {
                    "text": "DisadvantagesCumbersome testingExpensiveNo on-site kits for testingCannot detect recent drug use",
                    "sub_points": [
                      "Cumbersome testing",
                      "Expensive",
                      "No on-site kits for testing",
                      "Cannot detect recent drug use"
                    ]
                  }
                ],
                "Saliva Samples": [
                  {
                    "text": "Becoming more popular because of its noninvasive sample collection, and concentrations that can be correlated to blood concentrations"
                  },
                  {
                    "text": "High-sensitivity detection allows for detection of low concentrations"
                  },
                  {
                    "text": "AdvantagesEase of collectionAbility to witness collection (i.e., inability to tamper with sample)Good for measuring recent drug use",
                    "sub_points": [
                      "Ease of collection",
                      "Ability to witness collection (i.e., inability to tamper with sample)",
                      "Good for measuring recent drug use"
                    ]
                  },
                  {
                    "text": "DisadvantagesShort window of detection (similar to serum)",
                    "sub_points": [
                      "Short window of detection (similar to serum)"
                    ]
                  }
                ],
                "Nail Samples": [
                  {
                    "text": "Like hair samples, not widely used in clinical settings"
                  },
                  {
                    "text": "AdvantagesEase of collectionVery stable sampleEasy to store and transportLong period of detection",
                    "sub_points": [
                      "Ease of collection",
                      "Very stable sample",
                      "Easy to store and transport",
                      "Long period of detection"
                    ]
                  },
                  {
                    "text": "DisadvantagesRequires sensitive and specific analytical methodsMore research and experience needed for this relatively new source",
                    "sub_points": [
                      "Requires sensitive and specific analytical methods",
                      "More research and experience needed for this relatively new source"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sample Choice: Urine vs. Serum": {
            "name": "Sample Choice: Urine vs. Serum",
            "url": "https://app.pathprimer.com/document/85e813b4-9e50-4fbf-9c8c-dd52a7f07e20/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "CLINICAL CORRELATES": {
                "Overview": [
                  {
                    "text": "Urine and blood are 2 major samples for clinical toxicology and testing drug of abuse"
                  },
                  {
                    "text": "Random urine is commonly used"
                  }
                ],
                "Urine": [
                  {
                    "text": "Most commonly used sample for drugs of abuse"
                  },
                  {
                    "text": "AdvantagesHigh-volume sampleEasily detectable concentrations of compoundsEase of collectionSample stabilityAbility to freeze sampleInexpensive testingOn-site testing kits availableLong window of detection (compared to blood or serum)",
                    "sub_points": [
                      "High-volume sample",
                      "Easily detectable concentrations of compounds",
                      "Ease of collection",
                      "Sample stability",
                      "Ability to freeze sample",
                      "Inexpensive testing",
                      "On-site testing kits available",
                      "Long window of detection (compared to blood or serum)"
                    ]
                  },
                  {
                    "text": "DisadvantagesAbility to tamper with sampleNo established correlation of urine and plasma concentrations",
                    "sub_points": [
                      "Ability to tamper with sample",
                      "No established correlation of urine and plasma concentrations"
                    ]
                  }
                ],
                "Serum": [
                  {
                    "text": "Obtained from blood sample"
                  },
                  {
                    "text": "Usually collected in red-top tubes with no additives"
                  },
                  {
                    "text": "Best for electrophoresis, chemistry analytes (except potassium), and therapeutic drug monitoring (TDM) or toxicology testing"
                  },
                  {
                    "text": "Correlated most accurately with acute blood levels of compounds of interest"
                  },
                  {
                    "text": "AdvantagesReduced ability to tamper with specimenIncreased accuracy for quantification of blood levels",
                    "sub_points": [
                      "Reduced ability to tamper with specimen",
                      "Increased accuracy for quantification of blood levels"
                    ]
                  },
                  {
                    "text": "DisadvantagesShorter period of detection (compared to urine)Requires invasive collectionMay require special storage and transport methodsMay have decreased specimen stability (compared to urine)",
                    "sub_points": [
                      "Shorter period of detection (compared to urine)",
                      "Requires invasive collection",
                      "May require special storage and transport methods",
                      "May have decreased specimen stability (compared to urine)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection": [
                  {
                    "text": "UrineRandom clean catch urine sample",
                    "sub_points": [
                      "Random clean catch urine sample"
                    ]
                  },
                  {
                    "text": "BloodRed-top tube collection preferred",
                    "sub_points": [
                      "Red-top tube collection preferred"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sample Choice: Urine vs. Saliva": {
            "name": "Sample Choice: Urine vs. Saliva",
            "url": "https://app.pathprimer.com/document/fb5c5c8c-c5eb-4c72-9f8c-6d7b8c68b1bd/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "LABORATORY DIAGNOSIS": {
                "Urine": [
                  {
                    "text": "Most commonly used sample for drugs of abuse"
                  },
                  {
                    "text": "AdvantagesHigh-volume samplesGenerally contains easily detectable concentrations of compoundsEasy collectionStable samplesAbility to freeze for later useInexpensiveOn-site testing kits can be usedLonger window of detection (compared to blood)",
                    "sub_points": [
                      "High-volume samples",
                      "Generally contains easily detectable concentrations of compounds",
                      "Easy collection",
                      "Stable samples",
                      "Ability to freeze for later use",
                      "Inexpensive",
                      "On-site testing kits can be used",
                      "Longer window of detection (compared to blood)"
                    ]
                  },
                  {
                    "text": "DisadvantagesAbility to tamper with sampleNo established correlation with plasma concentrations",
                    "sub_points": [
                      "Ability to tamper with sample",
                      "No established correlation with plasma concentrations"
                    ]
                  }
                ],
                "Saliva": [
                  {
                    "text": "Use of saliva in drug testing is becoming more popular due to its noninvasive sample collection and concentrations that can be correlated to blood concentrations"
                  },
                  {
                    "text": "High-sensitivity detection allows for detection of low concentrations"
                  },
                  {
                    "text": "AdvantagesEasy collectionAbility to witness collection (i.e., inability to tamper with sample)Good for measuring recent drug use",
                    "sub_points": [
                      "Easy collection",
                      "Ability to witness collection (i.e., inability to tamper with sample)",
                      "Good for measuring recent drug use"
                    ]
                  },
                  {
                    "text": "DisadvantagesShort window of detection (similar to serum)Hygiene and pH effects﻿Differences in parent/metabolite profiles (compared with urine and serum)",
                    "sub_points": [
                      "Short window of detection (similar to serum)",
                      "Hygiene and pH effects﻿",
                      "Differences in parent/metabolite profiles (compared with urine and serum)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Forensic Toxicology: Chain of Custody": {
            "name": "Forensic Toxicology: Chain of Custody",
            "url": "https://app.pathprimer.com/document/4b97f935-67ab-4f25-a3f9-58627928eb24/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "CLINICAL CORRELATES": {
                "Background and Concepts": [
                  {
                    "text": "Forensic testingGathering of data for analysis and use in legal proceedingsLegal aspect of forensic testing differentiates it from clinical testingSamples must be handled in a certain waySpecific testing methods are used, as required by lawDocumentation in the chain of custody fashion is required",
                    "sub_points": [
                      "Gathering of data for analysis and use in legal proceedings",
                      "Legal aspect of forensic testing differentiates it from clinical testingSamples must be handled in a certain waySpecific testing methods are used, as required by lawDocumentation in the chain of custody fashion is required",
                      "Samples must be handled in a certain way",
                      "Specific testing methods are used, as required by law",
                      "Documentation in the chain of custody fashion is required"
                    ]
                  },
                  {
                    "text": "Chain of custodyRequired as an essential component of forensic toxicologyProcess is to maintain control and accountability of each specimen from point of collection to final dispositionStaff members handling forensic samples require special trainingSpecimen must be placed in permanently sealed, tamper-evident containerDocumentation required of every person who handles a sample and every location where sample is takenCorrect procedure is essential to ensure positive identity of samples when forensic results are admitted in court",
                    "sub_points": [
                      "Required as an essential component of forensic toxicologyProcess is to maintain control and accountability of each specimen from point of collection to final dispositionStaff members handling forensic samples require special trainingSpecimen must be placed in permanently sealed, tamper-evident containerDocumentation required of every person who handles a sample and every location where sample is takenCorrect procedure is essential to ensure positive identity of samples when forensic results are admitted in court",
                      "Process is to maintain control and accountability of each specimen from point of collection to final dispositionStaff members handling forensic samples require special trainingSpecimen must be placed in permanently sealed, tamper-evident containerDocumentation required of every person who handles a sample and every location where sample is taken",
                      "Staff members handling forensic samples require special training",
                      "Specimen must be placed in permanently sealed, tamper-evident container",
                      "Documentation required of every person who handles a sample and every location where sample is taken",
                      "Correct procedure is essential to ensure positive identity of samples when forensic results are admitted in court"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Organic and Inorganic Arsenic": {
            "name": "Organic and Inorganic Arsenic",
            "url": "https://app.pathprimer.com/document/f3cdc8bc-447b-41dc-a5bf-a89d2b1ac2c6/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Inorganic forms of arsenic more toxic than organic forms"
                  },
                  {
                    "text": "Arsenic toxic to nearly all organ systems"
                  },
                  {
                    "text": "Arsenic toxicity can be treated with chelating agents"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Inorganic forms of arsenic more toxic than organic forms"
                  },
                  {
                    "text": "Arsenic toxic to nearly all organ systems"
                  },
                  {
                    "text": "Trivalent forms more toxic than pentavalent forms"
                  },
                  {
                    "text": "Trivalent arsenic inhibits numerous cellular enzymes through sulfhydryl group bindingInhibits pyruvate dehydrogenaseDecreases gluconeogenesisReduces oxidative phosphorylationInhibits fatty acid oxidationInhibits production of glutathione",
                    "sub_points": [
                      "Inhibits pyruvate dehydrogenase",
                      "Decreases gluconeogenesis",
                      "Reduces oxidative phosphorylation",
                      "Inhibits fatty acid oxidation",
                      "Inhibits production of glutathione"
                    ]
                  },
                  {
                    "text": "Pentavalent inorganic arsenic toxicityOccurs partly because of its transformation to trivalent arsenicOccurs due to its resemblance to inorganic phosphateHigh-energy phosphate bonds are not made, and oxidative phosphorylation does not occurIn presence of arsenic, adenosine diphosphate (ADP)-arsenic is formed instead of adenosine triphosphate (ATP)",
                    "sub_points": [
                      "Occurs partly because of its transformation to trivalent arsenic",
                      "Occurs due to its resemblance to inorganic phosphateHigh-energy phosphate bonds are not made, and oxidative phosphorylation does not occurIn presence of arsenic, adenosine diphosphate (ADP)-arsenic is formed instead of adenosine triphosphate (ATP)",
                      "High-energy phosphate bonds are not made, and oxidative phosphorylation does not occur",
                      "In presence of arsenic, adenosine diphosphate (ADP)-arsenic is formed instead of adenosine triphosphate (ATP)"
                    ]
                  },
                  {
                    "text": "Arsine gas is most dangerous of 3 forms of arsenic"
                  },
                  {
                    "text": "Although no scientific consensus exists, arsenic is listed as presumed carcinogenic substance"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "According to American Association of Poison Control Centers National Poisoning Data System (NPDS) 2014 annual report738 human exposures related to arsenic (excluding pesticides)More than 50% were adults ≥ 20 years old (405/738 cases)2nd highest impacted population was children ≤ 4 years old (124/738 cases)34 exposures related to arsenic-containing pesticidesMost exposures were children ≤ 4 years old (16/34 cases)2nd highest impacted population was adults ≥ 21 years (11/34 cases)",
                    "sub_points": [
                      "738 human exposures related to arsenic (excluding pesticides)More than 50% were adults ≥ 20 years old (405/738 cases)2nd highest impacted population was children ≤ 4 years old (124/738 cases)",
                      "More than 50% were adults ≥ 20 years old (405/738 cases)",
                      "2nd highest impacted population was children ≤ 4 years old (124/738 cases)",
                      "34 exposures related to arsenic-containing pesticidesMost exposures were children ≤ 4 years old (16/34 cases)2nd highest impacted population was adults ≥ 21 years (11/34 cases)",
                      "Most exposures were children ≤ 4 years old (16/34 cases)",
                      "2nd highest impacted population was adults ≥ 21 years (11/34 cases)"
                    ]
                  },
                  {
                    "text": "Worldwide, 100 million people at risk of exposure due to excessive arsenic levels in drinking water"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Acute severe arsenic poisoningVital signsTachycardiaHypotensionSometimes shockCentral nervous system (CNS)Altered mental statusDeliriumComaSeizuresPatients often have garlic smell to their breath and tissue fluids",
                    "sub_points": [
                      "Vital signsTachycardiaHypotensionSometimes shock",
                      "Tachycardia",
                      "Hypotension",
                      "Sometimes shock",
                      "Central nervous system (CNS)Altered mental statusDeliriumComaSeizures",
                      "Altered mental status",
                      "Delirium",
                      "Coma",
                      "Seizures",
                      "Patients often have garlic smell to their breath and tissue fluids"
                    ]
                  },
                  {
                    "text": "Acute exposuresCholera-like gastrointestinal (GI) symptoms of vomiting and severe diarrhea (both often bloody)Acute distressDehydration (often)Hypovolemic shock",
                    "sub_points": [
                      "Cholera-like gastrointestinal (GI) symptoms of vomiting and severe diarrhea (both often bloody)",
                      "Acute distress",
                      "Dehydration (often)",
                      "Hypovolemic shock"
                    ]
                  },
                  {
                    "text": "Chronic exposurePresentation more insidiousMay manifest as classic dermatitis or peripheral neuropathyWhitish lines (Mees lines) on fingernailsChronic hepatic and renal damage common",
                    "sub_points": [
                      "Presentation more insidious",
                      "May manifest as classic dermatitis or peripheral neuropathy",
                      "Whitish lines (Mees lines) on fingernails",
                      "Chronic hepatic and renal damage common"
                    ]
                  },
                  {
                    "text": "Arsine gas exposureManifests with acute hemolytic anemia and striking chillsBlack urine due to hemoglobinuriaShaking chills often described",
                    "sub_points": [
                      "Manifests with acute hemolytic anemia and striking chills",
                      "Black urine due to hemoglobinuria",
                      "Shaking chills often described"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Acute arsenic poisoningSupportive careOrogastric lavage recommended if arsenic present in stomachActivated charcoal does not adsorb arsenic appreciably, so not recommendedWhole-bowel irrigation with polyethylene glycol may be effective to prevent GI tract absorption of arsenicChelating agentsDimercaprol or British antilewisite (BAL) oilFirst-line agent available in United States for treating arsenic poisoning2,3-DithioerythritolLess toxic derivative of BALSuccimerFood and Drug Administration (FDA) approved for childhood lead poisoning and demonstrated as efficacious for arsenic poisoning",
                    "sub_points": [
                      "Supportive careOrogastric lavage recommended if arsenic present in stomachActivated charcoal does not adsorb arsenic appreciably, so not recommendedWhole-bowel irrigation with polyethylene glycol may be effective to prevent GI tract absorption of arsenic",
                      "Orogastric lavage recommended if arsenic present in stomach",
                      "Activated charcoal does not adsorb arsenic appreciably, so not recommended",
                      "Whole-bowel irrigation with polyethylene glycol may be effective to prevent GI tract absorption of arsenic",
                      "Chelating agentsDimercaprol or British antilewisite (BAL) oilFirst-line agent available in United States for treating arsenic poisoning2,3-DithioerythritolLess toxic derivative of BALSuccimerFood and Drug Administration (FDA) approved for childhood lead poisoning and demonstrated as efficacious for arsenic poisoning",
                      "Dimercaprol or British antilewisite (BAL) oilFirst-line agent available in United States for treating arsenic poisoning",
                      "First-line agent available in United States for treating arsenic poisoning",
                      "2,3-DithioerythritolLess toxic derivative of BAL",
                      "Less toxic derivative of BAL",
                      "SuccimerFood and Drug Administration (FDA) approved for childhood lead poisoning and demonstrated as efficacious for arsenic poisoning",
                      "Food and Drug Administration (FDA) approved for childhood lead poisoning and demonstrated as efficacious for arsenic poisoning"
                    ]
                  },
                  {
                    "text": "Organic arsenic exposure (typically found in urine) not an indication of arsenic toxicityDoes not warrant therapeutic intervention",
                    "sub_points": [
                      "Does not warrant therapeutic intervention"
                    ]
                  }
                ],
                "Prevention": [
                  {
                    "text": "Reduce exposure to inorganic arsenic compounds (e.g., pesticides)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Total arsenic﻿Summation of all fractionated arsenic compounds",
                    "sub_points": [
                      "Summation of all fractionated arsenic compounds"
                    ]
                  },
                  {
                    "text": "Fractionated arsenicArsenic, organicArsenic, inorganicArsenic, methylated",
                    "sub_points": [
                      "Arsenic, organic",
                      "Arsenic, inorganic",
                      "Arsenic, methylated"
                    ]
                  },
                  {
                    "text": "CreatinineUsed to standardize urine volume and concentration",
                    "sub_points": [
                      "Used to standardize urine volume and concentration"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Quantitative inductively coupled plasma-mass spectrometry"
                  },
                  {
                    "text": "Quantitative high-performance liquid chromatography"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Sample typesUrineHairNailsBlood",
                    "sub_points": [
                      "Urine",
                      "Hair",
                      "Nails",
                      "Blood"
                    ]
                  },
                  {
                    "text": "UrinePreferred sample type24-hour or random urine collectionSpecimen must be collected in plastic container and refrigeratedStabilityAmbient: 1 weekRefrigerated: 2 weeksFrozen: 1 yearAvoid shellfish and seafood for 48-72 hours before collection",
                    "sub_points": [
                      "Preferred sample type",
                      "24-hour or random urine collectionSpecimen must be collected in plastic container and refrigerated",
                      "Specimen must be collected in plastic container and refrigerated",
                      "StabilityAmbient: 1 weekRefrigerated: 2 weeksFrozen: 1 year",
                      "Ambient: 1 week",
                      "Refrigerated: 2 weeks",
                      "Frozen: 1 year",
                      "Avoid shellfish and seafood for 48-72 hours before collection"
                    ]
                  },
                  {
                    "text": "BloodMay be useful for detection of recent exposure (< 24 hours after) &/or large-dose arsenic exposureRoyal blue tubes (K2EDTA or Na2EDTA)﻿Avoid shellfish and seafood for 48-72 hours before collection",
                    "sub_points": [
                      "May be useful for detection of recent exposure (< 24 hours after) &/or large-dose arsenic exposure",
                      "Royal blue tubes (K2EDTA or Na2EDTA)﻿",
                      "Avoid shellfish and seafood for 48-72 hours before collection"
                    ]
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Gadolinium (Gd)-containing contrast media"
                  },
                  {
                    "text": "Contamination from non-trace metal-free collection tubes"
                  },
                  {
                    "text": "Contamination from blood and fecal material for urine samples"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Blood0.0-13.0 µg/LPotentially toxic ranges for blood arsenic: ≥ 600 µg/L",
                    "sub_points": [
                      "0.0-13.0 µg/L",
                      "Potentially toxic ranges for blood arsenic: ≥ 600 µg/L"
                    ]
                  },
                  {
                    "text": "UrineArsenic, urine (per volume): 0.0-35.0 µg/L (based on biologic exposure indices [BEI])Arsenic, urine (per 24 hours): 0.0-50.0 µg/dArsenic, urine (ratio to creatinine): < 30.0 μg/g creatinine",
                    "sub_points": [
                      "Arsenic, urine (per volume): 0.0-35.0 µg/L (based on biologic exposure indices [BEI])",
                      "Arsenic, urine (per 24 hours): 0.0-50.0 µg/d",
                      "Arsenic, urine (ratio to creatinine): < 30.0 μg/g creatinine"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Opiates and Pathways": {
            "name": "Opiates and Pathways",
            "url": "https://app.pathprimer.com/document/91204cab-e086-4ded-b144-e70717ae8b77/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Heroin = most commonly abused opiate (rapid onset) in United States; harbors highly addictive potential"
                  },
                  {
                    "text": "Prescription opiate abuse is also rising"
                  },
                  {
                    "text": "Urine excretion contains predominantly morphine-3-glucuronide, but small amount of morphine can be excreted renally"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "False-positive results can be due to poppy seed ingestion and fluoroquinolones"
                  },
                  {
                    "text": "False-negative results are frequent with prescription opiate use or abuse"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Class of alkaloid compounds found in opium plant (morphine, codeine)"
                  },
                  {
                    "text": "Derivatives of opiates are considered semi-opiates (heroin,oxycodone, hydrocodone, hydromorphone, oxymorphone)Generally act through mu receptors to induce analgesic effect, which results in release of dopamine",
                    "sub_points": [
                      "Generally act through mu receptors to induce analgesic effect, which results in release of dopamine"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Heroin = most commonly abused opiate (rapid onset) in US; harbors highly addictive potential"
                  },
                  {
                    "text": "Prescription opiate abuse is also rising"
                  },
                  {
                    "text": "Intoxication manifestationsConfusionDeliriumRespiratory depressionNausea and vomitingDecreased GI motilityConstricted pupilsArrhythmias",
                    "sub_points": [
                      "Confusion",
                      "Delirium",
                      "Respiratory depression",
                      "Nausea and vomiting",
                      "Decreased GI motility",
                      "Constricted pupils",
                      "Arrhythmias"
                    ]
                  },
                  {
                    "text": "Long-term use can lead to lung fibrosis and dependencyIntravenous heroin users often have needle track marks on arms (and subsequent skin infections) and endocarditis",
                    "sub_points": [
                      "Intravenous heroin users often have needle track marks on arms (and subsequent skin infections) and endocarditis"
                    ]
                  },
                  {
                    "text": "Acute overdoses are counteracted with naloxoneLong-term management may be attempted with methadone (partial agonist of heroin)",
                    "sub_points": [
                      "Long-term management may be attempted with methadone (partial agonist of heroin)"
                    ]
                  },
                  {
                    "text": "Withdrawal onset is within 12 hours of last heroin useWithdrawal symptomsAgitationAnxietyRhinorrheaSweatingAs symptoms progressAbdominal crampingDiarrheaNauseaVomiting",
                    "sub_points": [
                      "Withdrawal symptomsAgitationAnxietyRhinorrheaSweating",
                      "Agitation",
                      "Anxiety",
                      "Rhinorrhea",
                      "Sweating",
                      "As symptoms progressAbdominal crampingDiarrheaNauseaVomiting",
                      "Abdominal cramping",
                      "Diarrhea",
                      "Nausea",
                      "Vomiting"
                    ]
                  },
                  {
                    "text": "Buprenorphine has been show to shorten detoxification"
                  }
                ],
                "Metabolism": [
                  {
                    "text": "HeroinQuickly metabolized (< 1 minute) to its active form 6-aceytlmorphineFurther metabolized via hydrolysis to active form morphine in < 40 minutesMorphine further metabolized into morphine-3-glucuronide (inactive) and morphine-6-glucuronide (more active than morphine) via glucuronidationUrine excretion contains predominantly morphine-3-glucuronide, but small amount of morphine can be excreted renally",
                    "sub_points": [
                      "Quickly metabolized (< 1 minute) to its active form 6-aceytlmorphineFurther metabolized via hydrolysis to active form morphine in < 40 minutesMorphine further metabolized into morphine-3-glucuronide (inactive) and morphine-6-glucuronide (more active than morphine) via glucuronidation",
                      "Further metabolized via hydrolysis to active form morphine in < 40 minutes",
                      "Morphine further metabolized into morphine-3-glucuronide (inactive) and morphine-6-glucuronide (more active than morphine) via glucuronidation",
                      "Urine excretion contains predominantly morphine-3-glucuronide, but small amount of morphine can be excreted renally"
                    ]
                  },
                  {
                    "text": "CodeineCodeine is metabolized into morphine (10%) via O-methylation, hydrocodone, and norcodeine via N-methylationMorphine then undergoes metabolic pathway described aboveMetabolism to morphine is mediated throughCYP2D6Genetic variants may be fast or slow metabolizerBoth codeine and morphine can be detected in urine; hydrocodone may be detected with higher doses of codeine",
                    "sub_points": [
                      "Codeine is metabolized into morphine (10%) via O-methylation, hydrocodone, and norcodeine via N-methylationMorphine then undergoes metabolic pathway described aboveMetabolism to morphine is mediated throughCYP2D6Genetic variants may be fast or slow metabolizer",
                      "Morphine then undergoes metabolic pathway described above",
                      "Metabolism to morphine is mediated throughCYP2D6Genetic variants may be fast or slow metabolizer",
                      "Genetic variants may be fast or slow metabolizer",
                      "Both codeine and morphine can be detected in urine; hydrocodone may be detected with higher doses of codeine"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Most immunoassays detect morphine"
                  },
                  {
                    "text": "Varying assay platforms can increase sensitivity for other opioid compounds or metabolites"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Immunoassay is first screening test for opiates"
                  },
                  {
                    "text": "Confirmation is performed via gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS)"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Urine samples are used for testing"
                  }
                ],
                "Interfering Substances and Special Considerations": [
                  {
                    "text": "False-positive results can be due to poppy seed ingestion and fluoroquinolones; setting appropriate cut-off values for true positive test is essential in evaluation of these results"
                  },
                  {
                    "text": "False-negative results are frequent with prescription opiate use or abuseAttributed to large number and variety of assays available, each with different sensitivity for various opioids and their metabolitesAdditionally, opioids themselves are diverse class of drugs and may not be detected with limited set of antibodies available for assays",
                    "sub_points": [
                      "Attributed to large number and variety of assays available, each with different sensitivity for various opioids and their metabolites",
                      "Additionally, opioids themselves are diverse class of drugs and may not be detected with limited set of antibodies available for assays"
                    ]
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Vary with each assay and compound of interest"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Benzodiazepine Pathway": {
            "name": "Benzodiazepine Pathway",
            "url": "https://app.pathprimer.com/document/ed204396-9a8e-4c70-8511-765b80973d3d/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Benzodiazepines (BZDs) produce depressant effect on central nervous system by activating GABA receptors"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Urine or serum immunoassay is method of choice as screening test for suspected overdoseIf screening test is positive, confirmatory test is performed via GC-MS",
                    "sub_points": [
                      "If screening test is positive, confirmatory test is performed via GC-MS"
                    ]
                  },
                  {
                    "text": "Detection by most immunoassays is enhanced by prior hydrolysis of urine with p-glucuronidase"
                  },
                  {
                    "text": "Oxaprozin (NSAID) is known to cause false-positive test result due to interference, rarely"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Benzodiazepines (BZDs): Class of compounds of minor tranquilizers with shared common molecular structure and similar pharmacological activity, including antianxiety, sedative, hypnotic, amnesic, anticonvulsant, and muscle relaxing effects"
                  },
                  {
                    "text": "BZDs produce depressant effect on central nervous system by activating GABA receptors"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "BZDs are safer than barbiturates and are now drug of choice; widely prescribedMuch lower addiction potentialDevelopment of tolerance can still occur with prolonged useGreater efficacyFewer side effects",
                    "sub_points": [
                      "Much lower addiction potentialDevelopment of tolerance can still occur with prolonged use",
                      "Development of tolerance can still occur with prolonged use",
                      "Greater efficacy",
                      "Fewer side effects"
                    ]
                  },
                  {
                    "text": "Withdrawal symptomsAnxietyTremorsAnorexiaNauseaVomitingConvulsions",
                    "sub_points": [
                      "Anxiety",
                      "Tremors",
                      "Anorexia",
                      "Nausea",
                      "Vomiting",
                      "Convulsions"
                    ]
                  },
                  {
                    "text": "Toxicity can manifest in various waysDrowsinessSlurred speechAtaxiaComaRespiratory depression or cardiotoxic effectsDeath is rare; usually in setting of multiple drug ingestion",
                    "sub_points": [
                      "Drowsiness",
                      "Slurred speech",
                      "Ataxia",
                      "Coma",
                      "Respiratory depression or cardiotoxic effects",
                      "Death is rare; usually in setting of multiple drug ingestion"
                    ]
                  },
                  {
                    "text": "Clinically important to detect presence of BZD alone and in presence of other compounds in cases of coingestion (e.g., opioids, tricyclic antidepressants, barbiturates)Combined ingestion of these compounds can lead to decreased metabolism, and therefore increased toxicity",
                    "sub_points": [
                      "Combined ingestion of these compounds can lead to decreased metabolism, and therefore increased toxicity"
                    ]
                  },
                  {
                    "text": "Abuse of these drugs is usually in combination with alcohol or other drugs (such as heroin to potentiate it’s effect)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treatment for overdose is generally supportive careAntagonist: Flumazenil, usually reserved for cases of multiple drug overdose &/or comaFlumazenil does not interfere with immunoassays used for BZD detection",
                    "sub_points": [
                      "Antagonist: Flumazenil, usually reserved for cases of multiple drug overdose &/or comaFlumazenil does not interfere with immunoassays used for BZD detection",
                      "Flumazenil does not interfere with immunoassays used for BZD detection"
                    ]
                  }
                ],
                "Metabolism": [
                  {
                    "text": "Because BZDs are largely protein bound (more than 85%), they confer large volume of distribution"
                  },
                  {
                    "text": "Metabolized through liver via hepatic oxidation and conjugation; many downstream products are active metabolitesSome are metabolized to oxazepam, which is excreted in urine as inactive metabolite (glucuronide)Some are first inactivated through glucuronidation and may or may not be further metabolized (e.g., lorazepam, temazepam)Some are metabolized quickly, prior to reaching significant concentrations in blood after administration, either by metabolism in stomach or by first-pass hepatic metabolism (e.g., clorazepate → nordiazepam in stomach acid, or flurazepam → prazepam in liver)",
                    "sub_points": [
                      "Some are metabolized to oxazepam, which is excreted in urine as inactive metabolite (glucuronide)",
                      "Some are first inactivated through glucuronidation and may or may not be further metabolized (e.g., lorazepam, temazepam)",
                      "Some are metabolized quickly, prior to reaching significant concentrations in blood after administration, either by metabolism in stomach or by first-pass hepatic metabolism (e.g., clorazepate → nordiazepam in stomach acid, or flurazepam → prazepam in liver)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Any compounds classified within BZD family"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Urine or serum immunoassay is method of choice as screening test for suspected overdoseGas chromatography–mass spectrometry (GC-MS) or liquid chromatography–mass spectrometry (LC-MS) used for confirmation of positive immunoassay test results or in suspected BZD ingestion cases with negative immunoassay test resultsGC-MS includes urine hydrolysis stepLC-MS typically uses dilute-and-shoot method",
                    "sub_points": [
                      "Gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–mass spectrometry (LC-MS) used for confirmation of positive immunoassay test results or in suspected BZD ingestion cases with negative immunoassay test resultsGC-MS includes urine hydrolysis stepLC-MS typically uses dilute-and-shoot method",
                      "GC-MS includes urine hydrolysis step",
                      "LC-MS typically uses dilute-and-shoot method"
                    ]
                  }
                ],
                "Biochemical Tests": [
                  {
                    "text": "Many commercial immunoassays are availableEach differs in type of BZDs and metabolites and glucuronide conjugates they can detect",
                    "sub_points": [
                      "Each differs in type of BZDs and metabolites and glucuronide conjugates they can detect"
                    ]
                  },
                  {
                    "text": "Benzodiazepine immunoassays have low sensitivity for detection"
                  },
                  {
                    "text": "Detection by most immunoassays is enhanced by prior hydrolysis of urine with p-glucuronidaseHydrolysis is needed to detect oxazepam, teinazepam, nordiazepam, and lorazepam",
                    "sub_points": [
                      "Hydrolysis is needed to detect oxazepam, teinazepam, nordiazepam, and lorazepam"
                    ]
                  },
                  {
                    "text": "Factors affecting detectionImmunoassay usedHydrolysis step includedSpecific BZD ingestedDoseDuration of drug ingestion",
                    "sub_points": [
                      "Immunoassay used",
                      "Hydrolysis step included",
                      "Specific BZD ingested",
                      "Dose",
                      "Duration of drug ingestion"
                    ]
                  },
                  {
                    "text": "Long-acting BZDs (diazepam, chlordiazepoxide, chlorazepate) are administered in larger doses and can be detected for longer periods of time (up to months)"
                  },
                  {
                    "text": "Short-acting BZDs (alprazolam, triazolam) are detected for period of days"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Clean urine or venous blood samples"
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Oxaprozin (NSAID) is known to cause false-positive test result due to interference, rarely"
                  },
                  {
                    "text": "False-negative test results are common due to variability of immunoassay platforms"
                  },
                  {
                    "text": "Flunitrazepam (Rophypnol) is difficult to detect due to its low level dose and low level of cross-reactivity of 7-aminoflunitrazepam (main metabolite found in urine)Highly selective ELISA improves detectionIn suspected cases of date rape and with negative immunoassay testing, GC-MS may be useful",
                    "sub_points": [
                      "Highly selective ELISA improves detection",
                      "In suspected cases of date rape and with negative immunoassay testing, GC-MS may be useful"
                    ]
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Vary depending on assay platform used and compound of interest"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Clonazepam Testing": {
            "name": "Clonazepam Testing",
            "url": "https://app.pathprimer.com/document/aa47cdb2-4d8b-46c6-880e-71ec566eff94/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Clonazepam: Benzodiazepine (BZD) that produces depressant effect on central nervous system by activating GABA receptors"
                  },
                  {
                    "text": "Half-life = ~ 20-60 hours"
                  },
                  {
                    "text": "Clonazepam is eliminated in urine as 7-amino-3-hydroxy conjugates at low levels"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Best method of detection is via liquid chromatography–mass spectrometry (LC-MS) on serum or plasma sample"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Clonazepam: Benzodiazepine that produces depressant effect on central nervous system by activating GABA receptorsGenerally used as anti-convulsant for seizure disorders",
                    "sub_points": [
                      "Generally used as anti-convulsant for seizure disorders"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Withdrawal symptoms includeAnxietyTremorsAnorexiaNauseaVomitingConvulsions",
                    "sub_points": [
                      "Anxiety",
                      "Tremors",
                      "Anorexia",
                      "Nausea",
                      "Vomiting",
                      "Convulsions"
                    ]
                  },
                  {
                    "text": "Toxicity presentation includesDrowsinessSlurred speechAtaxia and comaRespiratory depression or cardiotoxic effect",
                    "sub_points": [
                      "Drowsiness",
                      "Slurred speech",
                      "Ataxia and coma",
                      "Respiratory depression or cardiotoxic effect"
                    ]
                  },
                  {
                    "text": "Half-life = ~ 20-60 hours"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Overdose is generally treated with supportive careAntagonist: Flumazenil, usually reserved for cases of multiple drug overdose &/or comaFlumazenil does not interfere with immunoassays used for BZD detection",
                    "sub_points": [
                      "Antagonist: Flumazenil, usually reserved for cases of multiple drug overdose &/or comaFlumazenil does not interfere with immunoassays used for BZD detection",
                      "Flumazenil does not interfere with immunoassays used for BZD detection"
                    ]
                  }
                ],
                "Metabolism and Excretion": [
                  {
                    "text": "Clonazepam is eliminated in urine as 7-amino-3-hydroxy conjugates at low levelsUndergoes various metabolism stages resulting in 7-amino-3-hydroxy conjugates, eventually into glucuronide",
                    "sub_points": [
                      "Undergoes various metabolism stages resulting in 7-amino-3-hydroxy conjugates, eventually into glucuronide"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "7-amino-3-hydroxy conjugates"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Detection of clonazepam is not effectively done via traditional immunoassays for BZDs on urine samples due to decreased levels"
                  },
                  {
                    "text": "Best method of detection is via LC-MS on serum or plasma sample"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Serum or plasma sample is tested within 2 hours of collectionCollection should be done in gray-top tube, however can be collected in red-, green-, lavender-, or pink-top tubesSample must be transported in refrigerated environment; will remain stable for up to 3 years if frozen",
                    "sub_points": [
                      "Collection should be done in gray-top tube, however can be collected in red-, green-, lavender-, or pink-top tubes",
                      "Sample must be transported in refrigerated environment; will remain stable for up to 3 years if frozen"
                    ]
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Therapeutic dosesPediatric patients: 20-70 ng/mLAdult patients: 1-8 mg/dL",
                    "sub_points": [
                      "Pediatric patients: 20-70 ng/mL",
                      "Adult patients: 1-8 mg/dL"
                    ]
                  },
                  {
                    "text": "Toxic doses > 80 ng/mL"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Screening vs. Confirmation": {
            "name": "Screening vs. Confirmation",
            "url": "https://app.pathprimer.com/document/166b710f-be6c-4735-be3f-cac85dcd528e/lesson/c37a21e1-b81e-4fb3-b57c-9a4258f2ddc9",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Screening tests are always first step of testingIn drug testing, these are most often immunoassays",
                    "sub_points": [
                      "In drug testing, these are most often immunoassays"
                    ]
                  },
                  {
                    "text": "Confirmation tests are implemented after positive result on screening test"
                  },
                  {
                    "text": "Confirmation for drug testing is usually done via gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–mass spectrometry (LC-MS)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Basic Concepts": [
                  {
                    "text": "Laboratory tests are generally categorized as screening tests or confirmation testsScreening test: Laboratory test that helps to identify population with condition, disease, or other characteristicConfirmation test: Generally utilized to distinguish between those with truly positive test result and those with false-positive result",
                    "sub_points": [
                      "Screening test: Laboratory test that helps to identify population with condition, disease, or other characteristic",
                      "Confirmation test: Generally utilized to distinguish between those with truly positive test result and those with false-positive result"
                    ]
                  }
                ],
                "Screening Test": [
                  {
                    "text": "Screening tests are always first step of testing"
                  },
                  {
                    "text": "In drug testing, these are most often immunoassays, which can exhibit some cross-reactivity"
                  },
                  {
                    "text": "Attributes of screening testRapid performanceHigh sensitivityInexpensiveOn site (if possible)Usually qualitative (provide positive or negative result)",
                    "sub_points": [
                      "Rapid performance",
                      "High sensitivity",
                      "Inexpensive",
                      "On site (if possible)",
                      "Usually qualitative (provide positive or negative result)"
                    ]
                  },
                  {
                    "text": "Disadvantages of screening testUsually have low specificity (can result in false-positives)Can result in false-negatives (depending on antibodies and limits of detection cut-offs)",
                    "sub_points": [
                      "Usually have low specificity (can result in false-positives)",
                      "Can result in false-negatives (depending on antibodies and limits of detection cut-offs)"
                    ]
                  }
                ],
                "Confirmation Test": [
                  {
                    "text": "Confirmation tests are implemented after positive result on screening test"
                  },
                  {
                    "text": "Essential in drug testing, as immunoassays are not highly specific and may result in false-positives"
                  },
                  {
                    "text": "Confirmation for drug testing is usually done via GC-MS or LC-MS"
                  },
                  {
                    "text": "Attributes of confirmation testHigh sensitivityMost can provide quantitative analysis",
                    "sub_points": [
                      "High sensitivity",
                      "Most can provide quantitative analysis"
                    ]
                  },
                  {
                    "text": "Disadvantages of confirmation testExpensiveCumbersome testingRequires highly trained professionals",
                    "sub_points": [
                      "Expensive",
                      "Cumbersome testing",
                      "Requires highly trained professionals"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Urinalysis": {
        "name": "Urinalysis",
        "url": "https://app.pathprimer.com/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
        "topics": {
          "Decoy Cells in Urine": {
            "name": "Decoy Cells in Urine",
            "url": "https://app.pathprimer.com/document/27e76437-df74-4a58-8d79-6d11b91c3d8f/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Polyomaviruses are double-stranded nonenveloped DNA viruses that colonize urothelial cells"
                  },
                  {
                    "text": "Superficial umbrella cells form decoy cells when they are infected by polyomavirus"
                  },
                  {
                    "text": "Viropathic changes include nuclear enlargement, chromatin margination, viral inclusion bodies"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Lack of coarse chromatin and nuclear membrane irregularity distinguish decoy cells from malignant urothelial cells"
                  },
                  {
                    "text": "BK viral load can be tested in plasma and urine via PCR"
                  },
                  {
                    "text": "Renal biopsy is gold standard to diagnose transplant rejection and BK virus nephropathy"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Polyomaviruses are double-stranded nonenveloped DNA viruses that colonize urothelial cellsSubgroup includes BK, JC, and SV-40 strains",
                    "sub_points": [
                      "Subgroup includes BK, JC, and SV-40 strains"
                    ]
                  },
                  {
                    "text": "BK virus can proliferate in urothelium of immunocompromised patientDamage and sloughing of renal tubular epithelial cells result",
                    "sub_points": [
                      "Damage and sloughing of renal tubular epithelial cells result"
                    ]
                  },
                  {
                    "text": "Superficial umbrella cells form \"decoy cells\" when they are infected by polyomavirus"
                  },
                  {
                    "text": "Viropathic changes include nuclear enlargement, chromatin margination, viral inclusion bodies"
                  },
                  {
                    "text": "Cells are called decoy cells because they can mimic malignant cells when shed in urine"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Polyomavirus infection is increasingly recognized as cause of renal allograft dysfunction in transplant recipientsPresence of decoy cells in urine has positive predictive value of 27% and negative predictive value of 99% for transplant rejectionBK virus produces serious nephropathy in approximately 2% of renal transplant recipientsProgressive loss of graft functionTransplant failure",
                    "sub_points": [
                      "Presence of decoy cells in urine has positive predictive value of 27% and negative predictive value of 99% for transplant rejection",
                      "BK virus produces serious nephropathy in approximately 2% of renal transplant recipientsProgressive loss of graft functionTransplant failure",
                      "Progressive loss of graft function",
                      "Transplant failure"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "BK viral load can be tested in plasma and urine via polymerase chain reaction (PCR)PCR tests have lower positive predictive value for disease because they may detect clinically irrelevant levels of BK virus activation",
                    "sub_points": [
                      "PCR tests have lower positive predictive value for disease because they may detect clinically irrelevant levels of BK virus activation"
                    ]
                  },
                  {
                    "text": "Renal biopsy is gold standard to diagnose transplant rejection and BK virus nephropathy"
                  },
                  {
                    "text": "Electron microscopy can demonstrate BK virus intracellular crystalline arraysCan distinguish BK virus from herpesvirus and cytomegalovirus",
                    "sub_points": [
                      "Can distinguish BK virus from herpesvirus and cytomegalovirus"
                    ]
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Lack of coarse chromatin and nuclear membrane irregularity distinguish decoy cells from malignant urothelial cells"
                  },
                  {
                    "text": "Severe cytoplasmic degeneration is another morphologic clue of polyoma infection"
                  },
                  {
                    "text": "Four morphology variants have been described"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Granular Casts in Urine": {
            "name": "Granular Casts in Urine",
            "url": "https://app.pathprimer.com/document/1505cb6d-7cd6-4b3d-b633-4a8890a3b4b1/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Granular casts are common and appear in pathologic and nonpathologic conditions"
                  },
                  {
                    "text": "Granular casts may be increased in number in patients with intrinsic renal disease, pyelonephritis, viral infections, chronic lead poisoning"
                  },
                  {
                    "text": "Granular casts may appear with cellular and erythrocyte casts in very high numbers in normal individuals after long-distance run"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Granular casts have fine, sandpaper appearance or may have coarse granules"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Granular casts are common and appear in pathologic and nonpathologic conditions"
                  },
                  {
                    "text": "Granular casts form when cellular degradation products are incorporated into hyaline matrix with Tamm-Horsfall protein"
                  },
                  {
                    "text": "Degradation products result from damaged renal tubular cells, leukocytes, erythrocytes"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Granular casts may be increased in number in patients with intrinsic renal disease, pyelonephritis, viral infections, chronic lead poisoningPresence of granular casts and renal tubular epithelial cells associated with acute tubular necrosisPresence of coarsely granular casts with hematuria associated with renal papillary necrosis",
                    "sub_points": [
                      "Presence of granular casts and renal tubular epithelial cells associated with acute tubular necrosis",
                      "Presence of coarsely granular casts with hematuria associated with renal papillary necrosis"
                    ]
                  },
                  {
                    "text": "Granular casts may appear with cellular and erythrocyte casts in very high numbers (median of 14,000 casts/mL) in normal individuals after long-distance run"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Microscopy": [
                  {
                    "text": "Granular casts have fine, sandpaper appearanceSome have coarse granules",
                    "sub_points": [
                      "Some have coarse granules"
                    ]
                  },
                  {
                    "text": "Size and number of granules within granular casts vary"
                  },
                  {
                    "text": "If granular casts remain in tubules, granules degenerate and cast develops waxy appearance"
                  },
                  {
                    "text": "Granular casts are not birefringent"
                  },
                  {
                    "text": "Supravital staining (Sternheimer-Malbin) useful in visualizing granules"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Umbrella Cells": {
            "name": "Umbrella Cells",
            "url": "https://app.pathprimer.com/document/3cb3600d-c6a7-4ed6-8ccf-a57d06fffaf8/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Umbrella cells have critical role in regulating ion, solute, and and water flow"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Umbrella cells are large, with ﻿abundant granular cytoplasm"
                  },
                  {
                    "text": "Umbrella cells have centrally placed nuclei with small nucleoli and ﻿lack hyperchromasia"
                  },
                  {
                    "text": "Multinucleation is frequent, with round, smooth nuclear borders"
                  },
                  {
                    "text": "Low nuclear-to-cytoplasmic ratio, lack of hyperchromasia, and lack of nuclear irregularities are important distinguishing features from urothelial carcinoma cells"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Urothelium is composed of superficial umbrella, intermediate, and basal cell layers"
                  },
                  {
                    "text": "Umbrella cells are highly differentiated and polarized cells that have distinct apical and basolateral membrane domains demarcated by tight junctions"
                  },
                  {
                    "text": "Umbrella cells have critical role in regulating ion, solute, and and water flow"
                  },
                  {
                    "text": "During bladder filling, openings in the network become largerNumber of walls per unit area and their thickness decrease as umbrella cells flatten and elongate",
                    "sub_points": [
                      "Number of walls per unit area and their thickness decrease as umbrella cells flatten and elongate"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Microscopy": [
                  {
                    "text": "Umbrella cells are large, with ﻿abundant granular cytoplasm"
                  },
                  {
                    "text": "Umbrella cells have centrally placed nuclei with small nucleoli and lack hyperchromasia"
                  },
                  {
                    "text": "Multinucleation is frequent, with round, smooth nuclear borders"
                  },
                  {
                    "text": "Giant umbrella cells are commonly seen in specimens from renal pelvis and ureter"
                  },
                  {
                    "text": "Important distinguishing features from urothelial carcinoma cellsLow nuclear-to-cytoplasmic ratioLack of hyperchromasiaLack of nuclear irregularities",
                    "sub_points": [
                      "Low nuclear-to-cytoplasmic ratio",
                      "Lack of hyperchromasia",
                      "Lack of nuclear irregularities"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Urothelial Carcinoma in Urine": {
            "name": "Urothelial Carcinoma in Urine",
            "url": "https://app.pathprimer.com/document/bdb694e0-48b4-4aff-a5d1-e98fd5a42b86/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Most bladder cancers (90%) are urothelial cell carcinomas"
                  },
                  {
                    "text": "Most important risk factor for urothelial carcinoma is smoking"
                  },
                  {
                    "text": "Patients with bladder cancer typically present with painless gross or microscopic hematuria"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Cystoscopy and cytology mainstay for diagnosis of urothelial lesions"
                  },
                  {
                    "text": "Abnormal features on urinalysis include balls or clusters of cells and irregular pleomorphic or enlarged nuclei"
                  },
                  {
                    "text": "Urine cytology has higher sensitivity and specificity for detection of high-grade urothelial carcinoma than for low-grade tumors"
                  },
                  {
                    "text": "Low-grade tumors may show cellular groups in papillary arrangements with increased nuclear-to-cytoplasmic ratio, powdery chromatin, and nucleoli"
                  },
                  {
                    "text": "High-grade tumors show predominantly isolated cells with high nuclear-to-cytoplasmic ratio, bizarre shapes, and multinucleation"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Urothelial (or transitional) cells grow in multiple layers lining urethra, urinary bladder, ureters, and renal pelvis"
                  },
                  {
                    "text": "Most bladder cancers (90%) are urothelial cell carcinomas"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Urinary bladder carcinoma is 4th most common cancer in men and 9th most common cancer in women"
                  },
                  {
                    "text": "Urothelial carcinoma is 3 times more common in men than in women"
                  },
                  {
                    "text": "Most important risk factor for urothelial carcinoma is smoking"
                  },
                  {
                    "text": "Other risk factorsAniline dyesNitrites and nitratesChronic irritationIndwelling cathetersSchistosoma haematobiumCyclophosphamidePelvic radiation",
                    "sub_points": [
                      "Aniline dyes",
                      "Nitrites and nitrates",
                      "Chronic irritation",
                      "Indwelling catheters",
                      "Schistosoma haematobium",
                      "Cyclophosphamide",
                      "Pelvic radiation"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Patients with bladder cancer typically present with painless gross or microscopic hematuriaOther symptomsUrinary frequencyUrgencyIrritative voiding symptoms",
                    "sub_points": [
                      "Other symptomsUrinary frequencyUrgencyIrritative voiding symptoms",
                      "Urinary frequency",
                      "Urgency",
                      "Irritative voiding symptoms"
                    ]
                  },
                  {
                    "text": "30% of patients present with invasive disease associated with high risk of death from distant metastases"
                  }
                ],
                "Differential Diagnosis": [
                  {
                    "text": "Large clusters and sheets of transitional cells can be found after bladder instrumentation and mimic carcinoma cells"
                  },
                  {
                    "text": "Coarse vacuolization is commonly seen in benign, reactive conditions"
                  },
                  {
                    "text": "Vacuolization can be seen in adenocarcinomaNuclei in adenocarcinoma have high degree of atypia",
                    "sub_points": [
                      "Nuclei in adenocarcinoma have high degree of atypia"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Alternate Methods": [
                  {
                    "text": "Cystoscopy and cytology mainstay for diagnosis of urothelial lesionsUrine cytology has higher sensitivity and specificity for detection of high-grade urothelial carcinoma than for low-grade tumors",
                    "sub_points": [
                      "Urine cytology has higher sensitivity and specificity for detection of high-grade urothelial carcinoma than for low-grade tumors"
                    ]
                  },
                  {
                    "text": "UroVysion is multitarget fluorescence in situ hybridization (FISH) assay that detects aneuploidy in chromosomes 3, 7, and 17 and loss of 9p21 locusMore sensitive than cytology for high-grade tumors",
                    "sub_points": [
                      "More sensitive than cytology for high-grade tumors"
                    ]
                  },
                  {
                    "text": "Diagnosis and clinical stage established by transurethral resection"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Normal transitional cells appear smoothly rounded with central nucleusUrothelial cells smaller than squamous cells\"Caudate\" forms with tail are normalOccasional binucleate forms may be seen",
                    "sub_points": [
                      "Urothelial cells smaller than squamous cells",
                      "\"Caudate\" forms with tail are normal",
                      "Occasional binucleate forms may be seen"
                    ]
                  },
                  {
                    "text": "Abnormal features on urinalysisBalls or clusters of cellsIrregular pleomorphic or enlarged nucleiLow-grade tumorsCellular groups in papillary arrangementsIncreased nuclear-to-cytoplasmic ratioPowdery chromatinNucleoliHigh-grade tumorsPredominantly isolated cellsHigh nuclear-to-cytoplasmic ratioBizarre shapesMultinucleation",
                    "sub_points": [
                      "Balls or clusters of cells",
                      "Irregular pleomorphic or enlarged nuclei",
                      "Low-grade tumorsCellular groups in papillary arrangementsIncreased nuclear-to-cytoplasmic ratioPowdery chromatinNucleoli",
                      "Cellular groups in papillary arrangements",
                      "Increased nuclear-to-cytoplasmic ratio",
                      "Powdery chromatin",
                      "Nucleoli",
                      "High-grade tumorsPredominantly isolated cellsHigh nuclear-to-cytoplasmic ratioBizarre shapesMultinucleation",
                      "Predominantly isolated cells",
                      "High nuclear-to-cytoplasmic ratio",
                      "Bizarre shapes",
                      "Multinucleation"
                    ]
                  },
                  {
                    "text": "Formal urine cytology required if atypical features are identified"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Triple Phosphate Crystals in Urine": {
            "name": "Triple Phosphate Crystals in Urine",
            "url": "https://app.pathprimer.com/document/619c6676-ddab-4714-a380-e1dee05233e2/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Triple phosphate crystals (a.k.a. ﻿struvite crystals) are composed of magnesium, phosphate, and ammonium"
                  },
                  {
                    "text": "Urease-producing organisms (e.g.,Proteus,Ureaplasma urealyticum) promote formation of ammonia from urea"
                  },
                  {
                    "text": "Triple phosphate crystals in combination with bacteriuria and leukocyturia are hallmarks of UTI"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Colorless prisms with \"coffin-lid\" shape"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Triple phosphate crystals (a.k.a. ﻿struvite crystals) are composed of magnesium, phosphate, and ammonium"
                  },
                  {
                    "text": "These crystals are normal components of neutral or alkaline urine, but are often associated with bacterial growthUrease-producing organisms (e.g.,Proteus,Ureaplasma urealyticum) promote formation of ammonia from ureaStruvite crystals can form renal ﻿staghorn calculi when crystals are bound together with carbonate apatite into biofilm matrix generated by these urease-producing bacteriaStaghorn calculi can lead to hydronephrosis if untreated",
                    "sub_points": [
                      "Urease-producing organisms (e.g.,Proteus,Ureaplasma urealyticum) promote formation of ammonia from urea",
                      "Struvite crystals can form renal ﻿staghorn calculi when crystals are bound together with carbonate apatite into biofilm matrix generated by these urease-producing bacteriaStaghorn calculi can lead to hydronephrosis if untreated",
                      "Staghorn calculi can lead to hydronephrosis if untreated"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Occur most often in adult females and young boys, due to risk of urinary tract infections (UTIs) in these populations"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Triple phosphate crystals in combination with bacteriuria and leukocyturia are hallmarks of UTILeukocyte casts may also be present if pyelonephritis exists",
                    "sub_points": [
                      "Leukocyte casts may also be present if pyelonephritis exists"
                    ]
                  },
                  {
                    "text": "Large numbers of triple phosphate crystals in setting of untreated UTI may indicate struvite stone formation"
                  }
                ],
                "Differential Diagnosis": [
                  {
                    "text": "Calcium-phosphate and uric acid crystals may also have prism shape"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Moderately birefringent"
                  },
                  {
                    "text": "Soluble in dilute acetic acid"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Colorless prisms with \"coffin-lid\" shape"
                  },
                  {
                    "text": "Variations include rosette-shaped and fern-like forms"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Calcium Oxalate Crystals": {
            "name": "Calcium Oxalate Crystals",
            "url": "https://app.pathprimer.com/document/581dde0e-1b5b-46fc-ac3d-ded88645fb50/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Urine calcium and oxalate concentrations are main determinants of calcium oxalate supersaturation"
                  },
                  {
                    "text": "Calcium oxalate stones represent 70% of all kidney stones"
                  },
                  {
                    "text": "Calcium oxalate crystals occur in healthy patients but are more common in patients with kidney stones"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Crystals can occur in 2 formsDihydrate (weddellite) forms: Most common, resemble colorless \"envelopes\"Monohydrate (whewellite) forms: Less common, have ovoid or dumbbell shapesAssociated with hyperoxaluric states and ethylene glycol ingestion",
                    "sub_points": [
                      "Dihydrate (weddellite) forms: Most common, resemble colorless \"envelopes\"",
                      "Monohydrate (whewellite) forms: Less common, have ovoid or dumbbell shapesAssociated with hyperoxaluric states and ethylene glycol ingestion",
                      "Associated with hyperoxaluric states and ethylene glycol ingestion"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Oxalate is derived from diet as well as metabolism of ascorbic acid"
                  },
                  {
                    "text": "Urine calcium and oxalate concentrations are main determinants of calcium oxalate supersaturation and calcium oxalate crystal formationNormally, oxalate binds dietary calcium and is excreted in fecesPatients with ﻿malabsorptive states have increasingly fatty intestinal contentsDietary calcium binds to fatty acids instead of oxalate, allowing higher amount of free oxalate to be absorbed in patients with malabsorptionExcess oxalate absorption occurs in setting of small bowel disease (i.e., Crohn disease), pyridoxine deficiency, and in patients with cystic fibrosisLarge numbers of calcium oxalate crystals may also result from severe chronic renal disease or ethylene glycol toxicity",
                    "sub_points": [
                      "Normally, oxalate binds dietary calcium and is excreted in fecesPatients with ﻿malabsorptive states have increasingly fatty intestinal contentsDietary calcium binds to fatty acids instead of oxalate, allowing higher amount of free oxalate to be absorbed in patients with malabsorption",
                      "Patients with ﻿malabsorptive states have increasingly fatty intestinal contents",
                      "Dietary calcium binds to fatty acids instead of oxalate, allowing higher amount of free oxalate to be absorbed in patients with malabsorption",
                      "Excess oxalate absorption occurs in setting of small bowel disease (i.e., Crohn disease), pyridoxine deficiency, and in patients with cystic fibrosis",
                      "Large numbers of calcium oxalate crystals may also result from severe chronic renal disease or ethylene glycol toxicity"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Calcium oxalate stones represent 70% of all kidney stones"
                  },
                  {
                    "text": "Calcium oxalate crystals occur in healthy patients but are more common in patients with kidney stonesPatients with kidney stones are more likely to have larger calcium oxalate crystals (10-12 μm in diameter) compared to healthy individuals",
                    "sub_points": [
                      "Patients with kidney stones are more likely to have larger calcium oxalate crystals (10-12 μm in diameter) compared to healthy individuals"
                    ]
                  },
                  {
                    "text": "Calcium oxalate stones are more common in males than females"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Urine should be stored at room temperature or 37°C"
                  },
                  {
                    "text": "Calcium oxalate crystals are insoluble in acetic acid"
                  },
                  {
                    "text": "Crystals appear at pH 6 or in neutral urine"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Calcium oxalate crystals have 2 forms: Monohydrate and dihydrateDihydrate (weddellite) forms are most common, resemble colorless \"envelopes\"Usually do not polarize lightDihydrate stones most commonly associated with hypercalciuriaMonohydrate (whewellite) forms are less common, have ovoid or dumbbell shapesAlways polarize lightAssociated with hyperoxaluric states and ethylene glycol ingestion",
                    "sub_points": [
                      "Dihydrate (weddellite) forms are most common, resemble colorless \"envelopes\"Usually do not polarize lightDihydrate stones most commonly associated with hypercalciuria",
                      "Usually do not polarize light",
                      "Dihydrate stones most commonly associated with hypercalciuria",
                      "Monohydrate (whewellite) forms are less common, have ovoid or dumbbell shapesAlways polarize lightAssociated with hyperoxaluric states and ethylene glycol ingestion",
                      "Always polarize light",
                      "Associated with hyperoxaluric states and ethylene glycol ingestion"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Erythrocyte Casts in Urine": {
            "name": "Erythrocyte Casts in Urine",
            "url": "https://app.pathprimer.com/document/29db82db-fb74-4954-9799-823838376ad6/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Erythrocyte casts are important diagnostic indicator of renal pathology"
                  },
                  {
                    "text": "Erythrocyte casts (a.k.a. RBC casts) are formed in renal tubules of kidney secondary to renal damage, which allows RBCs to cross GBM or tubular basement membrane"
                  },
                  {
                    "text": "Erythrocyte casts usually are found in patients with glomerulonephritis and glomerulopathies; they are not found in healthy individuals"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Erythrocyte casts are reddish, elongated, and cylindrical and covered with intact or disrupted RBCs that are interspersed with finely granular Tamm-Horsfall matrix"
                  },
                  {
                    "text": "Phase-contrast microscopy and supravital staining can help to visualize erythrocyte casts"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Erythrocyte casts (a.k.a. red blood cell [RBC] casts) are formed in renal tubules of kidney secondary to renal damageRenal damage allows RBCs to cross glomerular basement membrane (GBM) or tubular basement membrane",
                    "sub_points": [
                      "Renal damage allows RBCs to cross glomerular basement membrane (GBM) or tubular basement membrane"
                    ]
                  },
                  {
                    "text": "Erythrocyte casts are important diagnostic indicator of renal pathologyHemoglobin casts may result either from glomerular pathology or from free hemoglobinuria in patients with intravascular hemolysis",
                    "sub_points": [
                      "Hemoglobin casts may result either from glomerular pathology or from free hemoglobinuria in patients with intravascular hemolysis"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Erythrocyte casts most often associated with glomerulonephritis and glomerulopathiesAre not found in healthy individuals",
                    "sub_points": [
                      "Are not found in healthy individuals"
                    ]
                  },
                  {
                    "text": "Erythrocyte casts may be found in patients with renal carcinoma, acute pyelonephritis, malignant hypertension"
                  },
                  {
                    "text": "Patients with relapse of proliferative lupus nephritis may have erythrocyte and leukocyte casts"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Erythrocyte casts are extremely fragile and are often seen as fragments or portions of castsFor patients with isolated microscopic hematuria of unknown origin, it is recommended to examine 50 low-power fields to search for erythrocyte casts",
                    "sub_points": [
                      "For patients with isolated microscopic hematuria of unknown origin, it is recommended to examine 50 low-power fields to search for erythrocyte casts"
                    ]
                  },
                  {
                    "text": "Phase-contrast microscopy and supravital staining can help to visualize erythrocyte casts"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Erythrocyte casts are reddish, elongated, and cylindrical and covered with intact or disrupted RBCs that are interspersed with finely granular Tamm-Horsfall matrixMorphologic differential diagnosis includes yeast cells, which are larger than RBCs and may show budding",
                    "sub_points": [
                      "Morphologic differential diagnosis includes yeast cells, which are larger than RBCs and may show budding"
                    ]
                  },
                  {
                    "text": "Erythrocyte casts have high refractive index and are not birefringent"
                  },
                  {
                    "text": "Presence of dysmorphic RBCs is indicator of glomerular dysfunction because RBCs become deformed as they pass across GBM"
                  },
                  {
                    "text": "Hemoglobin casts (which appear granular) can form when RBCs degenerate"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Renal Tubular Cell Casts in Urine": {
            "name": "Renal Tubular Cell Casts in Urine",
            "url": "https://app.pathprimer.com/document/ac510676-edc4-4cad-af80-f053f7b05884/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Casts form from renal tubular epithelial cells (RTE casts) in setting of advanced tubular injury as large numbers of cells are sloughed"
                  },
                  {
                    "text": "RTE casts are associated with acute tubular necrosis, viral disease, heavy metal poisoning, ethylene glycol (antifreeze) ingestion, and salicylate intoxication"
                  },
                  {
                    "text": "Presence of singular round nuclei in renal tubular cells is most important distinguishing feature from leukocyte casts"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "RTE cells are polyhedral in shape with single central spherical nucleus"
                  },
                  {
                    "text": "Bilirubin staining of casts may occur in patients with jaundice secondary to viral hepatitis or other viral illnesses"
                  },
                  {
                    "text": "Prussian blue can be used to distinguish hemosiderin from melanin or bilirubin in pigmented casts"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Renal tubular epithelial (RTE) cells line collecting ducts and proximal and distal convoluted tubules of kidney"
                  },
                  {
                    "text": "Casts form from RTE cells in setting of advanced tubular injury as large numbers of cells are sloughed"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "RTE casts are associated with certain conditionsAcute tubular necrosisViral diseaseHeavy metal poisoningEthylene glycol (antifreeze) ingestionSalicylate intoxication",
                    "sub_points": [
                      "Acute tubular necrosis",
                      "Viral disease",
                      "Heavy metal poisoning",
                      "Ethylene glycol (antifreeze) ingestion",
                      "Salicylate intoxication"
                    ]
                  },
                  {
                    "text": "RTE casts can also be sign of acute allograft rejection in renal transplant patients"
                  }
                ],
                "Differential Diagnosis": [
                  {
                    "text": "Leukocyte castsRTE casts may contain granules secondary to cellular lysis and can be confused with leukocyte castsPresence of singular round nuclei in renal tubular cells is most important distinguishing feature from leukocyte castsSupravital staining, phase-contrast microscopy, and Papanicolaou staining can help evaluate these nuclear features",
                    "sub_points": [
                      "RTE casts may contain granules secondary to cellular lysis and can be confused with leukocyte casts",
                      "Presence of singular round nuclei in renal tubular cells is most important distinguishing feature from leukocyte castsSupravital staining, phase-contrast microscopy, and Papanicolaou staining can help evaluate these nuclear features",
                      "Supravital staining, phase-contrast microscopy, and Papanicolaou staining can help evaluate these nuclear features"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "RTE casts have high refractive index and are not birefringent"
                  },
                  {
                    "text": "If pigment is present, Prussian blue can be used to distinguish hemosiderin from melanin or bilirubin"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "RTE casts are cylindrical with adherent renal tubular epithelial cellsRTE cells are polyhedral in shape with single central spherical nucleusThese epithelial cells may have microvillus border if they are sloughed from proximal tubules",
                    "sub_points": [
                      "RTE cells are polyhedral in shape with single central spherical nucleus",
                      "These epithelial cells may have microvillus border if they are sloughed from proximal tubules"
                    ]
                  },
                  {
                    "text": "Cast pigmentationYellow-brown pigmentation of RTE casts by hemosiderin can occur secondary to hemoglobinuria or myoglobinuriaBrown pigmentation may occur secondary to melanin granules in rare cases of melanuriaYellow pigmentation of RTE casts may also occur secondary to bilirubinBilirubin staining of casts may occur in patients with jaundice secondary to viral hepatitis or other viral illnesses",
                    "sub_points": [
                      "Yellow-brown pigmentation of RTE casts by hemosiderin can occur secondary to hemoglobinuria or myoglobinuria",
                      "Brown pigmentation may occur secondary to melanin granules in rare cases of melanuria",
                      "Yellow pigmentation of RTE casts may also occur secondary to bilirubinBilirubin staining of casts may occur in patients with jaundice secondary to viral hepatitis or other viral illnesses",
                      "Bilirubin staining of casts may occur in patients with jaundice secondary to viral hepatitis or other viral illnesses"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hexagonal Uric Acid Crystal": {
            "name": "Hexagonal Uric Acid Crystal",
            "url": "https://app.pathprimer.com/document/17f1dbca-ad50-42e3-95be-fe0c60924d9c/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Uric acid: End product of metabolism of purine nucleotides"
                  },
                  {
                    "text": "Uric acid crystals associated with hyperuricemia and nephrolithiasis"
                  },
                  {
                    "text": "Increased uric acid crystals may also been seen in Lesch-Nyhan syndrome, gout urate nephropathy, and tumor lysis syndrome"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Uric acid crystals produce variety of crystalline structures, including rods, cubes, rosettes, rhombi, and 6-sided shapesHexagonal uric acid crystals must be distinguished from cystine crystals (which are also hexagonal), due to diagnostic significance of cystinuria",
                    "sub_points": [
                      "Hexagonal uric acid crystals must be distinguished from cystine crystals (which are also hexagonal), due to diagnostic significance of cystinuria"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Uric acid: End product of metabolism of purine nucleotidesTwo-thirds of uric acid is produced endogenously (liver, muscle, and intestine); one-third is derived from dietary sourcesExcreted primarily via kidneys",
                    "sub_points": [
                      "Two-thirds of uric acid is produced endogenously (liver, muscle, and intestine); one-third is derived from dietary sources",
                      "Excreted primarily via kidneys"
                    ]
                  },
                  {
                    "text": "Increased serum uric acid levels can lead to urate crystallization, kidney stones, and gout"
                  },
                  {
                    "text": "Probenecid also promotes uric acid lithogenesis"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Associated with hyperuricemia and nephrolithiasisTwo-thirds of patients with elevated serum uric acid do not develop gout or uric acid renal disease, and may be considered as asymptomatic hyperuricemia",
                    "sub_points": [
                      "Two-thirds of patients with elevated serum uric acid do not develop gout or uric acid renal disease, and may be considered as asymptomatic hyperuricemia"
                    ]
                  },
                  {
                    "text": "Increased uric acid crystals may been seen in Lesch-Nyhan syndrome, gout urate nephropathy, and tumor lysis syndrome"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Xanthine oxidase inhibitor allopurinol may useful to lower serum uric acid levels in patients with chronic kidney disease"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Uric acid crystalsSoluble in alkaline solutions; insoluble in acidSoluble at 60°C",
                    "sub_points": [
                      "Soluble in alkaline solutions; insoluble in acid",
                      "Soluble at 60°C"
                    ]
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Uric acid crystals produce variety of crystalline structures, including rods, cubes, rosettes, rhombi, and 6-sided shapesHexagonal uric acid crystals must be distinguished from cystine crystals (which are also hexagonal), due to diagnostic significance of cystinuriaHexagonal uric acid crystals show polychromatism under polarizationCystine crystals have positive nitroprusside test and are not birefringent",
                    "sub_points": [
                      "Hexagonal uric acid crystals must be distinguished from cystine crystals (which are also hexagonal), due to diagnostic significance of cystinuriaHexagonal uric acid crystals show polychromatism under polarizationCystine crystals have positive nitroprusside test and are not birefringent",
                      "Hexagonal uric acid crystals show polychromatism under polarization",
                      "Cystine crystals have positive nitroprusside test and are not birefringent"
                    ]
                  },
                  {
                    "text": "Amorphous urates are granular, birefringent, and colorless"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "White Blood Cell Casts in Urine": {
            "name": "White Blood Cell Casts in Urine",
            "url": "https://app.pathprimer.com/document/5b0ff024-5008-4148-a752-2d1035bbb7fa/lesson/7f0ec528-b7a3-4fde-af5e-d6bbb59e882e",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "WBC casts are composed of Tamm-Horsfall protein and WBCs"
                  },
                  {
                    "text": "WBC casts occur secondary to intrinsic renal inflammation and occur in pyelonephritis, lupus nephritis, and polyarteritis nodosa"
                  },
                  {
                    "text": "Pyelonephritis is most common cause of WBC casts"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Bright-field microscopy demonstrates cylindrical hyaline casts coated by leukocytes (usually neutrophils)"
                  },
                  {
                    "text": "Phase-contrast and supravital stains can help demonstrate nuclear segmentation of neutrophils, which is important to distinguish from other cellular casts"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "White blood cell (WBC) casts are composed of Tamm-Horsfall protein and WBCsTamm-Horsfall protein is produced by renal tubular cells of the distal loop of Henle",
                    "sub_points": [
                      "Tamm-Horsfall protein is produced by renal tubular cells of the distal loop of Henle"
                    ]
                  },
                  {
                    "text": "WBC casts occur secondary to intrinsic renal inflammationOccur in pyelonephritis, lupus nephritis, polyarteritis nodosa",
                    "sub_points": [
                      "Occur in pyelonephritis, lupus nephritis, polyarteritis nodosa"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "WBC casts are indicator of intrinsic renal inflammatory conditionsAre not found in healthy individuals",
                    "sub_points": [
                      "Are not found in healthy individuals"
                    ]
                  },
                  {
                    "text": "Pyelonephritis most common cause of WBC casts"
                  },
                  {
                    "text": "Mixed red blood cell and WBC casts can be seen in glomerular disease"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Gram stain can be additionally performed in patients with pyelonephritis to highlight admixed bacteria"
                  },
                  {
                    "text": "Positive leukocyte esterase dipstick can be helpful to distinguish WBC casts from other types of cellular casts"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Bright-field microscopy demonstrates cylindrical hyaline casts coated by leukocytes (usually neutrophils)WBC casts are refractileCellular disruption of leukocytes may cause granular appearance to cast surfacePhase-contrast and supravital stains can help demonstrate nuclear segmentation of neutrophilsUseful feature to distinguish WBC casts from other cellular casts",
                    "sub_points": [
                      "WBC casts are refractile",
                      "Cellular disruption of leukocytes may cause granular appearance to cast surface",
                      "Phase-contrast and supravital stains can help demonstrate nuclear segmentation of neutrophilsUseful feature to distinguish WBC casts from other cellular casts",
                      "Useful feature to distinguish WBC casts from other cellular casts"
                    ]
                  },
                  {
                    "text": "Differential diagnosisEpithelial castsLarge central nuclei rather than segmented nucleiLack cytoplasmic granulesFatty castsHighly refractile oval fat bodies incorporated into cast matrixLack nucleiCoarse granular castsSandpaper appearanceLow refractive indexLack nuclei",
                    "sub_points": [
                      "Epithelial castsLarge central nuclei rather than segmented nucleiLack cytoplasmic granules",
                      "Large central nuclei rather than segmented nuclei",
                      "Lack cytoplasmic granules",
                      "Fatty castsHighly refractile oval fat bodies incorporated into cast matrixLack nuclei",
                      "Highly refractile oval fat bodies incorporated into cast matrix",
                      "Lack nuclei",
                      "Coarse granular castsSandpaper appearanceLow refractive indexLack nuclei",
                      "Sandpaper appearance",
                      "Low refractive index",
                      "Lack nuclei"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Body Fluids": {
        "name": "Body Fluids",
        "url": "https://app.pathprimer.com/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
        "topics": {
          "Stool Testing": {
            "name": "Stool Testing",
            "url": "https://app.pathprimer.com/document/d37c46ed-7f3f-44e1-9aac-d1f1b788a732/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Malabsorption: Pathologic state of impaired nutrient absorption in gastrointestinal tract; can result from disruption of any step involved in nutrient absorption"
                  },
                  {
                    "text": "Steatorrhea: Presence of pale, bulky, and foul-smelling stools with high fat content (> 14 g per day), resulting from malabsorption, which may be caused by small intestinal mucosal disease, insufficient bile acid concentration, small-bowel bacterial overgrowth, or pancreatic exocrine insufficiency"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Low fecal pH (< 5.3) is characteristic for diarrhea caused by carbohydrate malabsorption, whereas fecal pH > 5.6 argues against carbohydrate malabsorption as cause of diarrhea"
                  },
                  {
                    "text": "Osmotic diarrhea produces stool with low levels of electrolytes, with osmotic gap > 50-75 mOsm/kg"
                  },
                  {
                    "text": "Secretory diarrhea produces stool isoosmolar with plasma, and so leads to osmotic gap of stool < 50 mOsm/kg; may have associated serum hypokalemia and acidosis"
                  },
                  {
                    "text": "Fecal immunochemical test detects globin component of hemoglobin rather than heme component, and so is more sensitive and specific than stool guaiac testing"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Majority of water and electrolytes are absorbed in small intestines, with net amount of 800-1,000 mL of fluid entering colon"
                  },
                  {
                    "text": "Absorption of nutrients and water across small intestinal mucosa is driven by active transport of ions (principally Na+, Cl−, and HCO3−) via membrane-associated channels, endocytic uptake, and paracellular channelsNormal nutrient absorptionRequires processing at luminal and brush border, absorption into intestinal mucosa, and transport into circulationMalabsorptionPathologic state of impaired nutrient absorption in gastrointestinal (GI) tract and can result from disruption of any step involved in nutrient absorption",
                    "sub_points": [
                      "Normal nutrient absorptionRequires processing at luminal and brush border, absorption into intestinal mucosa, and transport into circulation",
                      "Requires processing at luminal and brush border, absorption into intestinal mucosa, and transport into circulation",
                      "MalabsorptionPathologic state of impaired nutrient absorption in gastrointestinal (GI) tract and can result from disruption of any step involved in nutrient absorption",
                      "Pathologic state of impaired nutrient absorption in gastrointestinal (GI) tract and can result from disruption of any step involved in nutrient absorption"
                    ]
                  },
                  {
                    "text": "DiarrheaCharacterized by reduced stool consistency due to incomplete absorption of water and electrolytes by intestineMay result from variety of processes, including altered electrolyte absorption or secretion, as well as presence of osmotically active substances that accumulate in intestinal lumenChronic diarrhea = passage of loose stools for > 4 weeks",
                    "sub_points": [
                      "Characterized by reduced stool consistency due to incomplete absorption of water and electrolytes by intestine",
                      "May result from variety of processes, including altered electrolyte absorption or secretion, as well as presence of osmotically active substances that accumulate in intestinal lumen",
                      "Chronic diarrhea = passage of loose stools for > 4 weeks"
                    ]
                  },
                  {
                    "text": "Causes of chronic diarrhea can be classified as inflammatory, osmotic, secretory, iatrogenic, disrupted motility, and functional diseaseInflammatory diarrhea [e.g., inflammatory bowel disease (IBD)]Presents with malabsorption or rectal bleeding and may be accompanied by other symptoms, such as mucus and blood in stool, abdominal pain, or extraintestinal symptoms involving skin, eyes, and jointsIn ulcerative colitis, main pathogenesis of diarrhea is decrease in net absorption of sodium, chloride, and water from lumen of colonOsmotic diarrheaOccurs when osmotically active substances draw fluid from plasma into jejunumMay result from bacterial overgrowth, osmotic laxatives, disaccharidase deficiency, or pancreatic exocrine insufficiencySecretory diarrheaResults from secretion of isoosmolar fluid, leading to hypokalemia and acidosisMay result from disease states such as VIPoma or congenital chloridorrheaIatrogenic diarrheaMotility disordersCan result in diarrhea by overwhelming reabsorptive capacity of colon in cases of rapid transit disorders or slow transit disorders (such as bacterial overgrowth, which leads to bile acid deconjugation, poor micelle formation, and steatorrhea)Altered gut motility can be associated with variety of disease conditions, including postsurgical states, carcinoid syndromes, diabetes, or infiltrative small bowel diseaseFunctional diseaseFunctional disorders, such as irritable bowel syndrome, can also lead to diarrhea",
                    "sub_points": [
                      "Inflammatory diarrhea [e.g., inflammatory bowel disease (IBD)]Presents with malabsorption or rectal bleeding and may be accompanied by other symptoms, such as mucus and blood in stool, abdominal pain, or extraintestinal symptoms involving skin, eyes, and jointsIn ulcerative colitis, main pathogenesis of diarrhea is decrease in net absorption of sodium, chloride, and water from lumen of colon",
                      "Presents with malabsorption or rectal bleeding and may be accompanied by other symptoms, such as mucus and blood in stool, abdominal pain, or extraintestinal symptoms involving skin, eyes, and joints",
                      "In ulcerative colitis, main pathogenesis of diarrhea is decrease in net absorption of sodium, chloride, and water from lumen of colon",
                      "Osmotic diarrheaOccurs when osmotically active substances draw fluid from plasma into jejunumMay result from bacterial overgrowth, osmotic laxatives, disaccharidase deficiency, or pancreatic exocrine insufficiency",
                      "Occurs when osmotically active substances draw fluid from plasma into jejunumMay result from bacterial overgrowth, osmotic laxatives, disaccharidase deficiency, or pancreatic exocrine insufficiency",
                      "May result from bacterial overgrowth, osmotic laxatives, disaccharidase deficiency, or pancreatic exocrine insufficiency",
                      "Secretory diarrheaResults from secretion of isoosmolar fluid, leading to hypokalemia and acidosisMay result from disease states such as VIPoma or congenital chloridorrhea",
                      "Results from secretion of isoosmolar fluid, leading to hypokalemia and acidosisMay result from disease states such as VIPoma or congenital chloridorrhea",
                      "May result from disease states such as VIPoma or congenital chloridorrhea",
                      "Iatrogenic diarrhea",
                      "Motility disordersCan result in diarrhea by overwhelming reabsorptive capacity of colon in cases of rapid transit disorders or slow transit disorders (such as bacterial overgrowth, which leads to bile acid deconjugation, poor micelle formation, and steatorrhea)Altered gut motility can be associated with variety of disease conditions, including postsurgical states, carcinoid syndromes, diabetes, or infiltrative small bowel disease",
                      "Can result in diarrhea by overwhelming reabsorptive capacity of colon in cases of rapid transit disorders or slow transit disorders (such as bacterial overgrowth, which leads to bile acid deconjugation, poor micelle formation, and steatorrhea)",
                      "Altered gut motility can be associated with variety of disease conditions, including postsurgical states, carcinoid syndromes, diabetes, or infiltrative small bowel disease",
                      "Functional diseaseFunctional disorders, such as irritable bowel syndrome, can also lead to diarrhea",
                      "Functional disorders, such as irritable bowel syndrome, can also lead to diarrhea"
                    ]
                  },
                  {
                    "text": "SteatorrheaPresence of pale, bulky, and foul-smelling stools with high fat content resulting from malabsorptionMay result from small intestinal mucosal disease, insufficient bile acid concentration, small bowel bacterial overgrowth, or pancreatic exocrine insufficiencyBile acids are required for absorption of dietary fats and sterols from intestinePancreatic exocrine insufficiency is most common cause of severe steatorrhea90% of pancreatic acinar tissue must be destroyed before patient develops symptomatic pancreatic exocrine insufficiencyMilder forms of steatorrhea can occur with mucosal or structural disease",
                    "sub_points": [
                      "Presence of pale, bulky, and foul-smelling stools with high fat content resulting from malabsorptionMay result from small intestinal mucosal disease, insufficient bile acid concentration, small bowel bacterial overgrowth, or pancreatic exocrine insufficiencyBile acids are required for absorption of dietary fats and sterols from intestinePancreatic exocrine insufficiency is most common cause of severe steatorrhea90% of pancreatic acinar tissue must be destroyed before patient develops symptomatic pancreatic exocrine insufficiency",
                      "May result from small intestinal mucosal disease, insufficient bile acid concentration, small bowel bacterial overgrowth, or pancreatic exocrine insufficiency",
                      "Bile acids are required for absorption of dietary fats and sterols from intestine",
                      "Pancreatic exocrine insufficiency is most common cause of severe steatorrhea90% of pancreatic acinar tissue must be destroyed before patient develops symptomatic pancreatic exocrine insufficiency",
                      "90% of pancreatic acinar tissue must be destroyed before patient develops symptomatic pancreatic exocrine insufficiency",
                      "Milder forms of steatorrhea can occur with mucosal or structural disease"
                    ]
                  },
                  {
                    "text": "Carbohydrate malabsorptionUsually results from mucosal disease, and subsequent bacterial metabolism of carbohydrates in colon leads to symptoms such as bloating, abdominal cramping, passing of gas, flatulence, and diarrheaLactose intolerance may result from deficiency of intestinal brush border enzyme lactase or small bowel injury (as in Celiac disease, or transiently after acute diarrheal illness)Lactase activity decreases rapidly in most non-white population groups after 2 years of age; a relative lactase deficiency should be regarded as normal in these individualsFructose deficiency can result in similar symptoms",
                    "sub_points": [
                      "Usually results from mucosal disease, and subsequent bacterial metabolism of carbohydrates in colon leads to symptoms such as bloating, abdominal cramping, passing of gas, flatulence, and diarrhea",
                      "Lactose intolerance may result from deficiency of intestinal brush border enzyme lactase or small bowel injury (as in Celiac disease, or transiently after acute diarrheal illness)Lactase activity decreases rapidly in most non-white population groups after 2 years of age; a relative lactase deficiency should be regarded as normal in these individuals",
                      "Lactase activity decreases rapidly in most non-white population groups after 2 years of age; a relative lactase deficiency should be regarded as normal in these individuals",
                      "Fructose deficiency can result in similar symptoms"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection": [
                  {
                    "text": "Stool should be collected into bedpan or boiled glass jar"
                  },
                  {
                    "text": "Instruct patients not to contaminate outside of container and not to overfill itOverfilling stool containers can result in explosive release of contents due to accumulation of gas",
                    "sub_points": [
                      "Overfilling stool containers can result in explosive release of contents due to accumulation of gas"
                    ]
                  }
                ],
                "Gross Examination": [
                  {
                    "text": "Stool with steatorrhea is typically gray and foul-smelling; floats on water"
                  },
                  {
                    "text": "Clay-colored stool suggests absence of bile or presence of barium sulfate"
                  },
                  {
                    "text": "Upper GI bleeding, bismuth, and iron may cause stool to be black"
                  },
                  {
                    "text": "Lower digestive bleeding or beets may cause stool to be red"
                  },
                  {
                    "text": "Mucus in stool specimens is abnormal and should be reported"
                  }
                ],
                "Fecal Calprotectin": [
                  {
                    "text": "Calprotectin: Protein released by activated neutrophils and therefore marker of inflammation"
                  },
                  {
                    "text": "Can be used to distinguish inflammatory disorders from irritable bowel syndrome (IBS)"
                  },
                  {
                    "text": "Sensitivity of 93% and specificity of 94% at 50 µg/g"
                  },
                  {
                    "text": "Sensitivities and specificities are higher than that of lactoferrin, which is another marker of inflammation"
                  },
                  {
                    "text": "False-positives can occur with nonsteroidal antiinflammatory drugs (NSAIDs)"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Sudan stains can be used to microscopically evaluate for neutral fats, which appear as large orange or red droplets> 60 droplets per HPF indicates steatorrheaAddition of acetic acid with Sudan staining can evaluate for fatty acids and soaps> 100 droplets per HPF indicates steatorrheaPancreatic disease is more likely to result in steatorrhea with increased fatty acids and soaps",
                    "sub_points": [
                      "> 60 droplets per HPF indicates steatorrhea",
                      "Addition of acetic acid with Sudan staining can evaluate for fatty acids and soaps> 100 droplets per HPF indicates steatorrhea",
                      "> 100 droplets per HPF indicates steatorrhea",
                      "Pancreatic disease is more likely to result in steatorrhea with increased fatty acids and soaps"
                    ]
                  },
                  {
                    "text": "Stool microscopy can evaluate for fecal leukocytes (hallmark of inflammatory diarrhea)"
                  },
                  {
                    "text": "Microscopic evaluation for increased muscle fibers (> 10 fibers per HPF, stained with solution of eosin in 10% ethanol) can be performed in cases of suspected malabsorption or hypermotility"
                  },
                  {
                    "text": "Leukocytes can be quantitated using methylene blue stain via 200-cell differentialOther markers of fecal leukocytes include lactoferrin and calprotectin",
                    "sub_points": [
                      "Other markers of fecal leukocytes include lactoferrin and calprotectin"
                    ]
                  }
                ],
                "Stool pH": [
                  {
                    "text": "Normally close to 7; may be lowered by fermentation of sugars in colon by colonic floraFecal pH < 5.3 is characteristic for diarrhea caused by carbohydrate malabsorptionFecal pH > 5.6 argues against carbohydrate malabsorption as cause of diarrhea",
                    "sub_points": [
                      "Fecal pH < 5.3 is characteristic for diarrhea caused by carbohydrate malabsorption",
                      "Fecal pH > 5.6 argues against carbohydrate malabsorption as cause of diarrhea"
                    ]
                  }
                ],
                "Stool Electrolytes": [
                  {
                    "text": "Normally, stool water is electroneutral, equivalent to osmolality of plasma (280-290 mOsm/kg)Low stool osmolality (< 290 mosmol/kg) suggests contamination of stool with dilute urine, water, or excess ingestion of hypotonic fluid",
                    "sub_points": [
                      "Low stool osmolality (< 290 mosmol/kg) suggests contamination of stool with dilute urine, water, or excess ingestion of hypotonic fluid"
                    ]
                  },
                  {
                    "text": "Fecal sodium and potassium are measured after homogenization and centrifugation of specimen"
                  },
                  {
                    "text": "Fecal electrolytes can help distinguish osmotic and secretory diarrhea by calculation of fecal osmotic gapFecal osmotic gap estimation formula: 290 − 2 × [(Na+) + (K+)]Osmotic diarrhea produces stool with low levels of electrolytes, with osmotic gap > 50-75 mOsm/kgElevated stool osmotic gap with stool water pH < 5 indicates disaccharidase deficiencyThis formula should be used to determine osmotic gap rather than using measured fecal osmolality, which can be affected by in vitro bacterial fermentationSecretory diarrhea produces stool isoosmolar with plasma, and so leads to osmotic gap of stool < 50 mOsm/kg; may have associated serum hypokalemia and acidosis",
                    "sub_points": [
                      "Fecal osmotic gap estimation formula: 290 − 2 × [(Na+) + (K+)]Osmotic diarrhea produces stool with low levels of electrolytes, with osmotic gap > 50-75 mOsm/kgElevated stool osmotic gap with stool water pH < 5 indicates disaccharidase deficiency",
                      "Osmotic diarrhea produces stool with low levels of electrolytes, with osmotic gap > 50-75 mOsm/kgElevated stool osmotic gap with stool water pH < 5 indicates disaccharidase deficiency",
                      "Elevated stool osmotic gap with stool water pH < 5 indicates disaccharidase deficiency",
                      "This formula should be used to determine osmotic gap rather than using measured fecal osmolality, which can be affected by in vitro bacterial fermentation",
                      "Secretory diarrhea produces stool isoosmolar with plasma, and so leads to osmotic gap of stool < 50 mOsm/kg; may have associated serum hypokalemia and acidosis"
                    ]
                  },
                  {
                    "text": "Soluble fecal Mg concentration > 45 mmol/L suggests Mg-induced diarrhea"
                  }
                ],
                "Fecal Fat": [
                  {
                    "text": "Steatorrhea: Presence of increased fecal fat output due to malabsorption"
                  },
                  {
                    "text": "Quantitative fecal fat measurement for 48 or 72 hours (van de Kamer method) is gold standard for diagnosis, but has many limitationsAlthough upper limit of normal is 7 g/24 hours, fecal fat values ranging from 7-14 g/24 hours have low specificity for diagnosisFecal fat output > 14 g/24 hours is more predictive of malabsorptionOther limitations include issues with collection, dietary fat control, and lack of quality-control procedures",
                    "sub_points": [
                      "Although upper limit of normal is 7 g/24 hours, fecal fat values ranging from 7-14 g/24 hours have low specificity for diagnosisFecal fat output > 14 g/24 hours is more predictive of malabsorption",
                      "Fecal fat output > 14 g/24 hours is more predictive of malabsorption",
                      "Other limitations include issues with collection, dietary fat control, and lack of quality-control procedures"
                    ]
                  },
                  {
                    "text": "Fecal fat concentration (g fecal fat/100 g wet stool weight) can be used to estimate total fat excretion"
                  },
                  {
                    "text": "Spot stool tests via lipophilic stains (Sudan) can be used to microscopically evaluate stool fat"
                  },
                  {
                    "text": "Alternative methods include breath tests (e.g., 14C triolein test, which measures breath excretion of 14CO2 after fat meal containing 5 μCi 14C-triolein)Sensitivities of 85-100% have been reported with specificity > 90% using fat load of ~ 20 gThis 14C triolein test is inappropriate in patients with diabetes, liver disease, or obesity",
                    "sub_points": [
                      "Sensitivities of 85-100% have been reported with specificity > 90% using fat load of ~ 20 g",
                      "This 14C triolein test is inappropriate in patients with diabetes, liver disease, or obesity"
                    ]
                  }
                ],
                "Fecal Occult Blood Testing": [
                  {
                    "text": "Fetal occult blood testing (FOBT) can be used as part of colorectal cancer screeningPositive test result should prompt further evaluation using sigmoidoscopy or full colonoscopy",
                    "sub_points": [
                      "Positive test result should prompt further evaluation using sigmoidoscopy or full colonoscopy"
                    ]
                  },
                  {
                    "text": "Stool guaiac testing (gFOBT)Tests for ability of heme to catalyze oxidation of guaiacol in presence of H2O2 to blue-colored quinoneCan detect presence of > 5-10 mL per day of blood in stool, with sensitivity between 15-30%False-positive results can occurMyoglobin or hemoglobin in ingested meat or fishGastrointestinal irritation from medications such as aspirin or bismuth subsalicylate (Pepto-Bismol)Presence of bacterial peroxidaseFalse-negative results can occurPresence of large amounts of antioxidants (e.g., vitamin C)",
                    "sub_points": [
                      "Tests for ability of heme to catalyze oxidation of guaiacol in presence of H2O2 to blue-colored quinone",
                      "Can detect presence of > 5-10 mL per day of blood in stool, with sensitivity between 15-30%",
                      "False-positive results can occurMyoglobin or hemoglobin in ingested meat or fishGastrointestinal irritation from medications such as aspirin or bismuth subsalicylate (Pepto-Bismol)Presence of bacterial peroxidase",
                      "Myoglobin or hemoglobin in ingested meat or fish",
                      "Gastrointestinal irritation from medications such as aspirin or bismuth subsalicylate (Pepto-Bismol)",
                      "Presence of bacterial peroxidase",
                      "False-negative results can occurPresence of large amounts of antioxidants (e.g., vitamin C)",
                      "Presence of large amounts of antioxidants (e.g., vitamin C)"
                    ]
                  },
                  {
                    "text": "Fecal immunochemical test (FIT)Detects globin component of hemoglobin (rather than heme component)More sensitive and specific than stool guaiac testing, with fewer false-negative resultsHighly specific for occult lower GI bleeding, as globin is largely degraded by upper GI enzymes and is not affected by diet, animal hemoglobin, or human myoglobin",
                    "sub_points": [
                      "Detects globin component of hemoglobin (rather than heme component)More sensitive and specific than stool guaiac testing, with fewer false-negative results",
                      "More sensitive and specific than stool guaiac testing, with fewer false-negative results",
                      "Highly specific for occult lower GI bleeding, as globin is largely degraded by upper GI enzymes and is not affected by diet, animal hemoglobin, or human myoglobin"
                    ]
                  },
                  {
                    "text": "Alternative techniquesFecal DNA testing for cancer genes (e.g., mutantras, mutant p53, or adenomatous polyposis coli (APC)Reverse transcriptase polymerase chain reaction (RT-PCR)",
                    "sub_points": [
                      "Fecal DNA testing for cancer genes (e.g., mutantras, mutant p53, or adenomatous polyposis coli (APC)",
                      "Reverse transcriptase polymerase chain reaction (RT-PCR)"
                    ]
                  }
                ],
                "Blood in Newborn Feces (Apt Test for Swallowed Blood)": [
                  {
                    "text": "Apt test helps distinguish whether blood found in neonatal stool is of swallowed maternal origin or from newbornLow sensitivity",
                    "sub_points": [
                      "Low sensitivity"
                    ]
                  },
                  {
                    "text": "Stool sample is mixed with water and then centrifuged, with subsequent supernatant mixed with 1% sodium hydroxide in 5:1 ratioFetal blood is resistant to alkali denaturation and remains pinkMaternal blood turns yellow-brown",
                    "sub_points": [
                      "Fetal blood is resistant to alkali denaturation and remains pink",
                      "Maternal blood turns yellow-brown"
                    ]
                  }
                ],
                "Stool Pancreatic Testing": [
                  {
                    "text": "Fecal elastase: Pancreatic proteolytic enzyme that is not degraded during intestinal transport, and therefore is concentrated in stoolELISA testing for fecal elastase can be used to discriminate between pancreatic and nonpancreatic originFecal elastase level < 100 μg/g is consistent with severe exocrine pancreatic insufficiency, with 73-100% sensitivity for severe exocrine pancreatic insufficiencyFecal elastase has lower sensitivity for mild or moderate forms of exocrine pancreatic insufficiencyTesting for fecal elastase is unaffected by pancreatic enzyme replacement therapy",
                    "sub_points": [
                      "ELISA testing for fecal elastase can be used to discriminate between pancreatic and nonpancreatic originFecal elastase level < 100 μg/g is consistent with severe exocrine pancreatic insufficiency, with 73-100% sensitivity for severe exocrine pancreatic insufficiencyFecal elastase has lower sensitivity for mild or moderate forms of exocrine pancreatic insufficiency",
                      "Fecal elastase level < 100 μg/g is consistent with severe exocrine pancreatic insufficiency, with 73-100% sensitivity for severe exocrine pancreatic insufficiency",
                      "Fecal elastase has lower sensitivity for mild or moderate forms of exocrine pancreatic insufficiency",
                      "Testing for fecal elastase is unaffected by pancreatic enzyme replacement therapy"
                    ]
                  },
                  {
                    "text": "Fecal chymotrypsin has lower sensitivity for exocrine pancreatic insufficiency and is affected by pancreatic enzyme replacement therapy, and so is no longer routinely used"
                  }
                ],
                "Bile Acid Malabsorption Testing": [
                  {
                    "text": "Bile acids can be measured by 14C-glycocholate breath and stool testPerformed by quantifying fecal 14C-glycocholate in stool over 48-72 hours after ingestionTest is laborious and no longer in wide clinical use",
                    "sub_points": [
                      "Performed by quantifying fecal 14C-glycocholate in stool over 48-72 hours after ingestion",
                      "Test is laborious and no longer in wide clinical use"
                    ]
                  },
                  {
                    "text": "SeHCAT nuclear medicine test is most widely used alternativeIngestion of synthetic analogue of natural conjugated bile acid taurocholic acidAssessment by gamma camera 7 days after oral administration",
                    "sub_points": [
                      "Ingestion of synthetic analogue of natural conjugated bile acid taurocholic acid",
                      "Assessment by gamma camera 7 days after oral administration"
                    ]
                  }
                ],
                "Stool Carbohydrate Testing": [
                  {
                    "text": "Can be useful to assess for malabsorption states"
                  },
                  {
                    "text": "Clinitest tablet: Semiquantitative test that analyzes for presence of reducing substances (> 0.5 g/dL is considered abnormal)Clinitest uses ability of sugars to act as reducing agent, and assesses color of obtained precipitateReducing sugars include all monosaccharides (glucose, fructose, and galactose) and most disaccharides (lactose and maltose), whereas sucrose is nonreducing sugarIncrease in reducing substances is consistent with primary or secondary disaccharidase deficiency, or intestinal monosaccharide malabsorptionFalse-negative results can occur by bacterial overgrowth in ambient temperature transportDiapers reabsorb fluid, and therefore diaper stools have poor sensitivity for reducing substances",
                    "sub_points": [
                      "Clinitest uses ability of sugars to act as reducing agent, and assesses color of obtained precipitateReducing sugars include all monosaccharides (glucose, fructose, and galactose) and most disaccharides (lactose and maltose), whereas sucrose is nonreducing sugar",
                      "Reducing sugars include all monosaccharides (glucose, fructose, and galactose) and most disaccharides (lactose and maltose), whereas sucrose is nonreducing sugar",
                      "Increase in reducing substances is consistent with primary or secondary disaccharidase deficiency, or intestinal monosaccharide malabsorption",
                      "False-negative results can occur by bacterial overgrowth in ambient temperature transportDiapers reabsorb fluid, and therefore diaper stools have poor sensitivity for reducing substances",
                      "Diapers reabsorb fluid, and therefore diaper stools have poor sensitivity for reducing substances"
                    ]
                  },
                  {
                    "text": "Alternative testing for carbohydrate malabsorption includeHydrogen breath test (most common test used for lactose malabsorption)D-xylose absorption test, which is performed on urine",
                    "sub_points": [
                      "Hydrogen breath test (most common test used for lactose malabsorption)",
                      "D-xylose absorption test, which is performed on urine"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cerebrospinal Fluid (CSF)": {
            "name": "Cerebrospinal Fluid (CSF)",
            "url": "https://app.pathprimer.com/document/b03df139-d1c2-4ae3-ae90-58d7611cf663/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Cerebrospinal fluid (CSF) provides physical support to brain, protects against sudden change in venous or arterial blood pressure, provides excretory waste function for brain, transports hypothalamus releasing factors, and maintains central nervous system ionic homeostasis"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Lumbar puncture (LP): Method used to obtain sample of CSF to aid in diagnosis of infectious, inflammatory, oncologic, and metabolic processes"
                  },
                  {
                    "text": "Xanthochromia is yellow, orange, or pink discoloration of CSF, most often caused by lysis of RBCs, but can also result from hyperbilirubinemia, elevated CSF protein levels, or a traumatic tap"
                  },
                  {
                    "text": "WBC count seen in normal adult CSF comprises ~ 70% lymphocytes and 30% monocytes"
                  },
                  {
                    "text": "Peripheral blood in CSF after traumatic tap results in artificial increase in WBCs by 1 WBC for every 500-1000 RBCs in CSF"
                  },
                  {
                    "text": "Intrathecal immunoglobulin synthesis in oligoclonal pattern is most common immunologic abnormality detected in patients with multiple sclerosis"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "CSF is produced predominantly by choroid plexuses; contained in brain ventricles and cranial and spinal subarachnoid spacesProvides physical support to brain, protects against sudden change in venous or arterial blood pressure, provides excretory waste function for brain, transports hypothalamus releasing factors, and maintains central nervous system ionic homeostasisRenewed about 4 times every 24 hours and is absorbed into internal jugular system via cranial arachnoid granulationsLeaves ventricular system through medial and lateral foramina, flowing over brain and spinal cord surfaces within subarachnoid space",
                    "sub_points": [
                      "Provides physical support to brain, protects against sudden change in venous or arterial blood pressure, provides excretory waste function for brain, transports hypothalamus releasing factors, and maintains central nervous system ionic homeostasis",
                      "Renewed about 4 times every 24 hours and is absorbed into internal jugular system via cranial arachnoid granulations",
                      "Leaves ventricular system through medial and lateral foramina, flowing over brain and spinal cord surfaces within subarachnoid space"
                    ]
                  },
                  {
                    "text": "Mean CSF volume: 150 ml (25 ml in ventricles, 125 ml in subarachnoid spaces)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection": [
                  {
                    "text": "Lumbar puncture (LP): Method used to obtain CSF sample to aid in diagnosis of infectious, inflammatory, oncologic, and metabolic processesMost common complication is headacheOccurs in up to 36.5% of patients within 48 hours after procedureOther complicationsHerniationCardiorespiratory compromiseLocal or referred painBleedingInfection",
                    "sub_points": [
                      "Most common complication is headacheOccurs in up to 36.5% of patients within 48 hours after procedure",
                      "Occurs in up to 36.5% of patients within 48 hours after procedure",
                      "Other complicationsHerniationCardiorespiratory compromiseLocal or referred painBleedingInfection",
                      "Herniation",
                      "Cardiorespiratory compromise",
                      "Local or referred pain",
                      "Bleeding",
                      "Infection"
                    ]
                  },
                  {
                    "text": "Patients with CSF shunts, hydrocephalus, trauma, space-occupying lesions, immunocompromised state, papilledema, new onset seizures, or focal neurologic signs should undergo computed tomography of brain before LP"
                  }
                ],
                "Gross Examination": [
                  {
                    "text": "Xanthochromia: Yellow, orange, or pink discoloration of CSF, most often caused by lysis of RBCs; can also result from traumatic tap, hyperbilirubinemia, or elevated CSF protein levelsGreen discoloration can result from hyperbilirubinemia or purulenceBrown discoloration can result from meningeal melanomatosis",
                    "sub_points": [
                      "Green discoloration can result from hyperbilirubinemia or purulence",
                      "Brown discoloration can result from meningeal melanomatosis"
                    ]
                  }
                ],
                "Cell Counts": [
                  {
                    "text": "WBC count seen in normal adult CSF comprises ~ 70% lymphocytes and 30% monocytes"
                  },
                  {
                    "text": "Leukocytosis may occur with bacterial meningitis, as well as after seizure, in intracerebral hemorrhage, with malignancy, and in variety of inflammatory conditionsEosinophilic meningitis (> 10 eosinophils per mm3 or > 10% eosinophils) may result from parasitic infection, rickettsial meningitis, ventriculoperitoneal shunts, malignancy, or adverse drug reactions",
                    "sub_points": [
                      "Eosinophilic meningitis (> 10 eosinophils per mm3 or > 10% eosinophils) may result from parasitic infection, rickettsial meningitis, ventriculoperitoneal shunts, malignancy, or adverse drug reactions"
                    ]
                  },
                  {
                    "text": "Presence of RBCs in CSF indicates intracranial hemorrhage, herpes simplex encephalitis, or traumatic tapPeripheral blood in CSF after traumatic tap results in artificial increase in WBCs by 1 WBC for every 500-1000 RBCs in CSF",
                    "sub_points": [
                      "Peripheral blood in CSF after traumatic tap results in artificial increase in WBCs by 1 WBC for every 500-1000 RBCs in CSF"
                    ]
                  }
                ],
                "Chemistry": [
                  {
                    "text": "Elevated CSF protein is seen in infections, intracranial hemorrhages, multiple sclerosis, Guillain-Barré syndrome (GBS), and malignanciesProteins are found to be elevated in 90% of bacterial meningitis casesElevated CSF protein level (100-1000 mg/dl) without accompanying pleocytosis is suggestive of GBS",
                    "sub_points": [
                      "Proteins are found to be elevated in 90% of bacterial meningitis cases",
                      "Elevated CSF protein level (100-1000 mg/dl) without accompanying pleocytosis is suggestive of GBS"
                    ]
                  },
                  {
                    "text": "Low CSF protein can been seen in repeated lumbar puncture or chronic leak, young children, and acute water intoxication"
                  },
                  {
                    "text": "CNS infections, chemical meningitis, inflammatory conditions, subarachnoid hemorrhage, and hypoglycemia can cause lowered CSF glucose levels"
                  }
                ],
                "Microbiology": [
                  {
                    "text": "Cultures done on 5% sheep blood agar and enriched chocolate agar remain gold standards for diagnosing bacterial meningitis"
                  },
                  {
                    "text": "CSF culture yields can be improved by inoculating culture media at bedside"
                  }
                ],
                "Cytology": [
                  {
                    "text": "Cytological examination should be performed within 30 minutes of CSF collection"
                  },
                  {
                    "text": "Neoplastic cells, plasma cells, and blasts in CSF are always abnormal"
                  },
                  {
                    "text": "Lymphoma patients can have clinical symptoms and neuroimaging features that suggest leptomeningeal involvement, but have negative CSF cytology in up to 50-60% of cases"
                  },
                  {
                    "text": "Nuclear pleomorphism, cytomegaly, and irregular cell shape can improve diagnostic accuracy for hematological malignancies"
                  },
                  {
                    "text": "Flow cytometry in conjunction with cytology also enhances detection of CSF lymphoproliferative disease"
                  }
                ],
                "CSF Immunoglobulin Analysis": [
                  {
                    "text": "CSF immunoglobulin (IgG, IgA, and IgM) are analyzed by electrophoresis"
                  },
                  {
                    "text": "Intrathecal immunoglobulin synthesis in oligoclonal pattern is most common immunologic abnormality detected in patients with multiple sclerosis (MS)Oligoclonal bands detected in 60-90% of patients with MSCSF IgG can also be detected in some neuroinfectious and autoimmune diseases (e.g., neurosyphilis, Lyme disease, subacute sclerosing panencephalitis, acute disseminated encephalomyelitis [ADEM])",
                    "sub_points": [
                      "Oligoclonal bands detected in 60-90% of patients with MS",
                      "CSF IgG can also be detected in some neuroinfectious and autoimmune diseases (e.g., neurosyphilis, Lyme disease, subacute sclerosing panencephalitis, acute disseminated encephalomyelitis [ADEM])"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Bronchoalveolar Lavage Fluid (BALF)": {
            "name": "Bronchoalveolar Lavage Fluid (BALF)",
            "url": "https://app.pathprimer.com/document/81cbc6e0-c47f-4b41-ad63-98f1ef797014/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Bronchoalveolar lavage (BAL): Diagnostic procedure performed during bronchoscopy to retrieve secretions coating apical surfaces of bronchial and alveolar epitheliumCan accurately diagnose infections, and can be used instead of more invasive techniques, such as needle biopsy and thoracoscopyComplications include decline in arterial oxygen saturation, fevers (~ 50% of patients) due to local cytokine release, and pneumothorax (rarely)",
                    "sub_points": [
                      "Can accurately diagnose infections, and can be used instead of more invasive techniques, such as needle biopsy and thoracoscopy",
                      "Complications include decline in arterial oxygen saturation, fevers (~ 50% of patients) due to local cytokine release, and pneumothorax (rarely)"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Patients with desquamative interstitial pneumonia develop marked increase in BAL fluid eosinophils"
                  },
                  {
                    "text": "Lymphocytic predominance suggests granulomatous lung disease, viral infection, or interstitial lung disease"
                  },
                  {
                    "text": "Presence of squamous epithelial cells suggests BAL fluid is contaminated with upper airway secretions, whereas large numbers of bronchial epithelial cells suggest that BAL may not have adequately sampled distal airspaces"
                  },
                  {
                    "text": "Colony counts of > 1000 CFU/mL organisms, and Gram stains with 1 or more bacteria without squamous epithelial cells per oil immersion field, strongly suggests acute bacterial pneumonia"
                  },
                  {
                    "text": "Testing for β-D-glucan, a component of fungal cell wall ofCandida,Aspergillus, andPneumocystisspp., can be used to exclude invasive fungal infections"
                  },
                  {
                    "text": "PCR can enhance sensitivity forPneumocystis(especially in non-HIV infected immunocompromised patients, who have lower organism burden), which may not be detected via routine staining"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definitions": [
                  {
                    "text": "Bronchoalveolar lavage (BAL): Diagnostic procedure performed during bronchoscopy to retrieve secretions coating apical surfaces of bronchial and alveolar epithelium"
                  },
                  {
                    "text": "Bronchial washing: Aspiration of fluid from large airways directly or following instillation of 10-30 mL of saline"
                  },
                  {
                    "text": "Whole lung lavage: Performed via delivery of double-lumen endotracheal tube under general anesthesia, for patients with silicosis and alveolar microlithiasis, as well as the treatment of alveolar proteinosis"
                  }
                ],
                "Clinical Applications": [
                  {
                    "text": "BAL can accurately diagnose infections, and can be used instead of more invasive techniques, such as needle biopsy and thoracoscopyCan be used for diagnosis of bacterial pneumonia in ventilated patients who have not received antimicrobial therapy, or infection in immunocompromised patientsCan enhance detection rates in sputum-negative tuberculosisCan be used therapeutically for removal of tenacious mucous plugs in asthma and cystic fibrosis",
                    "sub_points": [
                      "Can be used for diagnosis of bacterial pneumonia in ventilated patients who have not received antimicrobial therapy, or infection in immunocompromised patients",
                      "Can enhance detection rates in sputum-negative tuberculosis",
                      "Can be used therapeutically for removal of tenacious mucous plugs in asthma and cystic fibrosis"
                    ]
                  },
                  {
                    "text": "BAL can also be used to evaluate inflammatory patterns in patients with suspected interstitial lung disease"
                  },
                  {
                    "text": "Diagnostic yield of BAL is increased in patients with both fever and chest symptoms, compared to patients without symptoms and when performed in right middle lobe"
                  },
                  {
                    "text": "Contraindications to BAL include patients with life-threatening arrhythmias and refractory hypoxemia"
                  },
                  {
                    "text": "Complications of BALDecline in arterial oxygen saturationFevers (~ 50% of patients) due to local cytokine releasePneumothorax (rarely)",
                    "sub_points": [
                      "Decline in arterial oxygen saturation",
                      "Fevers (~ 50% of patients) due to local cytokine release",
                      "Pneumothorax (rarely)"
                    ]
                  },
                  {
                    "text": "Alternative sampling techniques (higher risk of complications)Transbronchial lung biopsy (TBLB)Surgical lung biopsy (SLB)",
                    "sub_points": [
                      "Transbronchial lung biopsy (TBLB)",
                      "Surgical lung biopsy (SLB)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection and Processing": [
                  {
                    "text": "Bronchoalveolar fluid (BALF) is collected by wedging tip of bronchoscope into airway lumen, injecting volume (100 and 300 ml) of saline, and sampling returned fluid using negative suction pressureShould be collected in silicone-coated glass or polypropylene containers to avoid cell adherence",
                    "sub_points": [
                      "Should be collected in silicone-coated glass or polypropylene containers to avoid cell adherence"
                    ]
                  }
                ],
                "Gross Examination of Fluid": [
                  {
                    "text": "Grossly bloody fluid may indicate acute diffuse alveolar hemorrhage"
                  },
                  {
                    "text": "Grossly cloudy or milky fluid with flocculent material suggests pulmonary alveolar proteinosis"
                  }
                ],
                "Cell Count": [
                  {
                    "text": "Total cell count is usually obtained via hemocytometer, and cell viability is determined by trypan blue exclusion"
                  },
                  {
                    "text": "Differential cell counts are performed via cytocentrifugation with staining (Wright-Giemsa or May-Grünwald-Giemsa)Predominantly inflammatory cellular pattern may help in differential diagnosis of specific type of interstitial lung diseasePatients with desquamative interstitial pneumonia develop marked increase in BAL fluid eosinophilsNeutrophil predominance is associated with both bacterial pneumonia and acute lung injuryLymphocytic predominance suggests granulomatous lung disease, viral infection, or interstitial lung disease",
                    "sub_points": [
                      "Predominantly inflammatory cellular pattern may help in differential diagnosis of specific type of interstitial lung diseasePatients with desquamative interstitial pneumonia develop marked increase in BAL fluid eosinophils",
                      "Patients with desquamative interstitial pneumonia develop marked increase in BAL fluid eosinophils",
                      "Neutrophil predominance is associated with both bacterial pneumonia and acute lung injury",
                      "Lymphocytic predominance suggests granulomatous lung disease, viral infection, or interstitial lung disease"
                    ]
                  },
                  {
                    "text": "Presence of squamous epithelial cells suggests that BAL fluid is contaminated with upper airway secretions; whereas large numbers of bronchial epithelial cells suggest that BAL may not have adequately sampled distal airspaces"
                  }
                ],
                "Microbiology": [
                  {
                    "text": "BAL can be used to identify bacterial infection by utilizing both Gram stains and cultureColony counts of > 1000 CFU/mL organisms, and Gram stains with 1 or more bacteria without squamous epithelial cells per oil immersion field, strongly suggests acute bacterial pneumoniaSputum specimens are preferable to BAL for culture ofLegionellaspp., because bronchoalveolar lavage samples are diluted with saline and may contain local anesthetic, which inhibits growth ofLegionella",
                    "sub_points": [
                      "Colony counts of > 1000 CFU/mL organisms, and Gram stains with 1 or more bacteria without squamous epithelial cells per oil immersion field, strongly suggests acute bacterial pneumonia",
                      "Sputum specimens are preferable to BAL for culture ofLegionellaspp., because bronchoalveolar lavage samples are diluted with saline and may contain local anesthetic, which inhibits growth ofLegionella"
                    ]
                  },
                  {
                    "text": "Causes of fungal pneumonia include histoplasmosis, blastomycosis, and coccidioidomycosis;Aspergillusand mucormycosis; andCandidaspp.Diagnosis aided by morphologic analysis with Gomori methenamine silver stained smearsTesting for β-D-glucan, a component of fungal cell wall ofCandida,Aspergillus, andPneumocystisspp., can be used to exclude invasive fungal infections",
                    "sub_points": [
                      "Diagnosis aided by morphologic analysis with Gomori methenamine silver stained smears",
                      "Testing for β-D-glucan, a component of fungal cell wall ofCandida,Aspergillus, andPneumocystisspp., can be used to exclude invasive fungal infections"
                    ]
                  },
                  {
                    "text": "BAL fluid can be used to enhance sensitivity of diagnosis forMycobacterium tuberculosisin patients with sputum-negative tuberculosisAcid-fast smears are limited by relatively low sensitivityNucleic acid amplification (NAA) testing can enhance sensitivity ofM. tuberculosisdiagnosis",
                    "sub_points": [
                      "Acid-fast smears are limited by relatively low sensitivity",
                      "Nucleic acid amplification (NAA) testing can enhance sensitivity ofM. tuberculosisdiagnosis"
                    ]
                  },
                  {
                    "text": "Pneumocystis jirovecipneumonia (PJP) can be diagnosed in BAL fluid with higher sensitivity than sputum samplesPneumocystiscan be diagnosed with methenamine silver and toluidine-blue-O stainsPCR can enhance sensitivity forPneumocystis (especially in non-HIV infected immunocompromised patients, who have a lower organism burden), which may not be detected via routine staining",
                    "sub_points": [
                      "Pneumocystiscan be diagnosed with methenamine silver and toluidine-blue-O stains",
                      "PCR can enhance sensitivity forPneumocystis (especially in non-HIV infected immunocompromised patients, who have a lower organism burden), which may not be detected via routine staining"
                    ]
                  },
                  {
                    "text": "Toxoplasmosis PCR from BAL fluid is diagnostic method of choice for pulmonary toxoplasmosis"
                  }
                ],
                "Cytopathology": [
                  {
                    "text": "Cytocentrifuge with Papanicolaou stain allows detection of cytopathic changes, such as in CMV pneumonia"
                  },
                  {
                    "text": "Periodic acid-Schiff staining may be used to detect pulmonary alveolar proteinosis"
                  },
                  {
                    "text": "Hemosiderin staining may help evaluate for hemorrhage"
                  },
                  {
                    "text": "Cytology can also be examined for malignancy (sensitivity 35%-70%)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pleural Fluid": {
            "name": "Pleural Fluid",
            "url": "https://app.pathprimer.com/document/ae998d46-8fdb-48ba-8080-166a068c0fa4/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Pleural fluid (normal amount 0.1 mL per kg): Produced by capillaries of parietal pleura and absorbed through lymphatic vessels in parietal pleura; facilitates movement between visceral and parietal membranes"
                  },
                  {
                    "text": "Pleural effusion: Results from imbalance between pleural fluid production and reabsorption, leading to fluid accumulation in pleural spacePatients with pleural effusion can present with dyspnea, nonproductive cough, or pleuritic chest pain",
                    "sub_points": [
                      "Patients with pleural effusion can present with dyspnea, nonproductive cough, or pleuritic chest pain"
                    ]
                  },
                  {
                    "text": "Transudates are more likely to be bilateral; exudates are more likely to be unilateral"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Thoracentesis: Removal of pleural fluid using needle or syringe, for diagnostic or therapeutic purposes"
                  },
                  {
                    "text": "Most pleural fluids are clear, straw-colored, odorless, and nonviscous"
                  },
                  {
                    "text": "Pleural fluid eosinophilia (PFE): Defined as > 10% of cells being eosinophils; results most commonly from pneumothorax or hemothorax, but can also occur secondary to paragonimiasis,Coccidioides, orHistoplasma, and drugs such as nitrofurantoin and valproic acid"
                  },
                  {
                    "text": "Malignant cells may demonstrate papillary clusters, cannonball shapes with round contour, or gland-like acinar groupings; tend to have larger cell groups and smoother borders"
                  },
                  {
                    "text": "Pleural fluid with pus should not be sent for pH determination, because it may clog blood-gas machine"
                  },
                  {
                    "text": "Direct inoculation of pleural fluid into blood culture media at bedside increases identification rate for causative microorganisms"
                  },
                  {
                    "text": "Adenosine deaminase (ADA): Enzyme released by activated lymphocytes, macrophages, and neutrophils; considered a nonspecific marker of inflammation; used to evaluate for TB pleurisy"
                  },
                  {
                    "text": "N-terminal brain natriuretic peptide precursor (NT-proBNP): Secreted from cardiac ventricles in response to pressure and volume overload; increased in pleural fluid and serum of patients with congestive heart failure"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Pleural cavity: Potential space between visceral and parietal pleurae of lungs"
                  },
                  {
                    "text": "Pleural fluid (normal amount = 0.1 mL per kg): Produced by capillaries of parietal pleura and absorbed through lymphatic vessels in parietal pleura; facilitates movement between visceral and parietal membranes"
                  },
                  {
                    "text": "Pleural effusion: Imbalance between pleural fluid production and reabsorption, leading to fluid accumulation in pleural space"
                  },
                  {
                    "text": "Transudates result from imbalance between hydrostatic and oncotic pressuresIncreased hydrostatic pressures (e.g., heart failure)Decreased oncotic forces (e.g., hypoproteinemia)Increased negative intrapleural pressure (e.g., atelectasis)Movement of ascitic fluid through diaphragm (e.g., hepatic hydrothorax)",
                    "sub_points": [
                      "Increased hydrostatic pressures (e.g., heart failure)",
                      "Decreased oncotic forces (e.g., hypoproteinemia)",
                      "Increased negative intrapleural pressure (e.g., atelectasis)",
                      "Movement of ascitic fluid through diaphragm (e.g., hepatic hydrothorax)"
                    ]
                  },
                  {
                    "text": "Exudates are due to increased capillary permeability &/or impaired lymphatic drainage (e.g., infections, malignancies, inflammation, impaired lymphatic drainage, or effects of drugs)"
                  },
                  {
                    "text": "Transudates are more likely to be bilateral; exudates are more likely to be unilateral"
                  },
                  {
                    "text": "Chylothorax occurs from leakage from thoracic duct, resulting from obstruction by lymphoma, carcinoma, or traumatic disruption"
                  },
                  {
                    "text": "Pseudochylothorax results from accumulation of cholesterol &/or lecithin-globulin complexes in long-standing pleural effusions"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Patients with pleural effusion can present withDyspneaNonproductive coughPleuritic chest pain",
                    "sub_points": [
                      "Dyspnea",
                      "Nonproductive cough",
                      "Pleuritic chest pain"
                    ]
                  },
                  {
                    "text": "Hemoptysis may occur with endobronchial cancer or pulmonary thromboembolism"
                  },
                  {
                    "text": "Physical examination may demonstrateDullness to percussionDecreased or absent tactile fremitusReduced chest expansionReduced breath sounds on auscultation",
                    "sub_points": [
                      "Dullness to percussion",
                      "Decreased or absent tactile fremitus",
                      "Reduced chest expansion",
                      "Reduced breath sounds on auscultation"
                    ]
                  },
                  {
                    "text": "Imaging modalities such as ultrasound or computed tomography (CT) scanning can be used to evaluate pleural effusionLoculated effusions can result from empyema, hemothorax, or tuberculosis (TB)Focal intrafissural fluid collection or bilateral pleural effusions can occur in patients with heart failureMediastinal shift resulting from massive pleural effusion may indicate endobronchial obstruction or mediastinal encasement by tumor",
                    "sub_points": [
                      "Loculated effusions can result from empyema, hemothorax, or tuberculosis (TB)",
                      "Focal intrafissural fluid collection or bilateral pleural effusions can occur in patients with heart failure",
                      "Mediastinal shift resulting from massive pleural effusion may indicate endobronchial obstruction or mediastinal encasement by tumor"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Biochemical Tests": [
                  {
                    "text": "Glucose measurements can help with differential diagnosisLow pleural fluid glucose (< 60 mg/dL) is mainly caused by complicated parapneumonic effusion, malignancy, TB, and rheumatoid pleuritisPleural fluid may be zero in cases of chronic rheumatoid pleurisy, empyema, and paragonimiasisHigh pleural fluid glucose may occur with esophageal rupture, extravascular migration of a central venous catheter with glucose infusion, and peritoneal dialysisTriglyceride and cholesterol levels are used to distinguish chylothorax from pseudochylothoraxTriglyceride concentrations > 1.2 mmol/L and cholesterol < 5.2 mmol/L are associated with chylothoraxTriglycerides < 0.6 mmol/L and cholesterol > 5.1 mmol/L are associated with pseudochylothorax",
                    "sub_points": [
                      "Low pleural fluid glucose (< 60 mg/dL) is mainly caused by complicated parapneumonic effusion, malignancy, TB, and rheumatoid pleuritis",
                      "Pleural fluid may be zero in cases of chronic rheumatoid pleurisy, empyema, and paragonimiasis",
                      "High pleural fluid glucose may occur with esophageal rupture, extravascular migration of a central venous catheter with glucose infusion, and peritoneal dialysis",
                      "Triglyceride and cholesterol levels are used to distinguish chylothorax from pseudochylothoraxTriglyceride concentrations > 1.2 mmol/L and cholesterol < 5.2 mmol/L are associated with chylothoraxTriglycerides < 0.6 mmol/L and cholesterol > 5.1 mmol/L are associated with pseudochylothorax",
                      "Triglyceride concentrations > 1.2 mmol/L and cholesterol < 5.2 mmol/L are associated with chylothorax",
                      "Triglycerides < 0.6 mmol/L and cholesterol > 5.1 mmol/L are associated with pseudochylothorax"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Thoracentesis: Removal of pleural fluid using needle or syringe, for diagnostic or therapeutic purposesThoracentesis specimen should be collected in heparinized tubes, EDTA tube (for cell counts), and blood culture media for cultures",
                    "sub_points": [
                      "Thoracentesis specimen should be collected in heparinized tubes, EDTA tube (for cell counts), and blood culture media for cultures"
                    ]
                  },
                  {
                    "text": "Blood sampling should be drawn within 30 minutes of thoracentesis to distinguish transudate from exudate"
                  }
                ],
                "Gross Examination of Fluid": [
                  {
                    "text": "Most pleural fluids are clear, straw-colored, odorless, and nonviscous"
                  },
                  {
                    "text": "Coloration of fluid can aid in differential diagnosis of pleural effusionBloody appearance suggests malignancy, embolism, or traumaYellow-white appearance suggests empyemaBlack appearance suggestsAspergillusinfectionMilky, greenish, or “gold paint” appearance suggests pseudochylous or chyliform effusions",
                    "sub_points": [
                      "Bloody appearance suggests malignancy, embolism, or trauma",
                      "Yellow-white appearance suggests empyema",
                      "Black appearance suggestsAspergillusinfection",
                      "Milky, greenish, or “gold paint” appearance suggests pseudochylous or chyliform effusions"
                    ]
                  },
                  {
                    "text": "Increased turbidity may result from increased cellularity (such as in empyema) or from high lipid concentration (as in chylothorax or pseudochylothorax)"
                  },
                  {
                    "text": "Increased viscosity may occur with empyema (due to pus) or malignant mesothelioma (due to hyaluronic acid)"
                  }
                ],
                "Cell Counts and Differential": [
                  {
                    "text": "Total cell counts are performed using manual hemocytometers or automated cell countsRed cell counts > 100,000/µL are suggestive of malignancy, trauma, or pulmonary infarctionPleural fluid hematocrit > 50% of blood hematocrit is consistent with hemothorax",
                    "sub_points": [
                      "Red cell counts > 100,000/µL are suggestive of malignancy, trauma, or pulmonary infarction",
                      "Pleural fluid hematocrit > 50% of blood hematocrit is consistent with hemothorax"
                    ]
                  },
                  {
                    "text": "White blood cell differentials can aid in differential diagnosisNeutrophil predominance may occur in cases of parapneumonia, pulmonary embolism, viral infections, gastrointestinal diseases, and tuberculous pleuritisLymphocyte predominance fluid suggests cancer or TBMononuclear predominance suggests subacute or chronic processPleural fluid eosinophilia (PFE): Defined as > 10% of cells being eosinophilsResults most commonly from pneumothorax or hemothorax, but can also occur secondary to paragonimiasis,Coccidioides, orHistoplasma, and drugs such as nitrofurantoin and valproic acid",
                    "sub_points": [
                      "Neutrophil predominance may occur in cases of parapneumonia, pulmonary embolism, viral infections, gastrointestinal diseases, and tuberculous pleuritis",
                      "Lymphocyte predominance fluid suggests cancer or TB",
                      "Mononuclear predominance suggests subacute or chronic process",
                      "Pleural fluid eosinophilia (PFE): Defined as > 10% of cells being eosinophilsResults most commonly from pneumothorax or hemothorax, but can also occur secondary to paragonimiasis,Coccidioides, orHistoplasma, and drugs such as nitrofurantoin and valproic acid",
                      "Results most commonly from pneumothorax or hemothorax, but can also occur secondary to paragonimiasis,Coccidioides, orHistoplasma, and drugs such as nitrofurantoin and valproic acid"
                    ]
                  }
                ],
                "Cytology": [
                  {
                    "text": "Mesothelial cells are present in pleural fluids with inflammatory processesHave oval to round shape with prominent cell borders, and cellular “windows” due to presence of microvilliReactive mesothelial cells may form small groups with papillary architecture and knobby, scalloped borderMalignant mesothelioma can have cellular aggregates of ≥ 200 cells, although single cells can also be present",
                    "sub_points": [
                      "Have oval to round shape with prominent cell borders, and cellular “windows” due to presence of microvilli",
                      "Reactive mesothelial cells may form small groups with papillary architecture and knobby, scalloped border",
                      "Malignant mesothelioma can have cellular aggregates of ≥ 200 cells, although single cells can also be present"
                    ]
                  },
                  {
                    "text": "Cytologic analysis (with smears and cell blocks) has 60-70% sensitivity for metastatic carcinoma and malignant pleural effusionsMay require immunocytochemical stainsCytology is less sensitive for certain malignancies, such as mesothelioma, sarcoma, and lymphomaMalignant cells may demonstrate papillary clusters, cannonball shapes with round contour, or gland-like acinar groupingsTend to have larger cell groups and smoother borders",
                    "sub_points": [
                      "May require immunocytochemical stains",
                      "Cytology is less sensitive for certain malignancies, such as mesothelioma, sarcoma, and lymphoma",
                      "Malignant cells may demonstrate papillary clusters, cannonball shapes with round contour, or gland-like acinar groupingsTend to have larger cell groups and smoother borders",
                      "Tend to have larger cell groups and smoother borders"
                    ]
                  }
                ],
                "pH": [
                  {
                    "text": "Pleural fluid for pH should be collected anaerobically in heparinized syringe and measured in blood-gas machine"
                  },
                  {
                    "text": "Pleural fluid with pus should not be sent for pH determination, because it may clog blood-gas machine"
                  },
                  {
                    "text": "Pleural pH level increases with exposure of sample to air with delay of testing > 4 hours"
                  },
                  {
                    "text": "Pleural fluid pH decreases with bacterial infection, or in abnormal pleural membrane (i.e., TB or chronic rheumatoid pleurisy)"
                  },
                  {
                    "text": "Pleural pH also has prognostic significance in certain situationspH value < 7.20 in patient with parapneumonic effusion indicates pleural loculation that needs to be drained via thoracotomy tubepH value < 7.30 in malignant pleural effusion is associated with shorter survival and poorer response to chemical pleurodesis",
                    "sub_points": [
                      "pH value < 7.20 in patient with parapneumonic effusion indicates pleural loculation that needs to be drained via thoracotomy tube",
                      "pH value < 7.30 in malignant pleural effusion is associated with shorter survival and poorer response to chemical pleurodesis"
                    ]
                  }
                ],
                "Microbiology": [
                  {
                    "text": "Bacterial cultures will identify microorganism in ~ 40% of parapneumonic effusions and < 40% of cases caused byMycobacterium tuberculosis"
                  },
                  {
                    "text": "Direct inoculation of pleural fluid into blood culture media at bedside increases identification rate for causative microorganisms"
                  },
                  {
                    "text": "Nongroupable streptococci (Streptococcus viridans,S. milleri) and pneumococcus are most commonly isolated pathogens in community-acquired empyema"
                  },
                  {
                    "text": "Staphylococcal species,Enterococcus, and Enterobacteriaceae are most common isolates in hospital-acquired infection"
                  }
                ],
                "Specific Biomarkers": [
                  {
                    "text": "Adenosine deaminase (ADA): Enzyme released by activated lymphocytes, macrophages, and neutrophils; considered nonspecific marker of inflammation; used to evaluate for TB pleurisyPleural fluid ADA level > 40 U/L has sensitivity of 90-100% and specificity of 85-95% for diagnosis of tuberculous pleurisyCan also be elevated in rheumatoid pleuritis or empyemaHas low positive predictive value in areas with low prevalence of TB",
                    "sub_points": [
                      "Pleural fluid ADA level > 40 U/L has sensitivity of 90-100% and specificity of 85-95% for diagnosis of tuberculous pleurisyCan also be elevated in rheumatoid pleuritis or empyemaHas low positive predictive value in areas with low prevalence of TB",
                      "Can also be elevated in rheumatoid pleuritis or empyema",
                      "Has low positive predictive value in areas with low prevalence of TB"
                    ]
                  },
                  {
                    "text": "N-terminal brain natriuretic peptide precursor (NT-proBNP): Secreted from cardiac ventricles in response to pressure and volume overload; increased in pleural fluid and serum of patients with congestive heart failurePleural fluid NT-proBNP values ≥ 1500 ng/L can differentiate pleural effusions caused by heart failure from those by other causes with sensitivity and specificity of 91% and 93%NT-proBNP may also be increased in elderly patients and in patients with renal failure",
                    "sub_points": [
                      "Pleural fluid NT-proBNP values ≥ 1500 ng/L can differentiate pleural effusions caused by heart failure from those by other causes with sensitivity and specificity of 91% and 93%",
                      "NT-proBNP may also be increased in elderly patients and in patients with renal failure"
                    ]
                  },
                  {
                    "text": "Pleural fluid amylase: May be elevated in pancreatic disease, esophageal rupture, or malignancy"
                  },
                  {
                    "text": "Procalcitonin (PCT): Biomarker higher in parapneumonic effusions than TB pleurisy or malignant effusion, but has limited diagnostic value because it lacks ability to distinguish complicated parapneumonic effusions from uncomplicated parapneumonic effusions"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Transudate and Exudate": {
            "name": "Transudate and Exudate",
            "url": "https://app.pathprimer.com/document/fc31ed49-0c26-484e-9843-b996a0a8ef94/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Transudates: Result from imbalance between hydrostatic and oncotic pressures; usually bilateral"
                  },
                  {
                    "text": "Exudates: Involve pleural surface that has become inflamed or infiltrated by tumor, thereby leading to increased capillary permeability (infection) or lymphatic obstruction (malignancy)"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Light’s criteria: Most reliable diagnostic tool to distinguish pericardial exudates and transudates, although pericardial transudates may have pericardial fluid, LDH, and total protein within exudate range by Light's criteria"
                  },
                  {
                    "text": "Serum–ascites albumin gradient (serum albumin concentration minus ascitic fluid albumin concentration): Most reliable method to differentiate peritoneal transudates from exudates"
                  },
                  {
                    "text": "Serum-effusion albumin gradient: Can be used to evaluate pleural effusions; represents difference between serum and pleural fluid albumin; concentration > 1.2 g per dL is suggestive of transudate"
                  },
                  {
                    "text": "SAAG ≥ 11 g/L suggests presence of portal hypertension (i.e., transudate) while SAAG values < 11 g/L are found in patients with normal portal pressure (i.e., exudate)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Pleural effusion: Accumulation of fluid in pleural space"
                  },
                  {
                    "text": "Peritoneal effusion (ascites): Accumulation of fluid in peritoneal cavity"
                  },
                  {
                    "text": "Pericardial effusion: Accumulation of fluid in pericardial space"
                  },
                  {
                    "text": "TransudatesResult from imbalance between hydrostatic and oncotic pressures; usually bilateralTransudative pleural effusionsResult from systemic noninflammatory conditions (e.g., heart failure and cirrhosis) and respond to treatment of the underlying diseaseTransudative ascitic effusionsResult from systemic conditions (e.g., cirrhosis, heart failure, or nephrotic syndrome)Transudative pericardial effusionsResult from systemic conditions (e.g., heart failure or hypoalbuminemia, or postradiation therapy)",
                    "sub_points": [
                      "Result from imbalance between hydrostatic and oncotic pressures; usually bilateralTransudative pleural effusionsResult from systemic noninflammatory conditions (e.g., heart failure and cirrhosis) and respond to treatment of the underlying diseaseTransudative ascitic effusionsResult from systemic conditions (e.g., cirrhosis, heart failure, or nephrotic syndrome)Transudative pericardial effusionsResult from systemic conditions (e.g., heart failure or hypoalbuminemia, or postradiation therapy)",
                      "Transudative pleural effusionsResult from systemic noninflammatory conditions (e.g., heart failure and cirrhosis) and respond to treatment of the underlying disease",
                      "Result from systemic noninflammatory conditions (e.g., heart failure and cirrhosis) and respond to treatment of the underlying disease",
                      "Transudative ascitic effusionsResult from systemic conditions (e.g., cirrhosis, heart failure, or nephrotic syndrome)",
                      "Result from systemic conditions (e.g., cirrhosis, heart failure, or nephrotic syndrome)",
                      "Transudative pericardial effusionsResult from systemic conditions (e.g., heart failure or hypoalbuminemia, or postradiation therapy)",
                      "Result from systemic conditions (e.g., heart failure or hypoalbuminemia, or postradiation therapy)"
                    ]
                  },
                  {
                    "text": "ExudatesInvolve pleural surface that has become inflamed or infiltrated by tumor, thereby leading to increased capillary permeability (infection) or lymphatic obstruction (malignancy)Exudative pleural effusionsCaused by inflammatory or malignant process affecting pleura, causing increased capillary permeability and fluid accumulationCommon causes include pneumonia, cancer, and tuberculosisExudative ascitic effusionsCaused by inflammation or malignancy of peritoneal surfaceExudative pericardial effusionsCaused by inflammatory, infectious, malignant, or autoimmune processes of pericardial surface",
                    "sub_points": [
                      "Involve pleural surface that has become inflamed or infiltrated by tumor, thereby leading to increased capillary permeability (infection) or lymphatic obstruction (malignancy)Exudative pleural effusionsCaused by inflammatory or malignant process affecting pleura, causing increased capillary permeability and fluid accumulationCommon causes include pneumonia, cancer, and tuberculosisExudative ascitic effusionsCaused by inflammation or malignancy of peritoneal surfaceExudative pericardial effusionsCaused by inflammatory, infectious, malignant, or autoimmune processes of pericardial surface",
                      "Exudative pleural effusionsCaused by inflammatory or malignant process affecting pleura, causing increased capillary permeability and fluid accumulationCommon causes include pneumonia, cancer, and tuberculosis",
                      "Caused by inflammatory or malignant process affecting pleura, causing increased capillary permeability and fluid accumulation",
                      "Common causes include pneumonia, cancer, and tuberculosis",
                      "Exudative ascitic effusionsCaused by inflammation or malignancy of peritoneal surface",
                      "Caused by inflammation or malignancy of peritoneal surface",
                      "Exudative pericardial effusionsCaused by inflammatory, infectious, malignant, or autoimmune processes of pericardial surface",
                      "Caused by inflammatory, infectious, malignant, or autoimmune processes of pericardial surface"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Light's Criteria": [
                  {
                    "text": "For pleural fluid, Light's criteria has 98-100% sensitivity and 73% specificity for identifying exudatesDiuretic therapy in patients with congestive heart failure can cause fluid shifts from pleural space, causing resultant increase in protein and lactate dehydrogenase (LDH)False-positives can occur in ~ 20% of patients with pleural effusion caused by congestive heart failure due to effect of diuretics",
                    "sub_points": [
                      "Diuretic therapy in patients with congestive heart failure can cause fluid shifts from pleural space, causing resultant increase in protein and lactate dehydrogenase (LDH)",
                      "False-positives can occur in ~ 20% of patients with pleural effusion caused by congestive heart failure due to effect of diuretics"
                    ]
                  },
                  {
                    "text": "Most reliable diagnostic tool to distinguish pericardial exudates and transudates, although pericardial transudates may have pericardial fluid, LDH, and total protein within exudate range by Light's criteriaExudative and transudative pericardial effusions can be differentiated using fluid total protein concentrations > 30 g/L, fluid/serum total protein ratio > 0.5, and fluid LD > 300 U/L",
                    "sub_points": [
                      "Exudative and transudative pericardial effusions can be differentiated using fluid total protein concentrations > 30 g/L, fluid/serum total protein ratio > 0.5, and fluid LD > 300 U/L"
                    ]
                  }
                ],
                "Serum-Effusion Albumin Gradient": [
                  {
                    "text": "Serum-effusion albumin gradient can be used to evaluate pleural effusions; reflects difference between serum and pleural fluid albumin concentrationSerum albumin gradient > 1.2 g/dl is consistent with true transudateSerum albumin gradient is less sensitive than Light's criteria, and if used as sole test for separating transudates from exudates it will misidentify approximately 37% of exudates as transudates",
                    "sub_points": [
                      "Serum albumin gradient > 1.2 g/dl is consistent with true transudate",
                      "Serum albumin gradient is less sensitive than Light's criteria, and if used as sole test for separating transudates from exudates it will misidentify approximately 37% of exudates as transudates"
                    ]
                  },
                  {
                    "text": "Serum-effusion albumin gradient is most useful in setting of congestive heart failure, to correctly identify cardiac effusions that are mislabeled by Light's criteriaSerum to pleural fluid albumin gradient > 1.2 g/dl correctly identified 83% of mislabeled cardiac effusions and 62% of false exudates linked to cirrhosis",
                    "sub_points": [
                      "Serum to pleural fluid albumin gradient > 1.2 g/dl correctly identified 83% of mislabeled cardiac effusions and 62% of false exudates linked to cirrhosis"
                    ]
                  }
                ],
                "Serum Ascites Albumin Gradient (SAAG)": [
                  {
                    "text": "Serum–ascites albumin gradient (serum albumin concentration minus ascitic fluid albumin concentration) is most reliable method to differentiate peritoneal transudates from exudatesSAAG ≥ 11 g/L suggests presence of portal hypertension (i.e., a transudate)Hepatic metastasesCirrhosisCongestive heart failureSAAG < 11 g/L suggests normal portal pressure (i.e., exudate)Peritoneal carcinomatosisPeritoneal tuberculosisPancreatitisNephrotic syndromeChylous ascites can have falsely elevated albumin concentrations due to lipid fraction interferenceHyperglobulinemia (> 50 g/L) can falsely decrease SAAG values because globulins contribute to colloid osmotic pressure",
                    "sub_points": [
                      "SAAG ≥ 11 g/L suggests presence of portal hypertension (i.e., a transudate)Hepatic metastasesCirrhosisCongestive heart failure",
                      "Hepatic metastases",
                      "Cirrhosis",
                      "Congestive heart failure",
                      "SAAG < 11 g/L suggests normal portal pressure (i.e., exudate)Peritoneal carcinomatosisPeritoneal tuberculosisPancreatitisNephrotic syndrome",
                      "Peritoneal carcinomatosis",
                      "Peritoneal tuberculosis",
                      "Pancreatitis",
                      "Nephrotic syndrome",
                      "Chylous ascites can have falsely elevated albumin concentrations due to lipid fraction interference",
                      "Hyperglobulinemia (> 50 g/L) can falsely decrease SAAG values because globulins contribute to colloid osmotic pressure"
                    ]
                  }
                ],
                "Natriuretic Peptides": [
                  {
                    "text": "Pleural fluid levels of N-terminal of prohormone brain natriuretic peptide (NT-proBNP) have sensitivity and specificity of 94% in identifying heart failure–related effusions"
                  },
                  {
                    "text": "NT-proBNP concentrations > 1500 pg/ml establish diagnosis of heart failure"
                  },
                  {
                    "text": "NT-proBNP is physiologically raised in elderly patients and in patients with renal failureMay be one cause of false-positives",
                    "sub_points": [
                      "May be one cause of false-positives"
                    ]
                  }
                ],
                "Additional Testing": [
                  {
                    "text": "Total and differential cell counts, smears, and cultures to identify infection, additional biochemical testing, cytological analysis, and testing for markers of tuberculous pleuritis"
                  },
                  {
                    "text": "Ascitic fluid/serum bilirubin ratio of 0.6 or greater is also significantly associated with exudates"
                  },
                  {
                    "text": "Analysis of additional pericardial biochemical tests and biomarkers may be used to distinguish exudates from transudatesPericardial effusion cholesterol ≥ 1.2 mmol/L has sensitivity of 88% and specificity of 56% for exudatesPericardial fluid/serum cholesterol ratio of ≥ 0.3 has sensitivity of 91% and specificity of 83% for pericardial exudatesAdenosine deaminase (ADA) of 40 U/L has 88% sensitivity and 83% specificity in identifying tuberculous pericarditis",
                    "sub_points": [
                      "Pericardial effusion cholesterol ≥ 1.2 mmol/L has sensitivity of 88% and specificity of 56% for exudates",
                      "Pericardial fluid/serum cholesterol ratio of ≥ 0.3 has sensitivity of 91% and specificity of 83% for pericardial exudates",
                      "Adenosine deaminase (ADA) of 40 U/L has 88% sensitivity and 83% specificity in identifying tuberculous pericarditis"
                    ]
                  },
                  {
                    "text": "Quantitative analysis of pleural fluid DNA levels may be used in future, because exudates have increased DNA levels"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Saliva": {
            "name": "Saliva",
            "url": "https://app.pathprimer.com/document/c6354080-4b5a-4dcc-a36f-d88837b9e36e/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Saliva is produced by 3 pairs of major salivary glands (parotid, submandibular, sublingual), as well as minor salivary glands, oral mucosa, and gingival crevices"
                  },
                  {
                    "text": "Saliva provides noninvasive means of collecting specimens under direct supervision without loss of privacy, thereby reducing risk of adulteration or substitution for drug testing"
                  },
                  {
                    "text": "Free, unbound drugs or toxins in plasma enter saliva via passive diffusion; therefore, saliva specimens reflect plasma-free drug or toxin concentrations"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Stimulated saliva leads to higher flow rate, which increases concentration of bicarbonate ions; may affect collection of weakly basic drugs, such as cocaine or opioids"
                  },
                  {
                    "text": "Salivary cortisol reflects levels of biologically active, nonprotein-bound cortisol, at approximately 1/10 level of serum cortisol"
                  },
                  {
                    "text": "OraSure: Commercially available, FDA-approved system that detects IgG to HIV-1 and HIV-2 with oral swab"
                  },
                  {
                    "text": "Gas chromatography–mass spectrometry (GC-MS) is most commonly used technique for toxicology on salivary specimens"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Saliva is produced by the followingThree pairs of major salivary glandsParotidSubmandibularSublingualMinor salivary glandsOral mucosaGingival crevices",
                    "sub_points": [
                      "Three pairs of major salivary glandsParotidSubmandibularSublingual",
                      "Parotid",
                      "Submandibular",
                      "Sublingual",
                      "Minor salivary glands",
                      "Oral mucosa",
                      "Gingival crevices"
                    ]
                  },
                  {
                    "text": "Saliva represents filtrate of plasmaComposed of water, mucins, digestion enzymes, and mineral salts",
                    "sub_points": [
                      "Composed of water, mucins, digestion enzymes, and mineral salts"
                    ]
                  },
                  {
                    "text": "Autonomic nervous system (sympathetic and parasympathetic) controls salivary secretionAverage adult produces 1000 mL per daySalivary output can be decreased in Sjögren syndrome",
                    "sub_points": [
                      "Average adult produces 1000 mL per daySalivary output can be decreased in Sjögren syndrome",
                      "Salivary output can be decreased in Sjögren syndrome"
                    ]
                  },
                  {
                    "text": "Saliva provides noninvasive means of collecting specimens under direct supervision without loss of privacy, thereby reducing risk of adulteration or substitution for drug testingFree, unbound drugs or toxins in plasma enter saliva via passive diffusionThus, saliva specimens reflect plasma-free drug or toxin concentrationsDrugs ingested orally or smoked may have higher detections in oral fluid following recent use, so may not be accurateDrugs have shorter half-life in saliva and blood than in hair, sweat, or urine",
                    "sub_points": [
                      "Free, unbound drugs or toxins in plasma enter saliva via passive diffusionThus, saliva specimens reflect plasma-free drug or toxin concentrations",
                      "Thus, saliva specimens reflect plasma-free drug or toxin concentrations",
                      "Drugs ingested orally or smoked may have higher detections in oral fluid following recent use, so may not be accurate",
                      "Drugs have shorter half-life in saliva and blood than in hair, sweat, or urine"
                    ]
                  },
                  {
                    "text": "Saliva also used for other applicationsCortisol levelsInfectious disease testingMolecular diagnostics",
                    "sub_points": [
                      "Cortisol levels",
                      "Infectious disease testing",
                      "Molecular diagnostics"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection": [
                  {
                    "text": "Oral fluid is usually collected by spitting into collection vial or by wiping oral cavity with swabSome individuals may not be able to provide enough saliva due to medication/drug effect (e.g., some tricyclic antidepressants and amphetamines)Saliva specimens may be used by police officers to evaluate impaired drivers (with on-site collection device)",
                    "sub_points": [
                      "Some individuals may not be able to provide enough saliva due to medication/drug effect (e.g., some tricyclic antidepressants and amphetamines)",
                      "Saliva specimens may be used by police officers to evaluate impaired drivers (with on-site collection device)"
                    ]
                  },
                  {
                    "text": "Saliva production may be stimulated prior to collection by placing sour candy, citric acid crystals, or mechanical stimulus (e.g., paraffin wax or Parafilm) in mouthStimulated saliva leads to higher flow rate, which also increases concentration of bicarbonate ionsMay affect collection of weakly basic drugs, such as cocaine or opioidsParafilm can affect drug concentrations by absorbing drugs or metabolites",
                    "sub_points": [
                      "Stimulated saliva leads to higher flow rate, which also increases concentration of bicarbonate ionsMay affect collection of weakly basic drugs, such as cocaine or opioidsParafilm can affect drug concentrations by absorbing drugs or metabolites",
                      "May affect collection of weakly basic drugs, such as cocaine or opioids",
                      "Parafilm can affect drug concentrations by absorbing drugs or metabolites"
                    ]
                  },
                  {
                    "text": "Commercially available collection devices consist of sorbent material that becomes saturated in donor’s mouth"
                  },
                  {
                    "text": "Specimen must be stored at -4°C to reduce bacterial and fungal growth and to lower viscosity so that centrifugation can be performed after thawing"
                  }
                ],
                "Salivary Cortisol": [
                  {
                    "text": "Salivary cortisol reflects levels of biologically active, nonprotein-bound cortisol at approximately 1/10 level of serum cortisolSalivary cortisol is not affected by concentrations of serum-binding proteins",
                    "sub_points": [
                      "Salivary cortisol is not affected by concentrations of serum-binding proteins"
                    ]
                  },
                  {
                    "text": "Cortisol levels peak in morning and have lowest levels at midnightLate-night salivary cortisol can be used as screening test for Cushing syndrome (> 90% sensitivity and specificity)Salivary cortisol can also be used to monitor glucocorticoid treatment in patients with congenital adrenal hyperplasia",
                    "sub_points": [
                      "Late-night salivary cortisol can be used as screening test for Cushing syndrome (> 90% sensitivity and specificity)",
                      "Salivary cortisol can also be used to monitor glucocorticoid treatment in patients with congenital adrenal hyperplasia"
                    ]
                  },
                  {
                    "text": "Immunoassays can detect salivary cortisol, but can cross-react with other steroids"
                  },
                  {
                    "text": "Liquid chromatography–mass spectrometry (LC-MS) methods are more sensitive and specific for salivary cortisol than immunoassays"
                  }
                ],
                "Salivary HIV Testing": [
                  {
                    "text": "Saliva testing for HIV offers advantagesIncreases accessibility for testingAvoids risk of accidental needle stick to health-care workers",
                    "sub_points": [
                      "Increases accessibility for testing",
                      "Avoids risk of accidental needle stick to health-care workers"
                    ]
                  },
                  {
                    "text": "OraSure: Commercially available, FDA-approved system that detects IgG to HIV-1 and HIV-2 with oral swab"
                  },
                  {
                    "text": "Oral swab is used for Western blot analysis with reported specificity and sensitivity of 99.98% and 93.0%"
                  }
                ],
                "Toxicology": [
                  {
                    "text": "Gas chromatography–mass spectrometry (GC-MS) is most commonly used technique for toxicology on salivary specimensPreservatives or stabilizers in salivary sampling devices may result in analytical problems (e.g., ion suppression or enhancement effects)Internal standards are necessary for quantification of THC, cocaine, and 6-acetylmorphine (6-MAM), due to presence of parent drugs in saliva",
                    "sub_points": [
                      "Preservatives or stabilizers in salivary sampling devices may result in analytical problems (e.g., ion suppression or enhancement effects)",
                      "Internal standards are necessary for quantification of THC, cocaine, and 6-acetylmorphine (6-MAM), due to presence of parent drugs in saliva"
                    ]
                  },
                  {
                    "text": "High-performance liquid chromatography (HPLC) can increase sensitivity and specificity in small sample volumes of oral fluid"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hair and Nails": {
            "name": "Hair and Nails",
            "url": "https://app.pathprimer.com/document/7f79f9a1-0af5-439a-bf4b-e779b4cee579/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Hair: Product of differentiated organs in skin of mammals; composed of keratin, water, and lipidsUnlike urine testing, hair analysis can distinguish between chronic use and single exposure to drug or toxinHair analysis provides larger detection window (weeks to months) than urine testing",
                    "sub_points": [
                      "Unlike urine testing, hair analysis can distinguish between chronic use and single exposure to drug or toxin",
                      "Hair analysis provides larger detection window (weeks to months) than urine testing"
                    ]
                  },
                  {
                    "text": "Nail plate: Toxins and drugs can be incorporated into nailVia nail matrix and nail bedFrom exposure to environmental contamination and biological fluids",
                    "sub_points": [
                      "Via nail matrix and nail bed",
                      "From exposure to environmental contamination and biological fluids"
                    ]
                  },
                  {
                    "text": "Forensics: Stability of drugs in hair and nails is useful in postmortem investigations, especially in cases with extensive decomposition of other body tissues"
                  },
                  {
                    "text": "Heavy metal poisoning: Keratin in hair and nails has sulfhydryl groups that bind heavy metals to form covalent complexes; thus, hair and nails are considered specimen of choice in determining chronic heavy metal poisoning, such as arsenic, mercury, and lead"
                  },
                  {
                    "text": "Fetal exposure: Nails grow continuously and are representative of 2nd and 3rd trimester of pregnancy, so may be more useful to test than hair, which is sparse on newborns and is grown in cycles (rather than continuously)"
                  },
                  {
                    "text": "Fungal infections: Hair and nail testing can be used to assess for dermatophyte infections"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Hair specimens are usually cut, except in suspicion of acute poisoning when analysis of plucked hair can provide intradermal portions of hair, which may be only positive portion of specimen"
                  },
                  {
                    "text": "Chromatography (gas, liquid) coupled to mass spectrometry is method of choice for hair toxicology analysis"
                  },
                  {
                    "text": "KOH (potassium hydroxide) preparations can be used on nails and hair to examine for presence of hyphae in dermatophyte infections"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Standard for drug testing in toxicology is immunoassay screen conducted on urine sample followed by confirmation by gas chromatography with mass spectrometric detectionHair and nails are commonly used alternative specimensTesting can provide information about long-term drug or toxin exposure",
                    "sub_points": [
                      "Hair and nails are commonly used alternative specimensTesting can provide information about long-term drug or toxin exposure",
                      "Testing can provide information about long-term drug or toxin exposure"
                    ]
                  },
                  {
                    "text": "HairProduct of differentiated organs in skin of mammals; composed of keratin, water, and lipidsCyclesPeriods of growth (anagen phase)Periods of quiescence (catagen and telogen phases)Proportions of anagen/telogen hair and growth rate vary with anatomical siteToxins and drugs can be incorporated into hairVia bloodstreamVia excretion by sweat and sebumVia environmental exposure to aerosols or smokeIncorporation of drug into hair is related to drug lipophilicity and to amount of melanin pigmentation in hairHair analysis can distinguish between chronic use and single exposure to drug or toxin (unlike urine analysis)Provides larger detection window (weeks to months) compared to urine testingExample: Decrease in drug or toxin in proximal sections of hair may indicate attenuation of use or exposureHair testing is more difficult to adulterate than urine testingAnalysis can help identify false-negative results in individuals who deliberately abstain prior to urine screeningDrawbacks to use of hair analysisHair specimens can become positive from secondary environmental exposure, and so are controversial in workplace testingCosmetic hair treatments (e.g., coloring, bleaching, relaxing) can cause hair damage and directly affect drug stability, causing drug concentrations to decline by 50-80%Certain compounds (e.g., peptide hormones) are not extractable from hair",
                    "sub_points": [
                      "Product of differentiated organs in skin of mammals; composed of keratin, water, and lipidsCyclesPeriods of growth (anagen phase)Periods of quiescence (catagen and telogen phases)Proportions of anagen/telogen hair and growth rate vary with anatomical siteToxins and drugs can be incorporated into hairVia bloodstreamVia excretion by sweat and sebumVia environmental exposure to aerosols or smokeIncorporation of drug into hair is related to drug lipophilicity and to amount of melanin pigmentation in hairHair analysis can distinguish between chronic use and single exposure to drug or toxin (unlike urine analysis)Provides larger detection window (weeks to months) compared to urine testingExample: Decrease in drug or toxin in proximal sections of hair may indicate attenuation of use or exposureHair testing is more difficult to adulterate than urine testingAnalysis can help identify false-negative results in individuals who deliberately abstain prior to urine screening",
                      "CyclesPeriods of growth (anagen phase)Periods of quiescence (catagen and telogen phases)Proportions of anagen/telogen hair and growth rate vary with anatomical site",
                      "Periods of growth (anagen phase)",
                      "Periods of quiescence (catagen and telogen phases)",
                      "Proportions of anagen/telogen hair and growth rate vary with anatomical site",
                      "Toxins and drugs can be incorporated into hairVia bloodstreamVia excretion by sweat and sebumVia environmental exposure to aerosols or smoke",
                      "Via bloodstream",
                      "Via excretion by sweat and sebum",
                      "Via environmental exposure to aerosols or smoke",
                      "Incorporation of drug into hair is related to drug lipophilicity and to amount of melanin pigmentation in hair",
                      "Hair analysis can distinguish between chronic use and single exposure to drug or toxin (unlike urine analysis)Provides larger detection window (weeks to months) compared to urine testingExample: Decrease in drug or toxin in proximal sections of hair may indicate attenuation of use or exposure",
                      "Provides larger detection window (weeks to months) compared to urine testing",
                      "Example: Decrease in drug or toxin in proximal sections of hair may indicate attenuation of use or exposure",
                      "Hair testing is more difficult to adulterate than urine testingAnalysis can help identify false-negative results in individuals who deliberately abstain prior to urine screening",
                      "Analysis can help identify false-negative results in individuals who deliberately abstain prior to urine screening",
                      "Drawbacks to use of hair analysisHair specimens can become positive from secondary environmental exposure, and so are controversial in workplace testingCosmetic hair treatments (e.g., coloring, bleaching, relaxing) can cause hair damage and directly affect drug stability, causing drug concentrations to decline by 50-80%Certain compounds (e.g., peptide hormones) are not extractable from hair",
                      "Hair specimens can become positive from secondary environmental exposure, and so are controversial in workplace testing",
                      "Cosmetic hair treatments (e.g., coloring, bleaching, relaxing) can cause hair damage and directly affect drug stability, causing drug concentrations to decline by 50-80%",
                      "Certain compounds (e.g., peptide hormones) are not extractable from hair"
                    ]
                  },
                  {
                    "text": "Nail plateProduced by nail matrix, with keratinization of both dorsal and ventral sides; overlies nail bedNail growth slows with increasing age, cold climatic conditions, disease, and malnutritionGrowth is faster in nail-bitersToxins and drugs can be incorporated into nailVia nail matrix and nail bedFrom exposure to environmental contamination and biological fluidsDrug incorporation into nails is lower and less well correlated with time of consumption compared to hair samplesFingernails provide superimposed incorporation over 3-5 months; toenails provide time frame of 8-14 monthsThus, toenail samples preferable to fingernail samplesPhysical handling of drugs may cause positivity in nail samples",
                    "sub_points": [
                      "Produced by nail matrix, with keratinization of both dorsal and ventral sides; overlies nail bed",
                      "Nail growth slows with increasing age, cold climatic conditions, disease, and malnutritionGrowth is faster in nail-biters",
                      "Growth is faster in nail-biters",
                      "Toxins and drugs can be incorporated into nailVia nail matrix and nail bedFrom exposure to environmental contamination and biological fluids",
                      "Via nail matrix and nail bed",
                      "From exposure to environmental contamination and biological fluids",
                      "Drug incorporation into nails is lower and less well correlated with time of consumption compared to hair samples",
                      "Fingernails provide superimposed incorporation over 3-5 months; toenails provide time frame of 8-14 monthsThus, toenail samples preferable to fingernail samples",
                      "Thus, toenail samples preferable to fingernail samples",
                      "Physical handling of drugs may cause positivity in nail samples"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "ForensicsHair and nail toxicology is used extensively in forensic settingHair testing is useful for drug-facilitated sexual assaults (DFSA) due to possible long delays between actual assault and involvement of police, making blood and urine testing less sensitive in these casesStability of drugs in hair and nails is useful in postmortem investigations, especially in cases with extensive decomposition of other body tissues",
                    "sub_points": [
                      "Hair and nail toxicology is used extensively in forensic settingHair testing is useful for drug-facilitated sexual assaults (DFSA) due to possible long delays between actual assault and involvement of police, making blood and urine testing less sensitive in these casesStability of drugs in hair and nails is useful in postmortem investigations, especially in cases with extensive decomposition of other body tissues",
                      "Hair testing is useful for drug-facilitated sexual assaults (DFSA) due to possible long delays between actual assault and involvement of police, making blood and urine testing less sensitive in these cases",
                      "Stability of drugs in hair and nails is useful in postmortem investigations, especially in cases with extensive decomposition of other body tissues"
                    ]
                  },
                  {
                    "text": "Drug testingHair toxicology can be used for drug testing in drug maintenance programs or to monitor patient compliance for certain medicationsHair testing for cannabinoids can be used, but may have false-positive from environmental exposureHair analysis can be used to monitor patient compliance for medications, including neuroleptics, antidepressants, or antipsychoticsHair concentrations of fatty acid ethyl esters (FAEE) are suitable markers for detection of heavy alcohol consumption",
                    "sub_points": [
                      "Hair toxicology can be used for drug testing in drug maintenance programs or to monitor patient compliance for certain medicationsHair testing for cannabinoids can be used, but may have false-positive from environmental exposureHair analysis can be used to monitor patient compliance for medications, including neuroleptics, antidepressants, or antipsychoticsHair concentrations of fatty acid ethyl esters (FAEE) are suitable markers for detection of heavy alcohol consumption",
                      "Hair testing for cannabinoids can be used, but may have false-positive from environmental exposure",
                      "Hair analysis can be used to monitor patient compliance for medications, including neuroleptics, antidepressants, or antipsychotics",
                      "Hair concentrations of fatty acid ethyl esters (FAEE) are suitable markers for detection of heavy alcohol consumption"
                    ]
                  },
                  {
                    "text": "Heavy metal poisoningKeratin in hair and nails has sulfhydryl groups that bind heavy metals to form covalent complexesTherefore, hair and nails are considered specimen of choice in determining chronic heavy metal poisoning (e.g., arsenic, mercury, lead)",
                    "sub_points": [
                      "Keratin in hair and nails has sulfhydryl groups that bind heavy metals to form covalent complexesTherefore, hair and nails are considered specimen of choice in determining chronic heavy metal poisoning (e.g., arsenic, mercury, lead)",
                      "Therefore, hair and nails are considered specimen of choice in determining chronic heavy metal poisoning (e.g., arsenic, mercury, lead)"
                    ]
                  },
                  {
                    "text": "Fetal exposureHair and nail analysis can be useful to confirm fetal drug exposure in neonates born to drug-addicted mothers, and allow treatment for possible withdrawalNails grow continuously and are representative of 2nd and 3rd trimester of pregnancy; thus, nails may be more useful to test than hair, which is sparse on newborns and is grown in cycles rather than continuously",
                    "sub_points": [
                      "Hair and nail analysis can be useful to confirm fetal drug exposure in neonates born to drug-addicted mothers, and allow treatment for possible withdrawalNails grow continuously and are representative of 2nd and 3rd trimester of pregnancy; thus, nails may be more useful to test than hair, which is sparse on newborns and is grown in cycles rather than continuously",
                      "Nails grow continuously and are representative of 2nd and 3rd trimester of pregnancy; thus, nails may be more useful to test than hair, which is sparse on newborns and is grown in cycles rather than continuously"
                    ]
                  },
                  {
                    "text": "Fungal infectionsHair and nail testing can be used to assess for dermatophyte infections",
                    "sub_points": [
                      "Hair and nail testing can be used to assess for dermatophyte infections"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Specimen Collection": [
                  {
                    "text": "Hair specimensUsually cut, except with suspicion of acute poisoning when analysis of plucked hair can provide intradermal portions of hair, which may be only positive portion of specimenCollected from posterior vertex of head, which has less variability in hair growth rateMay be collected from other sites as wellHighest concentrations of methadone and methamphetamine are found in axillary hairHighest concentration of morphine is found in pubic hairFacial hair is more likely to have false-positive toxicology results caused by passive exposure to drug or toxinHair sample is washed after collection (decontamination) to minimize false-positives resulting from environmental exposure",
                    "sub_points": [
                      "Usually cut, except with suspicion of acute poisoning when analysis of plucked hair can provide intradermal portions of hair, which may be only positive portion of specimen",
                      "Collected from posterior vertex of head, which has less variability in hair growth rateMay be collected from other sites as wellHighest concentrations of methadone and methamphetamine are found in axillary hairHighest concentration of morphine is found in pubic hairFacial hair is more likely to have false-positive toxicology results caused by passive exposure to drug or toxin",
                      "May be collected from other sites as wellHighest concentrations of methadone and methamphetamine are found in axillary hairHighest concentration of morphine is found in pubic hairFacial hair is more likely to have false-positive toxicology results caused by passive exposure to drug or toxin",
                      "Highest concentrations of methadone and methamphetamine are found in axillary hair",
                      "Highest concentration of morphine is found in pubic hair",
                      "Facial hair is more likely to have false-positive toxicology results caused by passive exposure to drug or toxin",
                      "Hair sample is washed after collection (decontamination) to minimize false-positives resulting from environmental exposure"
                    ]
                  }
                ],
                "Mass Spectrometry": [
                  {
                    "text": "Chromatography (gas, liquid) coupled to mass spectrometry (MS) is method of choice for hair toxicology analysisGas chromatography coupled to mass spectrometry is most widely used (by far) analytical tool for drug determination in hair specimensLiquid chromatography-based techniques have increased sensitivity and can detect very low levels of drugs in pictogram range",
                    "sub_points": [
                      "Gas chromatography coupled to mass spectrometry is most widely used (by far) analytical tool for drug determination in hair specimens",
                      "Liquid chromatography-based techniques have increased sensitivity and can detect very low levels of drugs in pictogram range"
                    ]
                  },
                  {
                    "text": "Prior to chromatographic analysis, analytes must be extracted from hair or nail matrix and concentrated within a solventHydrolysis by sodium hydroxide with subsequent solid-phase extraction provides high yields for alkaline-stable drugs (e.g., cannabinoids, amphetamines)Opioids and cocaine are best extracted using mild acidic hydrolysis to avoid conversion of heroin or 6-acetylmorphine to morphine, and of cocaine to benzoylecgonine",
                    "sub_points": [
                      "Hydrolysis by sodium hydroxide with subsequent solid-phase extraction provides high yields for alkaline-stable drugs (e.g., cannabinoids, amphetamines)",
                      "Opioids and cocaine are best extracted using mild acidic hydrolysis to avoid conversion of heroin or 6-acetylmorphine to morphine, and of cocaine to benzoylecgonine"
                    ]
                  },
                  {
                    "text": "Extraction yield depends on drug's structure, state of matrix, polarity of solvent, duration and manner of extraction"
                  }
                ],
                "Immunoassays": [
                  {
                    "text": "Enzyme-linked immunosorbent assay (ELISA) kits using coated well technology have been developed for toxicology in hair and nail specimens"
                  }
                ],
                "Microbiology": [
                  {
                    "text": "KOH (potassium hydroxide) preparations can be used on nails and hair to examine for presence of hyphae in dermatophyte infectionsSize and morphology of hyphae can help determine which dermatophytes are involved",
                    "sub_points": [
                      "Size and morphology of hyphae can help determine which dermatophytes are involved"
                    ]
                  },
                  {
                    "text": "Sabouraud dextrose agar can be used to culture dermatophytic fungi"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Reporting of Nontraditional Body Fluids": {
            "name": "Reporting of Nontraditional Body Fluids",
            "url": "https://app.pathprimer.com/document/45e66f8c-8cb3-40ab-b1e2-1a1d9561c84a/lesson/825d32cb-0034-4b84-84b3-763b55757b6c",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Nontraditional body fluids testing is important part of clinical diagnosis and management for variety of diseases"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Appropriate validation is essential for laboratories to report results on nontraditional fluid samples"
                  },
                  {
                    "text": "Analysis and reporting of results for nontraditional fluid samples require special attention to communicate properly with physicians for patient care"
                  },
                  {
                    "text": "Accrediting agencies require documented method validation for all specimen types"
                  },
                  {
                    "text": "Requests to perform assays using specimen types that have not been validated should be discouraged"
                  },
                  {
                    "text": "Testing on assays that are not fully validated should be done only under extreme circumstances, with disclaimer included in report regarding possible inaccuracies"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Overview": [
                  {
                    "text": "Nontraditional body fluids testing is important part of clinical diagnosis and management for variety of diseases"
                  },
                  {
                    "text": "Not derived from blood or urine"
                  },
                  {
                    "text": "Fluids includeCerebrospinal (CSF)AmnioticPleuralPericardialPeritonealSynovial",
                    "sub_points": [
                      "Cerebrospinal (CSF)",
                      "Amniotic",
                      "Pleural",
                      "Pericardial",
                      "Peritoneal",
                      "Synovial"
                    ]
                  },
                  {
                    "text": "Nontraditional fluid samples are not cited by manufacturer of FDA-cleared method in product's package insert “Intended Use” section"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Assay Validation": [
                  {
                    "text": "Appropriate validation is essential for laboratories to report results on nontraditional fluid samples"
                  },
                  {
                    "text": "Analytical validation of body fluids can be challenging but, in general, should follow same processes required for other clinical specimens"
                  },
                  {
                    "text": "Appropriate validation of nontraditional body fluid samples was enforced in 2009-2010 when College of American Pathologists (CAP) added it to inspection checklists"
                  },
                  {
                    "text": "Items to check for validation of nontraditional body fluidsAccuracyPrecisionAnalytical sensitivity/limit of quantificationAnalytic measurement rangeMaximum dilution and reportable rangeReference intervalAnalytical specificity/interferencesSample stability",
                    "sub_points": [
                      "Accuracy",
                      "Precision",
                      "Analytical sensitivity/limit of quantification",
                      "Analytic measurement range",
                      "Maximum dilution and reportable range",
                      "Reference interval",
                      "Analytical specificity/interferences",
                      "Sample stability"
                    ]
                  }
                ],
                "Results Reporting": [
                  {
                    "text": "Analysis and reporting of results for nontraditional fluid samples require special attention to communicate properly with physicians for patient care"
                  },
                  {
                    "text": "Accrediting agencies require documented method validation for all specimen types"
                  },
                  {
                    "text": "Requests to perform assays using specimen types that have not been validated should be discouraged"
                  },
                  {
                    "text": "Various clinical scenarios must be considered to provide body fluid tests that have pertinent interpretive information"
                  },
                  {
                    "text": "Testing on assays that are not fully validated should be done only under extreme circumstances﻿Permission of laboratory director or pathologist should be obtained prior to testingDisclaimer should be included in report regarding possible inaccuracy of resultsExample: \"This result was based on non-fully validated assay for this particular body fluid; interpret result with caution\"",
                    "sub_points": [
                      "Permission of laboratory director or pathologist should be obtained prior to testing",
                      "Disclaimer should be included in report regarding possible inaccuracy of resultsExample: \"This result was based on non-fully validated assay for this particular body fluid; interpret result with caution\"",
                      "Example: \"This result was based on non-fully validated assay for this particular body fluid; interpret result with caution\""
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Serum Proteins": {
        "name": "Serum Proteins",
        "url": "https://app.pathprimer.com/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
        "topics": {
          "Acute Phase Proteins (C-Reactive Protein)": {
            "name": "Acute Phase Proteins (C-Reactive Protein)",
            "url": "https://app.pathprimer.com/document/252a8a4b-4dc5-4c48-9c69-26dcd3383f6d/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Defined as proteins that increase or decrease in concentration in plasma after stimulation by inflammation"
                  },
                  {
                    "text": "In response to cytokine secretion, liver stimulates production of acute phase proteins (positive acute phase reaction) and decreases albumin synthesis (negative acute phase reaction)"
                  },
                  {
                    "text": "Main function of these proteins is to neutralize proteolytic enzymes released from leukocytes during inflammatory states to curb excess tissue damage"
                  },
                  {
                    "text": "C-reactive protein (CRP)Most widely used acute phase reactant in chemistry testing because it increases greatly and quickly and returns to baseline quicklyDetected through quantitative immunoturbidimetry in venous blood sample",
                    "sub_points": [
                      "Most widely used acute phase reactant in chemistry testing because it increases greatly and quickly and returns to baseline quickly",
                      "Detected through quantitative immunoturbidimetry in venous blood sample"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Defined as proteins that increase or decrease in concentration in plasma after stimulation by inflammation"
                  },
                  {
                    "text": "Inflammation can be due to stress, infection, injury, surgery, or necrosis"
                  },
                  {
                    "text": "Injury or insult causes granulocytes (neutrophils) and macrophages to secrete cytokines interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF) α"
                  },
                  {
                    "text": "In response to cytokines, liver stimulates production of acute phase proteins (positive acute phase reaction) and decreases albumin synthesis (negative acute phase reaction)α₁-AntitrypsinProtease inhibitor in serpin family of proteinsInhibits neutrophil elastase and superoxide anion synthesisα₁-Acid glycoprotein (orosomucoid)Binding protein for basic drugsHaptoglobinsAntioxidants that remove iron-bound cell-free hemoglobin and hemeIncrease angiogenesisCeruloplasminCopper transportAntioxidantFibrinogenEndothelial cell adhesion and proliferationSerum amyloid AApolipoprotein that alters cholesterol metabolismIncreases adhesion and chemotaxis of leukocytesC-reactive protein (CRP)Antiinflammatory rolesIL-1 receptor antagonistRelease of IL-10Proinflammatory rolesBinds phosphocholine, allowing for recognition of phospholipids in damaged host cells and foreign pathogensActivates complement, binds to Fc receptors, and targets for destructionInduces monocytes to produce cytokines (especially IL-6)OthersFactor VIIIFerritinLipoproteinsComplement proteins (chemotaxis and opsonization)Immunoglobulins",
                    "sub_points": [
                      "α₁-AntitrypsinProtease inhibitor in serpin family of proteinsInhibits neutrophil elastase and superoxide anion synthesis",
                      "Protease inhibitor in serpin family of proteins",
                      "Inhibits neutrophil elastase and superoxide anion synthesis",
                      "α₁-Acid glycoprotein (orosomucoid)Binding protein for basic drugs",
                      "Binding protein for basic drugs",
                      "HaptoglobinsAntioxidants that remove iron-bound cell-free hemoglobin and hemeIncrease angiogenesis",
                      "Antioxidants that remove iron-bound cell-free hemoglobin and heme",
                      "Increase angiogenesis",
                      "CeruloplasminCopper transportAntioxidant",
                      "Copper transport",
                      "Antioxidant",
                      "FibrinogenEndothelial cell adhesion and proliferation",
                      "Endothelial cell adhesion and proliferation",
                      "Serum amyloid AApolipoprotein that alters cholesterol metabolismIncreases adhesion and chemotaxis of leukocytes",
                      "Apolipoprotein that alters cholesterol metabolism",
                      "Increases adhesion and chemotaxis of leukocytes",
                      "C-reactive protein (CRP)Antiinflammatory rolesIL-1 receptor antagonistRelease of IL-10Proinflammatory rolesBinds phosphocholine, allowing for recognition of phospholipids in damaged host cells and foreign pathogensActivates complement, binds to Fc receptors, and targets for destructionInduces monocytes to produce cytokines (especially IL-6)",
                      "Antiinflammatory rolesIL-1 receptor antagonistRelease of IL-10",
                      "IL-1 receptor antagonist",
                      "Release of IL-10",
                      "Proinflammatory rolesBinds phosphocholine, allowing for recognition of phospholipids in damaged host cells and foreign pathogensActivates complement, binds to Fc receptors, and targets for destructionInduces monocytes to produce cytokines (especially IL-6)",
                      "Binds phosphocholine, allowing for recognition of phospholipids in damaged host cells and foreign pathogens",
                      "Activates complement, binds to Fc receptors, and targets for destruction",
                      "Induces monocytes to produce cytokines (especially IL-6)",
                      "OthersFactor VIIIFerritinLipoproteinsComplement proteins (chemotaxis and opsonization)Immunoglobulins",
                      "Factor VIII",
                      "Ferritin",
                      "Lipoproteins",
                      "Complement proteins (chemotaxis and opsonization)",
                      "Immunoglobulins"
                    ]
                  },
                  {
                    "text": "Main function of these proteins is to neutralize proteolytic enzymes released from leukocytes during inflammatory states to curb excess tissue damage"
                  },
                  {
                    "text": "Acute phase response occurs every time insult is encountered (similar to humoral immune system)"
                  },
                  {
                    "text": "CRPMost widely used acute phase reactant in chemistry testing because it increases greatly and quickly returns to baseline quicklyDetected through quantitative immunoturbidimetry in venous blood sample",
                    "sub_points": [
                      "Most widely used acute phase reactant in chemistry testing because it increases greatly and quickly returns to baseline quickly",
                      "Detected through quantitative immunoturbidimetry in venous blood sample"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "CRP is most commonly used to assess inflammatory state because it is fastest rising acute phase reactant and because it returns to normal levels posttreatment"
                  },
                  {
                    "text": "Levels can increase by > 50% during inflammatory state"
                  },
                  {
                    "text": "Often used to diagnose occult bacterial infections (viral infections do not increase CRP as much), autoimmune disorders, and other inflammatory states"
                  },
                  {
                    "text": "Less commonly tested analytesα₁-Antitrypsinα₁-Acid glycoproteinHaptoglobinTNFαCytokine panelsIL-2 receptor (soluble CD25)",
                    "sub_points": [
                      "α₁-Antitrypsin",
                      "α₁-Acid glycoprotein",
                      "Haptoglobin",
                      "TNFα",
                      "Cytokine panels",
                      "IL-2 receptor (soluble CD25)"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "CRP, α₁-antitrypsin, and haptoglobinQuantitative immunoturbidimetry",
                    "sub_points": [
                      "Quantitative immunoturbidimetry"
                    ]
                  },
                  {
                    "text": "α₁-Acid glycoproteinQuantitative nephelometry",
                    "sub_points": [
                      "Quantitative nephelometry"
                    ]
                  },
                  {
                    "text": "TNFα, cytokine, and cytokine panels, IL-2 receptor (soluble CD25)Quantitative multiplex bead assay",
                    "sub_points": [
                      "Quantitative multiplex bead assay"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood sample0.25 mLRed-top tubeRefrigeration preferred",
                    "sub_points": [
                      "0.25 mL",
                      "Red-top tube",
                      "Refrigeration preferred"
                    ]
                  },
                  {
                    "text": "Reject sample with gross hemolysis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Multiple Myeloma": {
            "name": "Multiple Myeloma",
            "url": "https://app.pathprimer.com/document/5b5a1648-bdb2-44e9-99cc-48b2cfef8819/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Plasma cells that are susceptible to genetic aberrations eventually become immortalized into plasma cell clone, which will proliferate in bone marrow"
                  },
                  {
                    "text": "Poor prognostic factorsNonhyperdiploid or hypodiploid karyotypeMMSET translocation t(4;14)(p16;q32)MAF translocation t(14;16)(q32;q23), t(14;20)(q32;q11), t(8;14)(q24;q32)TP53 deletion",
                    "sub_points": [
                      "Nonhyperdiploid or hypodiploid karyotype",
                      "MMSET translocation t(4;14)(p16;q32)",
                      "MAF translocation t(14;16)(q32;q23), t(14;20)(q32;q11), t(8;14)(q24;q32)",
                      "TP53 deletion"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Serum β₂-microglobulin (β₂MG): Correlated with stage of disease, tumor burden, and overall survival rates"
                  },
                  {
                    "text": "Serum protein electrophoresis (SPEP): Not quantitative; characteristic M-spike seen"
                  },
                  {
                    "text": "Urine protein electrophoresis (UPEP): Not quantitative"
                  },
                  {
                    "text": "Quantitative nephelometry for β₂MG: Quantification of monoclonal protein in serum or urine"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Neoplastic proliferation of plasma cells in bone marrow, spleen, or lymph nodes"
                  },
                  {
                    "text": "Sequelae may includeLytic bone lesionsRenal failureAnemiaHypercalcemia",
                    "sub_points": [
                      "Lytic bone lesions",
                      "Renal failure",
                      "Anemia",
                      "Hypercalcemia"
                    ]
                  },
                  {
                    "text": "Plasma cells that are susceptible to genetic aberrations eventually become immortalized into plasma cell clone, which will proliferate in bone marrow"
                  },
                  {
                    "text": "May also result from long-term exposure to chemicals, toxins, or radiation"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Increasing incidence with approximately 20,000 new diagnoses per year in United States"
                  },
                  {
                    "text": "Occurs in older populationAverage age 62 yearsPeak incidence in 8th decade of life",
                    "sub_points": [
                      "Average age 62 years",
                      "Peak incidence in 8th decade of life"
                    ]
                  },
                  {
                    "text": "M:F = 3:2"
                  },
                  {
                    "text": "Higher incidence in African Americans"
                  }
                ],
                "Imaging": [
                  {
                    "text": "X-ray may show lytic punched-out lesions in bone"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "General findingsBone painWeight lossFatigueRecurrent bacterial infections",
                    "sub_points": [
                      "Bone pain",
                      "Weight loss",
                      "Fatigue",
                      "Recurrent bacterial infections"
                    ]
                  },
                  {
                    "text": "CRAB symptomsHypercalcemia (due to high bone destruction by lytic lesions)Renal failure (due to Bence Jones proteinuria)Anemia of chronic diseaseBone lytic lesions",
                    "sub_points": [
                      "Hypercalcemia (due to high bone destruction by lytic lesions)",
                      "Renal failure (due to Bence Jones proteinuria)",
                      "Anemia of chronic disease",
                      "Bone lytic lesions"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Stem cell transplant"
                  },
                  {
                    "text": "Bisphosphonates for bone lesions"
                  },
                  {
                    "text": "Anti-plasma cell drugsRituximab",
                    "sub_points": [
                      "Rituximab"
                    ]
                  },
                  {
                    "text": "Immunomodulatory drugsThalidomideLenalidomidePomalidomide",
                    "sub_points": [
                      "Thalidomide",
                      "Lenalidomide",
                      "Pomalidomide"
                    ]
                  },
                  {
                    "text": "Protease inhibitorsBortezomib",
                    "sub_points": [
                      "Bortezomib"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Median overall survival> 5 years after stem cell transplant< 3 years for high-risk disease after treatment",
                    "sub_points": [
                      "> 5 years after stem cell transplant",
                      "< 3 years for high-risk disease after treatment"
                    ]
                  },
                  {
                    "text": "Poor prognostic factorsNonhyperdiploid or hypodiploid karyotypeMMSET translocation t(4;14)(p16;q32)MAF translocation t(14;16)(q32;q23), t(14;20)(q32;q11), t(8;14)(q24;q32)TP53 deletion",
                    "sub_points": [
                      "Nonhyperdiploid or hypodiploid karyotype",
                      "MMSET translocation t(4;14)(p16;q32)",
                      "MAF translocation t(14;16)(q32;q23), t(14;20)(q32;q11), t(8;14)(q24;q32)",
                      "TP53 deletion"
                    ]
                  },
                  {
                    "text": "Good prognostic factorsHyperdiploid karyotypeCyclin D translocations (18%): t(11;14)(q13;q32), t(6;14)(p21;q32), t(12;14)(p13;q32)",
                    "sub_points": [
                      "Hyperdiploid karyotype",
                      "Cyclin D translocations (18%): t(11;14)(q13;q32), t(6;14)(p21;q32), t(12;14)(p13;q32)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Serum or urine monoclonal protein (immunoglobulin heavy chain or light chain)"
                  },
                  {
                    "text": "Serum β₂-microglobulin (β₂MG)Correlated with stage of disease, tumor burden, and overall survival rates",
                    "sub_points": [
                      "Correlated with stage of disease, tumor burden, and overall survival rates"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Serum protein electrophoresis (SPEP)Not quantitativeCharacteristic M-spike seen (monoclonal protein-spike)",
                    "sub_points": [
                      "Not quantitative",
                      "Characteristic M-spike seen (monoclonal protein-spike)"
                    ]
                  },
                  {
                    "text": "Urine protein electrophoresis (UPEP)Not quantitative",
                    "sub_points": [
                      "Not quantitative"
                    ]
                  },
                  {
                    "text": "Quantitative nephelometry for β₂MGQuantification of monoclonal protein in serum or urine",
                    "sub_points": [
                      "Quantification of monoclonal protein in serum or urine"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood for SPEP and β₂MG"
                  },
                  {
                    "text": "24-hour urine sample for UPEP"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Peripheral blood smear shows rouleaux formation in red blood cells"
                  },
                  {
                    "text": "Bone marrow with increased clusters of plasma cells (> 10%)"
                  }
                ],
                "Morphology": [
                  {
                    "text": "Can appear morphologically benign but may have features of atypia (abnormal chromatin pattern, lack of perinuclear clearing, anaplasia)"
                  }
                ],
                "Immunophenotype": [
                  {
                    "text": "Plasma cells positive for CD138 with clonal evidence of either kappa or lambda light chain expression"
                  },
                  {
                    "text": "Aberrant expression of CD56 may been seen (70% of cases)"
                  }
                ],
                "Molecular and Cytogenetic Tests": [
                  {
                    "text": "Karyotype and other testingGains in chr 1q, 3, 5, 7, 8, 11, 15, 19, 21Loss in chr 1p, 6q, 8, 13q, 14q, 16q",
                    "sub_points": [
                      "Gains in chr 1q, 3, 5, 7, 8, 11, 15, 19, 21",
                      "Loss in chr 1p, 6q, 8, 13q, 14q, 16q"
                    ]
                  },
                  {
                    "text": "Fluorescence in situ hybridization (FISH) testingMonosomy or partial deletion of 13qTranslocations of 14q32 (IgH locus)",
                    "sub_points": [
                      "Monosomy or partial deletion of 13q",
                      "Translocations of 14q32 (IgH locus)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Inflammatory Response": {
            "name": "Acute Inflammatory Response",
            "url": "https://app.pathprimer.com/document/3c63602c-d573-4ddf-9cdc-6be756bc0abd/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Tissue macrophages use PRRs to recognize pathogen PAMPs and DAMPs; PAMPs are pathogen compounds, and DAMPs are host compounds"
                  },
                  {
                    "text": "Classic tetrad of signs and symptoms includes swelling (tumor), heat (calor), redness (rubor), and pain (dolor)"
                  },
                  {
                    "text": "Vasodilation mediated by prostaglandins, histamine, nitric oxide; vascular permeability mediated by histamine, bradykinin, leukotrienes, PAF; pain mediated by prostaglandins, bradykinin; fever mediated by IL-1, IL-6, TNFα, prostaglandins"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "ESR is nonspecific measure of inflammation; CRP rises and falls most rapidly"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology and Clinical Presentation": [
                  {
                    "text": "Short-lived initial inflammatory response to cell and tissue injury"
                  },
                  {
                    "text": "Tissue macrophages use pattern recognition receptors (PRRs) to recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs)PAMPs are pathogen compoundsDAMPs are host compounds",
                    "sub_points": [
                      "PAMPs are pathogen compounds",
                      "DAMPs are host compounds"
                    ]
                  },
                  {
                    "text": "After recognition, PRRs become activated and release inflammatory mediators resulting in vasodilationIncreased heat and rednessLeakage of fluid into interstitial spaces causing swelling and heightened sensitivity to pain",
                    "sub_points": [
                      "Increased heat and redness",
                      "Leakage of fluid into interstitial spaces causing swelling and heightened sensitivity to pain"
                    ]
                  },
                  {
                    "text": "Classic tetrad of signs and symptomsSwelling (tumor)Heat (calor)Redness (rubor)Pain (dolor)",
                    "sub_points": [
                      "Swelling (tumor)",
                      "Heat (calor)",
                      "Redness (rubor)",
                      "Pain (dolor)"
                    ]
                  },
                  {
                    "text": "MediationVasodilation mediated by prostaglandins, histamine, nitric oxideVascular permeability mediated by histamine, bradykinin, leukotrienes, platelet-activating factor (PAF)Pain mediated by prostaglandins, bradykininFever mediated by interleukin (IL)-1, IL-6, tumor necrosis factor (TNF) α, prostaglandins",
                    "sub_points": [
                      "Vasodilation mediated by prostaglandins, histamine, nitric oxide",
                      "Vascular permeability mediated by histamine, bradykinin, leukotrienes, platelet-activating factor (PAF)",
                      "Pain mediated by prostaglandins, bradykinin",
                      "Fever mediated by interleukin (IL)-1, IL-6, tumor necrosis factor (TNF) α, prostaglandins"
                    ]
                  },
                  {
                    "text": "Usually leukocytosis is appreciated because of IL-1 and TNFα (leukocytes), IL-4 and IL-5 (mast cells and eosinophils), granulocytes (granulocyte colony-stimulating factor [G-CSF]), monocytes (macrophage colony-stimulating factor [M-CSF]), and natural killer (NK) cells (IL-2)"
                  },
                  {
                    "text": "Acute phase reactants also elevated during this response (e.g., IL-1, IL-6, IL-8, TNFα, C-reactive protein [CRP], serum amyloid A [SAA])"
                  },
                  {
                    "text": "Allows for extravasation of leukocytes into tissue"
                  },
                  {
                    "text": "Activation of complement system and fibrinolysis systems"
                  },
                  {
                    "text": "Stimulus must be present for continued activation of this pathway; inflammation subsides if stimulus is removed"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Erythrocyte sedimentation rate (ESR): Nonspecific measure of inflammation"
                  },
                  {
                    "text": "CRP: Rises and falls most rapidly"
                  },
                  {
                    "text": "White blood cell count with differential"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Interpretation of Serum Protein Electrophoresis (SPEP) and Immunofixation Electrophoresis (IFE)": {
            "name": "Interpretation of Serum Protein Electrophoresis (SPEP) and Immunofixation Electrophoresis (IFE)",
            "url": "https://app.pathprimer.com/document/93cd3138-3549-4257-9b45-f3ffc60ed4e6/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Normal SPEP/IFE fractions contain 5 peaks as well as 1 additional peak: Prealbumin (not a true peak), albumin, alpha-1, alpha-2, beta (split into beta-1, beta-2), and gamma"
                  },
                  {
                    "text": "SPEP shows characteristic M-spike: Homogeneous band in gamma or beta regionsIf a light chain-producing myeloma, SPEP may show hypogammaglobulinemia",
                    "sub_points": [
                      "If a light chain-producing myeloma, SPEP may show hypogammaglobulinemia"
                    ]
                  },
                  {
                    "text": "IFE shows dark narrow band with sharply defined borders to indicate presence of monoclonal protein in gamma band"
                  },
                  {
                    "text": "Acute inflammatory statesShow increase in alpha-1 fractionPossible increase in alpha-2 fraction",
                    "sub_points": [
                      "Show increase in alpha-1 fraction",
                      "Possible increase in alpha-2 fraction"
                    ]
                  },
                  {
                    "text": "Chronic inflammatory stateAlbumin fraction is usually normal but may be decreased with increased gamma fraction because of presence of increased polyclonal immunoglobulins",
                    "sub_points": [
                      "Albumin fraction is usually normal but may be decreased with increased gamma fraction because of presence of increased polyclonal immunoglobulins"
                    ]
                  },
                  {
                    "text": "ParaproteinShows large spike in gamma fraction (monoclonal spike)",
                    "sub_points": [
                      "Shows large spike in gamma fraction (monoclonal spike)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Normal Serum Protein Electrophoresis/Immunofixation Electrophoresis Fractions": [
                  {
                    "text": "Normal serum protein electrophoresis (SPEP)/immunofixation electrophoresis (IFE) fractions contain 5 peaks as well as 1 additional peak (prealbumin, albumin, alpha-1, alpha-2, beta [split into beta-1, beta-2], gamma)Prealbumin (not a true peak)Not seen on SPEP/IFEFunctionsBinds to thyroxine and thyroxine-binding globulinTransport of vitamin A in vitamin A-prealbumin-retinol-binding-protein complexGood marker for nutrition status (because of its short half-life)Albumin (40%)Major functionsMaintain oncotic pressureTransport proteins in serumIncreased during dehydrationDecreased during chronic liver failure, chronic inflammation, enteropathies, proteinuriaAlpha-1α₁-Antitrypsin: Inactivates trypsin and other proteases in circulationα₁-Acid glycoprotein: Binds to progesterone and neutral and basic drugsα-Lipoprotein (high-density lipoprotein [HDL])Alpha-2α₂-Macroglobulin: Maintains plasma oncotic pressure, antiprotease roleHaptoglobin: Forms complex with hemoglobin for clearance through reticuloendothelial system (RES)Ceruloplasmin: Binds to CuBetaBeta-1Transferrin: Major role in Fe³⁺ transport to bone marrow for erythrocyte and leukocyte precursorsHemopexin: Binds to free hemoglobin after haptoglobin has been saturatedβ-Lipoprotein (low-density lipoprotein [LDL])C4Beta-2C3β₂-MicroglobulinGammaIgAIgGIgMC-reactive protein (CRP)",
                    "sub_points": [
                      "Prealbumin (not a true peak)Not seen on SPEP/IFEFunctionsBinds to thyroxine and thyroxine-binding globulinTransport of vitamin A in vitamin A-prealbumin-retinol-binding-protein complexGood marker for nutrition status (because of its short half-life)",
                      "Not seen on SPEP/IFE",
                      "FunctionsBinds to thyroxine and thyroxine-binding globulinTransport of vitamin A in vitamin A-prealbumin-retinol-binding-protein complexGood marker for nutrition status (because of its short half-life)",
                      "Binds to thyroxine and thyroxine-binding globulin",
                      "Transport of vitamin A in vitamin A-prealbumin-retinol-binding-protein complex",
                      "Good marker for nutrition status (because of its short half-life)",
                      "Albumin (40%)Major functionsMaintain oncotic pressureTransport proteins in serumIncreased during dehydrationDecreased during chronic liver failure, chronic inflammation, enteropathies, proteinuria",
                      "Major functionsMaintain oncotic pressureTransport proteins in serum",
                      "Maintain oncotic pressure",
                      "Transport proteins in serum",
                      "Increased during dehydration",
                      "Decreased during chronic liver failure, chronic inflammation, enteropathies, proteinuria",
                      "Alpha-1α₁-Antitrypsin: Inactivates trypsin and other proteases in circulationα₁-Acid glycoprotein: Binds to progesterone and neutral and basic drugsα-Lipoprotein (high-density lipoprotein [HDL])",
                      "α₁-Antitrypsin: Inactivates trypsin and other proteases in circulation",
                      "α₁-Acid glycoprotein: Binds to progesterone and neutral and basic drugs",
                      "α-Lipoprotein (high-density lipoprotein [HDL])",
                      "Alpha-2α₂-Macroglobulin: Maintains plasma oncotic pressure, antiprotease roleHaptoglobin: Forms complex with hemoglobin for clearance through reticuloendothelial system (RES)Ceruloplasmin: Binds to Cu",
                      "α₂-Macroglobulin: Maintains plasma oncotic pressure, antiprotease role",
                      "Haptoglobin: Forms complex with hemoglobin for clearance through reticuloendothelial system (RES)",
                      "Ceruloplasmin: Binds to Cu",
                      "BetaBeta-1Transferrin: Major role in Fe³⁺ transport to bone marrow for erythrocyte and leukocyte precursorsHemopexin: Binds to free hemoglobin after haptoglobin has been saturatedβ-Lipoprotein (low-density lipoprotein [LDL])C4Beta-2C3β₂-Microglobulin",
                      "Beta-1Transferrin: Major role in Fe³⁺ transport to bone marrow for erythrocyte and leukocyte precursorsHemopexin: Binds to free hemoglobin after haptoglobin has been saturatedβ-Lipoprotein (low-density lipoprotein [LDL])C4",
                      "Transferrin: Major role in Fe³⁺ transport to bone marrow for erythrocyte and leukocyte precursors",
                      "Hemopexin: Binds to free hemoglobin after haptoglobin has been saturated",
                      "β-Lipoprotein (low-density lipoprotein [LDL])",
                      "C4",
                      "Beta-2C3β₂-Microglobulin",
                      "C3",
                      "β₂-Microglobulin",
                      "GammaIgAIgGIgMC-reactive protein (CRP)",
                      "IgA",
                      "IgG",
                      "IgM",
                      "C-reactive protein (CRP)"
                    ]
                  }
                ],
                "AbnormalSerum Protein Electrophoresis/Immunofixation ElectrophoresisFractions": [
                  {
                    "text": "SPEP shows characteristic M spikeHomogeneous band in gamma or beta regionsIf a light chain-producing myeloma, SPEP may show hypogammaglobinemia",
                    "sub_points": [
                      "Homogeneous band in gamma or beta regionsIf a light chain-producing myeloma, SPEP may show hypogammaglobinemia",
                      "If a light chain-producing myeloma, SPEP may show hypogammaglobinemia"
                    ]
                  },
                  {
                    "text": "IFE shows dark, narrow band with sharply defined borders to indicate presence of monoclonal protein in gamma band"
                  },
                  {
                    "text": "Can occur in acute inflammation, chronic inflammation, and presence of a paraprotein"
                  },
                  {
                    "text": "Acute inflammatory statesIncrease in alpha-1 fractionPossible increase in alpha-2 fraction",
                    "sub_points": [
                      "Increase in alpha-1 fraction",
                      "Possible increase in alpha-2 fraction"
                    ]
                  },
                  {
                    "text": "Chronic inflammatory stateAlbumin fraction is usually normal but may be decreased with increased gamma fraction because of presence of increased polyclonal immunoglobulins",
                    "sub_points": [
                      "Albumin fraction is usually normal but may be decreased with increased gamma fraction because of presence of increased polyclonal immunoglobulins"
                    ]
                  },
                  {
                    "text": "ParaproteinShows large spike in gamma fractionAs a spike because it is monoclonal protein (monoclonal-spike) in setting of monoclonal gammopathies of undetermined significance (MGUS) or myelomaMost cases show monoclonal IgG proteinIgA in 20%IgD in < 1%IgE very rareOf patients with myeloma, 25% secrete only light chain (Bence Jones proteins)Proteinuria found in 50% of patientsIf other plasma proteins (albumin) found in urine, may be sign of extensive renal damage",
                    "sub_points": [
                      "Shows large spike in gamma fractionAs a spike because it is monoclonal protein (monoclonal-spike) in setting of monoclonal gammopathies of undetermined significance (MGUS) or myelomaMost cases show monoclonal IgG proteinIgA in 20%IgD in < 1%IgE very rareOf patients with myeloma, 25% secrete only light chain (Bence Jones proteins)Proteinuria found in 50% of patientsIf other plasma proteins (albumin) found in urine, may be sign of extensive renal damage",
                      "As a spike because it is monoclonal protein (monoclonal-spike) in setting of monoclonal gammopathies of undetermined significance (MGUS) or myeloma",
                      "Most cases show monoclonal IgG proteinIgA in 20%IgD in < 1%IgE very rare",
                      "IgA in 20%",
                      "IgD in < 1%",
                      "IgE very rare",
                      "Of patients with myeloma, 25% secrete only light chain (Bence Jones proteins)",
                      "Proteinuria found in 50% of patientsIf other plasma proteins (albumin) found in urine, may be sign of extensive renal damage",
                      "If other plasma proteins (albumin) found in urine, may be sign of extensive renal damage"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Methodology for Serum Protein Electrophoresis (SPEP)": {
            "name": "Methodology for Serum Protein Electrophoresis (SPEP)",
            "url": "https://app.pathprimer.com/document/fe9554a6-bdf3-41db-bfc3-dfbf737746d0/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Serum protein electrophoresis (SPEP)Technique in which serum is placed in polyacrylamide gel that is subjected to electrical currentCurrent causes proteins in serum to disperse according to size and electrical charge",
                    "sub_points": [
                      "Technique in which serum is placed in polyacrylamide gel that is subjected to electrical current",
                      "Current causes proteins in serum to disperse according to size and electrical charge"
                    ]
                  },
                  {
                    "text": "Immunofixation electrophoresis (IFE)Similar technique in which proteins are subjected to electrical current to allow for dispersionAntibodies against various immunoglobulins added to gel to identify narrow bands",
                    "sub_points": [
                      "Similar technique in which proteins are subjected to electrical current to allow for dispersion",
                      "Antibodies against various immunoglobulins added to gel to identify narrow bands"
                    ]
                  },
                  {
                    "text": "Dispersion depends on size and electrical charge of protein"
                  },
                  {
                    "text": "Pattern of migration results in normal dispersion of 5 fractions of serum protein (albumin, alpha-1, alpha-2, beta [split into beta-1, beta-2], gamma)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Definitions and Methods": [
                  {
                    "text": "Serum protein electrophoresis (SPEP)Technique in which serum is placed in polyacrylamide gel that is subjected to electrical currentCurrent causes proteins in serum to disperse according to size and electrical charge",
                    "sub_points": [
                      "Technique in which serum is placed in polyacrylamide gel that is subjected to electrical current",
                      "Current causes proteins in serum to disperse according to size and electrical charge"
                    ]
                  },
                  {
                    "text": "Immunofixation electrophoresis (IFE)Similar technique in which proteins are subjected to electrical current to allow for dispersionAntibodies against various immunoglobulins added to gel to identify narrow bands",
                    "sub_points": [
                      "Similar technique in which proteins are subjected to electrical current to allow for dispersion",
                      "Antibodies against various immunoglobulins added to gel to identify narrow bands"
                    ]
                  }
                ],
                "Theory": [
                  {
                    "text": "Dispersion depends on size and electrical charge of proteinProteins with lower molecular weight move more quickly through gel because of less dragHeavier proteins move more slowlyNegatively charged proteins move toward anode (positively charged)Positively charged proteins move toward cathode (negatively charged)",
                    "sub_points": [
                      "Proteins with lower molecular weight move more quickly through gel because of less drag",
                      "Heavier proteins move more slowly",
                      "Negatively charged proteins move toward anode (positively charged)",
                      "Positively charged proteins move toward cathode (negatively charged)"
                    ]
                  },
                  {
                    "text": "Pattern of migration results in normal dispersion of 5 fractions of serum protein (albumin, alpha-1, alpha-2, beta [split into beta-1, beta-2], gamma)Albumin (40%)Alpha-1α₁-Antitrypsinα₁-Acid glycoproteinα-Lipoprotein (high-density lipoprotein [HDL])Alpha-2α₂-MacroglobulinHaptoglobinCeruloplasminBetaBeta-1TransferrinHemopexinβ-Lipoprotein (low-density lipoprotein [LDL])C4Beta-2C3β₂-MicroglobulinGammaIgAIgGIgMC-reactive protein (CRP)",
                    "sub_points": [
                      "Albumin (40%)",
                      "Alpha-1α₁-Antitrypsinα₁-Acid glycoproteinα-Lipoprotein (high-density lipoprotein [HDL])",
                      "α₁-Antitrypsin",
                      "α₁-Acid glycoprotein",
                      "α-Lipoprotein (high-density lipoprotein [HDL])",
                      "Alpha-2α₂-MacroglobulinHaptoglobinCeruloplasmin",
                      "α₂-Macroglobulin",
                      "Haptoglobin",
                      "Ceruloplasmin",
                      "BetaBeta-1TransferrinHemopexinβ-Lipoprotein (low-density lipoprotein [LDL])C4Beta-2C3β₂-Microglobulin",
                      "Beta-1TransferrinHemopexinβ-Lipoprotein (low-density lipoprotein [LDL])C4",
                      "Transferrin",
                      "Hemopexin",
                      "β-Lipoprotein (low-density lipoprotein [LDL])",
                      "C4",
                      "Beta-2C3β₂-Microglobulin",
                      "C3",
                      "β₂-Microglobulin",
                      "GammaIgAIgGIgMC-reactive protein (CRP)",
                      "IgA",
                      "IgG",
                      "IgM",
                      "C-reactive protein (CRP)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cryoglobulinemia": {
            "name": "Cryoglobulinemia",
            "url": "https://app.pathprimer.com/document/d6689aa0-2a4d-40ce-9a34-b4a3d5fb11a0/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Cryoglobulinemia often results in state of systemic inflammation in which immunoglobulins precipitate after exposure to cooler temperatures"
                  },
                  {
                    "text": "Concentration of protein is proportional to temperature needed for precipitationPrecipitation may occur at warmer temperatures in patients with higher concentrations of protein",
                    "sub_points": [
                      "Precipitation may occur at warmer temperatures in patients with higher concentrations of protein"
                    ]
                  },
                  {
                    "text": "Type 1Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)",
                    "sub_points": [
                      "Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)"
                    ]
                  },
                  {
                    "text": "Type 2Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignancies",
                    "sub_points": [
                      "Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)",
                      "Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignancies"
                    ]
                  },
                  {
                    "text": "Type 3Polyclonal immunoglobulin (IgM &/or IgG usually)Associated with infections, AI disorders",
                    "sub_points": [
                      "Polyclonal immunoglobulin (IgM &/or IgG usually)",
                      "Associated with infections, AI disorders"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Cryoglobulins include immunoglobulins and complement proteins in serum or plasma that normally comprise small fraction of total protein"
                  },
                  {
                    "text": "Cryoglobulinemia often results in state of systemic inflammation in which immunoglobulins precipitate after exposure to cooler temperaturesCan occur as a result of 2 factorsWith increased levels of circulating immunoglobulin, as in chronic inflammationFormation of immune complexesInability to clear immune complexesConcentration of protein is proportional to temperature needed for precipitationPrecipitation may occur at warmer temperatures in patients with higher concentrations of proteinCryoproteins can be monoclonal (type 1) or polyclonal (types 2 and 3)Type 1Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)Type 2Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignanciesType 3Polyclonal immunoglobulin (IgM &/or IgG usually)Associated with infections, AI disorders",
                    "sub_points": [
                      "Can occur as a result of 2 factorsWith increased levels of circulating immunoglobulin, as in chronic inflammationFormation of immune complexesInability to clear immune complexes",
                      "With increased levels of circulating immunoglobulin, as in chronic inflammation",
                      "Formation of immune complexes",
                      "Inability to clear immune complexes",
                      "Concentration of protein is proportional to temperature needed for precipitationPrecipitation may occur at warmer temperatures in patients with higher concentrations of protein",
                      "Precipitation may occur at warmer temperatures in patients with higher concentrations of protein",
                      "Cryoproteins can be monoclonal (type 1) or polyclonal (types 2 and 3)Type 1Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)Type 2Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignanciesType 3Polyclonal immunoglobulin (IgM &/or IgG usually)Associated with infections, AI disorders",
                      "Type 1Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)",
                      "Single monoclonal immunoglobulin (usually multiple myeloma, Waldenström macroglobulinemia)",
                      "Type 2Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignancies",
                      "Polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)",
                      "Associated with chronic hepatitis C, autoimmune (AI) disorders, IgM-producing malignancies",
                      "Type 3Polyclonal immunoglobulin (IgM &/or IgG usually)Associated with infections, AI disorders",
                      "Polyclonal immunoglobulin (IgM &/or IgG usually)",
                      "Associated with infections, AI disorders"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Approximately 1 in 100,000 people have cryoglobulinemia that manifests clinically"
                  },
                  {
                    "text": "Many others may have increased cryoglobulins, but they do not clinically manifest with precipitation"
                  },
                  {
                    "text": "Often associated with HIV and hepatitis C, with highest incidence in patients with coinfection (up to 65%)"
                  },
                  {
                    "text": "F:M = 1.5:1"
                  },
                  {
                    "text": "Average age of onset in 6th decade of life"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Type 1 cryoglobulinemiaPatients often asymptomaticMost have underlying hematologic malignancy, such as Waldenström macroglobulinemia or multiple myeloma, or monoclonal gammopathy of uncertain significance (MGUS)Cutaneous findingsSkin lesions or ulcersRenal findingsMay develop membranoproliferative glomerulonephritis",
                    "sub_points": [
                      "Patients often asymptomatic",
                      "Most have underlying hematologic malignancy, such as Waldenström macroglobulinemia or multiple myeloma, or monoclonal gammopathy of uncertain significance (MGUS)",
                      "Cutaneous findingsSkin lesions or ulcers",
                      "Skin lesions or ulcers",
                      "Renal findingsMay develop membranoproliferative glomerulonephritis",
                      "May develop membranoproliferative glomerulonephritis"
                    ]
                  },
                  {
                    "text": "Type 2 or type 3 cryoglobulinemiaPatients symptomatic (mostly nonspecific)ArthralgiaMyalgiasPurpuraVasculitis in small to medium vesselsFatigueMeltzer’s triad (arthralgias, purpura, weakness)Cutaneous findingsMaculesPapulesPurpura with hemorrhagic crusts or ulcersRaynaud phenomenonLivedo reticularisMusculoskeletal findingsArthralgiasMyalgiasRarely, arthritis or myositisNeurologic findingsPeripheral neuropathyPulmonary findings (all of these are rare)Bronchiolitis obliterans organizing pneumonia (BOOP)Pulmonary hemorrhagePulmonary vasculitisRenal findingsMembranoproliferative glomerulonephritisNephrotic syndromeAcute renal failure",
                    "sub_points": [
                      "Patients symptomatic (mostly nonspecific)ArthralgiaMyalgiasPurpuraVasculitis in small to medium vesselsFatigueMeltzer’s triad (arthralgias, purpura, weakness)",
                      "Arthralgia",
                      "Myalgias",
                      "Purpura",
                      "Vasculitis in small to medium vessels",
                      "Fatigue",
                      "Meltzer’s triad (arthralgias, purpura, weakness)",
                      "Cutaneous findingsMaculesPapulesPurpura with hemorrhagic crusts or ulcersRaynaud phenomenonLivedo reticularis",
                      "Macules",
                      "Papules",
                      "Purpura with hemorrhagic crusts or ulcers",
                      "Raynaud phenomenon",
                      "Livedo reticularis",
                      "Musculoskeletal findingsArthralgiasMyalgiasRarely, arthritis or myositis",
                      "Arthralgias",
                      "Myalgias",
                      "Rarely, arthritis or myositis",
                      "Neurologic findingsPeripheral neuropathy",
                      "Peripheral neuropathy",
                      "Pulmonary findings (all of these are rare)Bronchiolitis obliterans organizing pneumonia (BOOP)Pulmonary hemorrhagePulmonary vasculitis",
                      "Bronchiolitis obliterans organizing pneumonia (BOOP)",
                      "Pulmonary hemorrhage",
                      "Pulmonary vasculitis",
                      "Renal findingsMembranoproliferative glomerulonephritisNephrotic syndromeAcute renal failure",
                      "Membranoproliferative glomerulonephritis",
                      "Nephrotic syndrome",
                      "Acute renal failure"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treat underlying disorder to control production of immune complexes"
                  },
                  {
                    "text": "Plasma exchange may be used in patients with severe hyperviscosity"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Overall 10-year survival rate approximately 50% after diagnosis"
                  },
                  {
                    "text": "Renal failure and non-Hodgkin lymphoma more common in patients with hepatitis C infection"
                  },
                  {
                    "text": "Patients with hematologic malignancies have prognosis based on treatment of underlying cancer"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Type 1Presence of monoclonal immunoglobulins",
                    "sub_points": [
                      "Presence of monoclonal immunoglobulins"
                    ]
                  },
                  {
                    "text": "Type 2Presence of polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)",
                    "sub_points": [
                      "Presence of polyclonal immunoglobulins (usually IgG), with predominant monoclonal immunoglobulin (usually IgM)"
                    ]
                  },
                  {
                    "text": "Type 3Presence of polyclonal immunoglobulin (usually IgM &/or IgG)",
                    "sub_points": [
                      "Presence of polyclonal immunoglobulin (usually IgM &/or IgG)"
                    ]
                  }
                ],
                "Specimen Collection and Analytic Techniques": [
                  {
                    "text": "Technique based on demonstrating precipitation of immune complexes in patient sample"
                  },
                  {
                    "text": "Blood must be collected in prewarmed tubes (37°C) without any anticoagulants (collection at room temperature may cause false-negative result)"
                  },
                  {
                    "text": "Sample is centrifuged at warm temperature and serum stored at 4°C and monitored for precipitation of cryoglobulins"
                  },
                  {
                    "text": "Precipitant is washed in cold buffer, and protein concentrate is rewarmed to 37°C"
                  },
                  {
                    "text": "Concentrate is analyzed by immunofixation or enzyme-linked immunosorbent assay (ELISA) to characterize type of protein present"
                  },
                  {
                    "text": "Quantification of protein present can be done by spectrophotometry, and a value (called the cryocrit) is reported"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Normal cryocrit in normal patient is close to 0"
                  },
                  {
                    "text": "Clinically significant cryocrit is 0.5%-1% or with a concentration of > 20 μg/mLHigher cryocrit is seen in patients with type 1 cryoglobulinemia (up to 50%)Lower levels usually associated with type 2 and type 3 disease",
                    "sub_points": [
                      "Higher cryocrit is seen in patients with type 1 cryoglobulinemia (up to 50%)",
                      "Lower levels usually associated with type 2 and type 3 disease"
                    ]
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Cutaneous findingsDirect immunofluorescence microscopy shows IgM, IgG, or C3 complement staining",
                    "sub_points": [
                      "Direct immunofluorescence microscopy shows IgM, IgG, or C3 complement staining"
                    ]
                  },
                  {
                    "text": "Neurologic findingsVasculitis of epineural vesselsDemyelinationImmunoglobulin or complement deposits are seen",
                    "sub_points": [
                      "Vasculitis of epineural vessels",
                      "Demyelination",
                      "Immunoglobulin or complement deposits are seen"
                    ]
                  },
                  {
                    "text": "Renal findingsMembranoproliferative nephritis characterized by endocapillary proliferation, deposits of immunoglobulin, or complementMay also see hyaline thrombi and fibrinoid necrotizing vasculitisElectron microscopy may show subendothelial deposits with fingerprint appearance",
                    "sub_points": [
                      "Membranoproliferative nephritis characterized by endocapillary proliferation, deposits of immunoglobulin, or complement",
                      "May also see hyaline thrombi and fibrinoid necrotizing vasculitis",
                      "Electron microscopy may show subendothelial deposits with fingerprint appearance"
                    ]
                  },
                  {
                    "text": "Bone marrow findingsIn patients with type 1 disease, infiltration with clusters of plasma cells may be seen",
                    "sub_points": [
                      "In patients with type 1 disease, infiltration with clusters of plasma cells may be seen"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Wilson Disease": {
            "name": "Wilson Disease",
            "url": "https://app.pathprimer.com/document/cba2ba28-ede3-4fbc-82d4-7adf7ac978d4/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Mutations ofATP7Bgene, which encodes for a P-type ATPase, a copper transport protein found in the biliary tractThis prevents copper from being transported into the Golgi apparatus and eventually impairs its excretion",
                    "sub_points": [
                      "This prevents copper from being transported into the Golgi apparatus and eventually impairs its excretion"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Serum ceruloplasminUsed as a diagnostic testDiagnosis can be made with the followingSerum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer ringsSerum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g",
                    "sub_points": [
                      "Used as a diagnostic test",
                      "Diagnosis can be made with the followingSerum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer ringsSerum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g",
                      "Serum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer rings",
                      "Serum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g"
                    ]
                  },
                  {
                    "text": "Serum and urine copper: Mass spectrometry"
                  },
                  {
                    "text": "Hepatic copper: Mass spectrometry after digestion of liver tissue"
                  },
                  {
                    "text": "OCPs and pregnancy may increase ceruloplasmin level"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Results from accumulation of copper in liver and other tissues owing to inability to excrete copper in biliary tract"
                  },
                  {
                    "text": "Mutations ofATP7Bgene, which encodes for a P-type adenosine triphosphatase (ATPase), a copper transport protein found in the biliary tractThis prevents copper from being transported into Golgi apparatus and eventually impairs its excretion",
                    "sub_points": [
                      "This prevents copper from being transported into Golgi apparatus and eventually impairs its excretion"
                    ]
                  },
                  {
                    "text": "Several mutations have been identified and have inconsistent phenotypes"
                  },
                  {
                    "text": "Increased levels of copper accumulate in liver, brain, and cornea, resulting in liver damage and cirrhosis and neurologic sequelae"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Approximately 1 in every 30,000 live births"
                  },
                  {
                    "text": "Female predominance"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Most patients 5-35 years old at diagnosis"
                  },
                  {
                    "text": "Liver disease usually manifests in late childhood (9-13 years old) because it is first site of copper accumulationKayser-Fleischer rings in cornea (Descemet membrane)JaundiceSplenomegalyMental status change caused by hepatic encephalopathy",
                    "sub_points": [
                      "Kayser-Fleischer rings in cornea (Descemet membrane)",
                      "Jaundice",
                      "Splenomegaly",
                      "Mental status change caused by hepatic encephalopathy"
                    ]
                  },
                  {
                    "text": "Neurologic symptoms manifest during and after adolescence (15-21 years old)DysarthriaDystoniaTremorParkinsonismChoreoathetosisCerebellar ataxiaPsychiatric disorders",
                    "sub_points": [
                      "Dysarthria",
                      "Dystonia",
                      "Tremor",
                      "Parkinsonism",
                      "Choreoathetosis",
                      "Cerebellar ataxia",
                      "Psychiatric disorders"
                    ]
                  },
                  {
                    "text": "Clinical presentation varies widely, even within same family"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Copper chelation therapy (penicillamine)"
                  },
                  {
                    "text": "Zinc therapy"
                  },
                  {
                    "text": "Liver transplant for patients in hepatic failure or resistant to medical therapy"
                  }
                ],
                "Prevention": [
                  {
                    "text": "Avoid foods with high copper content (shellfish, liver, chocolate, whole grain)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Untreated, disease is fatal because of progressive onset of cirrhosis and neuropsychiatric sequelae"
                  },
                  {
                    "text": "High mortality rate in weeks (95%) in patients with acute liver failure without transplant"
                  },
                  {
                    "text": "Patients with disease controlled with medical management have good prognosis"
                  },
                  {
                    "text": "Mildly elevated risk of hepatocellular carcinoma"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Serum ceruloplasmin"
                  },
                  {
                    "text": "Serum copper"
                  },
                  {
                    "text": "Urinary copper"
                  },
                  {
                    "text": "Hepatic copper"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Serum ceruloplasminUsed as a diagnostic testImmunoturbidimetric assaySome patients present with decreased ceruloplasmin (< 20 mg/dL), and all patients present with decreased plasma copper levelsCeruloplasmin should not be used as a screening test because 20% of compound heterozygotes may have reduced ceruloplasmin levelsIncreased total serum copper levels are due to reduced ceruloplasmin and serve as a marker of disease and disease progressionFree copper is elevated in patients with Wilson disease and is a better diagnostic testDiagnosis can be made with the followingSerum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer ringsSerum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g",
                    "sub_points": [
                      "Used as a diagnostic test",
                      "Immunoturbidimetric assay",
                      "Some patients present with decreased ceruloplasmin (< 20 mg/dL), and all patients present with decreased plasma copper levels",
                      "Ceruloplasmin should not be used as a screening test because 20% of compound heterozygotes may have reduced ceruloplasmin levels",
                      "Increased total serum copper levels are due to reduced ceruloplasmin and serve as a marker of disease and disease progression",
                      "Free copper is elevated in patients with Wilson disease and is a better diagnostic test",
                      "Diagnosis can be made with the followingSerum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer ringsSerum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g",
                      "Serum ceruloplasmin level < 20 mg/dL and Kayser-Fleischer rings",
                      "Serum ceruloplasmin level < 20 mg/dL and copper in liver biopsy > 250 μg/g"
                    ]
                  },
                  {
                    "text": "Serum and urine copper: Mass spectrometry"
                  },
                  {
                    "text": "Hepatic copper: Mass spectrometry after digestion of liver tissue"
                  }
                ],
                "Biochemical Tests": [
                  {
                    "text": "Liver function tests performed to determine extent of liver disease"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Serum testing done on venous blood"
                  },
                  {
                    "text": "Urine testing performed on 24-hour excretion sample"
                  },
                  {
                    "text": "Hepatic copper performed on liver biopsy"
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Oral contraceptive pills (OCPs) and pregnancy may increase ceruloplasmin level"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Males≤ 17 years old: 14.0-41.0 mg/dL≥ 18 years old: 15.0-30.0 mg/dL",
                    "sub_points": [
                      "≤ 17 years old: 14.0-41.0 mg/dL",
                      "≥ 18 years old: 15.0-30.0 mg/dL"
                    ]
                  },
                  {
                    "text": "Females≤ 17 years old: 14.0-41.0 mg/dL≥ 18 years old: 16.0-45.0 mg/dL",
                    "sub_points": [
                      "≤ 17 years old: 14.0-41.0 mg/dL",
                      "≥ 18 years old: 16.0-45.0 mg/dL"
                    ]
                  },
                  {
                    "text": "Values < 14 mg/dL expected in Wilson disease"
                  },
                  {
                    "text": "Hepatic liver content of > 40 μg/g is required"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Liver biopsy may show steatosis, Mallory hyaline, glycogen-rich nucleiLater stage liver disease shows interface hepatitis, fibrosis, cirrhosis, plasma cells",
                    "sub_points": [
                      "Later stage liver disease shows interface hepatitis, fibrosis, cirrhosis, plasma cells"
                    ]
                  },
                  {
                    "text": "Fulminant hepatic failure shows balloon degeneration, cholestasis, necrosis"
                  },
                  {
                    "text": "Electron microscopy may show aberrant widening of intercristal spaces in mitochondria, separation of inner and outer mitochondrial membranes"
                  }
                ],
                "Special Stains": [
                  {
                    "text": "Copper stains (rhodanine acid) show copper deposits in periportal hepatocytes"
                  },
                  {
                    "text": "Stains may not show copper deposits in fulminant hepatic failure"
                  },
                  {
                    "text": "Copper staining is not specific for copper accumulation and can also be seen more commonly with other hepatic injury, such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)"
                  }
                ],
                "Molecular and Cytogenetic Tests": [
                  {
                    "text": "Autosomal recessive genetic disorder of copper metabolism resulting from mutation in chromosome 13 encoding for an abnormal P-type copper transporting ATPase (ATP7B)"
                  },
                  {
                    "text": "More than 500 mutations identified with no good correlation to phenotypic expressionMost mutations are point or small mutations",
                    "sub_points": [
                      "Most mutations are point or small mutations"
                    ]
                  },
                  {
                    "text": "Multiplex polymerase chain reaction (PCR) technique used to identify mutations in exons, exon-intron boundaries, and promoter regions ofATP7B"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Rheumatoid Factors": {
            "name": "Rheumatoid Factors",
            "url": "https://app.pathprimer.com/document/9fbf8809-2a95-49ac-80ad-7b1a2f10207d/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Rheumatoid factor (RF)Defined as an autoantibody of any immunoglobulin class (mostly IgM) against Fc portion of IgGElevated in rheumatoid arthritis (RA) as well as other types of arthritis, other autoimmune diseases, infection, and organ rejection (nonspecific)",
                    "sub_points": [
                      "Defined as an autoantibody of any immunoglobulin class (mostly IgM) against Fc portion of IgG",
                      "Elevated in rheumatoid arthritis (RA) as well as other types of arthritis, other autoimmune diseases, infection, and organ rejection (nonspecific)"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Agglutination testBlood is mixed with latex beads coated with human antibodiesAgglutination of latex beads confirms presence of RF",
                    "sub_points": [
                      "Blood is mixed with latex beads coated with human antibodies",
                      "Agglutination of latex beads confirms presence of RF"
                    ]
                  },
                  {
                    "text": "Qualitative nephelometryBlood sample is mixed with antibodies to cause agglutinationLight source is directed through sample tube, and amount of light passing through decreases as agglutination increases",
                    "sub_points": [
                      "Blood sample is mixed with antibodies to cause agglutination",
                      "Light source is directed through sample tube, and amount of light passing through decreases as agglutination increases"
                    ]
                  },
                  {
                    "text": "ELISASolid-phase enzyme immunoassay",
                    "sub_points": [
                      "Solid-phase enzyme immunoassay"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Rheumatoid factor (RF)Defined as an autoantibody of any immunoglobulin class (mostly IgM) against Fc portion of IgGBinds to IgG to form immune complexesProduced after abnormal immune response selects this high-affinity antibody in response to antigen stimulusHas significant heterogeneity because of rearrangements and mutations in heavy and light chain genesElevated in rheumatoid arthritis (RA) as well as other types of arthritis, other autoimmune diseases, infection, and organ rejection (nonspecific)",
                    "sub_points": [
                      "Defined as an autoantibody of any immunoglobulin class (mostly IgM) against Fc portion of IgG",
                      "Binds to IgG to form immune complexes",
                      "Produced after abnormal immune response selects this high-affinity antibody in response to antigen stimulus",
                      "Has significant heterogeneity because of rearrangements and mutations in heavy and light chain genes",
                      "Elevated in rheumatoid arthritis (RA) as well as other types of arthritis, other autoimmune diseases, infection, and organ rejection (nonspecific)"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Healthy populationYounger patients: Up to 4%Older patients: Up to 25%",
                    "sub_points": [
                      "Younger patients: Up to 4%",
                      "Older patients: Up to 25%"
                    ]
                  },
                  {
                    "text": "RA: Up to 90%"
                  },
                  {
                    "text": "Sjögren syndrome: > 75%"
                  },
                  {
                    "text": "Mixed connective tissue disease: Approximately 50%"
                  },
                  {
                    "text": "Mixed cryoglobulinemia: > 40%"
                  },
                  {
                    "text": "Systemic lupus erythematosus: Up to 35%"
                  },
                  {
                    "text": "Polymyositis, dermatomyositis: < 10%"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Associations with rheumatic diseaseRASjögren syndromeMixed connective tissue diseaseMixed cryoglobulinemiaSystemic lupus erythematosusPolymyositisDermatomyositis",
                    "sub_points": [
                      "RA",
                      "Sjögren syndrome",
                      "Mixed connective tissue disease",
                      "Mixed cryoglobulinemia",
                      "Systemic lupus erythematosus",
                      "Polymyositis",
                      "Dermatomyositis"
                    ]
                  },
                  {
                    "text": "Associations with other diseaseSeen in chronic infections (hepatitis B and C)SarcoidosisB-cell malignanciesPrimary biliary cirrhosis",
                    "sub_points": [
                      "Seen in chronic infections (hepatitis B and C)",
                      "Sarcoidosis",
                      "B-cell malignancies",
                      "Primary biliary cirrhosis"
                    ]
                  },
                  {
                    "text": "Healthy populationSeen with increasing prevalence in older age groups",
                    "sub_points": [
                      "Seen with increasing prevalence in older age groups"
                    ]
                  },
                  {
                    "text": "Sensitivity of RF for RA is 60%-70%, and specificity is approximately 80%"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Positive RF titers associated with more aggressive joint damage in RA"
                  },
                  {
                    "text": "Many patients with RA may be seronegative for RF initially, but become seropositive later in disease course"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "RF"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Agglutination testBlood is mixed with latex beads coated with human antibodiesAgglutination of latex beads confirms presence of RF",
                    "sub_points": [
                      "Blood is mixed with latex beads coated with human antibodies",
                      "Agglutination of latex beads confirms presence of RF"
                    ]
                  },
                  {
                    "text": "Qualitative nephelometryBlood sample is mixed with antibodies to cause agglutinationLight source is directed through sample tube, and amount of light passing through decreases as agglutination increases",
                    "sub_points": [
                      "Blood sample is mixed with antibodies to cause agglutination",
                      "Light source is directed through sample tube, and amount of light passing through decreases as agglutination increases"
                    ]
                  },
                  {
                    "text": "Enzyme-linked immunosorbent assay (ELISA)Solid-phase enzyme immunoassay",
                    "sub_points": [
                      "Solid-phase enzyme immunoassay"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood sample"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Antinuclear Antibody (ANA) Testing": {
            "name": "Autoimmune Antinuclear Antibody (ANA) Testing",
            "url": "https://app.pathprimer.com/document/ff347598-e244-4e15-a396-832f32f8744a/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Autoantibodies that form to bind to proteins in cell nucleus (ANAs)Can be associated with autoimmunity or infection",
                    "sub_points": [
                      "Can be associated with autoimmunity or infection"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "IFAPatient’s blood added to fixed cells on slide, which allows any antibodies present to bind to cellsFluorescent antibody reagent added and cells examined microscopically for presence or absence of fluorescenceHomogeneous fluorescence: SLE, MCTD, drug-induced lupusSpeckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTDNucleolar pattern: Scleroderma, polymyositisCentromere pattern: Scleroderma, CREST",
                    "sub_points": [
                      "Patient’s blood added to fixed cells on slide, which allows any antibodies present to bind to cells",
                      "Fluorescent antibody reagent added and cells examined microscopically for presence or absence of fluorescenceHomogeneous fluorescence: SLE, MCTD, drug-induced lupusSpeckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTDNucleolar pattern: Scleroderma, polymyositisCentromere pattern: Scleroderma, CREST",
                      "Homogeneous fluorescence: SLE, MCTD, drug-induced lupus",
                      "Speckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTD",
                      "Nucleolar pattern: Scleroderma, polymyositis",
                      "Centromere pattern: Scleroderma, CREST"
                    ]
                  },
                  {
                    "text": "ELISAMay be less sensitive than IFA",
                    "sub_points": [
                      "May be less sensitive than IFA"
                    ]
                  },
                  {
                    "text": "Positive test does not rule in autoimmune diseaseUp to 35% of healthy individuals may present with positive test result (increasing incidence with age)",
                    "sub_points": [
                      "Up to 35% of healthy individuals may present with positive test result (increasing incidence with age)"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Autoantibodies that form to and bind to proteins in cell nucleus (antinuclear antibodies [ANAs])Can be associated with autoimmunity or infection",
                    "sub_points": [
                      "Can be associated with autoimmunity or infection"
                    ]
                  },
                  {
                    "text": "Association with autoimmune disordersSystemic lupus erythematosus (SLE)Sjögren syndromeMixed connective tissue disease (MCTD)Drug-induced lupusPolymyositisDermatomyositisRheumatoid arthritisHashimoto thyroiditisPrimary biliary cholangitisIdiopathic pulmonary fibrosis",
                    "sub_points": [
                      "Systemic lupus erythematosus (SLE)",
                      "Sjögren syndrome",
                      "Mixed connective tissue disease (MCTD)",
                      "Drug-induced lupus",
                      "Polymyositis",
                      "Dermatomyositis",
                      "Rheumatoid arthritis",
                      "Hashimoto thyroiditis",
                      "Primary biliary cholangitis",
                      "Idiopathic pulmonary fibrosis"
                    ]
                  },
                  {
                    "text": "Association with infectionsHepatitis CParvovirusTuberculosisSchistosomiasis",
                    "sub_points": [
                      "Hepatitis C",
                      "Parvovirus",
                      "Tuberculosis",
                      "Schistosomiasis"
                    ]
                  },
                  {
                    "text": "Subsequent inflammation and tissue damage affects multiple organs"
                  }
                ],
                "Types of Antinuclear Antibodies": [
                  {
                    "text": "Anti-Ro/SS/A, anti-La/SS-BFound in Sjögren syndrome and SLEAnti-Ro antibodies can cross placenta and cause neonatal lupus",
                    "sub_points": [
                      "Found in Sjögren syndrome and SLE",
                      "Anti-Ro antibodies can cross placenta and cause neonatal lupus"
                    ]
                  },
                  {
                    "text": "Anti-SmithHighly specific marker for SLE, but only 20% of patients with SLE have this antibodyNot associated with disease activity in SLE",
                    "sub_points": [
                      "Highly specific marker for SLE, but only 20% of patients with SLE have this antibody",
                      "Not associated with disease activity in SLE"
                    ]
                  },
                  {
                    "text": "Antinuclear ribonucleoproteinAssociated with SLE and MCTD",
                    "sub_points": [
                      "Associated with SLE and MCTD"
                    ]
                  },
                  {
                    "text": "Anti-Scl-70/anti-topoisomerase 1Associated with scleroderma",
                    "sub_points": [
                      "Associated with scleroderma"
                    ]
                  },
                  {
                    "text": "Anti-Jo-1Associated with polymyositis, dermatomyositis, and interstitial lung disease",
                    "sub_points": [
                      "Associated with polymyositis, dermatomyositis, and interstitial lung disease"
                    ]
                  },
                  {
                    "text": "Anti-dsDNAHighly associated and specific (100%) for SLEAlso associated with lupus nephritis (especially with low C3 level)",
                    "sub_points": [
                      "Highly associated and specific (100%) for SLE",
                      "Also associated with lupus nephritis (especially with low C3 level)"
                    ]
                  },
                  {
                    "text": "Anti-histoneAssociated with drug-induced lupus",
                    "sub_points": [
                      "Associated with drug-induced lupus"
                    ]
                  },
                  {
                    "text": "Anti-gp210 and anti-p62Associated with primary biliary cirrhosis (PBC)",
                    "sub_points": [
                      "Associated with primary biliary cirrhosis (PBC)"
                    ]
                  },
                  {
                    "text": "Anti-centromereCREST syndrome, PBC, and proximal scleroderma",
                    "sub_points": [
                      "CREST syndrome, PBC, and proximal scleroderma"
                    ]
                  },
                  {
                    "text": "Anti-sp100Highly specific marker for PBC",
                    "sub_points": [
                      "Highly specific marker for PBC"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Anti-Ro/SS/A, anti-La/SS-B antibodies"
                  },
                  {
                    "text": "Anti-Smith antibodies"
                  },
                  {
                    "text": "Antinuclear ribonucleoprotein antibodies"
                  },
                  {
                    "text": "Anti-Scl-70/anti-topoisomerase 1 antibodies"
                  },
                  {
                    "text": "Anti-Jo-1 antibodies"
                  },
                  {
                    "text": "Anti-dsDNA antibodies"
                  },
                  {
                    "text": "Anti-histone antibodies"
                  },
                  {
                    "text": "Anti-gp210 antibodies"
                  },
                  {
                    "text": "Anti-p62 antibodies"
                  },
                  {
                    "text": "Anti-centromere antibodies"
                  },
                  {
                    "text": "Anti-sp100 antibodies"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Indirect fluorescent antibody (IFA)Patient’s blood added to fixed cells on slide, which allows any antibodies present to bind to cellsFluorescent antibody reagent added and cells examined microscopically for presence or absence of fluorescenceHomogeneous fluorescence: SLE, MCTD, drug-induced lupusSpeckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTDNucleolar pattern: Scleroderma, polymyositisCentromere pattern: Scleroderma, CREST",
                    "sub_points": [
                      "Patient’s blood added to fixed cells on slide, which allows any antibodies present to bind to cells",
                      "Fluorescent antibody reagent added and cells examined microscopically for presence or absence of fluorescenceHomogeneous fluorescence: SLE, MCTD, drug-induced lupusSpeckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTDNucleolar pattern: Scleroderma, polymyositisCentromere pattern: Scleroderma, CREST",
                      "Homogeneous fluorescence: SLE, MCTD, drug-induced lupus",
                      "Speckled pattern: SLE, Sjögren syndrome, scleroderma, polymyositis, rheumatoid arthritis, MCTD",
                      "Nucleolar pattern: Scleroderma, polymyositis",
                      "Centromere pattern: Scleroderma, CREST"
                    ]
                  },
                  {
                    "text": "Enzyme-linked immunosorbent assay (ELISA)May be less sensitive than IFA",
                    "sub_points": [
                      "May be less sensitive than IFA"
                    ]
                  },
                  {
                    "text": "Positive test does not rule in autoimmune diseaseUp to 35% of healthy individuals may present with positive test result (increasing incidence with age)",
                    "sub_points": [
                      "Up to 35% of healthy individuals may present with positive test result (increasing incidence with age)"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood samples"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Erythrocyte Sedimentation Rate (ESR): Nonspecific Testing": {
            "name": "Erythrocyte Sedimentation Rate (ESR): Nonspecific Testing",
            "url": "https://app.pathprimer.com/document/198eb0ae-baa8-4ff3-ad6f-0947a749d884/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "ESRMeasurement of length or rate at which erythrocytes travel in a vertical tubeMay be increased in inflammation (infection), malignancy, tissue injury, and traumaUseful in monitoring disease state and establishing diagnosis (especially in temporal arteritis)",
                    "sub_points": [
                      "Measurement of length or rate at which erythrocytes travel in a vertical tube",
                      "May be increased in inflammation (infection), malignancy, tissue injury, and trauma",
                      "Useful in monitoring disease state and establishing diagnosis (especially in temporal arteritis)"
                    ]
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Testing modalitiesWestergren methodMost commonly usedUses undiluted whole blood and sodium citrate solution as anticoagulantRuns for 60 minutesModified Westergren methodUses EDTA for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies",
                    "sub_points": [
                      "Westergren methodMost commonly usedUses undiluted whole blood and sodium citrate solution as anticoagulantRuns for 60 minutes",
                      "Most commonly used",
                      "Uses undiluted whole blood and sodium citrate solution as anticoagulant",
                      "Runs for 60 minutes",
                      "Modified Westergren methodUses EDTA for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies",
                      "Uses EDTA for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Erythrocyte sedimentation rate (ESR)Measurement of length or rate at which erythrocytes travel in a vertical tubeIndirect measurement of acute phase responseMay be increased in inflammation (infection), malignancy, tissue injury, and traumaIncreased age and female sex associated with elevated ESRNonspecific test that is of little value as screening testUseful in monitoring disease state and establishing diagnosis (especially in temporal arteritis)",
                    "sub_points": [
                      "Measurement of length or rate at which erythrocytes travel in a vertical tube",
                      "Indirect measurement of acute phase response",
                      "May be increased in inflammation (infection), malignancy, tissue injury, and trauma",
                      "Increased age and female sex associated with elevated ESR",
                      "Nonspecific test that is of little value as screening test",
                      "Useful in monitoring disease state and establishing diagnosis (especially in temporal arteritis)"
                    ]
                  },
                  {
                    "text": "Plasma factors that affect ESRIncreased fibrinogen and α₂-, β-, and γ-globulins cause shorter ESR (reduce negative charge between red blood cells, called zeta potential, and promote rouleau formation)Increased albumin, lecithin, and cholesterol increase ESRIncreased hematocrit increases ESRHemoglobinopathies (e.g., sickle cell anemia) decrease rouleau formation and increase ESR",
                    "sub_points": [
                      "Increased fibrinogen and α₂-, β-, and γ-globulins cause shorter ESR (reduce negative charge between red blood cells, called zeta potential, and promote rouleau formation)",
                      "Increased albumin, lecithin, and cholesterol increase ESR",
                      "Increased hematocrit increases ESR",
                      "Hemoglobinopathies (e.g., sickle cell anemia) decrease rouleau formation and increase ESR"
                    ]
                  },
                  {
                    "text": "Elevated ESR﻿Monoclonal protein disease (multiple myeloma)Polyclonal hyperglobulinemiasChronic infectionRheumatoid arthritis (RA)Collagen diseaseMalignancies (renal cell carcinoma, Hodgkin lymphoma, multiple myeloma)Coronary artery disease (CAD)",
                    "sub_points": [
                      "Monoclonal protein disease (multiple myeloma)",
                      "Polyclonal hyperglobulinemias",
                      "Chronic infection",
                      "Rheumatoid arthritis (RA)",
                      "Collagen disease",
                      "Malignancies (renal cell carcinoma, Hodgkin lymphoma, multiple myeloma)",
                      "Coronary artery disease (CAD)"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "ESR"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Defined as length or rate at which erythrocytes travel in vertical tube of venous blood over given time interval"
                  },
                  {
                    "text": "Three stages0-10 minutes: Rouleau form, little sedimentation10-40 minutes: Sedimentation occurs at constant rate40-50 minutes: Sedimentation slows down as cells reach bottom of tube",
                    "sub_points": [
                      "0-10 minutes: Rouleau form, little sedimentation",
                      "10-40 minutes: Sedimentation occurs at constant rate",
                      "40-50 minutes: Sedimentation slows down as cells reach bottom of tube"
                    ]
                  },
                  {
                    "text": "Testing modalitiesWestergren methodMost commonly usedUses undiluted whole blood and sodium citrate solution as anticoagulantRuns for 60 minutesModified Westergren methodUses ethylenediaminetetraacetic acid (EDTA) for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies",
                    "sub_points": [
                      "Westergren methodMost commonly usedUses undiluted whole blood and sodium citrate solution as anticoagulantRuns for 60 minutes",
                      "Most commonly used",
                      "Uses undiluted whole blood and sodium citrate solution as anticoagulant",
                      "Runs for 60 minutes",
                      "Modified Westergren methodUses ethylenediaminetetraacetic acid (EDTA) for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies",
                      "Uses ethylenediaminetetraacetic acid (EDTA) for anticoagulant (instead of sodium citrate), which allows same tube of blood to be used for other hematologic studies"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous whole blood sample, 4 mL"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Adults (Westergren method)Men < 50 years old: < 15 mm/hMen > 50 years old: < 20 mm/hWomen < 50 years old: < 20 mm/hWomen > 50 years old: < 30 mm/h",
                    "sub_points": [
                      "Men < 50 years old: < 15 mm/h",
                      "Men > 50 years old: < 20 mm/h",
                      "Women < 50 years old: < 20 mm/h",
                      "Women > 50 years old: < 30 mm/h"
                    ]
                  },
                  {
                    "text": "Children (Westergren method)Newborn: 0-2 mm/hNewborn to puberty: 3-13 mm/h",
                    "sub_points": [
                      "Newborn: 0-2 mm/h",
                      "Newborn to puberty: 3-13 mm/h"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Albumin and Microalbumin; Hydrostatic Pressure": {
            "name": "Albumin and Microalbumin; Hydrostatic Pressure",
            "url": "https://app.pathprimer.com/document/64af4232-593d-4af0-8191-a41708e50f69/lesson/5de68a2c-5d03-4f02-9c87-4f863d8fcad9",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Albumin is the most abundant protein in plasma (up to 67% of total protein in plasma)"
                  },
                  {
                    "text": "Many genetic variants exist with single amino-acid substitutions, which can lead to the appearance of 2 albumin peaks"
                  },
                  {
                    "text": "Major function is to maintain plasma oncotic pressure and carry and bind to small molecules and amino acidsVarious drugs and inorganic molecules also bind to albumin",
                    "sub_points": [
                      "Various drugs and inorganic molecules also bind to albumin"
                    ]
                  },
                  {
                    "text": "Elevations of albumin are usually caused by dehydration or tourniquet application"
                  },
                  {
                    "text": "Decreased albumin can occur in many conditions"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "AlbuminMost abundant protein in plasma (up to 67% of total protein in plasma)Molecular weight 66.5 kDa585 amino acids with 9 loops bound by disulfide bonds allow for multiple binding sitesHalf-life of 17 days",
                    "sub_points": [
                      "Most abundant protein in plasma (up to 67% of total protein in plasma)",
                      "Molecular weight 66.5 kDa",
                      "585 amino acids with 9 loops bound by disulfide bonds allow for multiple binding sites",
                      "Half-life of 17 days"
                    ]
                  },
                  {
                    "text": "Many genetic variants exist with single amino-acid substitutions, which can lead to the appearance of 2 albumin peaks"
                  },
                  {
                    "text": "Major function is to maintain plasma oncotic pressure and carry and bind to small molecules and amino acidsVarious drugs and inorganic molecules also bind to albumin",
                    "sub_points": [
                      "Various drugs and inorganic molecules also bind to albumin"
                    ]
                  },
                  {
                    "text": "Because albumin is a large protein in a large concentration, it is unable to cross capillary membrane and is retained in intravascular spaceAlmost 80% of total oncotic pressure (28 mm Hg) maintained in plasma is due to presence of albumin (22 mm Hg)Pressure gradient draws water into vascular space",
                    "sub_points": [
                      "Almost 80% of total oncotic pressure (28 mm Hg) maintained in plasma is due to presence of albumin (22 mm Hg)",
                      "Pressure gradient draws water into vascular space"
                    ]
                  },
                  {
                    "text": "Normally 8% of albumin is nonenzymatically glycosylated, but may be higher in patients with diabetesGlycosylated albumin is a good measure of diabetic control in patients with hemoglobinopathies (e.g., sickle cell anemia)May be unreliable in setting of proteinuria or nephrotic syndrome",
                    "sub_points": [
                      "Glycosylated albumin is a good measure of diabetic control in patients with hemoglobinopathies (e.g., sickle cell anemia)",
                      "May be unreliable in setting of proteinuria or nephrotic syndrome"
                    ]
                  },
                  {
                    "text": "α₂-Macroglobulin (AMG)In nephrotic syndrome, AMG synthesis and concentration can increase by 10 timesAMG is not lost in urine because of its large sizeAMG can exceed level of albumin in plasma and can act as the major plasma protein for maintenance of oncotic pressure",
                    "sub_points": [
                      "In nephrotic syndrome, AMG synthesis and concentration can increase by 10 times",
                      "AMG is not lost in urine because of its large size",
                      "AMG can exceed level of albumin in plasma and can act as the major plasma protein for maintenance of oncotic pressure"
                    ]
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Elevations of albumin are usually caused by dehydration or tourniquet application"
                  },
                  {
                    "text": "Decreased albumin can occur in many conditionsIV fluidsNutritional deficiencyEnteropathiesChronic liver diseaseNephrotic syndromeProteinuriaChronic inflammation",
                    "sub_points": [
                      "IV fluids",
                      "Nutritional deficiency",
                      "Enteropathies",
                      "Chronic liver disease",
                      "Nephrotic syndrome",
                      "Proteinuria",
                      "Chronic inflammation"
                    ]
                  },
                  {
                    "text": "Congenital absence of albumin rarely results in pathologic disease owing to other mechanisms in place for maintenance of hydrostatic pressure"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Serum albumin"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Serum protein electrophoresis (SPEP)"
                  },
                  {
                    "text": "Colorimetric assay (if part of comprehensive metabolic panel)"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood sample"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Normal range 3.5-5.5 g/dL"
                  },
                  {
                    "text": "Causes of increased albumin levels in bloodAnabolic steroidsAndrogensGrowth hormonesInsulin",
                    "sub_points": [
                      "Anabolic steroids",
                      "Androgens",
                      "Growth hormones",
                      "Insulin"
                    ]
                  },
                  {
                    "text": "IV fluids may falsely decrease albumin levels"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Methods": {
        "name": "Methods",
        "url": "https://app.pathprimer.com/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
        "topics": {
          "Hook Effect": {
            "name": "Hook Effect",
            "url": "https://app.pathprimer.com/document/36bfce49-7aab-45d6-bbca-e2cf77a10451/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Hook effect: Also known as prozone effect"
                  },
                  {
                    "text": "Cause of false low result"
                  },
                  {
                    "text": "Due to high concentration of analyte of interest"
                  },
                  {
                    "text": "Happens only to homogeneous immunoassays"
                  }
                ],
                "Cause": [
                  {
                    "text": "In presence of excess analyte, classic sandwich structure unable to form in immunoassay"
                  }
                ],
                "Frequency": [
                  {
                    "text": "Assays reported to have been affected by hook effect include (but not limited to)Human chorionic gonadotropin (hCG)ProlactinGrowth hormoneThyroid-stimulating hormoneGonadotropin (luteinizing hormone [LH] and follicle-stimulating hormone [FSH])Tumor markersProstate-specific antigenCA19-9CalcitoninCA 125",
                    "sub_points": [
                      "Human chorionic gonadotropin (hCG)",
                      "Prolactin",
                      "Growth hormone",
                      "Thyroid-stimulating hormone",
                      "Gonadotropin (luteinizing hormone [LH] and follicle-stimulating hormone [FSH])",
                      "Tumor markersProstate-specific antigenCA19-9CalcitoninCA 125",
                      "Prostate-specific antigen",
                      "CA19-9",
                      "Calcitonin",
                      "CA 125"
                    ]
                  },
                  {
                    "text": "Not many assays affected by hook effect these days"
                  },
                  {
                    "text": "Point-of-care assays reported to be affected"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Alternate Methods": [
                  {
                    "text": "Hook effect can be evaluated by serial dilution of sample of interestHigher result observed after dilution indicates hook effectOtherwise, low result was real or sample had other interference",
                    "sub_points": [
                      "Higher result observed after dilution indicates hook effect",
                      "Otherwise, low result was real or sample had other interference"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Assay Performance": {
            "name": "Assay Performance",
            "url": "https://app.pathprimer.com/document/0acf2b6b-d886-41f2-bcf7-b968f9a9ccb4/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Immunoassay (IA): Biochemical laboratory testing platform that aids in detection &/or measurement of compound of interest through use of antibody or antigen; may incorporate a label to aid detection or quantification"
                  },
                  {
                    "text": "Various types of assaysPrecipitation immunoassay: Antigen and antibody react without label; resulting precipitation can be seen or detected through detectorRadioimmunoassay: Makes use of radioisotopes as labelEnzyme immunoassay: Makes use of enzymes as labelsFluorescent immunoassay: Makes use of fluorophores as labelsChemiluminescent immunoassay: Makes use of chemiluminescent compounds as labels",
                    "sub_points": [
                      "Precipitation immunoassay: Antigen and antibody react without label; resulting precipitation can be seen or detected through detector",
                      "Radioimmunoassay: Makes use of radioisotopes as label",
                      "Enzyme immunoassay: Makes use of enzymes as labels",
                      "Fluorescent immunoassay: Makes use of fluorophores as labels",
                      "Chemiluminescent immunoassay: Makes use of chemiluminescent compounds as labels"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Classification of Assays": [
                  {
                    "text": "Competitive, homogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound labeled analyte is quantifiedAmount of unbound labeled analyte present is proportional to amount in sample",
                    "sub_points": [
                      "Labeled and unlabeled analytes compete to bind to antibody",
                      "Unbound labeled analyte is quantified",
                      "Amount of unbound labeled analyte present is proportional to amount in sample"
                    ]
                  },
                  {
                    "text": "Competitive, heterogeneous immunoassayLabeled and unlabeled analytes compete to bind to antibodyUnbound analyte is washed away, and remaining labeled bound analyte is quantified",
                    "sub_points": [
                      "Labeled and unlabeled analytes compete to bind to antibody",
                      "Unbound analyte is washed away, and remaining labeled bound analyte is quantified"
                    ]
                  },
                  {
                    "text": "One-site, noncompetitive immunoassayLabeled antibodies are added to unknown analyteUnbound labeled antibodies are washed away, and bound labeled antibodies are quantifiedIntensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample",
                    "sub_points": [
                      "Labeled antibodies are added to unknown analyte",
                      "Unbound labeled antibodies are washed away, and bound labeled antibodies are quantified",
                      "Intensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample"
                    ]
                  },
                  {
                    "text": "Two-site, noncompetitive immunoassay (“sandwich” assay)Analyte and unlabeled antibodies are bound, causing conformational change in structureLabeled antibodies are added to sample, which can bind to analyte if bound to unlabeled antibodyAmount of bound labeled antibodies is quantifiedIntensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample",
                    "sub_points": [
                      "Analyte and unlabeled antibodies are bound, causing conformational change in structure",
                      "Labeled antibodies are added to sample, which can bind to analyte if bound to unlabeled antibody",
                      "Amount of bound labeled antibodies is quantified",
                      "Intensity of signal produced by bound labeled antibodies is proportional to amount of analyte in sample"
                    ]
                  }
                ],
                "Types of Assays": [
                  {
                    "text": "Precipitation immunoassay: Antigen and antibody react without label; resulting precipitation can be seen or detected through detector"
                  },
                  {
                    "text": "Particle immunoassay: Uses inert particles attached to either antigens or antibodies, which cause agglutination (e.g., erythrocytes or latex)"
                  },
                  {
                    "text": "Radioimmunoassay: Uses radioisotopes as label"
                  },
                  {
                    "text": "Enzyme immunoassay: Uses enzymes as labels"
                  },
                  {
                    "text": "Fluorescent immunoassay: Uses fluorophores as labels"
                  },
                  {
                    "text": "Chemiluminescent immunoassay: Uses chemiluminescent compounds as labels"
                  }
                ],
                "Assay Sensitivity": [
                  {
                    "text": "Affected by association constant, signal intensity, and signal-to-noise ratio"
                  },
                  {
                    "text": "Immunoassays can be tremendously affected by interference by other molecules"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Precipitation immunoassayAntigen-antibody complexes are formed, which are insoluble and can be seen with naked eye or detected with detectorFactors that alter assay performanceConcentrations of reactantsTemperaturepH of samplePoint of equivalence: Point of optimal precipitation during reaction; addition of more antigen will cause dissolution of precipitateLimitation: Decreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)",
                    "sub_points": [
                      "Antigen-antibody complexes are formed, which are insoluble and can be seen with naked eye or detected with detector",
                      "Factors that alter assay performanceConcentrations of reactantsTemperaturepH of sample",
                      "Concentrations of reactants",
                      "Temperature",
                      "pH of sample",
                      "Point of equivalence: Point of optimal precipitation during reaction; addition of more antigen will cause dissolution of precipitate",
                      "Limitation: Decreased sensitivity (lower limit of detection 0.1-0.5 mg/dL)"
                    ]
                  },
                  {
                    "text": "Particle immunoassayInert particles attached cause agglutinationVarious particles have been implemented in different immunoassaysDirect agglutination: Antibodies bind directly to antigens and agglutinateIndirect (passive) agglutination: Inert particles or cells are coated with antigen, which are exposed to antibodies and then agglutinateReverse agglutination: Inert particles or cells are coated with antibody, which are exposed to antigens and then agglutinate",
                    "sub_points": [
                      "Inert particles attached cause agglutination",
                      "Various particles have been implemented in different immunoassays",
                      "Direct agglutination: Antibodies bind directly to antigens and agglutinate",
                      "Indirect (passive) agglutination: Inert particles or cells are coated with antigen, which are exposed to antibodies and then agglutinate",
                      "Reverse agglutination: Inert particles or cells are coated with antibody, which are exposed to antigens and then agglutinate"
                    ]
                  },
                  {
                    "text": "Radioimmunoassay (RIA)Can be either competitive or noncompetitive heterogeneous assayAssay is dependent upon binding affinity of antibody (K)Scatchard Plot is delineated by B/F =K([Ab]t – B)Can be used to evaluate performance of an antibodyB/F = ratio of bound to free antigenK =binding affinity constantAb = antibody concentrationAdvantagesHigher sensitivityReduced interferenceDisadvantagesShorter shelf life for assayRadioactivity",
                    "sub_points": [
                      "Can be either competitive or noncompetitive heterogeneous assay",
                      "Assay is dependent upon binding affinity of antibody (K)Scatchard Plot is delineated by B/F =K([Ab]t – B)Can be used to evaluate performance of an antibodyB/F = ratio of bound to free antigenK =binding affinity constantAb = antibody concentration",
                      "Scatchard Plot is delineated by B/F =K([Ab]t – B)Can be used to evaluate performance of an antibodyB/F = ratio of bound to free antigenK =binding affinity constantAb = antibody concentration",
                      "Can be used to evaluate performance of an antibody",
                      "B/F = ratio of bound to free antigen",
                      "K =binding affinity constant",
                      "Ab = antibody concentration",
                      "AdvantagesHigher sensitivityReduced interference",
                      "Higher sensitivity",
                      "Reduced interference",
                      "DisadvantagesShorter shelf life for assayRadioactivity",
                      "Shorter shelf life for assay",
                      "Radioactivity"
                    ]
                  },
                  {
                    "text": "Enzyme immunoassay (EIA)Can be either heterogeneous competitive or noncompetitive, similar to RIA without radioactivityCan also be homogeneous assays without washing stepVarious enzymes are used as labelsHeterogeneous EIA contains washing step for separationHomogeneous EIA uses 1 solution for entire reactionDetection for all EIA is by optical density, fluorescence, or luminescenceAdvantagesHigh sensitivityCheap long-lasting reagentsInexpensive assay and equipmentNo hazardsDisadvantagesComplex quantificationInterference by plasma proteinsPossible need for complex reagents",
                    "sub_points": [
                      "Can be either heterogeneous competitive or noncompetitive, similar to RIA without radioactivity",
                      "Can also be homogeneous assays without washing step",
                      "Various enzymes are used as labels",
                      "Heterogeneous EIA contains washing step for separation",
                      "Homogeneous EIA uses 1 solution for entire reaction",
                      "Detection for all EIA is by optical density, fluorescence, or luminescence",
                      "AdvantagesHigh sensitivityCheap long-lasting reagentsInexpensive assay and equipmentNo hazards",
                      "High sensitivity",
                      "Cheap long-lasting reagents",
                      "Inexpensive assay and equipment",
                      "No hazards",
                      "DisadvantagesComplex quantificationInterference by plasma proteinsPossible need for complex reagents",
                      "Complex quantification",
                      "Interference by plasma proteins",
                      "Possible need for complex reagents"
                    ]
                  },
                  {
                    "text": "Fluorescent immunoassaySimilar to EIA except makes use of fluorophores as labelsEnzyme reaction causes production of fluorophore with specific excitation wavelengthDetected by fluorometer or photomultiplier tube",
                    "sub_points": [
                      "Similar to EIA except makes use of fluorophores as labels",
                      "Enzyme reaction causes production of fluorophore with specific excitation wavelengthDetected by fluorometer or photomultiplier tube",
                      "Detected by fluorometer or photomultiplier tube"
                    ]
                  },
                  {
                    "text": "Chemiluminescent immunoassayCompound of interest causes chemical reaction that results in oxidation of a compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygen; usually in presence of nonbiological catalystLuminometer: Instrumentation for measuring this type of light emissionChemical reaction comprises sample cell, which is protected from external light; injection system, used to add various reagents to sample cell; and detector (photomultiplier tube)Bioluminescence is similar, except it uses biological catalyst (such as luciferase or aequorin)Electroluminescence is similar, except that oxidation reaction occurs on surface of electrodeAdvantagesVery low level of detection; in zeptomole range (10-21)DisadvantagesAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                    "sub_points": [
                      "Compound of interest causes chemical reaction that results in oxidation of a compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygen; usually in presence of nonbiological catalystLuminometer: Instrumentation for measuring this type of light emissionChemical reaction comprises sample cell, which is protected from external light; injection system, used to add various reagents to sample cell; and detector (photomultiplier tube)",
                      "Luminometer: Instrumentation for measuring this type of light emissionChemical reaction comprises sample cell, which is protected from external light; injection system, used to add various reagents to sample cell; and detector (photomultiplier tube)",
                      "Chemical reaction comprises sample cell, which is protected from external light; injection system, used to add various reagents to sample cell; and detector (photomultiplier tube)",
                      "Bioluminescence is similar, except it uses biological catalyst (such as luciferase or aequorin)",
                      "Electroluminescence is similar, except that oxidation reaction occurs on surface of electrode",
                      "AdvantagesVery low level of detection; in zeptomole range (10-21)",
                      "Very low level of detection; in zeptomole range (10-21)",
                      "DisadvantagesAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                      "Any light entering sample cell can cause inaccurate results",
                      "Assay reagents and instrumentation tubing can add background light into system"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chemiluminescence Immunoassays": {
            "name": "Chemiluminescence Immunoassays",
            "url": "https://app.pathprimer.com/document/e2a2ecd8-1dbe-471d-b0e1-3a4b2315014f/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Chemiluminescence, bioluminescence, and electrochemiluminescence are types of luminescence in which excitation event is caused by chemical, biochemical, or electrochemical reaction, and not by photo illumination"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "In chemiluminescence assays, compound of interest reacts, causing chemical reaction that results in oxidation of a compound"
                  },
                  {
                    "text": "Benefits include very low level of detection, in zeptomole range (10-21)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Background": [
                  {
                    "text": "Chemiluminescence: Emission of light by molecules in excited states produced by chemical reactionEmission of light occurs when electron in excited state due to chemical reaction returns to unexcited state and releases its energy in form of light",
                    "sub_points": [
                      "Emission of light occurs when electron in excited state due to chemical reaction returns to unexcited state and releases its energy in form of light"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Chemiluminescence assaysCompound of interest reacts, causing chemical reaction that results in oxidation of compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygen; usually in presence of nonbiological catalystLuminometer: Instrumentation for measuring this type of light emissionComprisesSample cell, which is protected from external lightInjection system used to add various reagents to sample cellDetector (photomultiplier tube)",
                    "sub_points": [
                      "Compound of interest reacts, causing chemical reaction that results in oxidation of compound (such as luminol, isoluminol, acridinium esters, or luciferin) by hydrogen peroxide, hypochlorite, or oxygen; usually in presence of nonbiological catalyst",
                      "Luminometer: Instrumentation for measuring this type of light emissionComprisesSample cell, which is protected from external lightInjection system used to add various reagents to sample cellDetector (photomultiplier tube)",
                      "ComprisesSample cell, which is protected from external lightInjection system used to add various reagents to sample cellDetector (photomultiplier tube)",
                      "Sample cell, which is protected from external light",
                      "Injection system used to add various reagents to sample cell",
                      "Detector (photomultiplier tube)"
                    ]
                  },
                  {
                    "text": "BioluminescenceSimilar to chemiluminescence, except it uses biological catalyst (such as luciferase or aequorin)",
                    "sub_points": [
                      "Similar to chemiluminescence, except it uses biological catalyst (such as luciferase or aequorin)"
                    ]
                  },
                  {
                    "text": "ElectroluminescenceSimilar to chemiluminescence, except that oxidation reaction occurs on surface of electrode",
                    "sub_points": [
                      "Similar to chemiluminescence, except that oxidation reaction occurs on surface of electrode"
                    ]
                  },
                  {
                    "text": "Benefits include very low level of detection, in zeptomole range (10-21)"
                  },
                  {
                    "text": "LimitationsAny light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                    "sub_points": [
                      "Any light entering sample cell can cause inaccurate resultsAssay reagents and instrumentation tubing can add background light into system",
                      "Assay reagents and instrumentation tubing can add background light into system"
                    ]
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Any light entering system can interfere with results"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cloned Enzyme Donor Immunoassay (CEDIA)": {
            "name": "Cloned Enzyme Donor Immunoassay (CEDIA)",
            "url": "https://app.pathprimer.com/document/e656fe42-985d-4d89-9ae6-5c5f44bdd87d/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "CLINICAL CORRELATES": {
                "Background": [
                  {
                    "text": "Cloned enzyme donor immunoassay (CEDIA): Type of competitive homogenous enzyme immunoassayRelies on 2 inactive fragments of enzyme reassembling into active enzymeDeveloped through genetic engineering of ﻿lac﻿operon inEscherichiacolispeciesZ gene contained enzyme of interest, P-galactosidase",
                    "sub_points": [
                      "Relies on 2 inactive fragments of enzyme reassembling into active enzyme",
                      "Developed through genetic engineering of ﻿lac﻿operon inEscherichiacolispeciesZ gene contained enzyme of interest, P-galactosidase",
                      "Z gene contained enzyme of interest, P-galactosidase"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "CEDIA relies on 2 inactive fragments of enzyme reassembling into active enzyme in presence of antibody for antigen of interestOne inactive enzyme fragment (enzyme donor) is bound to an antigenInactive fragments of enzyme can reassemble with antigen-bound; however, antibody also binds to antigen and can prevent assembly of enzyme fragmentsThis creates competitive environment between assembling of enzyme fragments and binding of limited antibody to antigen bound to enzyme-donor",
                    "sub_points": [
                      "One inactive enzyme fragment (enzyme donor) is bound to an antigen",
                      "Inactive fragments of enzyme can reassemble with antigen-bound; however, antibody also binds to antigen and can prevent assembly of enzyme fragments",
                      "This creates competitive environment between assembling of enzyme fragments and binding of limited antibody to antigen bound to enzyme-donor"
                    ]
                  },
                  {
                    "text": "Higher levels of antigen result in decreased inhibition of enzyme activity (because antibody has more antigens to which it can bind)"
                  },
                  {
                    "text": "Lower concentrations of antigen cause increased inhibition of enzyme activity (because antibody has limited amount of antigens to which it can bind)"
                  },
                  {
                    "text": "Level of enzyme activity is proportional to concentration of analyte of interest"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fluorescence Assay and Stokes Shift": {
            "name": "Fluorescence Assay and Stokes Shift",
            "url": "https://app.pathprimer.com/document/6146f091-435e-42c4-a7d1-06c1fb68def0/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Fluorescence immunoassays make use of fluorescent compounds as labels for detection of antigensAdvantages include high sensitivity, low cost, no hazardous reagents",
                    "sub_points": [
                      "Advantages include high sensitivity, low cost, no hazardous reagents"
                    ]
                  },
                  {
                    "text": "Stokes shift: Difference in either energy or wavelength between excitation and emission wavelengths during first and last stages of fluorescence"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Fluorescence Assay": [
                  {
                    "text": "OverviewFluorescence immunoassays make use of fluorescent compounds as labels for detection of antigensChoosing correct label for assay is crucial to optimal assay performance",
                    "sub_points": [
                      "Fluorescence immunoassays make use of fluorescent compounds as labels for detection of antigens",
                      "Choosing correct label for assay is crucial to optimal assay performance"
                    ]
                  },
                  {
                    "text": "Classification of assaysCan be heterogenous or homogenousLigand or antibody labeledCompetitive or noncompetitiveSolid or nonsolid",
                    "sub_points": [
                      "Can be heterogenous or homogenous",
                      "Ligand or antibody labeled",
                      "Competitive or noncompetitive",
                      "Solid or nonsolid"
                    ]
                  },
                  {
                    "text": "Types of assaysHeterogeneous fluorescent immunoassayIncludes washing step to wash away unbound labels (similar to enzyme immunoassay [EIA] and radioimmunoassay [RIA])Radial partition immunofluorometric assayTime-resolved fluoroimmunoassayHomogeneous fluorescent immunoassayFluorescence polarization assayFluorescence excitation transfer immunoassayFluorescence protection immunoassay",
                    "sub_points": [
                      "Heterogeneous fluorescent immunoassayIncludes washing step to wash away unbound labels (similar to enzyme immunoassay [EIA] and radioimmunoassay [RIA])",
                      "Includes washing step to wash away unbound labels (similar to enzyme immunoassay [EIA] and radioimmunoassay [RIA])",
                      "Radial partition immunofluorometric assay",
                      "Time-resolved fluoroimmunoassay",
                      "Homogeneous fluorescent immunoassay",
                      "Fluorescence polarization assay",
                      "Fluorescence excitation transfer immunoassay",
                      "Fluorescence protection immunoassay"
                    ]
                  },
                  {
                    "text": "Analytic techniqueImmunoassay that makes use of fluorophores as labelsEnzyme reaction causes production of fluorophore with specific excitation wavelengthRelease of this energy is then detected by fluorometer or photomultiplier tubeAdvantages includeHigh sensitivityLow costNo hazardous reagents",
                    "sub_points": [
                      "Immunoassay that makes use of fluorophores as labels",
                      "Enzyme reaction causes production of fluorophore with specific excitation wavelength",
                      "Release of this energy is then detected by fluorometer or photomultiplier tube",
                      "Advantages includeHigh sensitivityLow costNo hazardous reagents",
                      "High sensitivity",
                      "Low cost",
                      "No hazardous reagents"
                    ]
                  }
                ],
                "Stokes Shift": [
                  {
                    "text": "Fluorescence process occurs in 3 stagesExcitation: Fluorophore absorbs energyExcited-state lifetime: Fluorophore undergoes confirmation changeFluorescence emission: Energy is released, returning fluorophore back to ground state",
                    "sub_points": [
                      "Excitation: Fluorophore absorbs energy",
                      "Excited-state lifetime: Fluorophore undergoes confirmation change",
                      "Fluorescence emission: Energy is released, returning fluorophore back to ground state"
                    ]
                  },
                  {
                    "text": "Stokes shift: Difference in either energy or wavelength between excitation and emission wavelengths during first and last stages of fluorescence"
                  },
                  {
                    "text": "Fluorescent techniques and assays rely on this phenomenon for detection and analysis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Time-Resolved Fluorescence Immunoassays": {
            "name": "Time-Resolved Fluorescence Immunoassays",
            "url": "https://app.pathprimer.com/document/26c37388-ae4e-4813-8a62-3e4a6e7e390a/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "LABORATORY DIAGNOSIS": {
                "Background": [
                  {
                    "text": "Time-resolved fluorescence immunoassay (TRFIA): Fluorescent immunoassay that makes use of fluorescent labels that have delayed fluorescenceHelps to resolve and extinguish short-lived background fluorescence that occurs with most substances",
                    "sub_points": [
                      "Helps to resolve and extinguish short-lived background fluorescence that occurs with most substances"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "TRFIA uses fluorescent labels, which are excited with external beam of light"
                  },
                  {
                    "text": "Light results in the followingExcitation of label (absorption of energy)In TRFIA, prolonged excited-state lifetimeUsually this is < 10 ns; in TRFIA, however, this can last over 100 nsDelay allows short-lived background fluorescence to extinguish, eliminating background noiseAfter delayed period, label returns to ground state and emission wavelength is read by fluorometer",
                    "sub_points": [
                      "Excitation of label (absorption of energy)",
                      "In TRFIA, prolonged excited-state lifetimeUsually this is < 10 ns; in TRFIA, however, this can last over 100 ns",
                      "Usually this is < 10 ns; in TRFIA, however, this can last over 100 ns",
                      "Delay allows short-lived background fluorescence to extinguish, eliminating background noise",
                      "After delayed period, label returns to ground state and emission wavelength is read by fluorometer"
                    ]
                  },
                  {
                    "text": "Special labels must be used to implement this delayPyrene derivatives (100 ns)Rare earth metal chelates, including Eu, Sm, Tb (50-100 μs)",
                    "sub_points": [
                      "Pyrene derivatives (100 ns)",
                      "Rare earth metal chelates, including Eu, Sm, Tb (50-100 μs)"
                    ]
                  },
                  {
                    "text": "Major benefit of this type of assay is elimination of background noise"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Heterophile Antibodies": {
            "name": "Heterophile Antibodies",
            "url": "https://app.pathprimer.com/document/da9283d2-b1fa-41a7-b9b8-14450e239625/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Heterophile antibodies: Antibodies induced by external antigens (e.g., Epstein-Barr virus, animal antigens)"
                  },
                  {
                    "text": "Antibodies against animals: Human anti-animal antibodies (HAAA)"
                  },
                  {
                    "text": "Antibodies against mice: Human anti-mouse antibodies (HAMA)"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Analytic Techniques": [
                  {
                    "text": "Immunoassays"
                  }
                ],
                "Interfering Substances": [
                  {
                    "text": "Heterophile antibodies can cause false results for immunoassaysResults can be falsely high or falsely low",
                    "sub_points": [
                      "Results can be falsely high or falsely low"
                    ]
                  }
                ],
                "Alternate Methods": [
                  {
                    "text": "Heterophile antibody interference can be blockedBy removing immunoglobulins from sample [such as with polyethylene glycol (PEG)]By modifying antibodies that may be present in sample or by using buffers to reduce interference",
                    "sub_points": [
                      "By removing immunoglobulins from sample [such as with polyethylene glycol (PEG)]",
                      "By modifying antibodies that may be present in sample or by using buffers to reduce interference"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Enzyme-Multiplied Immunoassay Technique (EMIT)": {
            "name": "Enzyme-Multiplied Immunoassay Technique (EMIT)",
            "url": "https://app.pathprimer.com/document/d4f66794-4c11-4540-8911-460c25e9d600/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "LABORATORY DIAGNOSIS": {
                "Overview": [
                  {
                    "text": "Homogenous enzyme immunoassay that utilizes analyte-bound enzyme in assay mixtureAllows for antibodies to bind to analyte-bound enzyme and inactivate enzyme",
                    "sub_points": [
                      "Allows for antibodies to bind to analyte-bound enzyme and inactivate enzyme"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "First, sample to be analyzed is mixed with solution of known concentrations of antibody and enzyme substrate"
                  },
                  {
                    "text": "After incubation, known concentration of conjugate is addedIf high concentration of analyte in sampleAntibodies bind to it, resulting in many analyte-bound enzymes free in solutionThis allows for enzymatic conversion of bound analyteIf low concentration of analyte in sampleExcess of antibodies will remain, which bind to analyte-bound enzyme to deactivateThis prevents enzymatic conversion of bound analyte",
                    "sub_points": [
                      "If high concentration of analyte in sampleAntibodies bind to it, resulting in many analyte-bound enzymes free in solutionThis allows for enzymatic conversion of bound analyte",
                      "Antibodies bind to it, resulting in many analyte-bound enzymes free in solution",
                      "This allows for enzymatic conversion of bound analyte",
                      "If low concentration of analyte in sampleExcess of antibodies will remain, which bind to analyte-bound enzyme to deactivateThis prevents enzymatic conversion of bound analyte",
                      "Excess of antibodies will remain, which bind to analyte-bound enzyme to deactivate",
                      "This prevents enzymatic conversion of bound analyte"
                    ]
                  },
                  {
                    "text": "Enzyme activity is proportional to concentration of analyte in sample"
                  },
                  {
                    "text": "Major benefits of this assay are its cost-effective, simple, and quick methodology"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fluorescent Polarization Immunoassay (FPIA)": {
            "name": "Fluorescent Polarization Immunoassay (FPIA)",
            "url": "https://app.pathprimer.com/document/2919135f-433e-4370-bdd2-1be29e959785/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "LABORATORY DIAGNOSIS": {
                "Background": [
                  {
                    "text": "Fluorescence polarization immunoassays (FPIAs): Homogenous fluorescent immunoassays that make use of polarization of fluorescence with antibody bindingMajor benefit of this type of assay is its ability to detect small antigens and haptens",
                    "sub_points": [
                      "Major benefit of this type of assay is its ability to detect small antigens and haptens"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Polarization can excite both bound and unbound conjugates to same angleHowever, upon emission, smaller molecules can rapidly rotate and do not emit fluorescence",
                    "sub_points": [
                      "However, upon emission, smaller molecules can rapidly rotate and do not emit fluorescence"
                    ]
                  },
                  {
                    "text": "Larger conjugates, which are antibody-bound, have slower rotation and will emit fluorescence"
                  },
                  {
                    "text": "This fluorescence is then measured by fluorometer and can be used to calculate concentration of antigen in sample"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Reflectance Photometry": {
            "name": "Reflectance Photometry",
            "url": "https://app.pathprimer.com/document/50f7a41e-74d5-4652-a1bd-dd23a8f887e4/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "LABORATORY DIAGNOSIS": {
                "Overview": [
                  {
                    "text": "Reflectance photometry: Measurement technique for diffuse reflected light"
                  },
                  {
                    "text": "Generally used for urine dipstick analysis"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Beam of light is projected onto surface, and reflected light is measuredMixture of interest is illuminated with diffuse light with a known intensityIntensity of reflected light is measured and compared",
                    "sub_points": [
                      "Mixture of interest is illuminated with diffuse light with a known intensity",
                      "Intensity of reflected light is measured and compared"
                    ]
                  },
                  {
                    "text": "Intensity of reflected light exhibits nonlinear relationship with concentration of analyte in sample and can be shown in linear model with mathematical transformations"
                  },
                  {
                    "text": "Instrumentation used includes light source and detectorIn contrast to absorbance photometry, both are on same side of sample",
                    "sub_points": [
                      "In contrast to absorbance photometry, both are on same side of sample"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Liquid Chromatography": {
            "name": "Liquid Chromatography",
            "url": "https://app.pathprimer.com/document/d6fef75b-0b02-45c2-8795-943d508e2256/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Liquid chromatography can be used alone, but is commonly coupled with mass spectrometryLC-MS = powerful separation technique for laboratory analysis",
                    "sub_points": [
                      "LC-MS = powerful separation technique for laboratory analysis"
                    ]
                  },
                  {
                    "text": "Retention time is key parameter to determine compound of interest in LC analysis"
                  },
                  {
                    "text": "LC has different types of separation columns and mechanisms to fulfill various functions"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Clinical Applications": [
                  {
                    "text": "Liquid chromatography (LC) is used to separate nonvolatile compounds"
                  },
                  {
                    "text": "Liquid chromatography coupled with mass spectrometry (LC-MS) = powerful analytical techniqueConsidered gold standard for many assays, including drug confirmation",
                    "sub_points": [
                      "Considered gold standard for many assays, including drug confirmation"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "LC used for analysis of compounds﻿ExamplesVitaminsAmino acidsOrganic acidsTricyclic antidepressants",
                    "sub_points": [
                      "ExamplesVitaminsAmino acidsOrganic acidsTricyclic antidepressants",
                      "Vitamins",
                      "Amino acids",
                      "Organic acids",
                      "Tricyclic antidepressants"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "LC can perform qualitative and quantitative analysis"
                  },
                  {
                    "text": "Internal standards typically used for quantitative analysis to help correct losses of analyte of interest in separation and sample preparation processes"
                  }
                ],
                "Instrument Components": [
                  {
                    "text": "ColumnsPacked with stationary phase materialsPolar (silicic acid)Nonpolar (C-18 or C4)Reverse phase (nonpolar) commonly used for clinical laboratoriesSeparates compounds based on their hydrophobicityMore hydrophobic compounds have higher affinity to column and are eluted later in runRetention time = metric for compound identification",
                    "sub_points": [
                      "Packed with stationary phase materialsPolar (silicic acid)Nonpolar (C-18 or C4)",
                      "Polar (silicic acid)",
                      "Nonpolar (C-18 or C4)",
                      "Reverse phase (nonpolar) commonly used for clinical laboratoriesSeparates compounds based on their hydrophobicityMore hydrophobic compounds have higher affinity to column and are eluted later in run",
                      "Separates compounds based on their hydrophobicityMore hydrophobic compounds have higher affinity to column and are eluted later in run",
                      "More hydrophobic compounds have higher affinity to column and are eluted later in run",
                      "Retention time = metric for compound identification"
                    ]
                  },
                  {
                    "text": "DetectorsVariety of detectors are usedUV and mass spectrometry are most common",
                    "sub_points": [
                      "Variety of detectors are usedUV and mass spectrometry are most common",
                      "UV and mass spectrometry are most common"
                    ]
                  },
                  {
                    "text": "AutosamplerCan accommodate various settings (e.g., single vial, 96 well plates, and 384 well plates)Essential component for automation and efficiency",
                    "sub_points": [
                      "Can accommodate various settings (e.g., single vial, 96 well plates, and 384 well plates)",
                      "Essential component for automation and efficiency"
                    ]
                  },
                  {
                    "text": "Mobile phasesLiquid solvents provide separation conditions in columns; carry compounds to detectorsPrecision flow is essential for separation reproducibility; controlled by delivery pumps",
                    "sub_points": [
                      "Liquid solvents provide separation conditions in columns; carry compounds to detectors",
                      "Precision flow is essential for separation reproducibility; controlled by delivery pumps"
                    ]
                  }
                ],
                "Column Parameters": [
                  {
                    "text": "Length: Millimeters (e.g., 50 mm)"
                  },
                  {
                    "text": "Inner diameter: Millimeters (e.g., 2.1 mm)"
                  },
                  {
                    "text": "Particle size: Micrometers (e.g., 2.5 μm)"
                  },
                  {
                    "text": "Pore size: Angstrom (e.g., 100 A)"
                  },
                  {
                    "text": "Packing material (e.g., C18)"
                  }
                ],
                "Separation Mechanisms": [
                  {
                    "text": "Normal phase: Separation based on compound hydrophobicity; retains hydrophilic compounds"
                  },
                  {
                    "text": "Reverse phase: Separation based on compound hydrophobicity; retains hydrophobic compounds"
                  },
                  {
                    "text": "Hydrophilic interactions liquid chromatography (HILIC): modern normal phase column"
                  },
                  {
                    "text": "Size exclusion: Separation based on compound size; small ones have longer retention time"
                  },
                  {
                    "text": "Ion exchange: Separation based on compound charge; positive or negative ion exchange column"
                  },
                  {
                    "text": "Chiral chromatography: Separation based on compound chiral structure"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mass Spectrometry": {
            "name": "Mass Spectrometry",
            "url": "https://app.pathprimer.com/document/f3766913-4d0b-47ea-9d68-51c7a0cc4e26/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Mass spectrometry (MS): Powerful qualitative and quantitative analytical technique"
                  },
                  {
                    "text": "Analyte needs to be positively or negatively charged to be analyzedAnalysis is through measurement of mass to charge (m/z) ratio",
                    "sub_points": [
                      "Analysis is through measurement of mass to charge (m/z) ratio"
                    ]
                  },
                  {
                    "text": "Mass spectrometers have 3 major components: Ion source, mass analyzer, and detector"
                  },
                  {
                    "text": "Most commonly used tandem mass spectrometer is triple-quadrupole"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Definition": [
                  {
                    "text": "Mass spectrometry (MS): Powerful qualitative and quantitative analytical technique"
                  },
                  {
                    "text": "To be analyzed, analyte needs to be positively or negatively charged"
                  },
                  {
                    "text": "Analysis is through measurement of mass to charge (m/z) ratioCompound with molecular weight of 500 will have m/z of 501, if it has 1 positive chargeCompound with molecular weight of 500 will have m/z of 251, if it has 2 positive charges",
                    "sub_points": [
                      "Compound with molecular weight of 500 will have m/z of 501, if it has 1 positive charge",
                      "Compound with molecular weight of 500 will have m/z of 251, if it has 2 positive charges"
                    ]
                  },
                  {
                    "text": "Different types of mass spectrometry used for different purposes of measurements"
                  },
                  {
                    "text": "MS typically couples with liquid chromatography (LC) or gas chromatography for clinical analysis"
                  }
                ],
                "Major Components": [
                  {
                    "text": "Mass spectrometers have 3 major components1) Ion sourceCreates positive or negative ions for MS analysisIonization techniques includeElectron ionization (EI)Chemical ionization (CI)Electrospray ionization (ESI)Atmospheric pressure chemical ionization (APCI)Atmospheric pressure photoionization (APPI)Inductively coupled plasma ionization (ICP)Matrix-assisted laser desorption ionization (MALDI)2) Mass analyzerAnalyzes m/z ratios of precursor or fragment ions of interestExamplesTime of flight (TOF)Quadrupole or triple quadrupoleIon trap analyzerOrbitrap3) DetectorMultiplies and captures analyte m/z signalsCommon detectorsElectron multiplierIon-photon conversion detector",
                    "sub_points": [
                      "1) Ion sourceCreates positive or negative ions for MS analysisIonization techniques includeElectron ionization (EI)Chemical ionization (CI)Electrospray ionization (ESI)Atmospheric pressure chemical ionization (APCI)Atmospheric pressure photoionization (APPI)Inductively coupled plasma ionization (ICP)Matrix-assisted laser desorption ionization (MALDI)",
                      "Creates positive or negative ions for MS analysis",
                      "Ionization techniques includeElectron ionization (EI)Chemical ionization (CI)Electrospray ionization (ESI)Atmospheric pressure chemical ionization (APCI)Atmospheric pressure photoionization (APPI)Inductively coupled plasma ionization (ICP)Matrix-assisted laser desorption ionization (MALDI)",
                      "Electron ionization (EI)",
                      "Chemical ionization (CI)",
                      "Electrospray ionization (ESI)",
                      "Atmospheric pressure chemical ionization (APCI)",
                      "Atmospheric pressure photoionization (APPI)",
                      "Inductively coupled plasma ionization (ICP)",
                      "Matrix-assisted laser desorption ionization (MALDI)",
                      "2) Mass analyzerAnalyzes m/z ratios of precursor or fragment ions of interestExamplesTime of flight (TOF)Quadrupole or triple quadrupoleIon trap analyzerOrbitrap",
                      "Analyzes m/z ratios of precursor or fragment ions of interest",
                      "ExamplesTime of flight (TOF)Quadrupole or triple quadrupoleIon trap analyzerOrbitrap",
                      "Time of flight (TOF)",
                      "Quadrupole or triple quadrupole",
                      "Ion trap analyzer",
                      "Orbitrap",
                      "3) DetectorMultiplies and captures analyte m/z signalsCommon detectorsElectron multiplierIon-photon conversion detector",
                      "Multiplies and captures analyte m/z signals",
                      "Common detectorsElectron multiplierIon-photon conversion detector",
                      "Electron multiplier",
                      "Ion-photon conversion detector"
                    ]
                  },
                  {
                    "text": "Tandem mass spectrometer has more than 1 mass analyzerTriple quadrupole is most commonly used tandem mass spectrometer",
                    "sub_points": [
                      "Triple quadrupole is most commonly used tandem mass spectrometer"
                    ]
                  }
                ],
                "Common Types of Ion Source": [
                  {
                    "text": "Electrospray ionization (ESI)"
                  },
                  {
                    "text": "Atmosphere pressure chemical ionization (APCI)"
                  },
                  {
                    "text": "Atmospheric pressure photoionization (APPI)"
                  },
                  {
                    "text": "Matrix-assisted laser desorption ionization (MALDI)"
                  }
                ],
                "Common Types of Mass Analyzers": [
                  {
                    "text": "Quadrupole"
                  },
                  {
                    "text": "Time of flight (TOF)"
                  },
                  {
                    "text": "Orbitrap"
                  }
                ],
                "Common Types of Tandem Mass Spectrometers": [
                  {
                    "text": "Triple quadrupole (QQQ)"
                  },
                  {
                    "text": "Quadrupole-TOF"
                  },
                  {
                    "text": "TOF-TOF"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Nearly all analytes that can be ionized in gas phase can be analyzed by mass spectrometry"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Triple quadrupleMost commonly used tandem mass spectrometer in clinical laboratoriesPopularity due to its various scan modes for diversityFull scan: Measures molecular weight of all compounds in mass range of interestFragment ion scan: Measures fragments of compound of interestParent ion scan: Measures all compounds that produce certain common fragmentNeutral loss ion scan: Measures compounds that produce certain nonionized fragmentSingle reaction monitoring: Measures precursor and fragment ion pair for compound of interest",
                    "sub_points": [
                      "Most commonly used tandem mass spectrometer in clinical laboratoriesPopularity due to its various scan modes for diversityFull scan: Measures molecular weight of all compounds in mass range of interestFragment ion scan: Measures fragments of compound of interestParent ion scan: Measures all compounds that produce certain common fragmentNeutral loss ion scan: Measures compounds that produce certain nonionized fragmentSingle reaction monitoring: Measures precursor and fragment ion pair for compound of interest",
                      "Popularity due to its various scan modes for diversityFull scan: Measures molecular weight of all compounds in mass range of interestFragment ion scan: Measures fragments of compound of interestParent ion scan: Measures all compounds that produce certain common fragmentNeutral loss ion scan: Measures compounds that produce certain nonionized fragmentSingle reaction monitoring: Measures precursor and fragment ion pair for compound of interest",
                      "Full scan: Measures molecular weight of all compounds in mass range of interest",
                      "Fragment ion scan: Measures fragments of compound of interest",
                      "Parent ion scan: Measures all compounds that produce certain common fragment",
                      "Neutral loss ion scan: Measures compounds that produce certain nonionized fragment",
                      "Single reaction monitoring: Measures precursor and fragment ion pair for compound of interest"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gas Chromatography": {
            "name": "Gas Chromatography",
            "url": "https://app.pathprimer.com/document/2b5652e4-6d95-4ea1-b11e-83ece8742a3e/lesson/161f665b-0bb8-4c65-ac5b-71c6426dc7de",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "GC can be used for detecting volatile alcohols and small molecules"
                  },
                  {
                    "text": "GC-MS is considered gold standard technique for drug confirmation"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Most commonly used detectors are flame ionization detector and mass spectrometer"
                  },
                  {
                    "text": "Accurate and precise control of column and injector temperatures is critical for optimal performance and reliable and reproducible results"
                  },
                  {
                    "text": "Analytes are identified based on retention time and fragment patterns (fingerprint)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Background": [
                  {
                    "text": "Gas chromatography (GC) was developed in 1952 by James and Martin to separate fatty acids"
                  }
                ],
                "Clinical Applications": [
                  {
                    "text": "Used for detecting volatile alcohols and small molecules"
                  },
                  {
                    "text": "Used for confirmation of drugs in clinical and forensic toxicology"
                  },
                  {
                    "text": "Gas chromatography-mass spectrometry (GC-MS) is considered gold standard technique for drug confirmation"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "GC has been used for analysis of compoundsVolatile alcohols (e.g., alcohol, methanol)Small molecules (e.g., opiates)",
                    "sub_points": [
                      "Volatile alcohols (e.g., alcohol, methanol)",
                      "Small molecules (e.g., opiates)"
                    ]
                  },
                  {
                    "text": "Compounds need to be volatile to be analyzed by GCCan be directly heated into gas phaseCan be derivatized to make labile for analysis",
                    "sub_points": [
                      "Can be directly heated into gas phase",
                      "Can be derivatized to make labile for analysis"
                    ]
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "GC can perform qualitative and quantitative analysisQualitative analysis provide identification of analyte of interestAnalytes identified based on their retention times and fragment patterns (fingerprint)Quantitative analysis requires use of calibrators and calculation of areas under peaks",
                    "sub_points": [
                      "Qualitative analysis provide identification of analyte of interestAnalytes identified based on their retention times and fragment patterns (fingerprint)",
                      "Analytes identified based on their retention times and fragment patterns (fingerprint)",
                      "Quantitative analysis requires use of calibrators and calculation of areas under peaks"
                    ]
                  },
                  {
                    "text": "Analytical mechanismCompounds are volatilized and moved by inert gas over analytical columnCompounds are maintained in gas phase by high temperature created by oven that surrounds columnSeparated compounds enter mass spectrometer and are bombarded by electrons into molecule ion speciesMolecule ions are accelerated in field and passed through electric quadrupole fieldQuadrupole plays role as mass filter, and only ions with narrow range of mass/charge (m/z) ratios pass through and reach detectorDetector records electric currents from ions and digitized signals are stored in computer for further analysis",
                    "sub_points": [
                      "Compounds are volatilized and moved by inert gas over analytical column",
                      "Compounds are maintained in gas phase by high temperature created by oven that surrounds column",
                      "Separated compounds enter mass spectrometer and are bombarded by electrons into molecule ion species",
                      "Molecule ions are accelerated in field and passed through electric quadrupole field",
                      "Quadrupole plays role as mass filter, and only ions with narrow range of mass/charge (m/z) ratios pass through and reach detector",
                      "Detector records electric currents from ions and digitized signals are stored in computer for further analysis"
                    ]
                  }
                ],
                "Instrument Components": [
                  {
                    "text": "Basic GC componentsColumnBoth packed and capillary columns are usedColumns contain stationary phase that often consists of hydrocarbon or silicone oilColumns vary from 1-4 mm in inner diameter and ≥ 1 m in lengthNarrow columns are more efficientWider columns have more sample capacityCarrier gas supply and flow controlProvide carrier gas to column and regulate its constant flowConstant flow is essential for column efficiency and reproducible resultsFlow rates are dependent on type of column, varying from 1-2 mL/min for capillary columns to 10-60 mL/min for packed columnsHigh-purity and dry hydrogen and helium are carrier gases of choiceInjectorDelivers aliquot of sample to column with minimal disruption of gas flow into columnMost GC instruments have automated, highly precise, and rapid in-line injectorInject volume typically varies from 1-10 uLTo ensure rapid and complete solute volatilization, temperature of injector is higher than column temperature and maintained to at least 30°C-50°CTemperature controlColumn, injector, and detector all require careful temperature controlControl of column temperature typically achieved by placing column in ovenControl of injector and detector temperatures controlled by electrical resistance heatingFor most clinical applications, column temperature is typically programmed and controlled by computer softwareAccurate and precise control of column and injector temperatures is critical for optimal performance and reliable and reproducible resultsTemperature directly impacts retention time1°C temperature change can cause 5% change in retention timeThermal stability of stationary phase is importantDetectorsVariety of detectors usedMost common: Flame ionization detector and mass spectrometerExamplesFlame ionization detector (FID)Thermionic selective detector (TSD)Electron capture detector (ECD)Photoionization detector (PID)Thermal conductivity detector (TCD)Mass spectrometer (MS)ComputerFunctions as process controller and data processor",
                    "sub_points": [
                      "ColumnBoth packed and capillary columns are usedColumns contain stationary phase that often consists of hydrocarbon or silicone oilColumns vary from 1-4 mm in inner diameter and ≥ 1 m in lengthNarrow columns are more efficientWider columns have more sample capacity",
                      "Both packed and capillary columns are used",
                      "Columns contain stationary phase that often consists of hydrocarbon or silicone oil",
                      "Columns vary from 1-4 mm in inner diameter and ≥ 1 m in lengthNarrow columns are more efficientWider columns have more sample capacity",
                      "Narrow columns are more efficient",
                      "Wider columns have more sample capacity",
                      "Carrier gas supply and flow controlProvide carrier gas to column and regulate its constant flowConstant flow is essential for column efficiency and reproducible resultsFlow rates are dependent on type of column, varying from 1-2 mL/min for capillary columns to 10-60 mL/min for packed columnsHigh-purity and dry hydrogen and helium are carrier gases of choice",
                      "Provide carrier gas to column and regulate its constant flowConstant flow is essential for column efficiency and reproducible resultsFlow rates are dependent on type of column, varying from 1-2 mL/min for capillary columns to 10-60 mL/min for packed columns",
                      "Constant flow is essential for column efficiency and reproducible results",
                      "Flow rates are dependent on type of column, varying from 1-2 mL/min for capillary columns to 10-60 mL/min for packed columns",
                      "High-purity and dry hydrogen and helium are carrier gases of choice",
                      "InjectorDelivers aliquot of sample to column with minimal disruption of gas flow into columnMost GC instruments have automated, highly precise, and rapid in-line injectorInject volume typically varies from 1-10 uLTo ensure rapid and complete solute volatilization, temperature of injector is higher than column temperature and maintained to at least 30°C-50°C",
                      "Delivers aliquot of sample to column with minimal disruption of gas flow into column",
                      "Most GC instruments have automated, highly precise, and rapid in-line injector",
                      "Inject volume typically varies from 1-10 uL",
                      "To ensure rapid and complete solute volatilization, temperature of injector is higher than column temperature and maintained to at least 30°C-50°C",
                      "Temperature controlColumn, injector, and detector all require careful temperature controlControl of column temperature typically achieved by placing column in ovenControl of injector and detector temperatures controlled by electrical resistance heatingFor most clinical applications, column temperature is typically programmed and controlled by computer softwareAccurate and precise control of column and injector temperatures is critical for optimal performance and reliable and reproducible resultsTemperature directly impacts retention time1°C temperature change can cause 5% change in retention timeThermal stability of stationary phase is important",
                      "Column, injector, and detector all require careful temperature controlControl of column temperature typically achieved by placing column in ovenControl of injector and detector temperatures controlled by electrical resistance heating",
                      "Control of column temperature typically achieved by placing column in oven",
                      "Control of injector and detector temperatures controlled by electrical resistance heating",
                      "For most clinical applications, column temperature is typically programmed and controlled by computer software",
                      "Accurate and precise control of column and injector temperatures is critical for optimal performance and reliable and reproducible resultsTemperature directly impacts retention time1°C temperature change can cause 5% change in retention time",
                      "Temperature directly impacts retention time",
                      "1°C temperature change can cause 5% change in retention time",
                      "Thermal stability of stationary phase is important",
                      "DetectorsVariety of detectors usedMost common: Flame ionization detector and mass spectrometerExamplesFlame ionization detector (FID)Thermionic selective detector (TSD)Electron capture detector (ECD)Photoionization detector (PID)Thermal conductivity detector (TCD)Mass spectrometer (MS)",
                      "Variety of detectors usedMost common: Flame ionization detector and mass spectrometer",
                      "Most common: Flame ionization detector and mass spectrometer",
                      "ExamplesFlame ionization detector (FID)Thermionic selective detector (TSD)Electron capture detector (ECD)Photoionization detector (PID)Thermal conductivity detector (TCD)Mass spectrometer (MS)",
                      "Flame ionization detector (FID)",
                      "Thermionic selective detector (TSD)",
                      "Electron capture detector (ECD)",
                      "Photoionization detector (PID)",
                      "Thermal conductivity detector (TCD)",
                      "Mass spectrometer (MS)",
                      "ComputerFunctions as process controller and data processor",
                      "Functions as process controller and data processor"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Tumor Markers": {
        "name": "Tumor Markers",
        "url": "https://app.pathprimer.com/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
        "topics": {
          "Cancer Diagnosis": {
            "name": "Cancer Diagnosis",
            "url": "https://app.pathprimer.com/document/fc756f2a-9051-4b7a-820d-b9f5f7f3778a/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Tumor markers are compounds found to be elevated in body fluids or tissues in the presence of a malignancy (can be produced by or in response to malignant cells)"
                  },
                  {
                    "text": "Can be classified by association with cell proliferation, cell differentiation, metastasis, malignant transformation, inherited mutations, other tumor-associated events"
                  },
                  {
                    "text": "Tumor markers delineated for cancer diagnosis usually require high sensitivity and specificity; it is difficult to identify markers with these characteristics"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Most tumor markers are evaluated by immunoassay"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Tumor markers are compounds found to be elevated in body fluids or tissues in the presence of a malignancy (can be produced by or in response to malignant cells)Can be classified by associationCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                    "sub_points": [
                      "Can be classified by associationCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                      "Cell proliferation",
                      "Cell differentiation",
                      "Metastasis",
                      "Malignant transformation",
                      "Inherited mutations",
                      "Other tumor-associated events"
                    ]
                  },
                  {
                    "text": "Tumor markers delineated for cancer diagnosis usually require high sensitivity and specificityIt is difficult to identify markers with these characteristics",
                    "sub_points": [
                      "It is difficult to identify markers with these characteristics"
                    ]
                  },
                  {
                    "text": "Many potential tumor markers have been discovered through gene expression profiling data in various cancers"
                  },
                  {
                    "text": "Tumor marker for diagnosis ideally helps differentiate malignancy from other benign mimics of disease"
                  },
                  {
                    "text": "Many tumor markers are meant to aid in diagnosis of malignancy, rather than definitively diagnose malignancy"
                  },
                  {
                    "text": "Approved tumor markers for diagnosis or to aid in diagnosisAlpha fetoprotein (AFP): Diagnosis of liver cancerBCR-ABLfusion gene (Philadelphia chromosome): Confirmation of diagnosis of chronic myeloid leukemiaC-kit/CD117: Aid in diagnosis of gastrointestinal stromal tumor and mucosal melanomaCancer antigen 125 (CA-125): Aid in diagnosis of ovarian cancerCalcitonin: Aid in diagnosis of medullary thyroid cancerChromogranin A (CgA): Aid in diagnosis of neuroendocrine tumorsImmunoglobulins: Aid in diagnosis of multiple myeloma and Waldenström macroglobulinemiaNeuron-specific enolase (NSE): Aid in diagnosis of small cell lung cancer and neuroblastomaProstate-specific antigen (PSA): Aid in diagnosis of prostate cancer",
                    "sub_points": [
                      "Alpha fetoprotein (AFP): Diagnosis of liver cancer",
                      "BCR-ABLfusion gene (Philadelphia chromosome): Confirmation of diagnosis of chronic myeloid leukemia",
                      "C-kit/CD117: Aid in diagnosis of gastrointestinal stromal tumor and mucosal melanoma",
                      "Cancer antigen 125 (CA-125): Aid in diagnosis of ovarian cancer",
                      "Calcitonin: Aid in diagnosis of medullary thyroid cancer",
                      "Chromogranin A (CgA): Aid in diagnosis of neuroendocrine tumors",
                      "Immunoglobulins: Aid in diagnosis of multiple myeloma and Waldenström macroglobulinemia",
                      "Neuron-specific enolase (NSE): Aid in diagnosis of small cell lung cancer and neuroblastoma",
                      "Prostate-specific antigen (PSA): Aid in diagnosis of prostate cancer"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Specific tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Most tumor markers evaluated by immunoassay"
                  },
                  {
                    "text": "Serum protein electrophoresis (SPEP): Multiple myeloma"
                  }
                ],
                "Biochemical Tests": [
                  {
                    "text": "Used for metabolites testing in neuroendocrine tumorsNeuron-specific enolase (NSE)Chromogranin A",
                    "sub_points": [
                      "Neuron-specific enolase (NSE)",
                      "Chromogranin A"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood collected for most tumor markers"
                  },
                  {
                    "text": "Urine samples can be used for metabolite markers (e.g., PSA, 5-HIAA, and urinary catecholamines)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cancer Treatment Monitoring": {
            "name": "Cancer Treatment Monitoring",
            "url": "https://app.pathprimer.com/document/503d2ba7-fb0c-4f3c-9a99-078782688b1d/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Treatment monitoring is useful and successful application of tumor markers"
                  },
                  {
                    "text": "In event of cancer recurrence, it is crucial to keep “lead time” in mind; many tumor markers may not become detectable until 3-6 months after true recurrence"
                  },
                  {
                    "text": "Tumor markers delineated for treatment monitoring must be stable, identifiable compounds that appear early in tumorigenesis and can be followed through progression of disease"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Treatment monitoring is useful and successful application of tumor markers"
                  },
                  {
                    "text": "Monitoring level of established tumor marker has proven to aid in surveillance of recurrence, remission, and complete surgical resection in patients with cancer"
                  },
                  {
                    "text": "In event of cancer recurrence, it is crucial to keep “lead time” in mindMany tumor markers may not become detectable until 3-6 months after true recurrence",
                    "sub_points": [
                      "Many tumor markers may not become detectable until 3-6 months after true recurrence"
                    ]
                  },
                  {
                    "text": "Tumor markers can be classified by association withCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                    "sub_points": [
                      "Cell proliferation",
                      "Cell differentiation",
                      "Metastasis",
                      "Malignant transformation",
                      "Inherited mutations",
                      "Other tumor-associated events"
                    ]
                  },
                  {
                    "text": "Tumor markers delineated for treatment monitoring must be stable, identifiable compounds that appear early in tumorigenesis and can be followed through progression of disease"
                  },
                  {
                    "text": "Many potential tumor markers have been discovered through gene expression profiling data in various cancers"
                  },
                  {
                    "text": "Markers approved for cancer treatment monitoringALKgene rearrangements and overexpressionUsed to determine treatment in non-small cell lung cancer and anaplastic large cell lymphomaAlpha fetoprotein (AFP)Used to monitor response to treatment in liver cancer and germ cell tumorsβ₂-microglobulin (B2M)Used to follow response to treatment in multiple myeloma, chronic lymphocytic leukemia, some lymphomasβ-human chorionic gonadotropin (β-hCG)Used to follow response to treatment in germ cell tumorsBRCA1andBRCA2gene mutationsUsed to determine targeted treatment plan in breast and ovarian cancersBCR-ABLfusion geneUsed to predict response to targeted therapy in chronic myelogenous leukemia, acute lymphoblastic leukemia, acute myelogenous leukemiaBRAFV600 mutationsUsed to predict response to targeted therapy in cutaneous melanoma and colorectal cancerC-kit/CD117Used to determine treatment in gastrointestinal stromal tumor and mucosal melanomaCA15.3/CA27.29Used to monitor efficacy of treatment in breast cancerCancer antigen 19-9 (CA19-9)Used to monitor efficacy of treatment in pancreatic cancer, gallbladder cancer, bile duct cancer, gastric carcinomasCancer antigen 125 (CA 125)Used to assess response to treatment in ovarian cancerCalcitoninUsed to assess response to treatment in medullary thyroid cancerCarcinoembryonic antigen (CEA)Used to assess response to treatment in colorectal cancerCD20Used to determine whether treatment with targeted therapy is appropriate in non-Hodgkin lymphomaChromogranin A (CgA)Used to assess response to treatment in neuroendocrine tumorsEGFRgene mutation analysisUsed to determine treatment in non-small cell lung cancerEstrogen receptor (ER)/progesterone receptor (PR)Used to assess whether treatment with hormone therapy and some targeted therapies is appropriate in breast cancerFibrin/fibrinogenUsed to monitor response to treatment in bladder cancerHE4Used to plan treatment options in ovarian cancerHER2/neugene amplification or protein overexpressionUsed to assess treatment with targeted therapies in breast cancer, gastric cancer, gastroesophageal junction adenocarcinomaImmunoglobulinsUsed to assess response to treatment in multiple myeloma and Waldenström macroglobulinemiaKRASgene mutation analysisUsed to determine treatment with targeted therapy in colorectal cancer and non-small cell lung cancerLactate dehydrogenase (LDH)Used to monitor response to treatment in germ cell tumors, lymphoma, leukemia, melanoma, neuroblastomaNeuron-specific enolase (NSE)Used to assess response to treatment in small cell lung cancer and neuroblastomaNuclear matrix protein-22 (NMP-22)Used to monitor response to treatment in bladder cancerProgrammed death ligand 1 (PD-L1)Used to determine treatment with targeted therapy in non-small cell lung cancerProstate-specific antigen (PSA)Used to assess response to treatment in prostate cancerThyroglobulinUsed to evaluate response to treatment in thyroid cancerUrokinase plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1)Used to determine aggressiveness of breast cancer and treatment",
                    "sub_points": [
                      "ALKgene rearrangements and overexpressionUsed to determine treatment in non-small cell lung cancer and anaplastic large cell lymphoma",
                      "Used to determine treatment in non-small cell lung cancer and anaplastic large cell lymphoma",
                      "Alpha fetoprotein (AFP)Used to monitor response to treatment in liver cancer and germ cell tumors",
                      "Used to monitor response to treatment in liver cancer and germ cell tumors",
                      "β₂-microglobulin (B2M)Used to follow response to treatment in multiple myeloma, chronic lymphocytic leukemia, some lymphomas",
                      "Used to follow response to treatment in multiple myeloma, chronic lymphocytic leukemia, some lymphomas",
                      "β-human chorionic gonadotropin (β-hCG)Used to follow response to treatment in germ cell tumors",
                      "Used to follow response to treatment in germ cell tumors",
                      "BRCA1andBRCA2gene mutationsUsed to determine targeted treatment plan in breast and ovarian cancers",
                      "Used to determine targeted treatment plan in breast and ovarian cancers",
                      "BCR-ABLfusion geneUsed to predict response to targeted therapy in chronic myelogenous leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia",
                      "Used to predict response to targeted therapy in chronic myelogenous leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia",
                      "BRAFV600 mutationsUsed to predict response to targeted therapy in cutaneous melanoma and colorectal cancer",
                      "Used to predict response to targeted therapy in cutaneous melanoma and colorectal cancer",
                      "C-kit/CD117Used to determine treatment in gastrointestinal stromal tumor and mucosal melanoma",
                      "Used to determine treatment in gastrointestinal stromal tumor and mucosal melanoma",
                      "CA15.3/CA27.29Used to monitor efficacy of treatment in breast cancer",
                      "Used to monitor efficacy of treatment in breast cancer",
                      "Cancer antigen 19-9 (CA19-9)Used to monitor efficacy of treatment in pancreatic cancer, gallbladder cancer, bile duct cancer, gastric carcinomas",
                      "Used to monitor efficacy of treatment in pancreatic cancer, gallbladder cancer, bile duct cancer, gastric carcinomas",
                      "Cancer antigen 125 (CA 125)Used to assess response to treatment in ovarian cancer",
                      "Used to assess response to treatment in ovarian cancer",
                      "CalcitoninUsed to assess response to treatment in medullary thyroid cancer",
                      "Used to assess response to treatment in medullary thyroid cancer",
                      "Carcinoembryonic antigen (CEA)Used to assess response to treatment in colorectal cancer",
                      "Used to assess response to treatment in colorectal cancer",
                      "CD20Used to determine whether treatment with targeted therapy is appropriate in non-Hodgkin lymphoma",
                      "Used to determine whether treatment with targeted therapy is appropriate in non-Hodgkin lymphoma",
                      "Chromogranin A (CgA)Used to assess response to treatment in neuroendocrine tumors",
                      "Used to assess response to treatment in neuroendocrine tumors",
                      "EGFRgene mutation analysisUsed to determine treatment in non-small cell lung cancer",
                      "Used to determine treatment in non-small cell lung cancer",
                      "Estrogen receptor (ER)/progesterone receptor (PR)Used to assess whether treatment with hormone therapy and some targeted therapies is appropriate in breast cancer",
                      "Used to assess whether treatment with hormone therapy and some targeted therapies is appropriate in breast cancer",
                      "Fibrin/fibrinogenUsed to monitor response to treatment in bladder cancer",
                      "Used to monitor response to treatment in bladder cancer",
                      "HE4Used to plan treatment options in ovarian cancer",
                      "Used to plan treatment options in ovarian cancer",
                      "HER2/neugene amplification or protein overexpressionUsed to assess treatment with targeted therapies in breast cancer, gastric cancer, gastroesophageal junction adenocarcinoma",
                      "Used to assess treatment with targeted therapies in breast cancer, gastric cancer, gastroesophageal junction adenocarcinoma",
                      "ImmunoglobulinsUsed to assess response to treatment in multiple myeloma and Waldenström macroglobulinemia",
                      "Used to assess response to treatment in multiple myeloma and Waldenström macroglobulinemia",
                      "KRASgene mutation analysisUsed to determine treatment with targeted therapy in colorectal cancer and non-small cell lung cancer",
                      "Used to determine treatment with targeted therapy in colorectal cancer and non-small cell lung cancer",
                      "Lactate dehydrogenase (LDH)Used to monitor response to treatment in germ cell tumors, lymphoma, leukemia, melanoma, neuroblastoma",
                      "Used to monitor response to treatment in germ cell tumors, lymphoma, leukemia, melanoma, neuroblastoma",
                      "Neuron-specific enolase (NSE)Used to assess response to treatment in small cell lung cancer and neuroblastoma",
                      "Used to assess response to treatment in small cell lung cancer and neuroblastoma",
                      "Nuclear matrix protein-22 (NMP-22)Used to monitor response to treatment in bladder cancer",
                      "Used to monitor response to treatment in bladder cancer",
                      "Programmed death ligand 1 (PD-L1)Used to determine treatment with targeted therapy in non-small cell lung cancer",
                      "Used to determine treatment with targeted therapy in non-small cell lung cancer",
                      "Prostate-specific antigen (PSA)Used to assess response to treatment in prostate cancer",
                      "Used to assess response to treatment in prostate cancer",
                      "ThyroglobulinUsed to evaluate response to treatment in thyroid cancer",
                      "Used to evaluate response to treatment in thyroid cancer",
                      "Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1)Used to determine aggressiveness of breast cancer and treatment",
                      "Used to determine aggressiveness of breast cancer and treatment"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Specific tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Most tumor markers are evaluated by immunoassay"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood collected for most tumor markers"
                  },
                  {
                    "text": "Urine samples can be used for metabolite markers"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cancer Screening": {
            "name": "Cancer Screening",
            "url": "https://app.pathprimer.com/document/b2369164-065f-47c2-9b60-be127b33c90f/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "It may take ≥ 6 months for a tumor marker to increase to detectable level in body fluids, making it difficult to find markers for screening that have a clinical impact on patient"
                  },
                  {
                    "text": "Due to low sensitivity and specificity of many tumor markers, screening with these markers has proved to be challenging"
                  },
                  {
                    "text": "Markers used for cancer screeningPSA—routinely used as screening marker for prostate cancerCA-125—used as screening marker for ovarian cancer, with little success; implementing tumor marker panel with multiple markers, including HE4, may help increase sensitivity and specificity",
                    "sub_points": [
                      "PSA—routinely used as screening marker for prostate cancer",
                      "CA-125—used as screening marker for ovarian cancer, with little success; implementing tumor marker panel with multiple markers, including HE4, may help increase sensitivity and specificity"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Tumor markers can be used forScreeningDiagnosis &/or confirmationMonitoring of treatmentStagingPrognosis",
                    "sub_points": [
                      "Screening",
                      "Diagnosis &/or confirmation",
                      "Monitoring of treatment",
                      "Staging",
                      "Prognosis"
                    ]
                  },
                  {
                    "text": "Tumor markers are usually evaluated in serum and other body fluids"
                  },
                  {
                    "text": "Tumor markers can be classified by their association withCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                    "sub_points": [
                      "Cell proliferation",
                      "Cell differentiation",
                      "Metastasis",
                      "Malignant transformation",
                      "Inherited mutations",
                      "Other tumor-associated events"
                    ]
                  },
                  {
                    "text": "It may take ≥ 6 months for a tumor marker to increase to detectable level in body fluidsDifficult to find markers for screening that have a clinical impact on patient",
                    "sub_points": [
                      "Difficult to find markers for screening that have a clinical impact on patient"
                    ]
                  },
                  {
                    "text": "Due to low sensitivity and specificity of many tumor markers, screening with these markers has proved to be challenging"
                  },
                  {
                    "text": "Markers used for cancer screeningProstate-specific antigen (PSA)Routinely used as screening marker for prostate cancerControversy exists regarding its ability to have a clinical impact on patient’s overall survivalCancer antigen 125 (CA 125)Used as screening marker for ovarian cancer, with little successImplementing tumor marker panel with multiple markers, including human epididymis protein 4 (HE4), may help increase sensitivity and specificity",
                    "sub_points": [
                      "Prostate-specific antigen (PSA)Routinely used as screening marker for prostate cancerControversy exists regarding its ability to have a clinical impact on patient’s overall survival",
                      "Routinely used as screening marker for prostate cancer",
                      "Controversy exists regarding its ability to have a clinical impact on patient’s overall survival",
                      "Cancer antigen 125 (CA 125)Used as screening marker for ovarian cancer, with little successImplementing tumor marker panel with multiple markers, including human epididymis protein 4 (HE4), may help increase sensitivity and specificity",
                      "Used as screening marker for ovarian cancer, with little successImplementing tumor marker panel with multiple markers, including human epididymis protein 4 (HE4), may help increase sensitivity and specificity",
                      "Implementing tumor marker panel with multiple markers, including human epididymis protein 4 (HE4), may help increase sensitivity and specificity"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Specific tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Most tumor markers are evaluated by immunoassay"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Venous blood collected for most tumor markers"
                  },
                  {
                    "text": "Urine samples can be used for metabolite markers"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tumor Marker Limitations": {
            "name": "Tumor Marker Limitations",
            "url": "https://app.pathprimer.com/document/5a9ab7d5-a005-4b9d-8a82-46b5c6009f0b/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Many tumor markers are not sensitive or specific for particular malignancies"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Immunoassays to detect tumor markers can vary tremendously"
                  },
                  {
                    "text": "Be aware of hook effect; this is overcome with serial dilutions"
                  },
                  {
                    "text": "Keep in mind the possibility of interference with other compounds or heterophile antibodies (anti-mouse antibodies)"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Many tumor markers are not sensitive or specific for particular malignancies"
                  },
                  {
                    "text": "Not all cases of a particular malignancy express the same tumor markers"
                  },
                  {
                    "text": "Benign conditions can increase levels of compounds being followed as tumor markers"
                  },
                  {
                    "text": "Detection of tumor markers is difficult because of “lead time” of 3-6 months for biomarker to become detectableBe sure to also consider half-life of tumor marker",
                    "sub_points": [
                      "Be sure to also consider half-life of tumor marker"
                    ]
                  },
                  {
                    "text": "Many cancers do not have an identifiable tumor marker"
                  },
                  {
                    "text": "Tumor markers can appear and disappear as a malignancy mutates and progresses"
                  },
                  {
                    "text": "Level of tumor marker does not correlate well with tumor burden in many malignancies"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Most tumor markers are evaluated by immunoassay"
                  },
                  {
                    "text": "Immunoassays to detect tumor markers can vary tremendously"
                  },
                  {
                    "text": "Be aware of hook effectIn some cases, marker of interest is elevated beyond linear range of assay and falsely appears as normal or low valueThis results in falsely decreased laboratory result for compound of interest",
                    "sub_points": [
                      "In some cases, marker of interest is elevated beyond linear range of assay and falsely appears as normal or low value",
                      "This results in falsely decreased laboratory result for compound of interest"
                    ]
                  },
                  {
                    "text": "To overcome hook effect, serial dilutions must be performed"
                  },
                  {
                    "text": "Because most testing is done through immunoassay, it is crucial to keep in mind the possibility of interference with other compounds or heterophile antibodies (anti-mouse antibodies)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tumor Markers Based on Genetic Alterations": {
            "name": "Tumor Markers Based on Genetic Alterations",
            "url": "https://app.pathprimer.com/document/c1d4a2a6-229e-4bb7-a41e-8c4eee80de41/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Tumor marker: Compound that is found to be elevated in body fluids or tissues with presence of malignancyMay be elevated due to genetic aberration resulting in overproduction of certain marker or epigenetic modification",
                    "sub_points": [
                      "May be elevated due to genetic aberration resulting in overproduction of certain marker or epigenetic modification"
                    ]
                  },
                  {
                    "text": "These mutations can occur in growth factors, growth factor receptors, G proteins, cytosolic mitogenic kinases, or nuclear oncoproteins; result in abnormal cell growth and division"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Tumor marker: Compound that is found to be elevated in body fluids or tissues with presence of malignancyMay be elevated due to genetic aberration (resulting in overproduction) or epigenetic modificationCan be classified by association with the followingCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                    "sub_points": [
                      "May be elevated due to genetic aberration (resulting in overproduction) or epigenetic modification",
                      "Can be classified by association with the followingCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                      "Cell proliferation",
                      "Cell differentiation",
                      "Metastasis",
                      "Malignant transformation",
                      "Inherited mutations",
                      "Other tumor-associated events"
                    ]
                  },
                  {
                    "text": "Mutations and epigenetic modification allow for identification of those individuals predisposed to certain malignancies"
                  },
                  {
                    "text": "Examples of tumor markers with genetic alterations currently being used﻿﻿KRAS﻿﻿for colon adenocarcinomap53﻿EGFR﻿for non-small cell lung carcinomaerbB2BRCA1and ﻿BRCA2﻿for breast and ovarian carcinomasAbnormal methylation of p16,﻿CDKN2B﻿, and p14ARF for brain malignanciesHypermethylation ofMYOD1,CDH1, and ﻿CDH13﻿for cervical cancerHypermethylation of p16, p14 and ﻿RB1﻿Ras mutations at positions 12, 13, and 61 in adenocarcinoma in colon and pancreas",
                    "sub_points": [
                      "﻿﻿KRAS﻿﻿for colon adenocarcinoma",
                      "p53",
                      "﻿EGFR﻿for non-small cell lung carcinoma",
                      "erbB2",
                      "BRCA1and ﻿BRCA2﻿for breast and ovarian carcinomas",
                      "Abnormal methylation of p16,﻿CDKN2B﻿, and p14ARF for brain malignancies",
                      "Hypermethylation ofMYOD1,CDH1, and ﻿CDH13﻿for cervical cancer",
                      "Hypermethylation of p16, p14 and ﻿RB1﻿",
                      "Ras mutations at positions 12, 13, and 61 in adenocarcinoma in colon and pancreas"
                    ]
                  },
                  {
                    "text": "These mutations can occur in growth factors, growth factor receptors, G proteins, cytosolic mitogenic kinases, and nuclear oncoproteins; result in abnormal cell growth and division"
                  }
                ],
                "Growth Factors": [
                  {
                    "text": "Growth factors are secreted into extracellular environment to promote growth of cells"
                  },
                  {
                    "text": "These factors can be elevated in blood of patients with cancer and promote growth of cancer"
                  },
                  {
                    "text": "TGF-α (transforming growth factor-α)Binds toEGFRand promotes dimerization and subsequent cell proliferationElevations can be found in gastric cancers and melanoma",
                    "sub_points": [
                      "Binds toEGFRand promotes dimerization and subsequent cell proliferation",
                      "Elevations can be found in gastric cancers and melanoma"
                    ]
                  },
                  {
                    "text": "TGF-β (transforming growth factor-β)Binds to TGF-β receptors, which are Ser/Thr kinase receptors to promote mitosisTGF-β signaling involved in hepatocellular carcinoma (HCC) and bladder cancersElevations in blood and urine of TGF-β is found in patients with HCC",
                    "sub_points": [
                      "Binds to TGF-β receptors, which are Ser/Thr kinase receptors to promote mitosis",
                      "TGF-β signaling involved in hepatocellular carcinoma (HCC) and bladder cancers",
                      "Elevations in blood and urine of TGF-β is found in patients with HCC"
                    ]
                  },
                  {
                    "text": "PDGF (platelet derived growth factor)Binds to PDGR-receptors, which are tyrosine kinase receptors to promote cell proliferationPlays important roles in lymphoid and myeloid cancers, some sarcomas, and breast carcinomasIn breast cancer, elevations of PDGF-B correlate with stage",
                    "sub_points": [
                      "Binds to PDGR-receptors, which are tyrosine kinase receptors to promote cell proliferation",
                      "Plays important roles in lymphoid and myeloid cancers, some sarcomas, and breast carcinomas",
                      "In breast cancer, elevations of PDGF-B correlate with stage"
                    ]
                  },
                  {
                    "text": "FGF (fibroblastic growth factor)Binds to FGF-receptor, which dimerizes and induces mesenchymal cell proliferationElevations in serum are found with epithelial carcinomas, especially renal and lung cancersAlso seen in lymphoid malignancies",
                    "sub_points": [
                      "Binds to FGF-receptor, which dimerizes and induces mesenchymal cell proliferation",
                      "Elevations in serum are found with epithelial carcinomas, especially renal and lung cancersAlso seen in lymphoid malignancies",
                      "Also seen in lymphoid malignancies"
                    ]
                  },
                  {
                    "text": "EGF(epidermal growth factor)Also binds toEGF-receptors to promote dimerization and cell proliferationElevated in patients with stomach cancers and oral cancersMay also be elevated in patients with benign or no disease",
                    "sub_points": [
                      "Also binds toEGF-receptors to promote dimerization and cell proliferation",
                      "Elevated in patients with stomach cancers and oral cancersMay also be elevated in patients with benign or no disease",
                      "May also be elevated in patients with benign or no disease"
                    ]
                  }
                ],
                "Growth Factor Receptors": [
                  {
                    "text": "When growth factors bind to their respective receptors, receptors generally dimerize and undergo autophosphorylation and promote signal transduction; downstream effects of this result in cell growth and proliferationCell proliferation can be mediated by increased signaling via increased presence of growth factors, as discussed above",
                    "sub_points": [
                      "Cell proliferation can be mediated by increased signaling via increased presence of growth factors, as discussed above"
                    ]
                  },
                  {
                    "text": "Another mechanism is via upregulation of these receptors on tumor cell surfaceThese receptors have become important target for therapyMutations in these receptors can lead to increased expression or constitutive activation",
                    "sub_points": [
                      "These receptors have become important target for therapy",
                      "Mutations in these receptors can lead to increased expression or constitutive activation"
                    ]
                  },
                  {
                    "text": "EGF-receptorCan be overexpressed, or mutations within gene contribute to development of many cancers (including colon, breast, lung, and ovarian carcinomas)May play role in development of glioblastomasImportant target for therapy in colon and lung cancers (cetuximab)",
                    "sub_points": [
                      "Can be overexpressed, or mutations within gene contribute to development of many cancers (including colon, breast, lung, and ovarian carcinomas)May play role in development of glioblastomas",
                      "May play role in development of glioblastomas",
                      "Important target for therapy in colon and lung cancers (cetuximab)"
                    ]
                  },
                  {
                    "text": "HER2/neu receptorOverexpression is well-known contributor to oncogenesis of breast cancersHER2overexpression is important to determine because targeted therapy is available (trastuzumab)HER2overexpression has also been found in lung, liver, colorectal, pancreatic, prostatic, and ovarian cancers",
                    "sub_points": [
                      "Overexpression is well-known contributor to oncogenesis of breast cancers",
                      "HER2overexpression is important to determine because targeted therapy is available (trastuzumab)",
                      "HER2overexpression has also been found in lung, liver, colorectal, pancreatic, prostatic, and ovarian cancers"
                    ]
                  }
                ],
                "G Proteins (Guanine Nucleotide Binding Proteins)": [
                  {
                    "text": "G proteins play important role in cell signaling via extracellular stimuliThey require hydrolysis of GTP for functioningThese signaling pathways are important in maintaining cell homeostasis and regulation of cell proliferation",
                    "sub_points": [
                      "They require hydrolysis of GTP for functioning",
                      "These signaling pathways are important in maintaining cell homeostasis and regulation of cell proliferation"
                    ]
                  },
                  {
                    "text": "Uncontrolled or excess signaling through this pathway can result in oncogenesis"
                  },
                  {
                    "text": "Mutations in downstream proteins can also lead to overexpression or constitutive signaling"
                  },
                  {
                    "text": "Additionally, mutations in regulatory proteins can lead to loss of function and loss of regulation of cell proliferation"
                  },
                  {
                    "text": "Ras-p21 proteinSingle-point mutations in this protein at glycine 12 or glutamine 61 result in constitutive activation of Jun kinase and constitutive signalingRas-p21 can also be overexpressed resulting in increased signalingThese alterations have been found in breast, pancreatic, prostate, lung, liver, and colon cancers, as well as angiosarcoma",
                    "sub_points": [
                      "Single-point mutations in this protein at glycine 12 or glutamine 61 result in constitutive activation of Jun kinase and constitutive signaling",
                      "Ras-p21 can also be overexpressed resulting in increased signaling",
                      "These alterations have been found in breast, pancreatic, prostate, lung, liver, and colon cancers, as well as angiosarcoma"
                    ]
                  }
                ],
                "Cytosolic Mitogenic Kinases": [
                  {
                    "text": "Raf: Downstream target of ras-p21; protein that normally activates MEK pathway (MAP kinase) and results in cell growth, proliferation, and differentiation"
                  },
                  {
                    "text": "Two forms existRaf A (A-raf)Raf B (B-raf)",
                    "sub_points": [
                      "Raf A (A-raf)",
                      "Raf B (B-raf)"
                    ]
                  },
                  {
                    "text": "More than 30 mutations have been isolated in Raf that play role in oncogenesis"
                  },
                  {
                    "text": "Overexpression of Raf has been found in HCC"
                  },
                  {
                    "text": "Mutations in B-raf have been found in colon, bladder, endometrial, and thyroid cancers, as well as melanoma (most commonly V600E mutation)"
                  },
                  {
                    "text": "Important to isolate this mutation in cancers because targeted therapy for V600E mutation is available (vemurafenib)"
                  }
                ],
                "Nuclear Oncoproteins": [
                  {
                    "text": "Two major nuclear proteins that regulate cell growth and proliferation are p53 and p62/75 (c-myc)"
                  },
                  {
                    "text": "p53Binds directly to DNA and regulates transcription during mitosisCan also be activated in cell by Bax and caspase, which induces apoptosisNormal role of p53 is antioncogenicMutations result in inactivation and disruption of its normal rolesLoss of regulation of transcriptLoss of apoptosisVarious point mutations have been isolated in certain cancers, including colon, ovarian, breast, lung, liver, and bladder",
                    "sub_points": [
                      "Binds directly to DNA and regulates transcription during mitosis",
                      "Can also be activated in cell by Bax and caspase, which induces apoptosis",
                      "Normal role of p53 is antioncogenic",
                      "Mutations result in inactivation and disruption of its normal rolesLoss of regulation of transcriptLoss of apoptosis",
                      "Loss of regulation of transcript",
                      "Loss of apoptosis",
                      "Various point mutations have been isolated in certain cancers, including colon, ovarian, breast, lung, liver, and bladder"
                    ]
                  },
                  {
                    "text": "c-myc (p62/75)Normally, c-myc is transcription factor that induces expression of various genes via MAPK/ERK pathwayMutations in c-myc lead to overexpressionCommon mechanism of c-myc overexpression is via translocationTranslocation of c-myc gene (Chr 8) to area that is constitutively expressed results in its constitutive expression by proxyMutations and translocations of c-myc are common in B-cell lymphomas, but may also be found in breast, colon, and ovarian cancers",
                    "sub_points": [
                      "Normally, c-myc is transcription factor that induces expression of various genes via MAPK/ERK pathway",
                      "Mutations in c-myc lead to overexpressionCommon mechanism of c-myc overexpression is via translocationTranslocation of c-myc gene (Chr 8) to area that is constitutively expressed results in its constitutive expression by proxy",
                      "Common mechanism of c-myc overexpression is via translocation",
                      "Translocation of c-myc gene (Chr 8) to area that is constitutively expressed results in its constitutive expression by proxy",
                      "Mutations and translocations of c-myc are common in B-cell lymphomas, but may also be found in breast, colon, and ovarian cancers"
                    ]
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "PCR amplification and sequencing (EGFRmutations)"
                  },
                  {
                    "text": "Next-generation sequencing"
                  },
                  {
                    "text": "Fluorescence in situ hybridization (ALK break-apart probe, Philadelphia Chr)"
                  },
                  {
                    "text": "Enzyme-linked immunosorbent assay (ELISA)"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Testing can be performed on tissue samples of tumor or on blood samples"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Assay Performance": {
            "name": "Assay Performance",
            "url": "https://app.pathprimer.com/document/1980102f-b03f-4816-b703-28bcc2f7b092/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Diagnosis": [
                  {
                    "text": "Most tumor markers are identified by immunometric immunoassays"
                  },
                  {
                    "text": "Technique usually involves double-determinant immunoassay in which a capture antibody in excess is bound to the plateUpon addition of patient serum sample, tumor marker of interest binds to the capture antibodyDetection antibody also binds to this complex and releases a chemiluminescent compound or an enzyme reaction that can be measured",
                    "sub_points": [
                      "Upon addition of patient serum sample, tumor marker of interest binds to the capture antibody",
                      "Detection antibody also binds to this complex and releases a chemiluminescent compound or an enzyme reaction that can be measured"
                    ]
                  },
                  {
                    "text": "As concentration of tumor marker increases, detection signal also increases"
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Background and Pathophysiology": [
                  {
                    "text": "Tumor marker: Compound found to be elevated in body fluids or tissues with presence of malignancyCan be produced by tumor itself, or by host as response to tumor",
                    "sub_points": [
                      "Can be produced by tumor itself, or by host as response to tumor"
                    ]
                  },
                  {
                    "text": "Tumor markers have multiple usesScreeningDiagnosis &/or confirmationTreatment monitoringOne of their more useful and successful applicationsStaging and prognosis",
                    "sub_points": [
                      "Screening",
                      "Diagnosis &/or confirmation",
                      "Treatment monitoringOne of their more useful and successful applications",
                      "One of their more useful and successful applications",
                      "Staging and prognosis"
                    ]
                  },
                  {
                    "text": "Monitoring level of an established tumor marker has proved helpful with surveillance of recurrence, remission, and complete surgical resection in cancer patients"
                  },
                  {
                    "text": "Tumor markers can be classified by association with the followingCell proliferationCell differentiationMetastasisMalignant transformationInherited mutationsOther tumor-associated events",
                    "sub_points": [
                      "Cell proliferation",
                      "Cell differentiation",
                      "Metastasis",
                      "Malignant transformation",
                      "Inherited mutations",
                      "Other tumor-associated events"
                    ]
                  },
                  {
                    "text": "Tumor markers are usually evaluated in serum and other body fluids"
                  },
                  {
                    "text": "Due to low sensitivity and specificity of many tumor markers, screening with these markers is challenging"
                  },
                  {
                    "text": "Compound may be elevated due to genetic aberration, resulting in overproduction of a certain marker or epigenetic modification"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Tumor marker of interest"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Most tumor markers are identified by immunometric immunoassays"
                  },
                  {
                    "text": "Technique usually involves double-determinant immunoassay in which a capture antibody in excess is bound to the plateUpon addition of patient serum sample, tumor marker of interest binds to the capture antibodyDetection antibody also binds to this complex and releases a chemiluminescent compound or an enzyme reaction that can be measuredAs concentration of tumor marker increases, detection signal also increases",
                    "sub_points": [
                      "Upon addition of patient serum sample, tumor marker of interest binds to the capture antibody",
                      "Detection antibody also binds to this complex and releases a chemiluminescent compound or an enzyme reaction that can be measured",
                      "As concentration of tumor marker increases, detection signal also increases"
                    ]
                  },
                  {
                    "text": "Competitive immunoassays are best used for detection of small analytes, while noncompetitive assays are best suited for large analytes"
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Patient serum is usually used for tumor marker testing"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Bence Jones Proteinuria": {
            "name": "Bence Jones Proteinuria",
            "url": "https://app.pathprimer.com/document/86b623b0-12cf-4638-a78f-aae5f5ed3e51/lesson/5715eeac-6071-414d-8b2d-ae60ba0b2fb8",
            "content": {
              "KEY CONCEPTS": {
                "Clinical Correlates": [
                  {
                    "text": "Defined as chronic renal excretion of monoclonal light chain immunoglobulins resulting in progressive renal damage and renal failure"
                  },
                  {
                    "text": "Associated with multiple myeloma, Waldenström macroglobulinemia, and lymphomas"
                  },
                  {
                    "text": "Excess protein excretion leads to kidney tubular damage, protein cast formation in urine, Tamm-Horsfall proteins, and nephrotic syndrome"
                  }
                ],
                "Laboratory Diagnosis": [
                  {
                    "text": "Current diagnostic methods for detection and quantificationSerum free light chain (SFLC) assayUrine protein electrophoresis (UPEP)Serum protein electrophoresis (SPEP)Immunofixation electrophoresis (IFE)",
                    "sub_points": [
                      "Serum free light chain (SFLC) assay",
                      "Urine protein electrophoresis (UPEP)",
                      "Serum protein electrophoresis (SPEP)",
                      "Immunofixation electrophoresis (IFE)"
                    ]
                  },
                  {
                    "text": "SFLC assayAllows for quantification of free kappa and lambda light chainsMore sensitive than UPEP",
                    "sub_points": [
                      "Allows for quantification of free kappa and lambda light chains",
                      "More sensitive than UPEP"
                    ]
                  }
                ]
              },
              "CLINICAL CORRELATES": {
                "Pathophysiology": [
                  {
                    "text": "Defined as chronic renal excretion of monoclonal light chain immunoglobulins resulting in progressive renal damage and renal failure"
                  },
                  {
                    "text": "Associated withMultiple myelomaWaldenström macroglobulinemiaLymphomas",
                    "sub_points": [
                      "Multiple myeloma",
                      "Waldenström macroglobulinemia",
                      "Lymphomas"
                    ]
                  },
                  {
                    "text": "Excess production of free light chains by malignant plasma cells increases light chain filtration into glomerulusIf filtration of light chains overwhelms ability to reabsorb light chains by tubular cells, this leads to excess excretion of monoclonal proteins",
                    "sub_points": [
                      "If filtration of light chains overwhelms ability to reabsorb light chains by tubular cells, this leads to excess excretion of monoclonal proteins"
                    ]
                  },
                  {
                    "text": "Amount of proteinuria directly proportional to burden of serum free light chains"
                  },
                  {
                    "text": "Excess protein excretion leads toKidney tubular damageProtein cast formation in urineTamm-Horsfall proteinsNephrotic syndrome",
                    "sub_points": [
                      "Kidney tubular damage",
                      "Protein cast formation in urine",
                      "Tamm-Horsfall proteins",
                      "Nephrotic syndrome"
                    ]
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Can occur in 80% of patients with myeloma"
                  }
                ],
                "Classic Clinical Findings": [
                  {
                    "text": "Patients present with typical constellation of myeloma signs and symptomsCRAB: Calcium, Renal (creatinine), Anemia (hemoglobin), and Bone lesions",
                    "sub_points": [
                      "CRAB: Calcium, Renal (creatinine), Anemia (hemoglobin), and Bone lesions"
                    ]
                  },
                  {
                    "text": "Urine dipstick testing negative (light chains not detected by dipstick)"
                  },
                  {
                    "text": "Ultrasound of kidney usually normal"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients with undiagnosed or untreated myeloma progress to renal failure in 6 months"
                  }
                ]
              },
              "LABORATORY DIAGNOSIS": {
                "Laboratory Analytes": [
                  {
                    "text": "Free light chains in urine"
                  }
                ],
                "Analytic Techniques": [
                  {
                    "text": "Current diagnostic methods for detection and quantificationSerum free light chain (SFLC) assayUrine protein electrophoresis (UPEP)Serum protein electrophoresis (SPEP)Immunofixation electrophoresis (IFE)",
                    "sub_points": [
                      "Serum free light chain (SFLC) assay",
                      "Urine protein electrophoresis (UPEP)",
                      "Serum protein electrophoresis (SPEP)",
                      "Immunofixation electrophoresis (IFE)"
                    ]
                  },
                  {
                    "text": "SFLC assayAllows for quantification of free kappa and lambda light chainsMore sensitive method than UPEP",
                    "sub_points": [
                      "Allows for quantification of free kappa and lambda light chains",
                      "More sensitive method than UPEP"
                    ]
                  }
                ],
                "Specimen Collection": [
                  {
                    "text": "Urine for protein (24-hour collection)"
                  }
                ],
                "Reference Intervals": [
                  {
                    "text": "Normal light chain excretion < 30 mg/d"
                  },
                  {
                    "text": "In multiple myeloma, patient can excrete 100 mg/d"
                  }
                ],
                "Microscopy": [
                  {
                    "text": "Microscopic evaluation of urine may reveal granular casts"
                  },
                  {
                    "text": "Evaluation of bone marrow may reveal increased clusters of plasma cells (> 10%)"
                  },
                  {
                    "text": "Evaluation of kidney may reveal acute tubular injury with cast formation within tubules"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}